id	sid	tid	token	lemma	pos
aji-161	1	1	_	_	PUNCT
aji-161	2	1	_	_	PUNCT
aji-161	3	1	_	_	PUNCT
aji-161	4	1	_	_	PUNCT
aji-161	5	1	_	_	PUNCT
aji-161	6	1	_	_	PUNCT
aji-161	7	1	_	_	PUNCT
aji-161	8	1	_	_	PUNCT
aji-161	9	1	_	_	PUNCT
aji-161	10	1	_	_	PUNCT
aji-161	11	1	_	_	PUNCT
aji-161	12	1	_	_	PUNCT
aji-161	13	1	_	_	PUNCT
aji-161	14	1	_	_	PUNCT
aji-161	15	1	_	_	PUNCT
aji-161	16	1	_	_	PUNCT
aji-161	17	1	_	_	PUNCT
aji-161	18	1	_	_	PUNCT
aji-161	19	1	_	_	PUNCT
aji-161	20	1	_	_	PUNCT
aji-161	21	1	_	_	PUNCT
aji-161	22	1	_	_	PUNCT
aji-161	23	1	_	_	PUNCT
aji-161	24	1	_	_	PUNCT
aji-161	25	1	_	_	PUNCT
aji-161	26	1	_	_	PUNCT
aji-161	27	1	_	_	PUNCT
aji-161	28	1	_	_	PUNCT
aji-161	29	1	_	_	PUNCT
aji-161	30	1	_	_	PUNCT
aji-161	31	1	_	_	PUNCT
aji-161	32	1	_	_	PUNCT
aji-161	33	1	_	_	PUNCT
aji-161	34	1	_	_	PUNCT
aji-161	35	1	_	_	PUNCT
aji-161	36	1	_	_	PUNCT
aji-161	37	1	_	_	PUNCT
aji-161	38	1	_	_	PUNCT
aji-161	39	1	_	_	PUNCT
aji-161	40	1	_	_	PUNCT
aji-161	41	1	_	_	PUNCT
aji-161	42	1	_	_	PUNCT
aji-161	43	1	_	_	PUNCT
aji-161	44	1	_	_	PUNCT
aji-161	45	1	_	_	PUNCT
aji-161	46	1	_	_	PUNCT
aji-161	47	1	_	_	PUNCT
aji-161	48	1	_	_	PUNCT
aji-161	49	1	_	_	PUNCT
aji-161	50	1	_	_	PUNCT
aji-161	51	1	_	_	PUNCT
aji-161	52	1	_	_	PUNCT
aji-161	53	1	_	_	PUNCT
aji-161	54	1	_	_	PUNCT
aji-161	55	1	_	_	PUNCT
aji-161	56	1	_	_	PUNCT
aji-161	57	1	_	_	PUNCT
aji-161	58	1	_	_	PUNCT
aji-161	59	1	_	_	PUNCT
aji-161	60	1	_	_	PUNCT
aji-161	61	1	_	_	PUNCT
aji-161	62	1	_	_	PUNCT
aji-161	63	1	_	_	PUNCT
aji-161	64	1	_	_	PUNCT
aji-161	65	1	_	_	PUNCT
aji-161	66	1	_	_	PUNCT
aji-161	67	1	_	_	PUNCT
aji-161	68	1	_	_	PUNCT
aji-161	69	1	_	_	PUNCT
aji-161	70	1	_	_	PUNCT
aji-161	71	1	_	_	PUNCT
aji-161	72	1	_	_	PUNCT
aji-161	73	1	_	_	PUNCT
aji-161	74	1	_	_	PUNCT
aji-161	75	1	_	_	PUNCT
aji-161	76	1	_	_	PUNCT
aji-161	77	1	_	_	PUNCT
aji-161	78	1	_	_	PUNCT
aji-161	79	1	_	_	PUNCT
aji-161	80	1	_	_	PUNCT
aji-161	81	1	_	_	PUNCT
aji-161	82	1	_	_	PUNCT
aji-161	83	1	_	_	PUNCT
aji-161	84	1	_	_	PUNCT
aji-161	85	1	_	_	PUNCT
aji-161	86	1	_	_	PUNCT
aji-161	87	1	_	_	PUNCT
aji-161	88	1	_	_	PUNCT
aji-161	89	1	_	_	PUNCT
aji-161	90	1	_	_	PUNCT
aji-161	91	1	_	_	PUNCT
aji-161	92	1	_	_	PUNCT
aji-161	93	1	_	_	PUNCT
aji-161	94	1	_	_	PUNCT
aji-161	95	1	_	_	PUNCT
aji-161	96	1	_	_	PUNCT
aji-161	97	1	_	_	PUNCT
aji-161	98	1	_	_	PUNCT
aji-161	99	1	_	_	PUNCT
aji-161	100	1	_	_	PUNCT
aji-161	101	1	_	_	PUNCT
aji-161	102	1	*	*	PUNCT
aji-161	102	2	corresponding	correspond	VERB
aji-161	102	3	author	author	NOUN
aji-161	102	4	:	:	PUNCT
aji-161	102	5	e	e	NOUN
aji-161	102	6	-	-	NOUN
aji-161	102	7	mail	mail	NOUN
aji-161	102	8	:	:	PUNCT
aji-161	102	9	celso@alergoimuno.med.br	celso@alergoimuno.med.br	ADJ
aji-161	102	10	;	;	PUNCT
aji-161	102	11	cite	cite	VERB
aji-161	102	12	as	as	ADP
aji-161	102	13	:	:	PUNCT
aji-161	102	14	olivier	olivier	PROPN
aji-161	102	15	,	,	PUNCT
aji-161	102	16	celso	celso	PROPN
aji-161	102	17	eduardo	eduardo	PROPN
aji-161	102	18	,	,	PUNCT
aji-161	102	19	daiana	daiana	PROPN
aji-161	102	20	guedes	guedes	PROPN
aji-161	102	21	pinto	pinto	PROPN
aji-161	102	22	,	,	PUNCT
aji-161	102	23	ana	ana	PROPN
aji-161	102	24	paula	paula	PROPN
aji-161	102	25	monezzi	monezzi	PROPN
aji-161	102	26	teixeira	teixeira	PROPN
aji-161	102	27	,	,	PUNCT
aji-161	102	28	cibele	cibele	PROPN
aji-161	102	29	silva	silva	PROPN
aji-161	102	30	miguel	miguel	PROPN
aji-161	102	31	,	,	PUNCT
aji-161	102	32	jhéssica	jhéssica	PROPN
aji-161	102	33	letícia	letícia	PROPN
aji-161	102	34	santos	santos	PROPN
aji-161	102	35	santana	santana	PROPN
aji-161	102	36	,	,	PUNCT
aji-161	102	37	regiane	regiane	VERB
aji-161	102	38	patussi	patussi	PROPN
aji-161	102	39	santos	santos	PROPN
aji-161	102	40	lima	lima	PROPN
aji-161	102	41	,	,	PUNCT
aji-161	102	42	nicole	nicole	PROPN
aji-161	102	43	sartoreto	sartoreto	PROPN
aji-161	102	44	rocha	rocha	PROPN
aji-161	102	45	,	,	PUNCT
aji-161	102	46	and	and	CCONJ
aji-161	102	47	raquel	raquel	NOUN
aji-161	102	48	acácia	acácia	PROPN
aji-161	102	49	pereira	pereira	PROPN
aji-161	102	50	gonçalves	gonçalves	PROPN
aji-161	102	51	santos	santos	PROPN
aji-161	102	52	.	.	PUNCT
aji-161	103	1	2025	2025	NUM
aji-161	103	2	.	.	PUNCT
aji-161	104	1	“	"	PUNCT
aji-161	104	2	endotyping	endotype	VERB
aji-161	104	3	cellular	cellular	ADJ
aji-161	104	4	and	and	CCONJ
aji-161	104	5	humoral	humoral	ADJ
aji-161	104	6	immunoreactivity	immunoreactivity	NOUN
aji-161	104	7	against	against	ADP
aji-161	104	8	formaldehyde	formaldehyde	NOUN
aji-161	104	9	in	in	ADP
aji-161	104	10	patients	patient	NOUN
aji-161	104	11	with	with	ADP
aji-161	104	12	atopic	atopic	NOUN
aji-161	104	13	and/or	and/or	CCONJ
aji-161	104	14	contact	contact	NOUN
aji-161	104	15	dermatitis	dermatitis	NOUN
aji-161	104	16	”	"	PUNCT
aji-161	104	17	.	.	PUNCT
aji-161	105	1	asian	asian	ADJ
aji-161	105	2	journal	journal	NOUN
aji-161	105	3	of	of	ADP
aji-161	105	4	immunology	immunology	NOUN
aji-161	105	5	8	8	NUM
aji-161	105	6	(	(	PUNCT
aji-161	105	7	1):70	1):70	NUM
aji-161	105	8	-	-	SYM
aji-161	105	9	81	81	NUM
aji-161	105	10	.	.	PUNCT
aji-161	106	1	https://doi.org/10.9734/aji/2025/v8i1161	https://doi.org/10.9734/aji/2025/v8i1161	PROPN
aji-161	106	2	.	.	PUNCT
aji-161	106	3	asian	asian	ADJ
aji-161	106	4	journal	journal	NOUN
aji-161	106	5	of	of	ADP
aji-161	106	6	immunology	immunology	NOUN
aji-161	106	7	volume	volume	NOUN
aji-161	106	8	8	8	NUM
aji-161	106	9	,	,	PUNCT
aji-161	106	10	issue	issue	NOUN
aji-161	106	11	1	1	NUM
aji-161	106	12	,	,	PUNCT
aji-161	106	13	page	page	NOUN
aji-161	106	14	70	70	NUM
aji-161	106	15	-	-	SYM
aji-161	106	16	81	81	NUM
aji-161	106	17	,	,	PUNCT
aji-161	106	18	2025	2025	NUM
aji-161	106	19	;	;	PUNCT
aji-161	106	20	article	article	NOUN
aji-161	106	21	no.aji.134825	no.aji.134825	PROPN
aji-161	106	22	endotyping	endotype	VERB
aji-161	106	23	cellular	cellular	ADJ
aji-161	106	24	and	and	CCONJ
aji-161	106	25	humoral	humoral	ADJ
aji-161	106	26	immunoreactivity	immunoreactivity	NOUN
aji-161	106	27	against	against	ADP
aji-161	106	28	formaldehyde	formaldehyde	NOUN
aji-161	106	29	in	in	ADP
aji-161	106	30	patients	patient	NOUN
aji-161	106	31	with	with	ADP
aji-161	106	32	atopic	atopic	NOUN
aji-161	106	33	and/or	and/or	CCONJ
aji-161	106	34	contact	contact	NOUN
aji-161	106	35	dermatitis	dermatitis	PROPN
aji-161	106	36	celso	celso	PROPN
aji-161	106	37	eduardo	eduardo	PROPN
aji-161	106	38	olivier	olivier	PROPN
aji-161	106	39	a	a	PROPN
aji-161	106	40	*	*	PROPN
aji-161	106	41	,	,	PUNCT
aji-161	106	42	daiana	daiana	PROPN
aji-161	106	43	guedes	guede	VERB
aji-161	106	44	pinto	pinto	NOUN
aji-161	106	45	a	a	PRON
aji-161	106	46	,	,	PUNCT
aji-161	106	47	ana	ana	PROPN
aji-161	106	48	paula	paula	PROPN
aji-161	106	49	monezzi	monezzi	PROPN
aji-161	106	50	teixeira	teixeira	PROPN
aji-161	106	51	a	a	PROPN
aji-161	106	52	,	,	PUNCT
aji-161	106	53	cibele	cibele	PROPN
aji-161	106	54	silva	silva	PROPN
aji-161	106	55	miguel	miguel	PROPN
aji-161	106	56	a	a	PROPN
aji-161	106	57	,	,	PUNCT
aji-161	106	58	jhéssica	jhéssica	PROPN
aji-161	106	59	letícia	letícia	PROPN
aji-161	106	60	santos	santo	VERB
aji-161	106	61	santana	santana	PROPN
aji-161	106	62	b	b	PROPN
aji-161	106	63	,	,	PUNCT
aji-161	106	64	regiane	regiane	VERB
aji-161	106	65	patussi	patussi	PROPN
aji-161	106	66	santos	santos	PROPN
aji-161	106	67	lima	lima	PROPN
aji-161	106	68	c	c	PROPN
aji-161	106	69	,	,	PUNCT
aji-161	106	70	nicole	nicole	PROPN
aji-161	106	71	sartoreto	sartoreto	PROPN
aji-161	106	72	rocha	rocha	PROPN
aji-161	106	73	d	d	PROPN
aji-161	106	74	and	and	CCONJ
aji-161	106	75	raquel	raquel	PROPN
aji-161	106	76	acácia	acácia	PROPN
aji-161	106	77	pereira	pereira	PROPN
aji-161	106	78	gonçalves	gonçalves	PROPN
aji-161	106	79	santos	santo	VERB
aji-161	106	80	a	a	DET
aji-161	106	81	a	a	DET
aji-161	106	82	instituto	instituto	PROPN
aji-161	106	83	alergoimuno	alergoimuno	PROPN
aji-161	106	84	de	de	X
aji-161	106	85	americana	americana	PROPN
aji-161	106	86	,	,	PUNCT
aji-161	106	87	brazil	brazil	PROPN
aji-161	106	88	.	.	PUNCT
aji-161	107	1	b	b	PROPN
aji-161	107	2	instituto	instituto	PROPN
aji-161	107	3	de	de	PROPN
aji-161	107	4	ensino	ensino	PROPN
aji-161	107	5	e	e	PROPN
aji-161	107	6	pesquisa	pesquisa	NOUN
aji-161	107	7	do	do	VERB
aji-161	107	8	hospital	hospital	NOUN
aji-161	107	9	de	de	X
aji-161	107	10	amor	amor	PROPN
aji-161	107	11	de	de	X
aji-161	107	12	barretos	barretos	PROPN
aji-161	107	13	,	,	PUNCT
aji-161	107	14	brazil	brazil	PROPN
aji-161	107	15	.	.	PUNCT
aji-161	108	1	c	c	PROPN
aji-161	108	2	lavoisier	lavoisier	PROPN
aji-161	108	3	laboratórios	laboratórios	PROPN
aji-161	108	4	,	,	PUNCT
aji-161	108	5	são	são	PROPN
aji-161	108	6	paulo	paulo	PROPN
aji-161	108	7	,	,	PUNCT
aji-161	108	8	brazil	brazil	PROPN
aji-161	108	9	.	.	PUNCT
aji-161	109	1	d	d	PROPN
aji-161	109	2	faculdade	faculdade	PROPN
aji-161	109	3	de	de	X
aji-161	109	4	americana	americana	PROPN
aji-161	109	5	,	,	PUNCT
aji-161	109	6	são	são	PROPN
aji-161	109	7	paulo	paulo	PROPN
aji-161	109	8	,	,	PUNCT
aji-161	109	9	brazil	brazil	PROPN
aji-161	109	10	.	.	PUNCT
aji-161	110	1	authors	author	NOUN
aji-161	110	2	’	’	PART
aji-161	110	3	contributions	contribution	NOUN
aji-161	110	4	this	this	DET
aji-161	110	5	work	work	NOUN
aji-161	110	6	was	be	AUX
aji-161	110	7	carried	carry	VERB
aji-161	110	8	out	out	ADP
aji-161	110	9	in	in	ADP
aji-161	110	10	collaboration	collaboration	NOUN
aji-161	110	11	among	among	ADP
aji-161	110	12	all	all	DET
aji-161	110	13	authors	author	NOUN
aji-161	110	14	.	.	PUNCT
aji-161	111	1	author	author	NOUN
aji-161	111	2	ceo	ceo	PROPN
aji-161	111	3	conceptualized	conceptualize	VERB
aji-161	111	4	the	the	DET
aji-161	111	5	study	study	NOUN
aji-161	111	6	,	,	PUNCT
aji-161	111	7	did	do	VERB
aji-161	111	8	data	data	NOUN
aji-161	111	9	curation	curation	NOUN
aji-161	111	10	,	,	PUNCT
aji-161	111	11	formal	formal	ADJ
aji-161	111	12	analysis	analysis	NOUN
aji-161	111	13	,	,	PUNCT
aji-161	111	14	literature	literature	NOUN
aji-161	111	15	review	review	NOUN
aji-161	111	16	,	,	PUNCT
aji-161	111	17	and	and	CCONJ
aji-161	111	18	wrote	write	VERB
aji-161	111	19	the	the	DET
aji-161	111	20	original	original	ADJ
aji-161	111	21	draft	draft	NOUN
aji-161	111	22	.	.	PUNCT
aji-161	112	1	authors	author	NOUN
aji-161	112	2	dgp	dgp	PROPN
aji-161	112	3	,	,	PUNCT
aji-161	112	4	apmt	apmt	PROPN
aji-161	112	5	,	,	PUNCT
aji-161	112	6	csm	csm	PROPN
aji-161	112	7	,	,	PUNCT
aji-161	112	8	nsr	nsr	PROPN
aji-161	112	9	,	,	PUNCT
aji-161	112	10	jlss	jlss	PROPN
aji-161	112	11	and	and	CCONJ
aji-161	112	12	rpsl	rpsl	NOUN
aji-161	112	13	performed	perform	VERB
aji-161	112	14	the	the	DET
aji-161	112	15	laboratory	laboratory	NOUN
aji-161	112	16	procedures	procedure	NOUN
aji-161	112	17	.	.	PUNCT
aji-161	113	1	author	author	NOUN
aji-161	113	2	rapgs	rapgs	PROPN
aji-161	113	3	performed	perform	VERB
aji-161	113	4	the	the	DET
aji-161	113	5	cutaneous	cutaneous	ADJ
aji-161	113	6	tests	test	NOUN
aji-161	113	7	.	.	PUNCT
aji-161	114	1	all	all	DET
aji-161	114	2	authors	author	NOUN
aji-161	114	3	read	read	VERB
aji-161	114	4	and	and	CCONJ
aji-161	114	5	approved	approve	VERB
aji-161	114	6	the	the	DET
aji-161	114	7	final	final	ADJ
aji-161	114	8	manuscript	manuscript	NOUN
aji-161	114	9	.	.	PUNCT
aji-161	115	1	article	article	NOUN
aji-161	115	2	information	information	PROPN
aji-161	115	3	doi	doi	PROPN
aji-161	115	4	:	:	PUNCT
aji-161	115	5	https://doi.org/10.9734/aji/2025/v8i1161	https://doi.org/10.9734/aji/2025/v8i1161	ADJ
aji-161	115	6	open	open	ADJ
aji-161	115	7	peer	peer	NOUN
aji-161	115	8	review	review	NOUN
aji-161	115	9	history	history	NOUN
aji-161	115	10	:	:	PUNCT
aji-161	115	11	this	this	DET
aji-161	115	12	journal	journal	NOUN
aji-161	115	13	follows	follow	VERB
aji-161	115	14	the	the	DET
aji-161	115	15	advanced	advance	VERB
aji-161	115	16	open	open	ADJ
aji-161	115	17	peer	peer	NOUN
aji-161	115	18	review	review	NOUN
aji-161	115	19	policy	policy	NOUN
aji-161	115	20	.	.	PUNCT
aji-161	116	1	identity	identity	NOUN
aji-161	116	2	of	of	ADP
aji-161	116	3	the	the	DET
aji-161	116	4	reviewers	reviewer	NOUN
aji-161	116	5	,	,	PUNCT
aji-161	116	6	editor(s	editor(s	NOUN
aji-161	116	7	)	)	PUNCT
aji-161	116	8	and	and	CCONJ
aji-161	116	9	additional	additional	ADJ
aji-161	116	10	reviewers	reviewer	NOUN
aji-161	116	11	,	,	PUNCT
aji-161	116	12	peer	peer	NOUN
aji-161	116	13	review	review	NOUN
aji-161	116	14	comments	comment	NOUN
aji-161	116	15	,	,	PUNCT
aji-161	116	16	different	different	ADJ
aji-161	116	17	versions	version	NOUN
aji-161	116	18	of	of	ADP
aji-161	116	19	the	the	DET
aji-161	116	20	manuscript	manuscript	NOUN
aji-161	116	21	,	,	PUNCT
aji-161	116	22	comments	comment	NOUN
aji-161	116	23	of	of	ADP
aji-161	116	24	the	the	DET
aji-161	116	25	editors	editor	NOUN
aji-161	116	26	,	,	PUNCT
aji-161	116	27	etc	etc	X
aji-161	116	28	are	be	AUX
aji-161	116	29	available	available	ADJ
aji-161	116	30	here	here	ADV
aji-161	116	31	:	:	PUNCT
aji-161	116	32	https://pr.sdiarticle5.com/review-history/134825	https://pr.sdiarticle5.com/review-history/134825	PROPN
aji-161	116	33	received	receive	VERB
aji-161	116	34	:	:	PUNCT
aji-161	116	35	19/02/2025	19/02/2025	NUM
aji-161	116	36	published	publish	VERB
aji-161	116	37	:	:	PUNCT
aji-161	116	38	25/04/2025	25/04/2025	NUM
aji-161	116	39	original	original	ADJ
aji-161	116	40	research	research	NOUN
aji-161	116	41	article	article	NOUN
aji-161	116	42	https://doi.org/10.9734/aji/2025/v8i1161	https://doi.org/10.9734/aji/2025/v8i1161	ADJ
aji-161	116	43	https://pr.sdiarticle5.com/review-history/134825	https://pr.sdiarticle5.com/review-history/134825	PROPN
aji-161	116	44	olivier	olivier	NOUN
aji-161	116	45	et	et	PROPN
aji-161	116	46	al	al	PROPN
aji-161	116	47	.	.	PROPN
aji-161	116	48	;	;	PUNCT
aji-161	116	49	asian	asian	PROPN
aji-161	116	50	j.	j.	PROPN
aji-161	116	51	immunol	immunol	PROPN
aji-161	116	52	.	.	PROPN
aji-161	116	53	,	,	PUNCT
aji-161	116	54	vol	vol	NOUN
aji-161	116	55	.	.	PROPN
aji-161	116	56	8	8	NUM
aji-161	116	57	,	,	PUNCT
aji-161	116	58	no	no	INTJ
aji-161	116	59	.	.	NOUN
aji-161	116	60	1	1	NUM
aji-161	116	61	,	,	PUNCT
aji-161	116	62	pp	pp	ADJ
aji-161	116	63	.	.	PUNCT
aji-161	117	1	70	70	NUM
aji-161	117	2	-	-	SYM
aji-161	117	3	81	81	NUM
aji-161	117	4	,	,	PUNCT
aji-161	117	5	2025	2025	NUM
aji-161	117	6	;	;	PUNCT
aji-161	117	7	article	article	NOUN
aji-161	117	8	no.aji.134825	no.aji.134825	VERB
aji-161	117	9	71	71	NUM
aji-161	117	10	abstract	abstract	ADJ
aji-161	117	11	background	background	NOUN
aji-161	117	12	:	:	PUNCT
aji-161	117	13	several	several	ADJ
aji-161	117	14	publications	publication	NOUN
aji-161	117	15	report	report	VERB
aji-161	117	16	that	that	SCONJ
aji-161	117	17	formaldehyde	formaldehyde	NOUN
aji-161	117	18	is	be	AUX
aji-161	117	19	responsible	responsible	ADJ
aji-161	117	20	for	for	ADP
aji-161	117	21	hypersensitivity	hypersensitivity	NOUN
aji-161	117	22	reactions	reaction	NOUN
aji-161	117	23	in	in	ADP
aji-161	117	24	patients	patient	NOUN
aji-161	117	25	with	with	ADP
aji-161	117	26	contact	contact	NOUN
aji-161	117	27	dermatitis	dermatitis	NOUN
aji-161	117	28	,	,	PUNCT
aji-161	117	29	as	as	SCONJ
aji-161	117	30	diagnosed	diagnose	VERB
aji-161	117	31	by	by	ADP
aji-161	117	32	"	"	PUNCT
aji-161	117	33	in	in	ADP
aji-161	117	34	vivo	vivo	NOUN
aji-161	117	35	"	"	PUNCT
aji-161	117	36	provocation	provocation	NOUN
aji-161	117	37	tests	test	NOUN
aji-161	117	38	.	.	PUNCT
aji-161	118	1	there	there	PRON
aji-161	118	2	is	be	VERB
aji-161	118	3	no	no	DET
aji-161	118	4	standardized	standardized	ADJ
aji-161	118	5	lab	lab	NOUN
aji-161	118	6	exam	exam	NOUN
aji-161	118	7	that	that	PRON
aji-161	118	8	can	can	AUX
aji-161	118	9	endotype	endotype	VERB
aji-161	118	10	the	the	DET
aji-161	118	11	mechanisms	mechanism	NOUN
aji-161	118	12	responsible	responsible	ADJ
aji-161	118	13	for	for	ADP
aji-161	118	14	these	these	DET
aji-161	118	15	phenotypes	phenotype	NOUN
aji-161	118	16	,	,	PUNCT
aji-161	118	17	aim	aim	VERB
aji-161	118	18	:	:	PUNCT
aji-161	118	19	to	to	PART
aji-161	118	20	evaluate	evaluate	VERB
aji-161	118	21	the	the	DET
aji-161	118	22	potential	potential	NOUN
aji-161	118	23	of	of	ADP
aji-161	118	24	the	the	DET
aji-161	118	25	tube	tube	NOUN
aji-161	118	26	titration	titration	NOUN
aji-161	118	27	of	of	ADP
aji-161	118	28	precipitins	precipitin	NOUN
aji-161	118	29	(	(	PUNCT
aji-161	118	30	ttp	ttp	NOUN
aji-161	118	31	)	)	PUNCT
aji-161	118	32	and	and	CCONJ
aji-161	118	33	the	the	DET
aji-161	118	34	leukocyte	leukocyte	NOUN
aji-161	118	35	adherence	adherence	NOUN
aji-161	118	36	inhibition	inhibition	NOUN
aji-161	118	37	test	test	NOUN
aji-161	118	38	(	(	PUNCT
aji-161	118	39	lait	lait	NOUN
aji-161	118	40	)	)	PUNCT
aji-161	118	41	to	to	PART
aji-161	118	42	discriminate	discriminate	VERB
aji-161	118	43	and	and	CCONJ
aji-161	118	44	endotype	endotype	VERB
aji-161	118	45	cellular	cellular	ADJ
aji-161	118	46	and	and	CCONJ
aji-161	118	47	humoral	humoral	ADJ
aji-161	118	48	immunoreactivity	immunoreactivity	NOUN
aji-161	118	49	against	against	ADP
aji-161	118	50	formaldehyde	formaldehyde	NOUN
aji-161	118	51	in	in	ADP
aji-161	118	52	patients	patient	NOUN
aji-161	118	53	with	with	ADP
aji-161	118	54	contact	contact	NOUN
aji-161	118	55	dermatitis	dermatitis	NOUN
aji-161	118	56	.	.	PUNCT
aji-161	119	1	methods	method	NOUN
aji-161	119	2	:	:	PUNCT
aji-161	119	3	we	we	PRON
aji-161	119	4	retrospectively	retrospectively	ADV
aji-161	119	5	examined	examine	VERB
aji-161	119	6	the	the	DET
aji-161	119	7	medical	medical	ADJ
aji-161	119	8	charts	chart	NOUN
aji-161	119	9	of	of	ADP
aji-161	119	10	two	two	NUM
aji-161	119	11	cohorts	cohort	NOUN
aji-161	119	12	(	(	PUNCT
aji-161	119	13	n	n	NOUN
aji-161	119	14	=	=	SYM
aji-161	119	15	100	100	NUM
aji-161	119	16	,	,	PUNCT
aji-161	119	17	each	each	PRON
aji-161	119	18	)	)	PUNCT
aji-161	119	19	of	of	ADP
aji-161	119	20	patients	patient	NOUN
aji-161	119	21	diagnosed	diagnose	VERB
aji-161	119	22	with	with	ADP
aji-161	119	23	atopic	atopic	NOUN
aji-161	119	24	dermatitis	dermatitis	NOUN
aji-161	119	25	and/or	and/or	CCONJ
aji-161	119	26	contact	contact	NOUN
aji-161	119	27	dermatitis	dermatitis	NOUN
aji-161	119	28	with	with	ADP
aji-161	119	29	clinical	clinical	ADJ
aji-161	119	30	suspicion	suspicion	NOUN
aji-161	119	31	of	of	ADP
aji-161	119	32	formaldehyde	formaldehyde	NOUN
aji-161	119	33	hypersensitivity	hypersensitivity	NOUN
aji-161	119	34	,	,	PUNCT
aji-161	119	35	who	who	PRON
aji-161	119	36	were	be	AUX
aji-161	119	37	investigated	investigate	VERB
aji-161	119	38	with	with	ADP
aji-161	119	39	the	the	DET
aji-161	119	40	help	help	NOUN
aji-161	119	41	of	of	ADP
aji-161	119	42	ttp	ttp	PROPN
aji-161	119	43	or	or	CCONJ
aji-161	119	44	ex	ex	PRON
aji-161	119	45	vivo	vivo	NOUN
aji-161	119	46	challenge	challenge	NOUN
aji-161	119	47	tests	test	NOUN
aji-161	119	48	monitored	monitor	VERB
aji-161	119	49	by	by	ADP
aji-161	119	50	lait	lait	NOUN
aji-161	119	51	against	against	ADP
aji-161	119	52	formaldehyde	formaldehyde	NOUN
aji-161	119	53	.	.	PUNCT
aji-161	120	1	the	the	DET
aji-161	120	2	registered	register	VERB
aji-161	120	3	results	result	NOUN
aji-161	120	4	were	be	AUX
aji-161	120	5	distributed	distribute	VERB
aji-161	120	6	in	in	ADP
aji-161	120	7	ranges	range	NOUN
aji-161	120	8	through	through	ADP
aji-161	120	9	cascade	cascade	NOUN
aji-161	120	10	distribution	distribution	NOUN
aji-161	120	11	charts	chart	NOUN
aji-161	120	12	.	.	PUNCT
aji-161	121	1	the	the	DET
aji-161	121	2	statistical	statistical	ADJ
aji-161	121	3	characteristics	characteristic	NOUN
aji-161	121	4	of	of	ADP
aji-161	121	5	these	these	DET
aji-161	121	6	cohorts	cohort	NOUN
aji-161	121	7	were	be	AUX
aji-161	121	8	calculated	calculate	VERB
aji-161	121	9	.	.	PUNCT
aji-161	122	1	results	result	NOUN
aji-161	122	2	:	:	PUNCT
aji-161	122	3	ttp	ttp	PROPN
aji-161	122	4	showed	show	VERB
aji-161	122	5	a	a	DET
aji-161	122	6	distribution	distribution	NOUN
aji-161	122	7	concentrated	concentrate	VERB
aji-161	122	8	over	over	ADP
aji-161	122	9	the	the	DET
aji-161	122	10	more	more	ADV
aji-161	122	11	diluted	diluted	ADJ
aji-161	122	12	titrations	titration	NOUN
aji-161	122	13	with	with	ADP
aji-161	122	14	no	no	DET
aji-161	122	15	negative	negative	ADJ
aji-161	122	16	result	result	NOUN
aji-161	122	17	.	.	PUNCT
aji-161	123	1	the	the	DET
aji-161	123	2	mean	mean	NOUN
aji-161	123	3	was	be	AUX
aji-161	123	4	estimated	estimate	VERB
aji-161	123	5	at	at	ADP
aji-161	123	6	1:385	1:385	NUM
aji-161	123	7	;	;	PUNCT
aji-161	123	8	the	the	DET
aji-161	123	9	median	median	NOUN
aji-161	123	10	at	at	ADP
aji-161	123	11	1:512	1:512	NUM
aji-161	123	12	;	;	PUNCT
aji-161	123	13	and	and	CCONJ
aji-161	123	14	the	the	DET
aji-161	123	15	standard	standard	ADJ
aji-161	123	16	deviation	deviation	NOUN
aji-161	123	17	at	at	ADP
aji-161	123	18	1:166	1:166	NUM
aji-161	123	19	.	.	PUNCT
aji-161	124	1	the	the	DET
aji-161	124	2	lait	lait	PROPN
aji-161	124	3	results	result	NOUN
aji-161	124	4	demonstrated	demonstrate	VERB
aji-161	124	5	a	a	DET
aji-161	124	6	wide	wide	ADJ
aji-161	124	7	range	range	NOUN
aji-161	124	8	.	.	PUNCT
aji-161	125	1	the	the	DET
aji-161	125	2	lai	lai	PROPN
aji-161	125	3	ranged	range	VERB
aji-161	125	4	from	from	ADP
aji-161	125	5	0	0	NUM
aji-161	125	6	%	%	NOUN
aji-161	125	7	to	to	PART
aji-161	125	8	100	100	NUM
aji-161	125	9	%	%	NOUN
aji-161	125	10	.	.	PUNCT
aji-161	126	1	the	the	DET
aji-161	126	2	mean	mean	NOUN
aji-161	126	3	was	be	AUX
aji-161	126	4	57.5	57.5	NUM
aji-161	126	5	%	%	NOUN
aji-161	126	6	;	;	PUNCT
aji-161	126	7	the	the	DET
aji-161	126	8	median	median	NOUN
aji-161	126	9	was	be	AUX
aji-161	126	10	65.5	65.5	NUM
aji-161	126	11	%	%	NOUN
aji-161	126	12	;	;	PUNCT
aji-161	126	13	the	the	DET
aji-161	126	14	standard	standard	ADJ
aji-161	126	15	deviation	deviation	NOUN
aji-161	126	16	was	be	AUX
aji-161	126	17	37.4	37.4	NUM
aji-161	126	18	%	%	NOUN
aji-161	126	19	.	.	PUNCT
aji-161	127	1	conclusion	conclusion	NOUN
aji-161	127	2	:	:	PUNCT
aji-161	127	3	our	our	PRON
aji-161	127	4	preliminary	preliminary	ADJ
aji-161	127	5	results	result	NOUN
aji-161	127	6	support	support	VERB
aji-161	127	7	that	that	SCONJ
aji-161	127	8	the	the	DET
aji-161	127	9	ttp	ttp	NOUN
aji-161	127	10	and	and	CCONJ
aji-161	127	11	lait	lait	NOUN
aji-161	127	12	performed	perform	VERB
aji-161	127	13	with	with	ADP
aji-161	127	14	formaldehyde	formaldehyde	NOUN
aji-161	127	15	solution	solution	NOUN
aji-161	127	16	may	may	AUX
aji-161	127	17	discriminate	discriminate	VERB
aji-161	127	18	diverse	diverse	ADJ
aji-161	127	19	degrees	degree	NOUN
aji-161	127	20	of	of	ADP
aji-161	127	21	humoral	humoral	ADJ
aji-161	127	22	and	and	CCONJ
aji-161	127	23	cellular	cellular	ADJ
aji-161	127	24	immunoreactivity	immunoreactivity	NOUN
aji-161	127	25	in	in	ADP
aji-161	127	26	patients	patient	NOUN
aji-161	127	27	suffering	suffer	VERB
aji-161	127	28	from	from	ADP
aji-161	127	29	atopic	atopic	NOUN
aji-161	127	30	and/or	and/or	CCONJ
aji-161	127	31	contact	contact	NOUN
aji-161	127	32	dermatitis	dermatitis	NOUN
aji-161	127	33	.	.	PUNCT
aji-161	128	1	by	by	ADP
aji-161	128	2	evaluating	evaluate	VERB
aji-161	128	3	the	the	DET
aji-161	128	4	utility	utility	NOUN
aji-161	128	5	of	of	ADP
aji-161	128	6	ttp	ttp	NOUN
aji-161	128	7	and	and	CCONJ
aji-161	128	8	lait	lait	NOUN
aji-161	128	9	as	as	ADP
aji-161	128	10	diagnostic	diagnostic	ADJ
aji-161	128	11	tools	tool	NOUN
aji-161	128	12	,	,	PUNCT
aji-161	128	13	the	the	DET
aji-161	128	14	study	study	NOUN
aji-161	128	15	provides	provide	VERB
aji-161	128	16	preliminary	preliminary	ADJ
aji-161	128	17	evidence	evidence	NOUN
aji-161	128	18	for	for	ADP
aji-161	128	19	endotyping	endotype	VERB
aji-161	128	20	immunoreactivity	immunoreactivity	NOUN
aji-161	128	21	,	,	PUNCT
aji-161	128	22	which	which	PRON
aji-161	128	23	could	could	AUX
aji-161	128	24	advance	advance	VERB
aji-161	128	25	precision	precision	NOUN
aji-161	128	26	medicine	medicine	NOUN
aji-161	128	27	in	in	ADP
aji-161	128	28	allergy	allergy	PROPN
aji-161	128	29	management	management	NOUN
aji-161	128	30	.	.	PUNCT
aji-161	129	1	the	the	DET
aji-161	129	2	findings	finding	NOUN
aji-161	129	3	may	may	AUX
aji-161	129	4	guide	guide	VERB
aji-161	129	5	clinicians	clinician	NOUN
aji-161	129	6	in	in	ADP
aji-161	129	7	identifying	identify	VERB
aji-161	129	8	hidden	hidden	ADJ
aji-161	129	9	formaldehyde	formaldehyde	NOUN
aji-161	129	10	exposure	exposure	NOUN
aji-161	129	11	in	in	ADP
aji-161	129	12	products	product	NOUN
aji-161	129	13	and	and	CCONJ
aji-161	129	14	inform	inform	VERB
aji-161	129	15	safer	safe	ADJ
aji-161	129	16	therapeutic	therapeutic	ADJ
aji-161	129	17	strategies	strategy	NOUN
aji-161	129	18	for	for	ADP
aji-161	129	19	sensitized	sensitize	VERB
aji-161	129	20	patients	patient	NOUN
aji-161	129	21	.	.	PUNCT
aji-161	130	1	it	it	PRON
aji-161	130	2	is	be	AUX
aji-161	130	3	worthwhile	worthwhile	ADJ
aji-161	130	4	conducting	conduct	VERB
aji-161	130	5	more	more	ADJ
aji-161	130	6	in	in	ADP
aji-161	130	7	-	-	PUNCT
aji-161	130	8	depth	depth	NOUN
aji-161	130	9	studies	study	NOUN
aji-161	130	10	to	to	PART
aji-161	130	11	evaluate	evaluate	VERB
aji-161	130	12	the	the	DET
aji-161	130	13	usefulness	usefulness	NOUN
aji-161	130	14	of	of	ADP
aji-161	130	15	ttp	ttp	NOUN
aji-161	130	16	and	and	CCONJ
aji-161	130	17	lait	lait	NOUN
aji-161	130	18	in	in	ADP
aji-161	130	19	endotyping	endotype	VERB
aji-161	130	20	non	non	PROPN
aji-161	130	21	–	–	PUNCT
aji-161	130	22	ige	ige	ADJ
aji-161	130	23	-	-	PUNCT
aji-161	130	24	mediated	mediate	VERB
aji-161	130	25	hypersensitivity	hypersensitivity	NOUN
aji-161	130	26	to	to	ADP
aji-161	130	27	formaldehyde	formaldehyde	NOUN
aji-161	130	28	.	.	PUNCT
aji-161	131	1	keywords	keyword	NOUN
aji-161	131	2	:	:	PUNCT
aji-161	131	3	atopic	atopic	NOUN
aji-161	131	4	dermatitis	dermatitis	NOUN
aji-161	131	5	;	;	PUNCT
aji-161	131	6	contact	contact	NOUN
aji-161	131	7	dermatitis	dermatitis	NOUN
aji-161	131	8	;	;	PUNCT
aji-161	131	9	endotype	endotype	NOUN
aji-161	131	10	;	;	PUNCT
aji-161	131	11	hypersensitivity	hypersensitivity	NOUN
aji-161	131	12	;	;	PUNCT
aji-161	131	13	formaldehyde	formaldehyde	NOUN
aji-161	131	14	;	;	PUNCT
aji-161	131	15	leukocyte	leukocyte	ADJ
aji-161	131	16	adherence	adherence	NOUN
aji-161	131	17	inhibition	inhibition	NOUN
aji-161	131	18	test	test	NOUN
aji-161	131	19	;	;	PUNCT
aji-161	131	20	precipitins	precipitin	NOUN
aji-161	131	21	;	;	PUNCT
aji-161	131	22	precision	precision	NOUN
aji-161	131	23	medicine	medicine	NOUN
aji-161	131	24	.	.	PUNCT
aji-161	132	1	abbreviations	abbreviation	NOUN
aji-161	132	2	lai	lai	NOUN
aji-161	132	3	:	:	PUNCT
aji-161	132	4	leukocyte	leukocyte	ADJ
aji-161	132	5	adherence	adherence	NOUN
aji-161	132	6	inhibition	inhibition	NOUN
aji-161	132	7	lait	lait	NOUN
aji-161	132	8	:	:	PUNCT
aji-161	132	9	leukocyte	leukocyte	ADJ
aji-161	132	10	adherence	adherence	NOUN
aji-161	132	11	inhibition	inhibition	NOUN
aji-161	132	12	test	test	NOUN
aji-161	132	13	ttp	ttp	NOUN
aji-161	132	14	:	:	PUNCT
aji-161	132	15	tube	tube	NOUN
aji-161	132	16	titration	titration	NOUN
aji-161	132	17	of	of	ADP
aji-161	132	18	precipitins	precipitin	NOUN
aji-161	132	19	1	1	NUM
aji-161	132	20	.	.	PUNCT
aji-161	133	1	introduction	introduction	NOUN
aji-161	133	2	the	the	DET
aji-161	133	3	american	american	PROPN
aji-161	133	4	contact	contact	PROPN
aji-161	133	5	dermatitis	dermatitis	PROPN
aji-161	133	6	society	society	NOUN
aji-161	133	7	elected	elect	VERB
aji-161	133	8	formaldehyde	formaldehyde	NOUN
aji-161	133	9	as	as	ADP
aji-161	133	10	the	the	DET
aji-161	133	11	"	"	PUNCT
aji-161	133	12	allergen	allergen	NOUN
aji-161	133	13	of	of	ADP
aji-161	133	14	the	the	DET
aji-161	133	15	year	year	NOUN
aji-161	133	16	2015	2015	NUM
aji-161	133	17	"	"	PUNCT
aji-161	133	18	(	(	PUNCT
aji-161	133	19	pontén	pontén	NOUN
aji-161	133	20	&	&	CCONJ
aji-161	133	21	bruze	bruze	PROPN
aji-161	133	22	2015	2015	NUM
aji-161	133	23	)	)	PUNCT
aji-161	133	24	.	.	PUNCT
aji-161	134	1	formaldehyde	formaldehyde	NOUN
aji-161	134	2	(	(	PUNCT
aji-161	134	3	known	know	VERB
aji-161	134	4	as	as	ADP
aji-161	134	5	methanal	methanal	ADJ
aji-161	134	6	,	,	PUNCT
aji-161	134	7	methylene	methylene	ADJ
aji-161	134	8	oxide	oxide	NOUN
aji-161	134	9	,	,	PUNCT
aji-161	134	10	oxymethyline	oxymethyline	NOUN
aji-161	134	11	,	,	PUNCT
aji-161	134	12	methylaldehyde	methylaldehyde	NOUN
aji-161	134	13	,	,	PUNCT
aji-161	134	14	and	and	CCONJ
aji-161	134	15	oxomethane	oxomethane	NOUN
aji-161	134	16	)	)	PUNCT
aji-161	134	17	is	be	AUX
aji-161	134	18	the	the	DET
aji-161	134	19	simplest	simple	ADJ
aji-161	134	20	aldehyde	aldehyde	NOUN
aji-161	134	21	,	,	PUNCT
aji-161	134	22	with	with	ADP
aji-161	134	23	the	the	DET
aji-161	134	24	chemical	chemical	NOUN
aji-161	134	25	structure	structure	NOUN
aji-161	134	26	h2c	h2c	PROPN
aji-161	134	27	=	=	PROPN
aji-161	134	28	o	o	PROPN
aji-161	134	29	(	(	PUNCT
aji-161	134	30	gerberich	gerberich	PROPN
aji-161	134	31	&	&	CCONJ
aji-161	134	32	seaman	seaman	PROPN
aji-161	134	33	2013	2013	NUM
aji-161	134	34	)	)	PUNCT
aji-161	134	35	.	.	PUNCT
aji-161	135	1	usually	usually	ADV
aji-161	135	2	stored	store	VERB
aji-161	135	3	as	as	ADP
aji-161	135	4	an	an	DET
aji-161	135	5	aqueous	aqueous	ADJ
aji-161	135	6	solution	solution	NOUN
aji-161	135	7	containing	contain	VERB
aji-161	135	8	variable	variable	ADJ
aji-161	135	9	amounts	amount	NOUN
aji-161	135	10	of	of	ADP
aji-161	135	11	methanol	methanol	NOUN
aji-161	135	12	(	(	PUNCT
aji-161	135	13	formalin	formalin	NOUN
aji-161	135	14	)	)	PUNCT
aji-161	135	15	,	,	PUNCT
aji-161	135	16	it	it	PRON
aji-161	135	17	turns	turn	VERB
aji-161	135	18	on	on	ADP
aji-161	135	19	a	a	DET
aji-161	135	20	colorless	colorless	ADJ
aji-161	135	21	,	,	PUNCT
aji-161	135	22	pungent	pungent	ADJ
aji-161	135	23	,	,	PUNCT
aji-161	135	24	suffocating	suffocating	NOUN
aji-161	135	25	,	,	PUNCT
aji-161	135	26	flammable	flammable	ADJ
aji-161	135	27	gas	gas	NOUN
aji-161	135	28	when	when	SCONJ
aji-161	135	29	liberated	liberate	VERB
aji-161	135	30	into	into	ADP
aji-161	135	31	the	the	DET
aji-161	135	32	atmosphere	atmosphere	NOUN
aji-161	135	33	(	(	PUNCT
aji-161	135	34	commission	commission	NOUN
aji-161	135	35	,	,	PUNCT
aji-161	135	36	2024	2024	NUM
aji-161	135	37	)	)	PUNCT
aji-161	135	38	.	.	PUNCT
aji-161	136	1	formaldehyde	formaldehyde	NOUN
aji-161	136	2	in	in	ADP
aji-161	136	3	aqueous	aqueous	ADJ
aji-161	136	4	solutions	solution	NOUN
aji-161	136	5	spontaneously	spontaneously	ADV
aji-161	136	6	hydrates	hydrate	NOUN
aji-161	136	7	to	to	ADP
aji-161	136	8	h(h2c	h(h2c	NOUN
aji-161	136	9	=	=	ADJ
aji-161	136	10	o	o	NOUN
aji-161	136	11	)	)	PUNCT
aji-161	137	1	oh	oh	INTJ
aji-161	137	2	and	and	CCONJ
aji-161	137	3	aggregates	aggregate	NOUN
aji-161	137	4	to	to	PART
aji-161	137	5	form	form	VERB
aji-161	137	6	mixtures	mixture	NOUN
aji-161	137	7	of	of	ADP
aji-161	137	8	hydrated	hydrated	ADJ
aji-161	137	9	oligomers	oligomer	NOUN
aji-161	137	10	:	:	PUNCT
aji-161	138	1	h(h2c	h(h2c	X
aji-161	138	2	=	=	NOUN
aji-161	138	3	o)n	o)n	NOUN
aji-161	138	4	oh	oh	INTJ
aji-161	138	5	depending	depend	VERB
aji-161	138	6	on	on	ADP
aji-161	138	7	formaldehyde	formaldehyde	NOUN
aji-161	138	8	concentration	concentration	NOUN
aji-161	138	9	.	.	PUNCT
aji-161	139	1	methanol	methanol	NOUN
aji-161	139	2	stabilizes	stabilize	VERB
aji-161	139	3	aqueous	aqueous	ADJ
aji-161	139	4	formaldehyde	formaldehyde	NOUN
aji-161	139	5	solutions	solution	NOUN
aji-161	139	6	by	by	ADP
aji-161	139	7	decreasing	decrease	VERB
aji-161	139	8	the	the	DET
aji-161	139	9	average	average	ADJ
aji-161	139	10	value	value	NOUN
aji-161	139	11	of	of	ADP
aji-161	139	12	n	n	PROPN
aji-161	139	13	(	(	PUNCT
aji-161	139	14	dankelman	dankelman	NOUN
aji-161	139	15	&	&	CCONJ
aji-161	139	16	daemen	daeman	NOUN
aji-161	139	17	1976	1976	NUM
aji-161	139	18	)	)	PUNCT
aji-161	139	19	.	.	PUNCT
aji-161	140	1	the	the	DET
aji-161	140	2	"	"	PUNCT
aji-161	140	3	plastic	plastic	ADJ
aji-161	140	4	age	age	NOUN
aji-161	140	5	"	"	PUNCT
aji-161	140	6	was	be	AUX
aji-161	140	7	inaugurated	inaugurate	VERB
aji-161	140	8	in	in	ADP
aji-161	140	9	1910	1910	NUM
aji-161	140	10	by	by	ADP
aji-161	140	11	polymerizing	polymerize	VERB
aji-161	140	12	formaldehyde	formaldehyde	NOUN
aji-161	140	13	and	and	CCONJ
aji-161	140	14	phenol	phenol	NOUN
aji-161	140	15	,	,	PUNCT
aji-161	140	16	producing	produce	VERB
aji-161	140	17	bakelite	bakelite	NOUN
aji-161	140	18	(	(	PUNCT
aji-161	140	19	braun	braun	PROPN
aji-161	140	20	et	et	PROPN
aji-161	140	21	al	al	PROPN
aji-161	140	22	.	.	PROPN
aji-161	140	23	,	,	PUNCT
aji-161	140	24	2013	2013	NUM
aji-161	140	25	)	)	PUNCT
aji-161	140	26	.	.	PUNCT
aji-161	141	1	nowadays	nowadays	ADV
aji-161	141	2	,	,	PUNCT
aji-161	141	3	several	several	ADJ
aji-161	141	4	industrial	industrial	ADJ
aji-161	141	5	uses	use	NOUN
aji-161	141	6	have	have	AUX
aji-161	141	7	been	be	AUX
aji-161	141	8	discovered	discover	VERB
aji-161	141	9	for	for	ADP
aji-161	141	10	formaldehyde	formaldehyde	NOUN
aji-161	141	11	,	,	PUNCT
aji-161	141	12	turning	turn	VERB
aji-161	141	13	it	it	PRON
aji-161	141	14	into	into	ADP
aji-161	141	15	an	an	DET
aji-161	141	16	intermediate	intermediate	ADJ
aji-161	141	17	chemical	chemical	NOUN
aji-161	141	18	tool	tool	NOUN
aji-161	141	19	for	for	ADP
aji-161	141	20	the	the	DET
aji-161	141	21	production	production	NOUN
aji-161	141	22	of	of	ADP
aji-161	141	23	adhesives	adhesive	NOUN
aji-161	141	24	,	,	PUNCT
aji-161	141	25	fabrics	fabric	NOUN
aji-161	141	26	,	,	PUNCT
aji-161	141	27	polymers	polymer	NOUN
aji-161	141	28	,	,	PUNCT
aji-161	141	29	resins	resin	NOUN
aji-161	141	30	,	,	PUNCT
aji-161	141	31	plastics	plastic	NOUN
aji-161	141	32	,	,	PUNCT
aji-161	141	33	paints	paint	NOUN
aji-161	141	34	,	,	PUNCT
aji-161	141	35	lacquers	lacquer	NOUN
aji-161	141	36	,	,	PUNCT
aji-161	141	37	dyes	dye	NOUN
aji-161	141	38	,	,	PUNCT
aji-161	141	39	explosives	explosive	NOUN
aji-161	141	40	,	,	PUNCT
aji-161	141	41	and	and	CCONJ
aji-161	141	42	so	so	ADV
aji-161	141	43	forth	forth	ADV
aji-161	141	44	,	,	PUNCT
aji-161	141	45	stimulating	stimulate	VERB
aji-161	141	46	the	the	DET
aji-161	141	47	industrial	industrial	ADJ
aji-161	141	48	research	research	NOUN
aji-161	141	49	of	of	ADP
aji-161	141	50	diverse	diverse	ADJ
aji-161	141	51	patented	patented	ADJ
aji-161	141	52	productions	production	NOUN
aji-161	141	53	methods	method	NOUN
aji-161	141	54	worldwide	worldwide	ADV
aji-161	141	55	(	(	PUNCT
aji-161	141	56	walker	walker	NOUN
aji-161	141	57	,	,	PUNCT
aji-161	141	58	1964	1964	NUM
aji-161	141	59	disponible	disponible	ADJ
aji-161	141	60	at	at	ADP
aji-161	141	61	"	"	PUNCT
aji-161	141	62	internet	internet	NOUN
aji-161	141	63	archive	archive	NOUN
aji-161	141	64	"	"	PUNCT
aji-161	141	65	:	:	PUNCT
aji-161	141	66	https://archive.org/details/formaldehyde0000walk	https://archive.org/details/formaldehyde0000walk	NOUN
aji-161	141	67	)	)	PUNCT
aji-161	141	68	.	.	PUNCT
aji-161	142	1	formaldehyde	formaldehyde	NOUN
aji-161	142	2	may	may	AUX
aji-161	142	3	also	also	ADV
aji-161	142	4	be	be	AUX
aji-161	142	5	formed	form	VERB
aji-161	142	6	and	and	CCONJ
aji-161	142	7	liberated	liberate	VERB
aji-161	142	8	in	in	ADP
aji-161	142	9	the	the	DET
aji-161	142	10	atmosphere	atmosphere	NOUN
aji-161	142	11	by	by	ADP
aji-161	142	12	the	the	DET
aji-161	142	13	incomplete	incomplete	ADJ
aji-161	142	14	combustion	combustion	NOUN
aji-161	142	15	of	of	ADP
aji-161	142	16	tobacco	tobacco	NOUN
aji-161	142	17	,	,	PUNCT
aji-161	142	18	wood	wood	NOUN
aji-161	142	19	,	,	PUNCT
aji-161	142	20	coal	coal	NOUN
aji-161	142	21	,	,	PUNCT
aji-161	142	22	gasoline	gasoline	NOUN
aji-161	142	23	,	,	PUNCT
aji-161	142	24	diesel	diesel	NOUN
aji-161	142	25	,	,	PUNCT
aji-161	142	26	and	and	CCONJ
aji-161	142	27	ethanol	ethanol	NOUN
aji-161	142	28	in	in	ADP
aji-161	142	29	internal	internal	ADJ
aji-161	142	30	combustion	combustion	NOUN
aji-161	142	31	engines	engine	NOUN
aji-161	142	32	(	(	PUNCT
aji-161	142	33	dias	dias	PROPN
aji-161	142	34	et	et	PROPN
aji-161	142	35	al	al	PROPN
aji-161	142	36	.	.	PROPN
aji-161	142	37	,	,	PUNCT
aji-161	142	38	2012	2012	NUM
aji-161	142	39	)	)	PUNCT
aji-161	142	40	.	.	PUNCT
aji-161	143	1	gaseous	gaseous	ADJ
aji-161	143	2	formaldehyde	formaldehyde	NOUN
aji-161	143	3	at	at	ADP
aji-161	143	4	higher	high	ADJ
aji-161	143	5	concentrations	concentration	NOUN
aji-161	143	6	can	can	AUX
aji-161	143	7	irritate	irritate	VERB
aji-161	143	8	the	the	DET
aji-161	143	9	eyes	eye	NOUN
aji-161	143	10	and	and	CCONJ
aji-161	143	11	mucous	mucous	ADJ
aji-161	143	12	membranes	membrane	NOUN
aji-161	143	13	of	of	ADP
aji-161	143	14	the	the	DET
aji-161	143	15	respiratory	respiratory	ADJ
aji-161	143	16	tract	tract	NOUN
aji-161	143	17	,	,	PUNCT
aji-161	143	18	even	even	ADV
aji-161	143	19	producing	produce	VERB
aji-161	143	20	asthma	asthma	NOUN
aji-161	143	21	(	(	PUNCT
aji-161	143	22	bardana	bardana	PROPN
aji-161	143	23	&	&	CCONJ
aji-161	143	24	montanaro	montanaro	PROPN
aji-161	143	25	1991	1991	NUM
aji-161	143	26	;	;	PUNCT
aji-161	143	27	pougnet	pougnet	NOUN
aji-161	143	28	et	et	PROPN
aji-161	143	29	al	al	PROPN
aji-161	143	30	.	.	PROPN
aji-161	143	31	,	,	PUNCT
aji-161	143	32	2025	2025	NUM
aji-161	143	33	;	;	PUNCT
aji-161	143	34	zhang	zhang	PROPN
aji-161	143	35	et	et	PROPN
aji-161	143	36	al	al	PROPN
aji-161	143	37	.	.	PROPN
aji-161	143	38	;	;	PUNCT
aji-161	143	39	2025	2025	NUM
aji-161	143	40	)	)	PUNCT
aji-161	143	41	.	.	PUNCT
aji-161	144	1	olivier	olivier	PROPN
aji-161	144	2	et	et	PROPN
aji-161	144	3	al	al	PROPN
aji-161	144	4	.	.	PROPN
aji-161	144	5	;	;	PUNCT
aji-161	144	6	asian	asian	PROPN
aji-161	144	7	j.	j.	PROPN
aji-161	144	8	immunol	immunol	PROPN
aji-161	144	9	.	.	PROPN
aji-161	144	10	,	,	PUNCT
aji-161	144	11	vol	vol	NOUN
aji-161	144	12	.	.	PROPN
aji-161	144	13	8	8	NUM
aji-161	144	14	,	,	PUNCT
aji-161	144	15	no	no	INTJ
aji-161	144	16	.	.	NOUN
aji-161	144	17	1	1	NUM
aji-161	144	18	,	,	PUNCT
aji-161	144	19	pp	pp	ADJ
aji-161	144	20	.	.	PUNCT
aji-161	145	1	70	70	NUM
aji-161	145	2	-	-	SYM
aji-161	145	3	81	81	NUM
aji-161	145	4	,	,	PUNCT
aji-161	145	5	2025	2025	NUM
aji-161	145	6	;	;	PUNCT
aji-161	145	7	article	article	NOUN
aji-161	145	8	no.aji.134825	no.aji.134825	X
aji-161	145	9	72	72	NUM
aji-161	145	10	initially	initially	ADV
aji-161	145	11	used	use	VERB
aji-161	145	12	as	as	ADP
aji-161	145	13	a	a	DET
aji-161	145	14	disinfectant	disinfectant	NOUN
aji-161	145	15	,	,	PUNCT
aji-161	145	16	embalming	embalm	VERB
aji-161	145	17	(	(	PUNCT
aji-161	145	18	anatomy	anatomy	NOUN
aji-161	145	19	dissection	dissection	NOUN
aji-161	145	20	classrooms	classroom	NOUN
aji-161	145	21	)	)	PUNCT
aji-161	145	22	,	,	PUNCT
aji-161	145	23	and	and	CCONJ
aji-161	145	24	viral	viral	ADJ
aji-161	145	25	inactivator	inactivator	NOUN
aji-161	145	26	for	for	ADP
aji-161	145	27	the	the	DET
aji-161	145	28	production	production	NOUN
aji-161	145	29	of	of	ADP
aji-161	145	30	vaccines	vaccine	NOUN
aji-161	145	31	,	,	PUNCT
aji-161	145	32	nowadays	nowadays	ADV
aji-161	145	33	,	,	PUNCT
aji-161	145	34	formaldehyde	formaldehyde	NOUN
aji-161	145	35	is	be	AUX
aji-161	145	36	listed	list	VERB
aji-161	145	37	as	as	ADP
aji-161	145	38	a	a	DET
aji-161	145	39	human	human	ADJ
aji-161	145	40	carcinogen	carcinogen	NOUN
aji-161	145	41	with	with	ADP
aji-161	145	42	restricted	restricted	ADJ
aji-161	145	43	uses	use	NOUN
aji-161	145	44	(	(	PUNCT
aji-161	145	45	commission	commission	NOUN
aji-161	145	46	,	,	PUNCT
aji-161	145	47	2021	2021	NUM
aji-161	145	48	)	)	PUNCT
aji-161	145	49	.	.	PUNCT
aji-161	146	1	formaldehyde	formaldehyde	NOUN
aji-161	146	2	is	be	AUX
aji-161	146	3	prohibited	prohibit	VERB
aji-161	146	4	from	from	ADP
aji-161	146	5	use	use	NOUN
aji-161	146	6	in	in	ADP
aji-161	146	7	cosmetic	cosmetic	ADJ
aji-161	146	8	products	product	NOUN
aji-161	146	9	in	in	ADP
aji-161	146	10	most	most	ADJ
aji-161	146	11	countries	country	NOUN
aji-161	146	12	.	.	PUNCT
aji-161	147	1	however	however	ADV
aji-161	147	2	,	,	PUNCT
aji-161	147	3	the	the	DET
aji-161	147	4	so	so	ADV
aji-161	147	5	-	-	PUNCT
aji-161	147	6	called	call	VERB
aji-161	147	7	formaldehyde	formaldehyde	NOUN
aji-161	147	8	releasers	releaser	NOUN
aji-161	147	9	are	be	AUX
aji-161	147	10	usually	usually	ADV
aji-161	147	11	allowed	allow	VERB
aji-161	147	12	(	(	PUNCT
aji-161	147	13	commission	commission	NOUN
aji-161	147	14	,	,	PUNCT
aji-161	147	15	2019	2019	NUM
aji-161	147	16	)	)	PUNCT
aji-161	147	17	.	.	PUNCT
aji-161	148	1	to	to	PART
aji-161	148	2	avoid	avoid	VERB
aji-161	148	3	the	the	DET
aji-161	148	4	inconveniences	inconvenience	NOUN
aji-161	148	5	of	of	ADP
aji-161	148	6	formalin	formalin	NOUN
aji-161	148	7	,	,	PUNCT
aji-161	148	8	chemists	chemist	NOUN
aji-161	148	9	developed	develop	VERB
aji-161	148	10	the	the	DET
aji-161	148	11	formaldehyde	formaldehyde	NOUN
aji-161	148	12	releasers	releaser	NOUN
aji-161	148	13	(	(	PUNCT
aji-161	148	14	or	or	CCONJ
aji-161	148	15	formaldehyde	formaldehyde	NOUN
aji-161	148	16	donors	donor	NOUN
aji-161	148	17	)	)	PUNCT
aji-161	148	18	,	,	PUNCT
aji-161	148	19	reversible	reversible	ADJ
aji-161	148	20	linear	linear	NOUN
aji-161	148	21	or	or	CCONJ
aji-161	148	22	cyclic	cyclic	ADJ
aji-161	148	23	polymers	polymer	NOUN
aji-161	148	24	of	of	ADP
aji-161	148	25	formaldehyde	formaldehyde	NOUN
aji-161	148	26	that	that	PRON
aji-161	148	27	slowly	slowly	ADV
aji-161	148	28	release	release	VERB
aji-161	148	29	free	free	ADJ
aji-161	148	30	formaldehyde	formaldehyde	NOUN
aji-161	148	31	at	at	ADP
aji-161	148	32	levels	level	NOUN
aji-161	148	33	suppressing	suppress	VERB
aji-161	148	34	microbial	microbial	ADJ
aji-161	148	35	growth	growth	NOUN
aji-161	148	36	but	but	CCONJ
aji-161	148	37	(	(	PUNCT
aji-161	148	38	theoretically	theoretically	ADV
aji-161	148	39	)	)	PUNCT
aji-161	148	40	sufficiently	sufficiently	ADV
aji-161	148	41	low	low	ADJ
aji-161	148	42	not	not	PART
aji-161	148	43	to	to	PART
aji-161	148	44	harm	harm	VERB
aji-161	148	45	humans	human	NOUN
aji-161	148	46	(	(	PUNCT
aji-161	148	47	de	de	X
aji-161	148	48	groot	groot	X
aji-161	148	49	et	et	PROPN
aji-161	148	50	al	al	PROPN
aji-161	148	51	.	.	PROPN
aji-161	148	52	,	,	PUNCT
aji-161	148	53	2009	2009	NUM
aji-161	148	54	)	)	PUNCT
aji-161	148	55	.	.	PUNCT
aji-161	149	1	these	these	DET
aji-161	149	2	formaldehyde	formaldehyde	NOUN
aji-161	149	3	releasers	releaser	NOUN
aji-161	149	4	(	(	PUNCT
aji-161	149	5	such	such	ADJ
aji-161	149	6	as	as	ADP
aji-161	149	7	quaternium-15	quaternium-15	PROPN
aji-161	149	8	,	,	PUNCT
aji-161	149	9	diazolidinyl	diazolidinyl	NOUN
aji-161	149	10	urea	urea	NOUN
aji-161	149	11	,	,	PUNCT
aji-161	149	12	dmdm	dmdm	PROPN
aji-161	149	13	hydantoin	hydantoin	PROPN
aji-161	149	14	,	,	PUNCT
aji-161	149	15	imidazolidinyl	imidazolidinyl	NOUN
aji-161	149	16	urea	urea	NOUN
aji-161	149	17	,	,	PUNCT
aji-161	149	18	2	2	NUM
aji-161	149	19	-	-	PUNCT
aji-161	149	20	bromo-2	bromo-2	NUM
aji-161	149	21	-	-	PUNCT
aji-161	149	22	nitropropane-1,3diol	nitropropane-1,3diol	NOUN
aji-161	149	23	(	(	PUNCT
aji-161	149	24	bronopol	bronopol	NOUN
aji-161	149	25	)	)	PUNCT
aji-161	149	26	,	,	PUNCT
aji-161	149	27	germall-115	germall-115	NOUN
aji-161	149	28	,	,	PUNCT
aji-161	149	29	preventol	preventol	NOUN
aji-161	149	30	,	,	PUNCT
aji-161	149	31	and	and	CCONJ
aji-161	149	32	so	so	ADV
aji-161	149	33	forth	forth	ADV
aji-161	149	34	)	)	PUNCT
aji-161	149	35	are	be	AUX
aji-161	149	36	found	find	VERB
aji-161	149	37	in	in	ADP
aji-161	149	38	cosmetics	cosmetic	NOUN
aji-161	149	39	(	(	PUNCT
aji-161	149	40	creams	cream	NOUN
aji-161	149	41	,	,	PUNCT
aji-161	149	42	lotions	lotion	NOUN
aji-161	149	43	,	,	PUNCT
aji-161	149	44	make	make	VERB
aji-161	149	45	-	-	PUNCT
aji-161	149	46	up	up	ADP
aji-161	149	47	removers	remover	NOUN
aji-161	149	48	,	,	PUNCT
aji-161	149	49	soaps	soap	NOUN
aji-161	149	50	,	,	PUNCT
aji-161	149	51	shampoos	shampoo	NOUN
aji-161	149	52	,	,	PUNCT
aji-161	149	53	deodorants	deodorant	NOUN
aji-161	149	54	,	,	PUNCT
aji-161	149	55	toiletries	toiletry	NOUN
aji-161	149	56	,	,	PUNCT
aji-161	149	57	nail	nail	NOUN
aji-161	149	58	products	product	NOUN
aji-161	149	59	)	)	PUNCT
aji-161	149	60	,	,	PUNCT
aji-161	149	61	cleaning	clean	VERB
aji-161	149	62	household	household	NOUN
aji-161	149	63	products	product	NOUN
aji-161	149	64	(	(	PUNCT
aji-161	149	65	detergents	detergent	NOUN
aji-161	149	66	)	)	PUNCT
aji-161	149	67	and	and	CCONJ
aji-161	149	68	industrial	industrial	ADJ
aji-161	149	69	chemical	chemical	NOUN
aji-161	149	70	products	product	NOUN
aji-161	149	71	(	(	PUNCT
aji-161	149	72	flyvholm	flyvholm	NOUN
aji-161	149	73	&	&	CCONJ
aji-161	149	74	andersen	andersen	PROPN
aji-161	149	75	,	,	PUNCT
aji-161	149	76	1993	1993	NUM
aji-161	149	77	)	)	PUNCT
aji-161	149	78	.	.	PUNCT
aji-161	150	1	soon	soon	ADV
aji-161	150	2	,	,	PUNCT
aji-161	150	3	it	it	PRON
aji-161	150	4	was	be	AUX
aji-161	150	5	realized	realize	VERB
aji-161	150	6	that	that	SCONJ
aji-161	150	7	formaldehyde	formaldehyde	NOUN
aji-161	150	8	releasers	releaser	NOUN
aji-161	150	9	were	be	AUX
aji-161	150	10	also	also	ADV
aji-161	150	11	causes	cause	NOUN
aji-161	150	12	of	of	ADP
aji-161	150	13	contact	contact	NOUN
aji-161	150	14	dermatitis	dermatitis	NOUN
aji-161	150	15	in	in	ADP
aji-161	150	16	patients	patient	NOUN
aji-161	150	17	sensitized	sensitize	VERB
aji-161	150	18	to	to	ADP
aji-161	150	19	formaldehyde	formaldehyde	NOUN
aji-161	150	20	(	(	PUNCT
aji-161	150	21	dahlquist	dahlquist	VERB
aji-161	150	22	&	&	CCONJ
aji-161	150	23	fregert	fregert	PROPN
aji-161	150	24	1978	1978	NUM
aji-161	150	25	)	)	PUNCT
aji-161	150	26	.	.	PUNCT
aji-161	151	1	recently	recently	ADV
aji-161	151	2	,	,	PUNCT
aji-161	151	3	it	it	PRON
aji-161	151	4	was	be	AUX
aji-161	151	5	reported	report	VERB
aji-161	151	6	that	that	SCONJ
aji-161	151	7	about	about	ADP
aji-161	151	8	threequarters	threequarter	NOUN
aji-161	151	9	of	of	ADP
aji-161	151	10	tested	test	VERB
aji-161	151	11	us	we	PRON
aji-161	151	12	tattoo	tattoo	ADV
aji-161	151	13	inks	ink	NOUN
aji-161	151	14	analyzed	analyze	VERB
aji-161	151	15	by	by	ADP
aji-161	151	16	the	the	DET
aji-161	151	17	chromotropic	chromotropic	NOUN
aji-161	151	18	acid	acid	NOUN
aji-161	151	19	method	method	NOUN
aji-161	151	20	resulted	result	VERB
aji-161	151	21	in	in	ADP
aji-161	151	22	a	a	DET
aji-161	151	23	positive	positive	ADJ
aji-161	151	24	for	for	ADP
aji-161	151	25	formaldehyde	formaldehyde	NOUN
aji-161	151	26	releasers	releaser	NOUN
aji-161	151	27	(	(	PUNCT
aji-161	151	28	liou	liou	PROPN
aji-161	151	29	et	et	PROPN
aji-161	151	30	al	al	PROPN
aji-161	151	31	.	.	PROPN
aji-161	151	32	,	,	PUNCT
aji-161	151	33	2021	2021	NUM
aji-161	151	34	)	)	PUNCT
aji-161	151	35	.	.	PUNCT
aji-161	152	1	until	until	ADP
aji-161	152	2	recently	recently	ADV
aji-161	152	3	,	,	PUNCT
aji-161	152	4	textile	textile	NOUN
aji-161	152	5	finishes	finish	NOUN
aji-161	152	6	released	release	VERB
aji-161	152	7	an	an	DET
aji-161	152	8	elevated	elevated	ADJ
aji-161	152	9	level	level	NOUN
aji-161	152	10	of	of	ADP
aji-161	152	11	free	free	ADJ
aji-161	152	12	formaldehyde	formaldehyde	NOUN
aji-161	152	13	(	(	PUNCT
aji-161	152	14	textileformaldehyde	textileformaldehyde	NOUN
aji-161	152	15	resins	resin	NOUN
aji-161	152	16	)	)	PUNCT
aji-161	152	17	,	,	PUNCT
aji-161	152	18	causing	cause	VERB
aji-161	152	19	frequent	frequent	ADJ
aji-161	152	20	textile	textile	NOUN
aji-161	152	21	dermatitis	dermatitis	NOUN
aji-161	152	22	in	in	ADP
aji-161	152	23	individuals	individual	NOUN
aji-161	152	24	sensitive	sensitive	ADJ
aji-161	152	25	to	to	ADP
aji-161	152	26	formaldehyde	formaldehyde	NOUN
aji-161	152	27	.	.	PUNCT
aji-161	153	1	however	however	ADV
aji-161	153	2	,	,	PUNCT
aji-161	153	3	nowadays	nowadays	ADV
aji-161	153	4	,	,	PUNCT
aji-161	153	5	clothing	clothing	NOUN
aji-161	153	6	finishes	finish	NOUN
aji-161	153	7	release	release	VERB
aji-161	153	8	much	much	ADV
aji-161	153	9	less	less	ADV
aji-161	153	10	free	free	ADJ
aji-161	153	11	formaldehyde	formaldehyde	NOUN
aji-161	153	12	,	,	PUNCT
aji-161	153	13	and	and	CCONJ
aji-161	153	14	allergic	allergic	ADJ
aji-161	153	15	contact	contact	NOUN
aji-161	153	16	dermatitis	dermatitis	NOUN
aji-161	153	17	from	from	ADP
aji-161	153	18	clothing	clothing	NOUN
aji-161	153	19	due	due	ADP
aji-161	153	20	to	to	ADP
aji-161	153	21	formaldehyde	formaldehyde	NOUN
aji-161	153	22	releasers	releaser	NOUN
aji-161	153	23	is	be	AUX
aji-161	153	24	much	much	ADV
aji-161	153	25	less	less	ADV
aji-161	153	26	frequent	frequent	ADJ
aji-161	153	27	than	than	ADP
aji-161	153	28	in	in	ADP
aji-161	153	29	the	the	DET
aji-161	153	30	past	past	ADJ
aji-161	153	31	decades	decade	NOUN
aji-161	153	32	.	.	PUNCT
aji-161	154	1	(	(	PUNCT
aji-161	154	2	lazarov	lazarov	NOUN
aji-161	154	3	et	et	PROPN
aji-161	154	4	al	al	PROPN
aji-161	154	5	.	.	PROPN
aji-161	154	6	,	,	PUNCT
aji-161	154	7	2003	2003	NUM
aji-161	154	8	)	)	PUNCT
aji-161	154	9	.	.	PUNCT
aji-161	155	1	nowadays	nowadays	ADV
aji-161	155	2	,	,	PUNCT
aji-161	155	3	the	the	DET
aji-161	155	4	main	main	ADJ
aji-161	155	5	question	question	NOUN
aji-161	155	6	about	about	ADP
aji-161	155	7	formaldehyde	formaldehyde	NOUN
aji-161	155	8	hypersensitivity	hypersensitivity	NOUN
aji-161	155	9	is	be	AUX
aji-161	155	10	not	not	PART
aji-161	155	11	about	about	ADP
aji-161	155	12	the	the	DET
aji-161	155	13	known	know	VERB
aji-161	155	14	products	product	NOUN
aji-161	155	15	with	with	ADP
aji-161	155	16	the	the	DET
aji-161	155	17	declared	declare	VERB
aji-161	155	18	presence	presence	NOUN
aji-161	155	19	of	of	ADP
aji-161	155	20	formaldehyde	formaldehyde	NOUN
aji-161	155	21	or	or	CCONJ
aji-161	155	22	formaldehyde	formaldehyde	NOUN
aji-161	155	23	releasers	releaser	NOUN
aji-161	155	24	in	in	ADP
aji-161	155	25	their	their	PRON
aji-161	155	26	composition	composition	NOUN
aji-161	155	27	but	but	CCONJ
aji-161	155	28	the	the	DET
aji-161	155	29	undeclared	undeclared	ADJ
aji-161	155	30	presence	presence	NOUN
aji-161	155	31	of	of	ADP
aji-161	155	32	formaldehyde	formaldehyde	NOUN
aji-161	155	33	in	in	ADP
aji-161	155	34	industrial	industrial	ADJ
aji-161	155	35	products	product	NOUN
aji-161	155	36	.	.	PUNCT
aji-161	156	1	in	in	ADP
aji-161	156	2	a	a	DET
aji-161	156	3	recent	recent	ADJ
aji-161	156	4	sampling	sampling	NOUN
aji-161	156	5	,	,	PUNCT
aji-161	156	6	it	it	PRON
aji-161	156	7	was	be	AUX
aji-161	156	8	demonstrated	demonstrate	VERB
aji-161	156	9	by	by	ADP
aji-161	156	10	highperformance	highperformance	NOUN
aji-161	156	11	liquid	liquid	ADJ
aji-161	156	12	chromatography	chromatography	NOUN
aji-161	156	13	(	(	PUNCT
aji-161	156	14	hplc	hplc	PROPN
aji-161	156	15	)	)	PUNCT
aji-161	156	16	that	that	SCONJ
aji-161	156	17	23	23	NUM
aji-161	156	18	of	of	ADP
aji-161	156	19	130	130	NUM
aji-161	156	20	cosmetic	cosmetic	ADJ
aji-161	156	21	products	product	NOUN
aji-161	156	22	(	(	PUNCT
aji-161	156	23	18	18	NUM
aji-161	156	24	%	%	NOUN
aji-161	156	25	)	)	PUNCT
aji-161	156	26	(	(	PUNCT
aji-161	156	27	without	without	ADP
aji-161	156	28	formaldehyde	formaldehyde	NOUN
aji-161	156	29	or	or	CCONJ
aji-161	156	30	formaldehyde	formaldehyde	NOUN
aji-161	156	31	releasers	releaser	NOUN
aji-161	156	32	on	on	ADP
aji-161	156	33	the	the	DET
aji-161	156	34	package	package	NOUN
aji-161	156	35	ingredient	ingredient	NOUN
aji-161	156	36	list	list	NOUN
aji-161	156	37	)	)	PUNCT
aji-161	156	38	were	be	AUX
aji-161	156	39	presenting	present	VERB
aji-161	156	40	variable	variable	ADJ
aji-161	156	41	amounts	amount	NOUN
aji-161	156	42	(	(	PUNCT
aji-161	156	43	0.5–507	0.5–507	NOUN
aji-161	156	44	ppm	ppm	NOUN
aji-161	156	45	)	)	PUNCT
aji-161	156	46	of	of	ADP
aji-161	156	47	formaldehyde	formaldehyde	NOUN
aji-161	156	48	(	(	PUNCT
aji-161	156	49	søgaard	søgaard	NOUN
aji-161	156	50	et	et	PROPN
aji-161	156	51	al	al	PROPN
aji-161	156	52	.	.	PROPN
aji-161	156	53	,	,	PUNCT
aji-161	156	54	2024	2024	NUM
aji-161	156	55	)	)	PUNCT
aji-161	156	56	.	.	PUNCT
aji-161	157	1	the	the	DET
aji-161	157	2	undeclared	undeclared	ADJ
aji-161	157	3	presence	presence	NOUN
aji-161	157	4	of	of	ADP
aji-161	157	5	formaldehyde	formaldehyde	NOUN
aji-161	157	6	in	in	ADP
aji-161	157	7	industrial	industrial	ADJ
aji-161	157	8	products	product	NOUN
aji-161	157	9	results	result	NOUN
aji-161	157	10	from	from	ADP
aji-161	157	11	the	the	DET
aji-161	157	12	air	air	NOUN
aji-161	157	13	oxidation	oxidation	NOUN
aji-161	157	14	of	of	ADP
aji-161	157	15	ethoxylated	ethoxylate	VERB
aji-161	157	16	alcohols	alcohol	NOUN
aji-161	157	17	,	,	PUNCT
aji-161	157	18	such	such	ADJ
aji-161	157	19	as	as	ADP
aji-161	157	20	polyethylene	polyethylene	NOUN
aji-161	157	21	glycols	glycol	NOUN
aji-161	157	22	(	(	PUNCT
aji-161	157	23	bergh	bergh	PROPN
aji-161	157	24	et	et	PROPN
aji-161	157	25	al	al	PROPN
aji-161	157	26	.	.	PROPN
aji-161	157	27	,	,	PUNCT
aji-161	157	28	1998	1998	NUM
aji-161	157	29	)	)	PUNCT
aji-161	157	30	.	.	PUNCT
aji-161	158	1	polyethylene	polyethylene	NOUN
aji-161	158	2	glycols	glycol	NOUN
aji-161	158	3	are	be	AUX
aji-161	158	4	polymers	polymer	NOUN
aji-161	158	5	of	of	ADP
aji-161	158	6	ether	ether	ADJ
aji-161	158	7	monomers	monomer	NOUN
aji-161	158	8	such	such	ADJ
aji-161	158	9	as	as	ADP
aji-161	158	10	ethylene	ethylene	NOUN
aji-161	158	11	glycol	glycol	NOUN
aji-161	158	12	,	,	PUNCT
aji-161	158	13	ethylene	ethylene	NOUN
aji-161	158	14	oxide	oxide	NOUN
aji-161	158	15	,	,	PUNCT
aji-161	158	16	or	or	CCONJ
aji-161	158	17	oxyethylene	oxyethylene	ADJ
aji-161	158	18	,	,	PUNCT
aji-161	158	19	usually	usually	ADV
aji-161	158	20	available	available	ADJ
aji-161	158	21	as	as	ADP
aji-161	158	22	mixtures	mixture	NOUN
aji-161	158	23	of	of	ADP
aji-161	158	24	different	different	ADJ
aji-161	158	25	chain	chain	NOUN
aji-161	158	26	lengths	length	NOUN
aji-161	158	27	polymers	polymer	NOUN
aji-161	158	28	,	,	PUNCT
aji-161	158	29	used	use	VERB
aji-161	158	30	as	as	ADP
aji-161	158	31	emulsifiers	emulsifier	NOUN
aji-161	158	32	in	in	ADP
aji-161	158	33	industrialized	industrialize	VERB
aji-161	158	34	food	food	NOUN
aji-161	158	35	and	and	CCONJ
aji-161	158	36	food	food	NOUN
aji-161	158	37	supplements	supplement	NOUN
aji-161	158	38	(	(	PUNCT
aji-161	158	39	e	e	NOUN
aji-161	158	40	1521	1521	NUM
aji-161	158	41	)	)	PUNCT
aji-161	158	42	,	,	PUNCT
aji-161	158	43	medicines	medicine	NOUN
aji-161	158	44	(	(	PUNCT
aji-161	158	45	macrogol	macrogol	NOUN
aji-161	158	46	)	)	PUNCT
aji-161	158	47	,	,	PUNCT
aji-161	158	48	cosmetics	cosmetic	NOUN
aji-161	158	49	and	and	CCONJ
aji-161	158	50	housecleaning	housecleaning	NOUN
aji-161	158	51	products	product	NOUN
aji-161	158	52	(	(	PUNCT
aji-161	158	53	olivier	olivier	PROPN
aji-161	158	54	et	et	PROPN
aji-161	158	55	al	al	PROPN
aji-161	158	56	.	.	PROPN
aji-161	158	57	2024e	2024e	NUM
aji-161	158	58	)	)	PUNCT
aji-161	158	59	.	.	PUNCT
aji-161	159	1	even	even	ADV
aji-161	159	2	corticoid	corticoid	PROPN
aji-161	159	3	creams	cream	NOUN
aji-161	159	4	may	may	AUX
aji-161	159	5	present	present	VERB
aji-161	159	6	formaldehyde	formaldehyde	NOUN
aji-161	159	7	,	,	PUNCT
aji-161	159	8	mainly	mainly	ADV
aji-161	159	9	when	when	SCONJ
aji-161	159	10	presenting	present	VERB
aji-161	159	11	macrogol	macrogol	NOUN
aji-161	159	12	in	in	ADP
aji-161	159	13	their	their	PRON
aji-161	159	14	composition	composition	NOUN
aji-161	159	15	(	(	PUNCT
aji-161	159	16	dahlquist	dahlquist	VERB
aji-161	159	17	et	et	PROPN
aji-161	159	18	al	al	PROPN
aji-161	159	19	.	.	PROPN
aji-161	159	20	,	,	PUNCT
aji-161	159	21	1980	1980	NUM
aji-161	159	22	)	)	PUNCT
aji-161	159	23	.	.	PUNCT
aji-161	160	1	the	the	DET
aji-161	160	2	methyl	methyl	NOUN
aji-161	160	3	ester	ester	NOUN
aji-161	160	4	of	of	ADP
aji-161	160	5	the	the	DET
aji-161	160	6	aspartic	aspartic	ADJ
aji-161	160	7	acid	acid	NOUN
aji-161	160	8	/	/	SYM
aji-161	160	9	phenylalanine	phenylalanine	NOUN
aji-161	160	10	dipeptide	dipeptide	NOUN
aji-161	160	11	(	(	PUNCT
aji-161	160	12	aspartame	aspartame	PROPN
aji-161	160	13	)	)	PUNCT
aji-161	160	14	may	may	AUX
aji-161	160	15	also	also	ADV
aji-161	160	16	be	be	AUX
aji-161	160	17	degraded	degrade	VERB
aji-161	160	18	to	to	AUX
aji-161	160	19	formaldehyde	formaldehyde	VERB
aji-161	160	20	and	and	CCONJ
aji-161	160	21	produce	produce	VERB
aji-161	160	22	systemic	systemic	ADJ
aji-161	160	23	allergic	allergic	ADJ
aji-161	160	24	dermatitis	dermatitis	NOUN
aji-161	160	25	(	(	PUNCT
aji-161	160	26	veien	veien	PROPN
aji-161	160	27	&	&	CCONJ
aji-161	160	28	lomholt	lomholt	PROPN
aji-161	160	29	2012	2012	NUM
aji-161	160	30	,	,	PUNCT
aji-161	160	31	hill	hill	PROPN
aji-161	160	32	&	&	CCONJ
aji-161	160	33	belsito	belsito	PROPN
aji-161	160	34	2003	2003	NUM
aji-161	160	35	,	,	PUNCT
aji-161	160	36	castanedo	castanedo	PROPN
aji-161	160	37	-	-	PUNCT
aji-161	160	38	tardan	tardan	PROPN
aji-161	160	39	et	et	PROPN
aji-161	160	40	al	al	PROPN
aji-161	160	41	.	.	PROPN
aji-161	160	42	,	,	PUNCT
aji-161	160	43	2009	2009	NUM
aji-161	160	44	)	)	PUNCT
aji-161	160	45	.	.	PUNCT
aji-161	161	1	besides	besides	SCONJ
aji-161	161	2	producing	produce	VERB
aji-161	161	3	their	their	PRON
aji-161	161	4	characteristic	characteristic	ADJ
aji-161	161	5	hypersensitivity	hypersensitivity	NOUN
aji-161	161	6	conditions	condition	NOUN
aji-161	161	7	(	(	PUNCT
aji-161	161	8	generalized	generalized	ADJ
aji-161	161	9	and	and	CCONJ
aji-161	161	10	localized	localized	ADJ
aji-161	161	11	allergic	allergic	ADJ
aji-161	161	12	contact	contact	NOUN
aji-161	161	13	dermatitis	dermatitis	NOUN
aji-161	161	14	,	,	PUNCT
aji-161	161	15	airborne	airborne	ADJ
aji-161	161	16	symptoms	symptom	NOUN
aji-161	161	17	such	such	ADJ
aji-161	161	18	as	as	ADP
aji-161	161	19	rhino	rhino	NOUN
aji-161	161	20	-	-	ADJ
aji-161	161	21	conjunctivitis	conjunctivitis	NOUN
aji-161	161	22	and	and	CCONJ
aji-161	161	23	asthma	asthma	NOUN
aji-161	161	24	,	,	PUNCT
aji-161	161	25	immediate	immediate	ADJ
aji-161	161	26	-	-	PUNCT
aji-161	161	27	type	type	NOUN
aji-161	161	28	allergies	allergy	NOUN
aji-161	161	29	such	such	ADJ
aji-161	161	30	as	as	ADP
aji-161	161	31	urticaria	urticaria	NOUN
aji-161	161	32	and	and	CCONJ
aji-161	161	33	anaphylaxis	anaphylaxis	ADJ
aji-161	161	34	)	)	PUNCT
aji-161	161	35	,	,	PUNCT
aji-161	161	36	hypersensitivity	hypersensitivity	NOUN
aji-161	161	37	to	to	ADP
aji-161	161	38	formaldehyde	formaldehyde	NOUN
aji-161	161	39	may	may	AUX
aji-161	161	40	also	also	ADV
aji-161	161	41	aggravate	aggravate	VERB
aji-161	161	42	preexisting	preexisting	NOUN
aji-161	161	43	dermatoses	dermatosis	NOUN
aji-161	161	44	,	,	PUNCT
aji-161	161	45	producing	produce	VERB
aji-161	161	46	flares	flare	NOUN
aji-161	161	47	of	of	ADP
aji-161	161	48	atopic	atopic	NOUN
aji-161	161	49	dermatitis	dermatitis	NOUN
aji-161	161	50	,	,	PUNCT
aji-161	161	51	stasis	stasis	NOUN
aji-161	161	52	dermatitis	dermatitis	NOUN
aji-161	161	53	,	,	PUNCT
aji-161	161	54	and	and	CCONJ
aji-161	161	55	rosacea	rosacea	PROPN
aji-161	161	56	(	(	PUNCT
aji-161	161	57	goossens	goossen	NOUN
aji-161	161	58	&	&	CCONJ
aji-161	161	59	aerts	aert	NOUN
aji-161	161	60	2022	2022	NUM
aji-161	161	61	)	)	PUNCT
aji-161	161	62	.	.	PUNCT
aji-161	162	1	formaldehyde	formaldehyde	NOUN
aji-161	162	2	is	be	AUX
aji-161	162	3	unanimous	unanimous	ADJ
aji-161	162	4	among	among	ADP
aji-161	162	5	the	the	DET
aji-161	162	6	diverse	diverse	ADJ
aji-161	162	7	batteries	battery	NOUN
aji-161	162	8	recommended	recommend	VERB
aji-161	162	9	for	for	ADP
aji-161	162	10	composing	compose	VERB
aji-161	162	11	diagnostic	diagnostic	ADJ
aji-161	162	12	cutaneous	cutaneous	ADJ
aji-161	162	13	contact	contact	NOUN
aji-161	162	14	test	test	NOUN
aji-161	162	15	kits	kit	NOUN
aji-161	162	16	(	(	PUNCT
aji-161	162	17	patch	patch	NOUN
aji-161	162	18	tests	test	NOUN
aji-161	162	19	)	)	PUNCT
aji-161	162	20	(	(	PUNCT
aji-161	162	21	bruynzeel	bruynzeel	PROPN
aji-161	162	22	et	et	PROPN
aji-161	162	23	al	al	PROPN
aji-161	162	24	.	.	PROPN
aji-161	162	25	,	,	PUNCT
aji-161	162	26	1995	1995	NUM
aji-161	162	27	)	)	PUNCT
aji-161	162	28	.	.	PUNCT
aji-161	163	1	when	when	SCONJ
aji-161	163	2	cutaneous	cutaneous	ADJ
aji-161	163	3	tests	test	NOUN
aji-161	163	4	are	be	AUX
aji-161	163	5	inconclusive	inconclusive	ADJ
aji-161	163	6	,	,	PUNCT
aji-161	163	7	the	the	DET
aji-161	163	8	best	good	ADJ
aji-161	163	9	way	way	NOUN
aji-161	163	10	to	to	PART
aji-161	163	11	diagnose	diagnose	VERB
aji-161	163	12	formaldehyde	formaldehyde	NOUN
aji-161	163	13	hypersensitivity	hypersensitivity	NOUN
aji-161	163	14	is	be	AUX
aji-161	163	15	the	the	DET
aji-161	163	16	exclusion	exclusion	NOUN
aji-161	163	17	/	/	SYM
aji-161	163	18	provocation	provocation	NOUN
aji-161	163	19	test	test	NOUN
aji-161	163	20	,	,	PUNCT
aji-161	163	21	when	when	SCONJ
aji-161	163	22	the	the	DET
aji-161	163	23	patient	patient	NOUN
aji-161	163	24	interrupts	interrupt	VERB
aji-161	163	25	the	the	DET
aji-161	163	26	use	use	NOUN
aji-161	163	27	of	of	ADP
aji-161	163	28	the	the	DET
aji-161	163	29	suspected	suspect	VERB
aji-161	163	30	allergen	allergen	NOUN
aji-161	163	31	until	until	SCONJ
aji-161	163	32	the	the	DET
aji-161	163	33	symptoms	symptom	NOUN
aji-161	163	34	disappear	disappear	VERB
aji-161	163	35	.	.	PUNCT
aji-161	164	1	then	then	ADV
aji-161	164	2	,	,	PUNCT
aji-161	164	3	the	the	DET
aji-161	164	4	allergen	allergen	NOUN
aji-161	164	5	is	be	AUX
aji-161	164	6	re	re	VERB
aji-161	164	7	-	-	VERB
aji-161	164	8	introduced	introduce	VERB
aji-161	164	9	to	to	PART
aji-161	164	10	observe	observe	VERB
aji-161	164	11	reactions	reaction	NOUN
aji-161	164	12	.	.	PUNCT
aji-161	165	1	however	however	ADV
aji-161	165	2	,	,	PUNCT
aji-161	165	3	this	this	PRON
aji-161	165	4	is	be	AUX
aji-161	165	5	particularly	particularly	ADV
aji-161	165	6	difficult	difficult	ADJ
aji-161	165	7	when	when	SCONJ
aji-161	165	8	polysensitization	polysensitization	NOUN
aji-161	165	9	dominates	dominate	VERB
aji-161	165	10	the	the	DET
aji-161	165	11	clinical	clinical	ADJ
aji-161	165	12	picture	picture	NOUN
aji-161	165	13	.	.	PUNCT
aji-161	166	1	in	in	ADP
aji-161	166	2	order	order	NOUN
aji-161	166	3	to	to	PART
aji-161	166	4	shorten	shorten	VERB
aji-161	166	5	the	the	DET
aji-161	166	6	list	list	NOUN
aji-161	166	7	of	of	ADP
aji-161	166	8	suspected	suspect	VERB
aji-161	166	9	allergens	allergen	NOUN
aji-161	166	10	,	,	PUNCT
aji-161	166	11	we	we	PRON
aji-161	166	12	performed	perform	VERB
aji-161	166	13	triage	triage	NOUN
aji-161	166	14	tests	test	NOUN
aji-161	166	15	to	to	PART
aji-161	166	16	elect	elect	VERB
aji-161	166	17	the	the	DET
aji-161	166	18	allergens	allergen	NOUN
aji-161	166	19	that	that	PRON
aji-161	166	20	will	will	AUX
aji-161	166	21	be	be	AUX
aji-161	166	22	emphasized	emphasize	VERB
aji-161	166	23	in	in	ADP
aji-161	166	24	the	the	DET
aji-161	166	25	exhaustive	exhaustive	ADJ
aji-161	166	26	in	in	ADP
aji-161	166	27	vivo	vivo	ADJ
aji-161	166	28	exclusion	exclusion	NOUN
aji-161	166	29	/	/	SYM
aji-161	166	30	provocation	provocation	NOUN
aji-161	166	31	tests	test	NOUN
aji-161	166	32	.	.	PUNCT
aji-161	167	1	cellular	cellular	ADJ
aji-161	167	2	immunoreactivity	immunoreactivity	NOUN
aji-161	167	3	against	against	ADP
aji-161	167	4	haptens	haptens	PROPN
aji-161	167	5	and	and	CCONJ
aji-161	167	6	hapten	hapten	VERB
aji-161	167	7	-	-	PUNCT
aji-161	167	8	carrier	carrier	NOUN
aji-161	167	9	conjugates	conjugate	NOUN
aji-161	167	10	had	have	AUX
aji-161	167	11	been	be	AUX
aji-161	167	12	classically	classically	ADV
aji-161	167	13	olivier	olivi	ADJ
aji-161	167	14	et	et	PROPN
aji-161	167	15	al	al	PROPN
aji-161	167	16	.	.	PROPN
aji-161	167	17	;	;	PUNCT
aji-161	168	1	asian	asian	PROPN
aji-161	168	2	j.	j.	PROPN
aji-161	168	3	immunol	immunol	PROPN
aji-161	168	4	.	.	PROPN
aji-161	168	5	,	,	PUNCT
aji-161	168	6	vol	vol	NOUN
aji-161	168	7	.	.	PROPN
aji-161	168	8	8	8	NUM
aji-161	168	9	,	,	PUNCT
aji-161	168	10	no	no	INTJ
aji-161	168	11	.	.	NOUN
aji-161	168	12	1	1	NUM
aji-161	168	13	,	,	PUNCT
aji-161	168	14	pp	pp	ADJ
aji-161	168	15	.	.	PUNCT
aji-161	169	1	70	70	NUM
aji-161	169	2	-	-	SYM
aji-161	169	3	81	81	NUM
aji-161	169	4	,	,	PUNCT
aji-161	169	5	2025	2025	NUM
aji-161	169	6	;	;	PUNCT
aji-161	169	7	article	article	NOUN
aji-161	169	8	no.aji.134825	no.aji.134825	VERB
aji-161	169	9	73	73	NUM
aji-161	169	10	evaluated	evaluate	VERB
aji-161	169	11	by	by	ADP
aji-161	169	12	the	the	DET
aji-161	169	13	leukocyte	leukocyte	NOUN
aji-161	169	14	adherence	adherence	NOUN
aji-161	169	15	inhibition	inhibition	NOUN
aji-161	169	16	test	test	NOUN
aji-161	169	17	(	(	PUNCT
aji-161	169	18	lait	lait	NOUN
aji-161	169	19	)	)	PUNCT
aji-161	169	20	(	(	PUNCT
aji-161	169	21	kuratsuji	kuratsuji	PROPN
aji-161	169	22	,	,	PUNCT
aji-161	169	23	1981	1981	NUM
aji-161	169	24	)	)	PUNCT
aji-161	169	25	.	.	PUNCT
aji-161	170	1	humoral	humoral	ADJ
aji-161	170	2	immunoreactivity	immunoreactivity	NOUN
aji-161	170	3	against	against	ADP
aji-161	170	4	haptens	haptens	PROPN
aji-161	170	5	has	have	AUX
aji-161	170	6	been	be	AUX
aji-161	170	7	classically	classically	ADV
aji-161	170	8	evaluated	evaluate	VERB
aji-161	170	9	by	by	ADP
aji-161	170	10	precipitin	precipitin	ADJ
aji-161	170	11	research	research	PROPN
aji-161	170	12	(	(	PUNCT
aji-161	170	13	rittenberg	rittenberg	PROPN
aji-161	170	14	&	&	CCONJ
aji-161	170	15	amkraut	amkraut	PROPN
aji-161	170	16	1966	1966	NUM
aji-161	170	17	)	)	PUNCT
aji-161	170	18	.	.	PUNCT
aji-161	171	1	to	to	PART
aji-161	171	2	evaluate	evaluate	VERB
aji-161	171	3	cellular	cellular	ADJ
aji-161	171	4	immunoreactivity	immunoreactivity	NOUN
aji-161	171	5	,	,	PUNCT
aji-161	171	6	we	we	PRON
aji-161	171	7	employ	employ	VERB
aji-161	171	8	in	in	ADP
aji-161	171	9	our	our	PRON
aji-161	171	10	facilities	facility	NOUN
aji-161	171	11	the	the	DET
aji-161	171	12	lait	lait	NOUN
aji-161	171	13	(	(	PUNCT
aji-161	171	14	olivier	olivier	PROPN
aji-161	171	15	et	et	PROPN
aji-161	171	16	al	al	PROPN
aji-161	171	17	.	.	PROPN
aji-161	171	18	2022b	2022b	NUM
aji-161	171	19	,	,	PUNCT
aji-161	171	20	olivier	olivier	PROPN
aji-161	171	21	et	et	PROPN
aji-161	171	22	al	al	PROPN
aji-161	171	23	.	.	PROPN
aji-161	171	24	2022a	2022a	NUM
aji-161	171	25	,	,	PUNCT
aji-161	171	26	olivier	olivier	PROPN
aji-161	171	27	et	et	PROPN
aji-161	171	28	al	al	PROPN
aji-161	171	29	.	.	PROPN
aji-161	171	30	2022c	2022c	NUM
aji-161	171	31	,	,	PUNCT
aji-161	171	32	olivier	olivier	PROPN
aji-161	171	33	et	et	PROPN
aji-161	171	34	al	al	PROPN
aji-161	171	35	.	.	PROPN
aji-161	171	36	2023b	2023b	NUM
aji-161	171	37	,	,	PUNCT
aji-161	171	38	olivier	olivier	PROPN
aji-161	171	39	et	et	PROPN
aji-161	171	40	al	al	PROPN
aji-161	171	41	.	.	PROPN
aji-161	171	42	2023a	2023a	NUM
aji-161	171	43	)	)	PUNCT
aji-161	171	44	.	.	PUNCT
aji-161	172	1	to	to	PART
aji-161	172	2	evaluate	evaluate	VERB
aji-161	172	3	the	the	DET
aji-161	172	4	humoral	humoral	ADJ
aji-161	172	5	immunoreactivity	immunoreactivity	NOUN
aji-161	172	6	,	,	PUNCT
aji-161	172	7	we	we	PRON
aji-161	172	8	employ	employ	VERB
aji-161	172	9	at	at	ADP
aji-161	172	10	our	our	PRON
aji-161	172	11	facilities	facility	NOUN
aji-161	172	12	the	the	DET
aji-161	172	13	tube	tube	NOUN
aji-161	172	14	titration	titration	NOUN
aji-161	172	15	of	of	ADP
aji-161	172	16	precipitins	precipitin	NOUN
aji-161	172	17	(	(	PUNCT
aji-161	172	18	ttp	ttp	X
aji-161	172	19	)	)	PUNCT
aji-161	172	20	(	(	PUNCT
aji-161	172	21	olivier	olivier	PROPN
aji-161	172	22	et	et	PROPN
aji-161	172	23	al	al	PROPN
aji-161	172	24	.	.	PROPN
aji-161	172	25	2021c	2021c	NUM
aji-161	172	26	,	,	PUNCT
aji-161	172	27	olivier	olivier	PROPN
aji-161	172	28	et	et	PROPN
aji-161	172	29	al	al	PROPN
aji-161	172	30	.	.	PROPN
aji-161	172	31	2021e	2021e	NUM
aji-161	172	32	,	,	PUNCT
aji-161	172	33	olivier	olivier	PROPN
aji-161	172	34	et	et	PROPN
aji-161	172	35	al	al	PROPN
aji-161	172	36	.	.	PROPN
aji-161	172	37	2023c	2023c	PROPN
aji-161	172	38	,	,	PUNCT
aji-161	172	39	olivier	olivier	PROPN
aji-161	172	40	et	et	PROPN
aji-161	172	41	al	al	PROPN
aji-161	172	42	.	.	PROPN
aji-161	172	43	2024f	2024f	NOUN
aji-161	172	44	,	,	PUNCT
aji-161	172	45	olivier	olivier	PROPN
aji-161	172	46	et	et	PROPN
aji-161	172	47	al	al	PROPN
aji-161	172	48	.	.	PROPN
aji-161	172	49	2025b	2025b	NUM
aji-161	172	50	)	)	PUNCT
aji-161	172	51	.	.	PUNCT
aji-161	173	1	the	the	DET
aji-161	173	2	present	present	ADJ
aji-161	173	3	study	study	NOUN
aji-161	173	4	hypothesizes	hypothesize	VERB
aji-161	173	5	that	that	SCONJ
aji-161	173	6	the	the	DET
aji-161	173	7	lait	lait	NOUN
aji-161	173	8	and	and	CCONJ
aji-161	173	9	the	the	DET
aji-161	173	10	ttp	ttp	NOUN
aji-161	173	11	may	may	AUX
aji-161	173	12	help	help	VERB
aji-161	173	13	differentiate	differentiate	VERB
aji-161	173	14	diverse	diverse	ADJ
aji-161	173	15	endotypes	endotype	NOUN
aji-161	173	16	and	and	CCONJ
aji-161	173	17	degrees	degree	NOUN
aji-161	173	18	of	of	ADP
aji-161	173	19	immunoreactivity	immunoreactivity	NOUN
aji-161	173	20	against	against	ADP
aji-161	173	21	formaldehyde	formaldehyde	NOUN
aji-161	173	22	among	among	ADP
aji-161	173	23	patients	patient	NOUN
aji-161	173	24	suffering	suffer	VERB
aji-161	173	25	from	from	ADP
aji-161	173	26	non	non	ADJ
aji-161	173	27	–	–	PUNCT
aji-161	173	28	ige	ige	ADJ
aji-161	173	29	-	-	PUNCT
aji-161	173	30	mediated	mediate	VERB
aji-161	173	31	atopic	atopic	NOUN
aji-161	173	32	and/or	and/or	CCONJ
aji-161	173	33	contact	contact	NOUN
aji-161	173	34	dermatitis	dermatitis	NOUN
aji-161	173	35	.	.	PUNCT
aji-161	174	1	to	to	PART
aji-161	174	2	evaluate	evaluate	VERB
aji-161	174	3	the	the	DET
aji-161	174	4	potential	potential	NOUN
aji-161	174	5	of	of	ADP
aji-161	174	6	the	the	DET
aji-161	174	7	lait	lait	NOUN
aji-161	174	8	and	and	CCONJ
aji-161	174	9	the	the	DET
aji-161	174	10	ttp	ttp	NOUN
aji-161	174	11	to	to	ADP
aji-161	174	12	endotyping	endotype	VERB
aji-161	174	13	non	non	ADJ
aji-161	174	14	-	-	ADJ
aji-161	174	15	ige	ige	ADJ
aji-161	174	16	-	-	PUNCT
aji-161	174	17	mediated	mediate	VERB
aji-161	174	18	immunoreactivity	immunoreactivity	NOUN
aji-161	174	19	against	against	ADP
aji-161	174	20	formaldehyde	formaldehyde	NOUN
aji-161	174	21	,	,	PUNCT
aji-161	174	22	we	we	PRON
aji-161	174	23	retrospectively	retrospectively	ADV
aji-161	174	24	compiled	compile	VERB
aji-161	174	25	the	the	DET
aji-161	174	26	electronic	electronic	ADJ
aji-161	174	27	medical	medical	ADJ
aji-161	174	28	charts	chart	NOUN
aji-161	174	29	of	of	ADP
aji-161	174	30	patients	patient	NOUN
aji-161	174	31	with	with	ADP
aji-161	174	32	these	these	DET
aji-161	174	33	conditions	condition	NOUN
aji-161	174	34	who	who	PRON
aji-161	174	35	were	be	AUX
aji-161	174	36	investigated	investigate	VERB
aji-161	174	37	with	with	ADP
aji-161	174	38	these	these	DET
aji-161	174	39	procedures	procedure	NOUN
aji-161	174	40	in	in	ADP
aji-161	174	41	our	our	PRON
aji-161	174	42	outpatient	outpatient	NOUN
aji-161	174	43	clinic	clinic	NOUN
aji-161	174	44	.	.	PUNCT
aji-161	175	1	2	2	X
aji-161	175	2	.	.	X
aji-161	175	3	materials	material	NOUN
aji-161	175	4	and	and	CCONJ
aji-161	175	5	methods	method	NOUN
aji-161	175	6	2.1	2.1	NUM
aji-161	175	7	subjects	subject	NOUN
aji-161	175	8	after	after	ADP
aji-161	175	9	receiving	receive	VERB
aji-161	175	10	institutional	institutional	ADJ
aji-161	175	11	review	review	NOUN
aji-161	175	12	board	board	NOUN
aji-161	175	13	approval	approval	NOUN
aji-161	175	14	from	from	ADP
aji-161	175	15	the	the	DET
aji-161	175	16	instituto	instituto	PROPN
aji-161	175	17	alergoimuno	alergoimuno	PROPN
aji-161	175	18	de	de	X
aji-161	175	19	americana	americana	PROPN
aji-161	175	20	(	(	PUNCT
aji-161	175	21	brazil	brazil	PROPN
aji-161	175	22	;	;	PUNCT
aji-161	175	23	03/2025	03/2025	NUM
aji-161	175	24	)	)	PUNCT
aji-161	175	25	,	,	PUNCT
aji-161	175	26	we	we	PRON
aji-161	175	27	proceeded	proceed	VERB
aji-161	175	28	with	with	ADP
aji-161	175	29	the	the	DET
aji-161	175	30	electronic	electronic	ADJ
aji-161	175	31	chart	chart	NOUN
aji-161	175	32	review	review	NOUN
aji-161	175	33	of	of	ADP
aji-161	175	34	10,270	10,270	NUM
aji-161	175	35	outpatients	outpatient	NOUN
aji-161	175	36	who	who	PRON
aji-161	175	37	attended	attend	VERB
aji-161	175	38	our	our	PRON
aji-161	175	39	facility	facility	NOUN
aji-161	175	40	from	from	ADP
aji-161	175	41	january	january	PROPN
aji-161	175	42	2018	2018	NUM
aji-161	175	43	to	to	ADP
aji-161	175	44	april	april	PROPN
aji-161	175	45	2025	2025	NUM
aji-161	175	46	.	.	PUNCT
aji-161	176	1	a	a	DET
aji-161	176	2	cohort	cohort	NOUN
aji-161	176	3	of	of	ADP
aji-161	176	4	100	100	NUM
aji-161	176	5	outside	outside	ADJ
aji-161	176	6	patients	patient	NOUN
aji-161	176	7	had	have	AUX
aji-161	176	8	been	be	AUX
aji-161	176	9	submitted	submit	VERB
aji-161	176	10	to	to	ADP
aji-161	176	11	ttp	ttp	PROPN
aji-161	176	12	with	with	ADP
aji-161	176	13	formaldehyde	formaldehyde	NOUN
aji-161	176	14	solution	solution	NOUN
aji-161	176	15	for	for	ADP
aji-161	176	16	presenting	present	VERB
aji-161	176	17	atopic	atopic	NOUN
aji-161	176	18	and/or	and/or	CCONJ
aji-161	176	19	contact	contact	NOUN
aji-161	176	20	dermatitis	dermatitis	NOUN
aji-161	176	21	.	.	PUNCT
aji-161	177	1	this	this	DET
aji-161	177	2	cohort	cohort	NOUN
aji-161	177	3	counted	count	VERB
aji-161	177	4	29	29	NUM
aji-161	177	5	males	male	NOUN
aji-161	177	6	;	;	PUNCT
aji-161	177	7	mean	mean	VERB
aji-161	177	8	age	age	NOUN
aji-161	177	9	38.8	38.8	NUM
aji-161	177	10	years	year	NOUN
aji-161	177	11	;	;	PUNCT
aji-161	177	12	sd	sd	ADP
aji-161	177	13	19.6	19.6	NUM
aji-161	177	14	years	year	NOUN
aji-161	177	15	;	;	PUNCT
aji-161	177	16	range	range	VERB
aji-161	177	17	3	3	NUM
aji-161	177	18	to	to	PART
aji-161	177	19	90	90	NUM
aji-161	177	20	years	year	NOUN
aji-161	177	21	;	;	PUNCT
aji-161	177	22	median	median	NOUN
aji-161	177	23	38	38	NUM
aji-161	177	24	years	year	NOUN
aji-161	177	25	;	;	PUNCT
aji-161	177	26	modes	mode	NOUN
aji-161	177	27	:	:	PUNCT
aji-161	177	28	7	7	NUM
aji-161	177	29	;	;	PUNCT
aji-161	177	30	9	9	NUM
aji-161	177	31	;	;	PUNCT
aji-161	177	32	and	and	CCONJ
aji-161	177	33	70	70	NUM
aji-161	177	34	years	year	NOUN
aji-161	177	35	(	(	PUNCT
aji-161	177	36	each	each	PRON
aji-161	177	37	appeared	appear	VERB
aji-161	177	38	4	4	NUM
aji-161	177	39	times	time	NOUN
aji-161	177	40	)	)	PUNCT
aji-161	177	41	;	;	PUNCT
aji-161	177	42	geometric	geometric	ADJ
aji-161	177	43	mean	mean	NOUN
aji-161	177	44	=	=	SYM
aji-161	177	45	32	32	NUM
aji-161	177	46	years	year	NOUN
aji-161	177	47	.	.	PUNCT
aji-161	178	1	a	a	DET
aji-161	178	2	cohort	cohort	NOUN
aji-161	178	3	of	of	ADP
aji-161	178	4	100	100	NUM
aji-161	178	5	outside	outside	ADJ
aji-161	178	6	patients	patient	NOUN
aji-161	178	7	had	have	AUX
aji-161	178	8	been	be	AUX
aji-161	178	9	submitted	submit	VERB
aji-161	178	10	to	to	ADP
aji-161	178	11	an	an	DET
aji-161	178	12	ex	ex	X
aji-161	178	13	vivo	vivo	NOUN
aji-161	178	14	allergen	allergen	NOUN
aji-161	178	15	challenge	challenge	NOUN
aji-161	178	16	test	test	NOUN
aji-161	178	17	with	with	ADP
aji-161	178	18	formaldehyde	formaldehyde	NOUN
aji-161	178	19	solution	solution	NOUN
aji-161	178	20	monitored	monitor	VERB
aji-161	178	21	with	with	ADP
aji-161	178	22	lait	lait	NOUN
aji-161	178	23	for	for	ADP
aji-161	178	24	presenting	present	VERB
aji-161	178	25	non	non	ADJ
aji-161	178	26	–	–	PUNCT
aji-161	178	27	ige	ige	ADJ
aji-161	178	28	-	-	PUNCT
aji-161	178	29	mediated	mediate	VERB
aji-161	178	30	atopic	atopic	NOUN
aji-161	178	31	and/or	and/or	CCONJ
aji-161	178	32	contact	contact	NOUN
aji-161	178	33	dermatitis	dermatitis	NOUN
aji-161	178	34	.	.	PUNCT
aji-161	179	1	this	this	DET
aji-161	179	2	cohort	cohort	NOUN
aji-161	179	3	counted	count	VERB
aji-161	179	4	29	29	NUM
aji-161	179	5	males	male	NOUN
aji-161	179	6	;	;	PUNCT
aji-161	179	7	mean	mean	VERB
aji-161	179	8	age	age	NOUN
aji-161	179	9	44.7	44.7	NUM
aji-161	179	10	years	year	NOUN
aji-161	179	11	;	;	PUNCT
aji-161	179	12	sd	sd	ADP
aji-161	179	13	19.1	19.1	NUM
aji-161	179	14	years	year	NOUN
aji-161	179	15	;	;	PUNCT
aji-161	179	16	range	range	NOUN
aji-161	179	17	9	9	NUM
aji-161	179	18	to	to	PART
aji-161	179	19	91	91	NUM
aji-161	179	20	years	year	NOUN
aji-161	179	21	;	;	PUNCT
aji-161	179	22	median	median	NOUN
aji-161	179	23	45	45	NUM
aji-161	179	24	years	year	NOUN
aji-161	179	25	;	;	PUNCT
aji-161	179	26	modes	mode	NOUN
aji-161	179	27	=	=	SYM
aji-161	179	28	35	35	NUM
aji-161	179	29	;	;	PUNCT
aji-161	179	30	48	48	NUM
aji-161	179	31	and	and	CCONJ
aji-161	179	32	58	58	NUM
aji-161	179	33	years	year	NOUN
aji-161	179	34	(	(	PUNCT
aji-161	179	35	each	each	PRON
aji-161	179	36	appeared	appear	VERB
aji-161	179	37	three	three	NUM
aji-161	179	38	times	time	NOUN
aji-161	179	39	)	)	PUNCT
aji-161	179	40	;	;	PUNCT
aji-161	179	41	geometric	geometric	ADJ
aji-161	179	42	mean	mean	NOUN
aji-161	179	43	=	=	NOUN
aji-161	179	44	39.5	39.5	NUM
aji-161	179	45	years	year	NOUN
aji-161	179	46	.	.	PUNCT
aji-161	180	1	this	this	DET
aji-161	180	2	study	study	NOUN
aji-161	180	3	did	do	AUX
aji-161	180	4	not	not	PART
aji-161	180	5	include	include	VERB
aji-161	180	6	patients	patient	NOUN
aji-161	180	7	under	under	ADP
aji-161	180	8	biological	biological	ADJ
aji-161	180	9	and/or	and/or	CCONJ
aji-161	180	10	systemic	systemic	ADJ
aji-161	180	11	anti	anti	ADJ
aji-161	180	12	-	-	ADJ
aji-161	180	13	inflammatory	inflammatory	ADJ
aji-161	180	14	therapy	therapy	NOUN
aji-161	180	15	.	.	PUNCT
aji-161	181	1	these	these	DET
aji-161	181	2	procedures	procedure	NOUN
aji-161	181	3	were	be	AUX
aji-161	181	4	offered	offer	VERB
aji-161	181	5	to	to	ADP
aji-161	181	6	patients	patient	NOUN
aji-161	181	7	with	with	ADP
aji-161	181	8	clinical	clinical	ADJ
aji-161	181	9	suspicion	suspicion	NOUN
aji-161	181	10	of	of	ADP
aji-161	181	11	formaldehyde	formaldehyde	NOUN
aji-161	181	12	hypersensitivity	hypersensitivity	NOUN
aji-161	181	13	who	who	PRON
aji-161	181	14	demonstrated	demonstrate	VERB
aji-161	181	15	a	a	DET
aji-161	181	16	nonreactive	nonreactive	ADJ
aji-161	181	17	or	or	CCONJ
aji-161	181	18	inconclusive	inconclusive	ADJ
aji-161	181	19	skin	skin	NOUN
aji-161	181	20	test	test	NOUN
aji-161	181	21	performed	perform	VERB
aji-161	181	22	with	with	ADP
aji-161	181	23	formaldehyde	formaldehyde	NOUN
aji-161	181	24	solution	solution	NOUN
aji-161	181	25	(	(	PUNCT
aji-161	181	26	olivier	olivier	PROPN
aji-161	181	27	et	et	PROPN
aji-161	181	28	al	al	PROPN
aji-161	181	29	.	.	PROPN
aji-161	181	30	2013	2013	NUM
aji-161	181	31	)	)	PUNCT
aji-161	181	32	.	.	PUNCT
aji-161	182	1	2.2	2.2	NUM
aji-161	182	2	formaldehyde	formaldehyde	NOUN
aji-161	182	3	solution	solution	NOUN
aji-161	182	4	the	the	DET
aji-161	182	5	formaldehyde	formaldehyde	NOUN
aji-161	182	6	solution	solution	NOUN
aji-161	182	7	was	be	AUX
aji-161	182	8	prepared	prepare	VERB
aji-161	182	9	with	with	ADP
aji-161	182	10	1.5	1.5	NUM
aji-161	182	11	ml	ml	NOUN
aji-161	182	12	of	of	ADP
aji-161	182	13	a	a	DET
aji-161	182	14	solution	solution	NOUN
aji-161	182	15	of	of	ADP
aji-161	182	16	formaldehyde	formaldehyde	NOUN
aji-161	182	17	10	10	NUM
aji-161	182	18	%	%	NOUN
aji-161	182	19	(	(	PUNCT
aji-161	182	20	perfyl	perfyl	NOUN
aji-161	182	21	tech	tech	NOUN
aji-161	182	22	®	®	NOUN
aji-161	182	23	)	)	PUNCT
aji-161	182	24	diluted	dilute	VERB
aji-161	182	25	to	to	ADP
aji-161	182	26	15	15	NUM
aji-161	182	27	ml	ml	NOUN
aji-161	182	28	with	with	ADP
aji-161	182	29	distilled	distil	VERB
aji-161	182	30	water	water	NOUN
aji-161	182	31	to	to	PART
aji-161	182	32	finalize	finalize	VERB
aji-161	182	33	a	a	DET
aji-161	182	34	1	1	NUM
aji-161	182	35	mg	mg	NUM
aji-161	182	36	/	/	SYM
aji-161	182	37	ml	ml	NOUN
aji-161	182	38	solution	solution	NOUN
aji-161	182	39	to	to	PART
aji-161	182	40	perform	perform	VERB
aji-161	182	41	the	the	DET
aji-161	182	42	allergic	allergic	ADJ
aji-161	182	43	skin	skin	NOUN
aji-161	182	44	tests	test	NOUN
aji-161	182	45	,	,	PUNCT
aji-161	182	46	ttp	ttp	PROPN
aji-161	182	47	and	and	CCONJ
aji-161	182	48	lait	lait	NOUN
aji-161	182	49	.	.	PUNCT
aji-161	183	1	2.3	2.3	NUM
aji-161	183	2	ex	ex	X
aji-161	183	3	vivo	vivo	ADJ
aji-161	183	4	investigation	investigation	NOUN
aji-161	183	5	:	:	PUNCT
aji-161	183	6	leukocyte	leukocyte	ADJ
aji-161	183	7	adherence	adherence	NOUN
aji-161	183	8	inhibition	inhibition	NOUN
aji-161	183	9	test	test	NOUN
aji-161	183	10	2.3.1	2.3.1	NUM
aji-161	183	11	procedure	procedure	NOUN
aji-161	183	12	for	for	ADP
aji-161	183	13	allergen	allergen	NOUN
aji-161	183	14	ex	ex	PRON
aji-161	183	15	vivo	vivo	NOUN
aji-161	183	16	challenging	challenge	VERB
aji-161	183	17	we	we	PRON
aji-161	183	18	performed	perform	VERB
aji-161	183	19	the	the	DET
aji-161	183	20	lait	lait	NOUN
aji-161	183	21	as	as	ADP
aji-161	183	22	previously	previously	ADV
aji-161	183	23	described	describe	VERB
aji-161	183	24	(	(	PUNCT
aji-161	183	25	olivier	olivier	PROPN
aji-161	183	26	et	et	PROPN
aji-161	183	27	al	al	PROPN
aji-161	183	28	.	.	PROPN
aji-161	183	29	2012	2012	NUM
aji-161	183	30	,	,	PUNCT
aji-161	183	31	olivier	olivier	PROPN
aji-161	183	32	et	et	PROPN
aji-161	183	33	al	al	PROPN
aji-161	183	34	.	.	PROPN
aji-161	183	35	2014	2014	NUM
aji-161	183	36	,	,	PUNCT
aji-161	183	37	olivier	olivier	PROPN
aji-161	183	38	et	et	PROPN
aji-161	183	39	al	al	PROPN
aji-161	183	40	.	.	PROPN
aji-161	183	41	2021a	2021a	NUM
aji-161	183	42	,	,	PUNCT
aji-161	183	43	olivier	olivier	PROPN
aji-161	183	44	et	et	PROPN
aji-161	183	45	al	al	PROPN
aji-161	183	46	.	.	PROPN
aji-161	183	47	2021b	2021b	NUM
aji-161	183	48	,	,	PUNCT
aji-161	183	49	olivier	olivier	PROPN
aji-161	183	50	et	et	PROPN
aji-161	183	51	al	al	PROPN
aji-161	183	52	.	.	PROPN
aji-161	183	53	2021d	2021d	NUM
aji-161	183	54	)	)	PUNCT
aji-161	183	55	.	.	PUNCT
aji-161	184	1	shortly	shortly	ADV
aji-161	184	2	,	,	PUNCT
aji-161	184	3	each	each	DET
aji-161	184	4	donor	donor	NOUN
aji-161	184	5	's	's	PART
aji-161	184	6	fresh	fresh	ADJ
aji-161	184	7	plasma	plasma	NOUN
aji-161	184	8	was	be	AUX
aji-161	184	9	divided	divide	VERB
aji-161	184	10	into	into	ADP
aji-161	184	11	two	two	NUM
aji-161	184	12	parts	part	NOUN
aji-161	184	13	and	and	CCONJ
aji-161	184	14	used	use	VERB
aji-161	184	15	in	in	ADP
aji-161	184	16	paralleled	parallel	VERB
aji-161	184	17	ex	ex	PRON
aji-161	184	18	vivo	vivo	ADJ
aji-161	184	19	challenging	challenge	VERB
aji-161	184	20	tests	test	NOUN
aji-161	184	21	with	with	ADP
aji-161	184	22	formaldehyde	formaldehyde	NOUN
aji-161	184	23	solution	solution	NOUN
aji-161	184	24	and	and	CCONJ
aji-161	184	25	the	the	DET
aji-161	184	26	unchallenged	unchallenged	ADJ
aji-161	184	27	plasma	plasma	NOUN
aji-161	184	28	assay	assay	VERB
aji-161	184	29	.	.	PUNCT
aji-161	185	1	we	we	PRON
aji-161	185	2	collected	collect	VERB
aji-161	185	3	plasma	plasma	NOUN
aji-161	185	4	with	with	ADP
aji-161	185	5	high	high	ADJ
aji-161	185	6	leukocyte	leukocyte	NOUN
aji-161	185	7	content	content	NOUN
aji-161	185	8	(	(	PUNCT
aji-161	185	9	buffy	buffy	PROPN
aji-161	185	10	coat	coat	PROPN
aji-161	185	11	)	)	PUNCT
aji-161	185	12	from	from	ADP
aji-161	185	13	the	the	DET
aji-161	185	14	heparinized	heparinize	VERB
aji-161	185	15	tube	tube	NOUN
aji-161	185	16	after	after	ADP
aji-161	185	17	one	one	NUM
aji-161	185	18	hour	hour	NOUN
aji-161	185	19	of	of	ADP
aji-161	185	20	sedimentation	sedimentation	NOUN
aji-161	185	21	at	at	ADP
aji-161	185	22	37	37	NUM
aji-161	185	23	°	°	NOUN
aji-161	185	24	c	c	NOUN
aji-161	185	25	.	.	PUNCT
aji-161	186	1	then	then	ADV
aji-161	186	2	,	,	PUNCT
aji-161	186	3	we	we	PRON
aji-161	186	4	distributed	distribute	VERB
aji-161	186	5	aliquots	aliquot	NOUN
aji-161	186	6	of	of	ADP
aji-161	186	7	100	100	NUM
aji-161	186	8	μl	μl	ADV
aji-161	186	9	into	into	ADP
aji-161	186	10	eppendorf	eppendorf	PROPN
aji-161	186	11	tubes	tube	NOUN
aji-161	186	12	kept	keep	VERB
aji-161	186	13	under	under	ADP
aji-161	186	14	agitation	agitation	NOUN
aji-161	186	15	for	for	ADP
aji-161	186	16	30	30	NUM
aji-161	186	17	minutes	minute	NOUN
aji-161	186	18	(	(	PUNCT
aji-161	186	19	200	200	NUM
aji-161	186	20	rpm	rpm	NOUN
aji-161	186	21	at	at	ADP
aji-161	186	22	37	37	NUM
aji-161	186	23	°	°	NOUN
aji-161	186	24	c	c	NOUN
aji-161	186	25	)	)	PUNCT
aji-161	186	26	with	with	ADP
aji-161	186	27	formaldehyde	formaldehyde	NOUN
aji-161	186	28	solution	solution	NOUN
aji-161	186	29	(	(	PUNCT
aji-161	186	30	10μl	10μl	ADV
aji-161	186	31	)	)	PUNCT
aji-161	186	32	or	or	CCONJ
aji-161	186	33	without	without	ADP
aji-161	186	34	formaldehyde	formaldehyde	NOUN
aji-161	186	35	solution	solution	NOUN
aji-161	186	36	(	(	PUNCT
aji-161	186	37	when	when	SCONJ
aji-161	186	38	used	use	VERB
aji-161	186	39	as	as	ADP
aji-161	186	40	control	control	NOUN
aji-161	186	41	)	)	PUNCT
aji-161	186	42	.	.	PUNCT
aji-161	187	1	2.3.2	2.3.2	NUM
aji-161	187	2	procedure	procedure	NOUN
aji-161	187	3	for	for	ADP
aji-161	187	4	adherence	adherence	NOUN
aji-161	187	5	assay	assay	VERB
aji-161	187	6	after	after	ADP
aji-161	187	7	incubation	incubation	NOUN
aji-161	187	8	,	,	PUNCT
aji-161	187	9	the	the	DET
aji-161	187	10	plasma	plasma	NOUN
aji-161	187	11	was	be	AUX
aji-161	187	12	allocated	allocate	VERB
aji-161	187	13	into	into	ADP
aji-161	187	14	a	a	DET
aji-161	187	15	standard	standard	ADJ
aji-161	187	16	neubauer	neubauer	PROPN
aji-161	187	17	hemocytometer	hemocytometer	PROPN
aji-161	187	18	counting	counting	PROPN
aji-161	187	19	chamber	chamber	NOUN
aji-161	187	20	with	with	ADP
aji-161	187	21	a	a	DET
aji-161	187	22	plain	plain	ADJ
aji-161	187	23	,	,	PUNCT
aji-161	187	24	non	non	ADJ
aji-161	187	25	-	-	ADJ
aji-161	187	26	metallic	metallic	ADJ
aji-161	187	27	glass	glass	NOUN
aji-161	187	28	surface	surface	NOUN
aji-161	187	29	and	and	CCONJ
aji-161	187	30	left	leave	VERB
aji-161	187	31	to	to	PART
aji-161	187	32	stand	stand	VERB
aji-161	187	33	for	for	ADP
aji-161	187	34	2	2	NUM
aji-161	187	35	hours	hour	NOUN
aji-161	187	36	at	at	ADP
aji-161	187	37	37	37	NUM
aji-161	187	38	°	°	SYM
aji-161	187	39	c	c	NOUN
aji-161	187	40	in	in	ADP
aji-161	187	41	the	the	DET
aji-161	187	42	humidified	humidified	ADJ
aji-161	187	43	atmosphere	atmosphere	NOUN
aji-161	187	44	of	of	ADP
aji-161	187	45	the	the	DET
aji-161	187	46	covered	cover	VERB
aji-161	187	47	water	water	NOUN
aji-161	187	48	bath	bath	NOUN
aji-161	187	49	to	to	PART
aji-161	187	50	allow	allow	VERB
aji-161	187	51	leukocytes	leukocyte	NOUN
aji-161	187	52	to	to	PART
aji-161	187	53	adhere	adhere	VERB
aji-161	187	54	to	to	ADP
aji-161	187	55	the	the	DET
aji-161	187	56	glass	glass	NOUN
aji-161	187	57	.	.	PUNCT
aji-161	188	1	next	next	ADV
aji-161	188	2	,	,	PUNCT
aji-161	188	3	we	we	PRON
aji-161	188	4	counted	count	VERB
aji-161	188	5	the	the	DET
aji-161	188	6	leukocytes	leukocyte	NOUN
aji-161	188	7	,	,	PUNCT
aji-161	188	8	removed	remove	VERB
aji-161	188	9	the	the	DET
aji-161	188	10	coverslip	coverslip	NOUN
aji-161	188	11	,	,	PUNCT
aji-161	188	12	and	and	CCONJ
aji-161	188	13	washed	wash	VERB
aji-161	188	14	the	the	DET
aji-161	188	15	chamber	chamber	NOUN
aji-161	188	16	by	by	ADP
aji-161	188	17	immersion	immersion	NOUN
aji-161	188	18	in	in	ADP
aji-161	188	19	a	a	DET
aji-161	188	20	beaker	beaker	NOUN
aji-161	188	21	with	with	ADP
aji-161	188	22	pbs	pbs	PROPN
aji-161	188	23	(	(	PUNCT
aji-161	188	24	phosphatebuffered	phosphatebuffere	VERB
aji-161	188	25	saline	saline	NOUN
aji-161	188	26	)	)	PUNCT
aji-161	188	27	at	at	ADP
aji-161	188	28	37	37	NUM
aji-161	188	29	°	°	NOUN
aji-161	188	30	c	c	NOUN
aji-161	188	31	.	.	PUNCT
aji-161	189	1	then	then	ADV
aji-161	189	2	,	,	PUNCT
aji-161	189	3	we	we	PRON
aji-161	189	4	added	add	VERB
aji-161	189	5	a	a	DET
aji-161	189	6	drop	drop	NOUN
aji-161	189	7	of	of	ADP
aji-161	189	8	pbs	pbs	PROPN
aji-161	189	9	to	to	ADP
aji-161	189	10	the	the	DET
aji-161	189	11	hemocytometer	hemocytometer	NOUN
aji-161	189	12	's	's	PART
aji-161	189	13	chamber	chamber	NOUN
aji-161	189	14	and	and	CCONJ
aji-161	189	15	allocated	allocate	VERB
aji-161	189	16	a	a	DET
aji-161	189	17	clean	clean	ADJ
aji-161	189	18	coverslip	coverslip	NOUN
aji-161	189	19	over	over	ADP
aji-161	189	20	it	it	PRON
aji-161	189	21	.	.	PUNCT
aji-161	190	1	the	the	DET
aji-161	190	2	remaining	remain	VERB
aji-161	190	3	cells	cell	NOUN
aji-161	190	4	were	be	AUX
aji-161	190	5	counted	count	VERB
aji-161	190	6	in	in	ADP
aji-161	190	7	the	the	DET
aji-161	190	8	same	same	ADJ
aji-161	190	9	squares	square	NOUN
aji-161	190	10	as	as	SCONJ
aji-161	190	11	previously	previously	ADV
aji-161	190	12	examined	examine	VERB
aji-161	190	13	.	.	PUNCT
aji-161	191	1	olivier	olivier	PROPN
aji-161	191	2	et	et	PROPN
aji-161	191	3	al	al	PROPN
aji-161	191	4	.	.	PROPN
aji-161	191	5	;	;	PUNCT
aji-161	191	6	asian	asian	PROPN
aji-161	191	7	j.	j.	PROPN
aji-161	191	8	immunol	immunol	PROPN
aji-161	191	9	.	.	PROPN
aji-161	191	10	,	,	PUNCT
aji-161	191	11	vol	vol	NOUN
aji-161	191	12	.	.	PROPN
aji-161	191	13	8	8	NUM
aji-161	191	14	,	,	PUNCT
aji-161	191	15	no	no	INTJ
aji-161	191	16	.	.	NOUN
aji-161	191	17	1	1	NUM
aji-161	191	18	,	,	PUNCT
aji-161	191	19	pp	pp	ADJ
aji-161	191	20	.	.	PUNCT
aji-161	192	1	70	70	NUM
aji-161	192	2	-	-	SYM
aji-161	192	3	81	81	NUM
aji-161	192	4	,	,	PUNCT
aji-161	192	5	2025	2025	NUM
aji-161	192	6	;	;	PUNCT
aji-161	192	7	article	article	NOUN
aji-161	192	8	no.aji.134825	no.aji.134825	VERB
aji-161	192	9	74	74	NUM
aji-161	192	10	2.3.3	2.3.3	NUM
aji-161	192	11	procedure	procedure	NOUN
aji-161	192	12	for	for	ADP
aji-161	192	13	calculation	calculation	NOUN
aji-161	192	14	the	the	DET
aji-161	192	15	percentage	percentage	NOUN
aji-161	192	16	of	of	ADP
aji-161	192	17	leukocyte	leukocyte	NOUN
aji-161	192	18	adherence	adherence	NOUN
aji-161	192	19	(	(	PUNCT
aji-161	192	20	la	la	NOUN
aji-161	192	21	)	)	PUNCT
aji-161	192	22	of	of	ADP
aji-161	192	23	each	each	DET
aji-161	192	24	assay	assay	NOUN
aji-161	192	25	was	be	AUX
aji-161	192	26	estimated	estimate	VERB
aji-161	192	27	as	as	ADP
aji-161	192	28	:	:	PUNCT
aji-161	192	29	(	(	PUNCT
aji-161	192	30	the	the	DET
aji-161	192	31	number	number	NOUN
aji-161	192	32	of	of	ADP
aji-161	192	33	leukocytes	leukocyte	NOUN
aji-161	192	34	observed	observe	VERB
aji-161	192	35	on	on	ADP
aji-161	192	36	the	the	DET
aji-161	192	37	hemocytometry	hemocytometry	PROPN
aji-161	192	38	chamber	chamber	PROPN
aji-161	192	39	after	after	ADP
aji-161	192	40	washing	wash	VERB
aji-161	192	41	divided	divide	VERB
aji-161	192	42	by	by	ADP
aji-161	192	43	the	the	DET
aji-161	192	44	number	number	NOUN
aji-161	192	45	of	of	ADP
aji-161	192	46	leukocytes	leukocyte	NOUN
aji-161	192	47	observed	observe	VERB
aji-161	192	48	on	on	ADP
aji-161	192	49	the	the	DET
aji-161	192	50	hemocytometry	hemocytometry	PROPN
aji-161	192	51	chamber	chamber	PROPN
aji-161	192	52	before	before	ADP
aji-161	192	53	washing	washing	NOUN
aji-161	192	54	)	)	PUNCT
aji-161	192	55	and	and	CCONJ
aji-161	192	56	multiplied	multiply	VERB
aji-161	192	57	by	by	ADP
aji-161	192	58	100	100	NUM
aji-161	192	59	(	(	PUNCT
aji-161	192	60	%	%	NOUN
aji-161	192	61	)	)	PUNCT
aji-161	192	62	.	.	PUNCT
aji-161	193	1	the	the	DET
aji-161	193	2	leukocyte	leukocyte	NOUN
aji-161	193	3	adherence	adherence	NOUN
aji-161	193	4	ratio	ratio	NOUN
aji-161	193	5	(	(	PUNCT
aji-161	193	6	lar	lar	ADJ
aji-161	193	7	)	)	PUNCT
aji-161	193	8	was	be	AUX
aji-161	193	9	estimated	estimate	VERB
aji-161	193	10	based	base	VERB
aji-161	193	11	on	on	ADP
aji-161	193	12	the	the	DET
aji-161	193	13	ratio	ratio	NOUN
aji-161	193	14	between	between	ADP
aji-161	193	15	the	the	DET
aji-161	193	16	la	la	NOUN
aji-161	193	17	from	from	ADP
aji-161	193	18	the	the	DET
aji-161	193	19	antigen	antigen	NOUN
aji-161	193	20	-	-	PUNCT
aji-161	193	21	specific	specific	ADJ
aji-161	193	22	challenged	challenge	VERB
aji-161	193	23	plasma	plasma	NOUN
aji-161	193	24	and	and	CCONJ
aji-161	193	25	the	the	DET
aji-161	193	26	la	la	PROPN
aji-161	193	27	from	from	ADP
aji-161	193	28	the	the	DET
aji-161	193	29	unchallenged	unchallenged	ADJ
aji-161	193	30	control	control	NOUN
aji-161	193	31	plasma	plasma	NOUN
aji-161	193	32	:	:	PUNCT
aji-161	193	33	lar	lar	PROPN
aji-161	193	34	=	=	PUNCT
aji-161	193	35	la	la	PROPN
aji-161	193	36	of	of	ADP
aji-161	193	37	the	the	DET
aji-161	193	38	challenged	challenge	VERB
aji-161	193	39	sample	sample	NOUN
aji-161	193	40	divided	divide	VERB
aji-161	193	41	by	by	ADP
aji-161	193	42	la	la	PROPN
aji-161	193	43	of	of	ADP
aji-161	193	44	unchallenged	unchallenged	ADJ
aji-161	193	45	control	control	NOUN
aji-161	193	46	plasma	plasma	NOUN
aji-161	193	47	multiplied	multiply	VERB
aji-161	193	48	by	by	ADP
aji-161	193	49	100	100	NUM
aji-161	193	50	(	(	PUNCT
aji-161	193	51	%	%	NOUN
aji-161	193	52	)	)	PUNCT
aji-161	193	53	.	.	PUNCT
aji-161	194	1	to	to	PART
aji-161	194	2	further	far	ADV
aji-161	194	3	calculate	calculate	VERB
aji-161	194	4	the	the	DET
aji-161	194	5	leukocyte	leukocyte	NOUN
aji-161	194	6	adherence	adherence	NOUN
aji-161	194	7	inhibition	inhibition	NOUN
aji-161	194	8	(	(	PUNCT
aji-161	194	9	lai	lai	PROPN
aji-161	194	10	)	)	PUNCT
aji-161	194	11	,	,	PUNCT
aji-161	194	12	we	we	PRON
aji-161	194	13	subtracted	subtract	VERB
aji-161	194	14	the	the	DET
aji-161	194	15	lar	lar	NOUN
aji-161	194	16	from	from	ADP
aji-161	194	17	100	100	NUM
aji-161	194	18	(	(	PUNCT
aji-161	194	19	%	%	NOUN
aji-161	194	20	)	)	PUNCT
aji-161	194	21	.	.	PUNCT
aji-161	195	1	we	we	PRON
aji-161	195	2	employed	employ	VERB
aji-161	195	3	the	the	DET
aji-161	195	4	lai	lai	PROPN
aji-161	195	5	results	result	NOUN
aji-161	195	6	for	for	ADP
aji-161	195	7	the	the	DET
aji-161	195	8	cascade	cascade	NOUN
aji-161	195	9	distribution	distribution	NOUN
aji-161	195	10	chart	chart	NOUN
aji-161	195	11	and	and	CCONJ
aji-161	195	12	the	the	DET
aji-161	195	13	statistics	statistic	NOUN
aji-161	195	14	calculations	calculation	NOUN
aji-161	195	15	,	,	PUNCT
aji-161	195	16	both	both	PRON
aji-161	195	17	performed	perform	VERB
aji-161	195	18	with	with	ADP
aji-161	195	19	the	the	DET
aji-161	195	20	help	help	NOUN
aji-161	195	21	of	of	ADP
aji-161	195	22	the	the	DET
aji-161	195	23	microsoft	microsoft	PROPN
aji-161	195	24	excel	excel	PROPN
aji-161	195	25	®	®	NOUN
aji-161	195	26	statistical	statistical	ADJ
aji-161	195	27	package	package	NOUN
aji-161	195	28	.	.	PUNCT
aji-161	196	1	2.4	2.4	NUM
aji-161	196	2	in	in	ADP
aji-161	196	3	vitro	vitro	X
aji-161	196	4	investigation	investigation	NOUN
aji-161	196	5	:	:	PUNCT
aji-161	196	6	tube	tube	NOUN
aji-161	196	7	titration	titration	NOUN
aji-161	196	8	of	of	ADP
aji-161	196	9	precipitins	precipitin	NOUN
aji-161	196	10	(	(	PUNCT
aji-161	196	11	ttp	ttp	NOUN
aji-161	196	12	)	)	PUNCT
aji-161	196	13	as	as	SCONJ
aji-161	196	14	previously	previously	ADV
aji-161	196	15	reported	report	VERB
aji-161	196	16	,	,	PUNCT
aji-161	196	17	a	a	DET
aji-161	196	18	transparent	transparent	ADJ
aji-161	196	19	vitreous	vitreous	ADJ
aji-161	196	20	tube	tube	NOUN
aji-161	196	21	array	array	NOUN
aji-161	196	22	performed	perform	VERB
aji-161	196	23	the	the	DET
aji-161	196	24	semi	semi	ADJ
aji-161	196	25	-	-	ADJ
aji-161	196	26	quantitative	quantitative	ADJ
aji-161	196	27	ttp	ttp	NOUN
aji-161	196	28	against	against	ADP
aji-161	196	29	the	the	DET
aji-161	196	30	formaldehyde	formaldehyde	NOUN
aji-161	196	31	solution	solution	NOUN
aji-161	196	32	(	(	PUNCT
aji-161	196	33	olivier	olivier	PROPN
aji-161	196	34	et	et	PROPN
aji-161	196	35	al	al	PROPN
aji-161	196	36	.	.	PROPN
aji-161	196	37	2024b	2024b	NUM
aji-161	196	38	,	,	PUNCT
aji-161	196	39	olivier	olivier	PROPN
aji-161	196	40	et	et	PROPN
aji-161	196	41	al	al	PROPN
aji-161	196	42	.	.	PROPN
aji-161	196	43	2024c	2024c	NUM
aji-161	196	44	,	,	PUNCT
aji-161	196	45	olivier	olivier	PROPN
aji-161	196	46	et	et	PROPN
aji-161	196	47	al	al	PROPN
aji-161	196	48	.	.	PROPN
aji-161	196	49	2024a	2024a	NUM
aji-161	196	50	,	,	PUNCT
aji-161	196	51	olivier	olivier	PROPN
aji-161	196	52	et	et	PROPN
aji-161	196	53	al	al	PROPN
aji-161	196	54	.	.	PROPN
aji-161	196	55	2024d	2024d	NUM
aji-161	196	56	,	,	PUNCT
aji-161	196	57	olivier	olivier	PROPN
aji-161	196	58	et	et	PROPN
aji-161	196	59	al	al	PROPN
aji-161	196	60	.	.	PROPN
aji-161	196	61	2025a	2025a	NUM
aji-161	196	62	)	)	PUNCT
aji-161	196	63	.	.	PUNCT
aji-161	197	1	shortly	shortly	ADV
aji-161	197	2	,	,	PUNCT
aji-161	197	3	the	the	DET
aji-161	197	4	patient	patient	NOUN
aji-161	197	5	's	's	PART
aji-161	197	6	blood	blood	NOUN
aji-161	197	7	was	be	AUX
aji-161	197	8	collected	collect	VERB
aji-161	197	9	in	in	ADP
aji-161	197	10	a	a	DET
aji-161	197	11	clotactivator	clotactivator	NOUN
aji-161	197	12	collecting	collect	VERB
aji-161	197	13	tube	tube	NOUN
aji-161	197	14	.	.	PUNCT
aji-161	198	1	after	after	ADP
aji-161	198	2	separation	separation	NOUN
aji-161	198	3	,	,	PUNCT
aji-161	198	4	the	the	DET
aji-161	198	5	serum	serum	NOUN
aji-161	198	6	was	be	AUX
aji-161	198	7	centrifugated	centrifugate	VERB
aji-161	198	8	at	at	ADP
aji-161	198	9	2,000	2,000	NUM
aji-161	198	10	rpm	rpm	NOUN
aji-161	198	11	for	for	ADP
aji-161	198	12	10	10	NUM
aji-161	198	13	minutes	minute	NOUN
aji-161	198	14	.	.	PUNCT
aji-161	199	1	the	the	DET
aji-161	199	2	allergen	allergen	NOUN
aji-161	199	3	extracts	extract	NOUN
aji-161	199	4	were	be	AUX
aji-161	199	5	allocated	allocate	VERB
aji-161	199	6	in	in	ADP
aji-161	199	7	sets	set	NOUN
aji-161	199	8	of	of	ADP
aji-161	199	9	eleven	eleven	NUM
aji-161	199	10	glass	glass	NOUN
aji-161	199	11	tubes	tube	NOUN
aji-161	199	12	at	at	ADP
aji-161	199	13	progressive	progressive	ADJ
aji-161	199	14	duplicated	duplicate	VERB
aji-161	199	15	serum	serum	NOUN
aji-161	199	16	dilutions	dilution	NOUN
aji-161	199	17	.	.	PUNCT
aji-161	200	1	the	the	DET
aji-161	200	2	progressive	progressive	ADJ
aji-161	200	3	dilutions	dilution	NOUN
aji-161	200	4	were	be	AUX
aji-161	200	5	combined	combine	VERB
aji-161	200	6	with	with	ADP
aji-161	200	7	the	the	DET
aji-161	200	8	15	15	NUM
aji-161	200	9	μl	μl	NUM
aji-161	200	10	of	of	ADP
aji-161	200	11	the	the	DET
aji-161	200	12	antigen	antigen	ADJ
aji-161	200	13	solution	solution	NOUN
aji-161	200	14	with	with	ADP
aji-161	200	15	250	250	NUM
aji-161	200	16	μl	μl	ADP
aji-161	200	17	of	of	ADP
aji-161	200	18	the	the	DET
aji-161	200	19	patient	patient	NOUN
aji-161	200	20	's	's	PART
aji-161	200	21	serum	serum	NOUN
aji-161	200	22	,	,	PUNCT
aji-161	200	23	progressively	progressively	ADV
aji-161	200	24	diluted	dilute	VERB
aji-161	200	25	into	into	ADP
aji-161	200	26	physiological	physiological	ADJ
aji-161	200	27	saline	saline	NOUN
aji-161	200	28	solution	solution	NOUN
aji-161	200	29	(	(	PUNCT
aji-161	200	30	nacl	nacl	NOUN
aji-161	200	31	0,9	0,9	NUM
aji-161	200	32	%	%	NOUN
aji-161	200	33	)	)	PUNCT
aji-161	200	34	in	in	ADP
aji-161	200	35	the	the	DET
aji-161	200	36	dilution	dilution	NOUN
aji-161	200	37	ratios	ratio	NOUN
aji-161	200	38	of	of	ADP
aji-161	200	39	1:1	1:1	NUM
aji-161	200	40	;	;	PUNCT
aji-161	200	41	1:2	1:2	NUM
aji-161	200	42	;	;	PUNCT
aji-161	200	43	1:4	1:4	NUM
aji-161	200	44	;	;	PUNCT
aji-161	200	45	1:8	1:8	NUM
aji-161	200	46	;	;	PUNCT
aji-161	200	47	1:16	1:16	NUM
aji-161	200	48	;	;	PUNCT
aji-161	200	49	1:32	1:32	NUM
aji-161	200	50	;	;	PUNCT
aji-161	200	51	1:64	1:64	NUM
aji-161	200	52	;	;	PUNCT
aji-161	200	53	1:128	1:128	NUM
aji-161	200	54	;	;	PUNCT
aji-161	200	55	1:256	1:256	NUM
aji-161	200	56	;	;	PUNCT
aji-161	200	57	and	and	CCONJ
aji-161	200	58	1:512	1:512	NUM
aji-161	200	59	.	.	PUNCT
aji-161	201	1	one	one	NUM
aji-161	201	2	tube	tube	NOUN
aji-161	201	3	was	be	AUX
aji-161	201	4	a	a	DET
aji-161	201	5	blank	blank	ADJ
aji-161	201	6	control	control	NOUN
aji-161	201	7	done	do	VERB
aji-161	201	8	with	with	ADP
aji-161	201	9	the	the	DET
aji-161	201	10	water	water	NOUN
aji-161	201	11	and	and	CCONJ
aji-161	201	12	serum	serum	NOUN
aji-161	201	13	to	to	PART
aji-161	201	14	observe	observe	VERB
aji-161	201	15	occasional	occasional	ADJ
aji-161	201	16	spontaneous	spontaneous	ADJ
aji-161	201	17	precipitation	precipitation	NOUN
aji-161	201	18	(	(	PUNCT
aji-161	201	19	sia	sia	PROPN
aji-161	201	20	test	test	NOUN
aji-161	201	21	)	)	PUNCT
aji-161	201	22	.	.	PUNCT
aji-161	202	1	after	after	ADP
aji-161	202	2	24	24	NUM
aji-161	202	3	hours	hour	NOUN
aji-161	202	4	,	,	PUNCT
aji-161	202	5	the	the	DET
aji-161	202	6	tubes	tube	NOUN
aji-161	202	7	were	be	AUX
aji-161	202	8	examined	examine	VERB
aji-161	202	9	,	,	PUNCT
aji-161	202	10	and	and	CCONJ
aji-161	202	11	the	the	DET
aji-161	202	12	titers	titer	NOUN
aji-161	202	13	(	(	PUNCT
aji-161	202	14	the	the	DET
aji-161	202	15	highest	high	ADJ
aji-161	202	16	dilution	dilution	NOUN
aji-161	202	17	factor	factor	NOUN
aji-161	202	18	that	that	PRON
aji-161	202	19	yields	yield	VERB
aji-161	202	20	a	a	DET
aji-161	202	21	positive	positive	ADJ
aji-161	202	22	reading	reading	NOUN
aji-161	202	23	)	)	PUNCT
aji-161	202	24	were	be	AUX
aji-161	202	25	recorded	record	VERB
aji-161	202	26	(	(	PUNCT
aji-161	202	27	williams	williams	PROPN
aji-161	202	28	&	&	CCONJ
aji-161	202	29	chase	chase	PROPN
aji-161	202	30	.	.	PUNCT
aji-161	202	31	1971	1971	NUM
aji-161	202	32	)	)	PUNCT
aji-161	202	33	.	.	PUNCT
aji-161	203	1	3	3	X
aji-161	203	2	.	.	X
aji-161	203	3	results	result	NOUN
aji-161	203	4	as	as	ADP
aji-161	203	5	a	a	DET
aji-161	203	6	retrospective	retrospective	ADJ
aji-161	203	7	survey	survey	NOUN
aji-161	203	8	,	,	PUNCT
aji-161	203	9	there	there	PRON
aji-161	203	10	was	be	VERB
aji-161	203	11	no	no	DET
aji-161	203	12	research	research	NOUN
aji-161	203	13	protocol	protocol	NOUN
aji-161	203	14	;	;	PUNCT
aji-161	203	15	therefore	therefore	ADV
aji-161	203	16	,	,	PUNCT
aji-161	203	17	we	we	PRON
aji-161	203	18	report	report	VERB
aji-161	203	19	the	the	DET
aji-161	203	20	incidental	incidental	ADJ
aji-161	203	21	immune	immune	ADJ
aji-161	203	22	investigation	investigation	NOUN
aji-161	203	23	as	as	SCONJ
aji-161	203	24	registered	register	VERB
aji-161	203	25	in	in	ADP
aji-161	203	26	the	the	DET
aji-161	203	27	digital	digital	ADJ
aji-161	203	28	medical	medical	ADJ
aji-161	203	29	charts	chart	NOUN
aji-161	203	30	.	.	PUNCT
aji-161	204	1	the	the	DET
aji-161	204	2	ttp	ttp	PROPN
aji-161	204	3	showed	show	VERB
aji-161	204	4	a	a	DET
aji-161	204	5	distribution	distribution	NOUN
aji-161	204	6	concentrated	concentrate	VERB
aji-161	204	7	over	over	ADP
aji-161	204	8	the	the	DET
aji-161	204	9	more	more	ADV
aji-161	204	10	diluted	diluted	ADJ
aji-161	204	11	titrations	titration	NOUN
aji-161	204	12	(	(	PUNCT
aji-161	204	13	fig	fig	NOUN
aji-161	204	14	1	1	NUM
aji-161	204	15	)	)	PUNCT
aji-161	204	16	.	.	PUNCT
aji-161	205	1	there	there	PRON
aji-161	205	2	was	be	VERB
aji-161	205	3	no	no	DET
aji-161	205	4	negative	negative	ADJ
aji-161	205	5	result	result	NOUN
aji-161	205	6	.	.	PUNCT
aji-161	206	1	the	the	DET
aji-161	206	2	mean	mean	NOUN
aji-161	206	3	was	be	AUX
aji-161	206	4	estimated	estimate	VERB
aji-161	206	5	at	at	ADP
aji-161	206	6	1:385	1:385	NUM
aji-161	206	7	;	;	PUNCT
aji-161	206	8	the	the	DET
aji-161	206	9	median	median	NOUN
aji-161	206	10	was	be	AUX
aji-161	206	11	1:512	1:512	NUM
aji-161	206	12	;	;	PUNCT
aji-161	206	13	the	the	DET
aji-161	206	14	standard	standard	ADJ
aji-161	206	15	deviation	deviation	NOUN
aji-161	206	16	was	be	AUX
aji-161	206	17	estimated	estimate	VERB
aji-161	206	18	at	at	ADP
aji-161	206	19	1:166	1:166	NUM
aji-161	206	20	;	;	PUNCT
aji-161	206	21	the	the	DET
aji-161	206	22	mode	mode	NOUN
aji-161	206	23	was	be	AUX
aji-161	206	24	1:512	1:512	NUM
aji-161	206	25	(	(	PUNCT
aji-161	206	26	appeared	appear	VERB
aji-161	206	27	61	61	NUM
aji-161	206	28	times	time	NOUN
aji-161	206	29	)	)	PUNCT
aji-161	206	30	.	.	PUNCT
aji-161	207	1	all	all	PRON
aji-161	207	2	sia	sia	PROPN
aji-161	207	3	tests	test	NOUN
aji-161	207	4	were	be	AUX
aji-161	207	5	negative	negative	ADJ
aji-161	207	6	.	.	PUNCT
aji-161	208	1	the	the	DET
aji-161	208	2	cascade	cascade	NOUN
aji-161	208	3	distribution	distribution	NOUN
aji-161	208	4	of	of	ADP
aji-161	208	5	lai	lai	PROPN
aji-161	208	6	results	result	NOUN
aji-161	208	7	demonstrated	demonstrate	VERB
aji-161	208	8	a	a	DET
aji-161	208	9	wide	wide	ADJ
aji-161	208	10	range	range	NOUN
aji-161	208	11	(	(	PUNCT
aji-161	208	12	fig.2	fig.2	PROPN
aji-161	208	13	)	)	PUNCT
aji-161	208	14	.	.	PUNCT
aji-161	209	1	the	the	DET
aji-161	209	2	lai	lai	PROPN
aji-161	209	3	ranged	range	VERB
aji-161	209	4	from	from	ADP
aji-161	209	5	0	0	NUM
aji-161	209	6	%	%	NOUN
aji-161	209	7	to	to	PART
aji-161	209	8	100	100	NUM
aji-161	209	9	%	%	NOUN
aji-161	209	10	.	.	PUNCT
aji-161	210	1	the	the	DET
aji-161	210	2	mean	mean	NOUN
aji-161	210	3	was	be	AUX
aji-161	210	4	57.5	57.5	NUM
aji-161	210	5	%	%	NOUN
aji-161	210	6	;	;	PUNCT
aji-161	210	7	the	the	DET
aji-161	210	8	median	median	NOUN
aji-161	210	9	was	be	AUX
aji-161	210	10	65.5	65.5	NUM
aji-161	210	11	%	%	NOUN
aji-161	210	12	;	;	PUNCT
aji-161	210	13	the	the	DET
aji-161	210	14	standard	standard	ADJ
aji-161	210	15	deviation	deviation	NOUN
aji-161	210	16	was	be	AUX
aji-161	210	17	37.4	37.4	NUM
aji-161	210	18	%	%	NOUN
aji-161	210	19	;	;	PUNCT
aji-161	210	20	the	the	DET
aji-161	210	21	mode	mode	NOUN
aji-161	210	22	was	be	AUX
aji-161	210	23	0	0	NUM
aji-161	210	24	%	%	NOUN
aji-161	210	25	(	(	PUNCT
aji-161	210	26	appeared	appear	VERB
aji-161	210	27	eleven	eleven	NUM
aji-161	210	28	times	time	NOUN
aji-161	210	29	)	)	PUNCT
aji-161	210	30	.	.	PUNCT
aji-161	211	1	about	about	ADV
aji-161	211	2	half	half	DET
aji-161	211	3	the	the	DET
aji-161	211	4	patients	patient	NOUN
aji-161	211	5	presented	present	VERB
aji-161	211	6	high	high	ADJ
aji-161	211	7	immunoreactivity	immunoreactivity	NOUN
aji-161	211	8	during	during	ADP
aji-161	211	9	the	the	DET
aji-161	211	10	ex	ex	ADJ
aji-161	211	11	vivo	vivo	NOUN
aji-161	211	12	challenge	challenge	NOUN
aji-161	211	13	test	test	NOUN
aji-161	211	14	(	(	PUNCT
aji-161	211	15	lai	lai	PROPN
aji-161	211	16	>	>	X
aji-161	211	17	60	60	NUM
aji-161	211	18	%	%	NOUN
aji-161	211	19	)	)	PUNCT
aji-161	211	20	.	.	PUNCT
aji-161	212	1	fig	fig	NOUN
aji-161	212	2	.	.	PUNCT
aji-161	213	1	1	1	NUM
aji-161	213	2	.	.	X
aji-161	213	3	cascade	cascade	NOUN
aji-161	213	4	distribution	distribution	NOUN
aji-161	213	5	chart	chart	NOUN
aji-161	213	6	of	of	ADP
aji-161	213	7	the	the	DET
aji-161	213	8	tube	tube	NOUN
aji-161	213	9	titration	titration	NOUN
aji-161	213	10	of	of	ADP
aji-161	213	11	precipitins	precipitin	NOUN
aji-161	213	12	(	(	PUNCT
aji-161	213	13	x	x	NOUN
aji-161	213	14	-	-	ADJ
aji-161	213	15	axis	axis	ADJ
aji-161	213	16	%	%	NOUN
aji-161	213	17	)	)	PUNCT
aji-161	213	18	resulting	result	VERB
aji-161	213	19	from	from	ADP
aji-161	213	20	the	the	DET
aji-161	213	21	formaldehyde	formaldehyde	NOUN
aji-161	213	22	solution	solution	NOUN
aji-161	213	23	against	against	ADP
aji-161	213	24	the	the	DET
aji-161	213	25	serum	serum	NOUN
aji-161	213	26	of	of	ADP
aji-161	213	27	a	a	DET
aji-161	213	28	cohort	cohort	NOUN
aji-161	213	29	of	of	ADP
aji-161	213	30	100	100	NUM
aji-161	213	31	tests	test	NOUN
aji-161	213	32	/	/	SYM
aji-161	213	33	subjects	subject	NOUN
aji-161	213	34	(	(	PUNCT
aji-161	213	35	y	y	NOUN
aji-161	213	36	-	-	PUNCT
aji-161	213	37	axis	axis	NOUN
aji-161	213	38	)	)	PUNCT
aji-161	213	39	olivier	olivier	NOUN
aji-161	213	40	et	et	PROPN
aji-161	213	41	al	al	PROPN
aji-161	213	42	.	.	PROPN
aji-161	213	43	;	;	PUNCT
aji-161	213	44	asian	asian	PROPN
aji-161	213	45	j.	j.	PROPN
aji-161	213	46	immunol	immunol	PROPN
aji-161	213	47	.	.	PROPN
aji-161	213	48	,	,	PUNCT
aji-161	213	49	vol	vol	NOUN
aji-161	213	50	.	.	PROPN
aji-161	213	51	8	8	NUM
aji-161	213	52	,	,	PUNCT
aji-161	213	53	no	no	INTJ
aji-161	213	54	.	.	NOUN
aji-161	213	55	1	1	NUM
aji-161	213	56	,	,	PUNCT
aji-161	213	57	pp	pp	ADJ
aji-161	213	58	.	.	PUNCT
aji-161	214	1	70	70	NUM
aji-161	214	2	-	-	SYM
aji-161	214	3	81	81	NUM
aji-161	214	4	,	,	PUNCT
aji-161	214	5	2025	2025	NUM
aji-161	214	6	;	;	PUNCT
aji-161	214	7	article	article	NOUN
aji-161	214	8	no.aji.134825	no.aji.134825	VERB
aji-161	214	9	75	75	NUM
aji-161	214	10	fig	fig	NOUN
aji-161	214	11	.	.	PUNCT
aji-161	215	1	2	2	NUM
aji-161	215	2	.	.	NOUN
aji-161	215	3	cascade	cascade	NOUN
aji-161	215	4	distribution	distribution	NOUN
aji-161	215	5	chart	chart	NOUN
aji-161	215	6	of	of	ADP
aji-161	215	7	the	the	DET
aji-161	215	8	range	range	NOUN
aji-161	215	9	groups	group	NOUN
aji-161	215	10	of	of	ADP
aji-161	215	11	leukocyte	leukocyte	NOUN
aji-161	215	12	adherence	adherence	NOUN
aji-161	215	13	inhibition	inhibition	NOUN
aji-161	215	14	(	(	PUNCT
aji-161	215	15	lai	lai	NOUN
aji-161	215	16	)	)	PUNCT
aji-161	215	17	results	result	NOUN
aji-161	215	18	(	(	PUNCT
aji-161	215	19	x	x	NOUN
aji-161	215	20	-	-	ADJ
aji-161	215	21	axis	axis	ADJ
aji-161	215	22	%	%	NOUN
aji-161	215	23	)	)	PUNCT
aji-161	215	24	of	of	ADP
aji-161	215	25	ex	ex	PRON
aji-161	215	26	vivo	vivo	ADJ
aji-161	215	27	formaldehyde	formaldehyde	NOUN
aji-161	215	28	solution	solution	NOUN
aji-161	215	29	monitored	monitor	VERB
aji-161	215	30	by	by	ADP
aji-161	215	31	the	the	DET
aji-161	215	32	leukocyte	leukocyte	NOUN
aji-161	215	33	adherence	adherence	NOUN
aji-161	215	34	inhibition	inhibition	NOUN
aji-161	215	35	test	test	NOUN
aji-161	215	36	(	(	PUNCT
aji-161	215	37	lait	lait	NOUN
aji-161	215	38	)	)	PUNCT
aji-161	215	39	,	,	PUNCT
aji-161	215	40	according	accord	VERB
aji-161	215	41	to	to	ADP
aji-161	215	42	the	the	DET
aji-161	215	43	respective	respective	ADJ
aji-161	215	44	number	number	NOUN
aji-161	215	45	of	of	ADP
aji-161	215	46	outcomes	outcome	NOUN
aji-161	215	47	over	over	ADP
aji-161	215	48	a	a	DET
aji-161	215	49	cohort	cohort	NOUN
aji-161	215	50	with	with	ADP
aji-161	215	51	100	100	NUM
aji-161	215	52	tests	test	NOUN
aji-161	215	53	/	/	SYM
aji-161	215	54	subjects	subject	NOUN
aji-161	215	55	(	(	PUNCT
aji-161	215	56	y	y	NOUN
aji-161	215	57	-	-	PUNCT
aji-161	215	58	axis	axis	NOUN
aji-161	215	59	)	)	PUNCT
aji-161	215	60	all	all	DET
aji-161	215	61	patients	patient	NOUN
aji-161	215	62	evaluated	evaluate	VERB
aji-161	215	63	with	with	ADP
aji-161	215	64	ttp	ttp	PROPN
aji-161	215	65	demonstrated	demonstrate	VERB
aji-161	215	66	some	some	DET
aji-161	215	67	degree	degree	NOUN
aji-161	215	68	of	of	ADP
aji-161	215	69	humoral	humoral	ADJ
aji-161	215	70	immunoreactivity	immunoreactivity	NOUN
aji-161	215	71	,	,	PUNCT
aji-161	215	72	and	and	CCONJ
aji-161	215	73	most	most	ADV
aji-161	215	74	presented	present	VERB
aji-161	215	75	positivity	positivity	NOUN
aji-161	215	76	by	by	ADP
aji-161	215	77	the	the	DET
aji-161	215	78	more	more	ADV
aji-161	215	79	diluted	diluted	ADJ
aji-161	215	80	titrations	titration	NOUN
aji-161	215	81	.	.	PUNCT
aji-161	216	1	eleven	eleven	NUM
aji-161	216	2	patients	patient	NOUN
aji-161	216	3	did	do	AUX
aji-161	216	4	not	not	PART
aji-161	216	5	present	present	VERB
aji-161	216	6	cellular	cellular	ADJ
aji-161	216	7	immunoreactivity	immunoreactivity	NOUN
aji-161	216	8	against	against	ADP
aji-161	216	9	formaldehyde	formaldehyde	NOUN
aji-161	216	10	(	(	PUNCT
aji-161	216	11	lai	lai	NOUN
aji-161	216	12	=	=	PUNCT
aji-161	216	13	zero%	zero%	NUM
aji-161	216	14	)	)	PUNCT
aji-161	216	15	,	,	PUNCT
aji-161	216	16	while	while	SCONJ
aji-161	216	17	others	other	NOUN
aji-161	216	18	presented	present	VERB
aji-161	216	19	an	an	DET
aji-161	216	20	extensive	extensive	ADJ
aji-161	216	21	range	range	NOUN
aji-161	216	22	of	of	ADP
aji-161	216	23	inhibition	inhibition	NOUN
aji-161	216	24	of	of	ADP
aji-161	216	25	the	the	DET
aji-161	216	26	leukocyte	leukocyte	NOUN
aji-161	216	27	adherence	adherence	NOUN
aji-161	216	28	after	after	ADP
aji-161	216	29	the	the	DET
aji-161	216	30	ex	ex	ADJ
aji-161	216	31	vivo	vivo	ADJ
aji-161	216	32	provocation	provocation	NOUN
aji-161	216	33	test	test	NOUN
aji-161	216	34	.	.	PUNCT
aji-161	217	1	4	4	X
aji-161	217	2	.	.	X
aji-161	217	3	discussion	discussion	NOUN
aji-161	217	4	despite	despite	SCONJ
aji-161	217	5	being	be	AUX
aji-161	217	6	universally	universally	ADV
aji-161	217	7	recognized	recognize	VERB
aji-161	217	8	by	by	ADP
aji-161	217	9	its	its	PRON
aji-161	217	10	sensitizing	sensitize	VERB
aji-161	217	11	properties	property	NOUN
aji-161	217	12	,	,	PUNCT
aji-161	217	13	little	little	ADJ
aji-161	217	14	is	be	AUX
aji-161	217	15	known	know	VERB
aji-161	217	16	about	about	ADP
aji-161	217	17	the	the	DET
aji-161	217	18	intrinsic	intrinsic	ADJ
aji-161	217	19	physiopathology	physiopathology	NOUN
aji-161	217	20	of	of	ADP
aji-161	217	21	the	the	DET
aji-161	217	22	immunoreactivity	immunoreactivity	NOUN
aji-161	217	23	(	(	PUNCT
aji-161	217	24	or	or	CCONJ
aji-161	217	25	immunoreactivities	immunoreactivitie	NOUN
aji-161	217	26	)	)	PUNCT
aji-161	217	27	against	against	ADP
aji-161	217	28	formaldehyde	formaldehyde	NOUN
aji-161	217	29	.	.	PUNCT
aji-161	218	1	formaldehyde	formaldehyde	NOUN
aji-161	218	2	can	can	AUX
aji-161	218	3	establish	establish	VERB
aji-161	218	4	cross	cross	ADJ
aji-161	218	5	-	-	ADJ
aji-161	218	6	linking	linking	ADJ
aji-161	218	7	reactions	reaction	NOUN
aji-161	218	8	among	among	ADP
aji-161	218	9	several	several	ADJ
aji-161	218	10	amino	amino	ADJ
aji-161	218	11	acids	acid	NOUN
aji-161	218	12	,	,	PUNCT
aji-161	218	13	producing	produce	VERB
aji-161	218	14	deformation	deformation	NOUN
aji-161	218	15	in	in	ADP
aji-161	218	16	the	the	DET
aji-161	218	17	proteins	protein	NOUN
aji-161	218	18	'	'	PART
aji-161	218	19	tertiary	tertiary	ADJ
aji-161	218	20	structure	structure	NOUN
aji-161	218	21	and	and	CCONJ
aji-161	218	22	altering	alter	VERB
aji-161	218	23	their	their	PRON
aji-161	218	24	immunoreactivity	immunoreactivity	NOUN
aji-161	218	25	(	(	PUNCT
aji-161	218	26	sompuram	sompuram	PROPN
aji-161	218	27	et	et	PROPN
aji-161	218	28	al	al	PROPN
aji-161	218	29	.	.	PROPN
aji-161	218	30	2004	2004	NUM
aji-161	218	31	,	,	PUNCT
aji-161	218	32	fraenkel	fraenkel	NOUN
aji-161	218	33	-	-	PUNCT
aji-161	218	34	conrat	conrat	NOUN
aji-161	218	35	et	et	PROPN
aji-161	218	36	al	al	PROPN
aji-161	218	37	.	.	PROPN
aji-161	218	38	,	,	PUNCT
aji-161	218	39	1947	1947	NUM
aji-161	218	40	;	;	PUNCT
aji-161	218	41	fraenkelconrat	fraenkelconrat	NOUN
aji-161	218	42	&	&	CCONJ
aji-161	218	43	olcott	olcott	PROPN
aji-161	218	44	,	,	PUNCT
aji-161	218	45	1948b	1948b	NUM
aji-161	218	46	;	;	PUNCT
aji-161	218	47	fraenkel	fraenkel	NOUN
aji-161	218	48	-	-	PUNCT
aji-161	218	49	conrat	conrat	NOUN
aji-161	218	50	&	&	CCONJ
aji-161	218	51	olcott	olcott	ADJ
aji-161	218	52	1948a	1948a	NUM
aji-161	218	53	)	)	PUNCT
aji-161	218	54	.	.	PUNCT
aji-161	219	1	when	when	SCONJ
aji-161	219	2	absorbed	absorb	VERB
aji-161	219	3	into	into	ADP
aji-161	219	4	human	human	ADJ
aji-161	219	5	blood	blood	NOUN
aji-161	219	6	current	current	NOUN
aji-161	219	7	,	,	PUNCT
aji-161	219	8	formaldehyde	formaldehyde	NOUN
aji-161	219	9	may	may	AUX
aji-161	219	10	conjugate	conjugate	VERB
aji-161	219	11	with	with	ADP
aji-161	219	12	serum	serum	NOUN
aji-161	219	13	proteins	protein	NOUN
aji-161	219	14	,	,	PUNCT
aji-161	219	15	such	such	ADJ
aji-161	219	16	as	as	ADP
aji-161	219	17	the	the	DET
aji-161	219	18	human	human	ADJ
aji-161	219	19	serum	serum	NOUN
aji-161	219	20	albumin	albumin	NOUN
aji-161	219	21	(	(	PUNCT
aji-161	219	22	has	have	AUX
aji-161	219	23	)	)	PUNCT
aji-161	219	24	,	,	PUNCT
aji-161	219	25	forming	form	VERB
aji-161	219	26	hapten	hapten	VERB
aji-161	219	27	-	-	PUNCT
aji-161	219	28	carrier	carrier	NOUN
aji-161	219	29	complexes	complex	NOUN
aji-161	219	30	able	able	ADJ
aji-161	219	31	to	to	PART
aji-161	219	32	develop	develop	VERB
aji-161	219	33	the	the	DET
aji-161	219	34	production	production	NOUN
aji-161	219	35	of	of	ADP
aji-161	219	36	antibodies	antibody	NOUN
aji-161	219	37	(	(	PUNCT
aji-161	219	38	ige	ige	PROPN
aji-161	219	39	,	,	PUNCT
aji-161	219	40	igm	igm	PROPN
aji-161	219	41	,	,	PUNCT
aji-161	219	42	igg	igg	PROPN
aji-161	219	43	,	,	PUNCT
aji-161	219	44	and	and	CCONJ
aji-161	219	45	iga	iga	PROPN
aji-161	219	46	)	)	PUNCT
aji-161	219	47	against	against	ADP
aji-161	219	48	their	their	PRON
aji-161	219	49	non	non	ADJ
aji-161	219	50	-	-	ADJ
aji-161	219	51	self	self	NOUN
aji-161	219	52	-	-	PUNCT
aji-161	219	53	conjugates	conjugate	NOUN
aji-161	219	54	(	(	PUNCT
aji-161	219	55	patterson	patterson	PROPN
aji-161	219	56	et	et	PROPN
aji-161	219	57	al	al	PROPN
aji-161	219	58	.	.	PROPN
aji-161	219	59	1986	1986	NUM
aji-161	219	60	,	,	PUNCT
aji-161	219	61	patterson	patterson	PROPN
aji-161	219	62	et	et	PROPN
aji-161	219	63	al	al	PROPN
aji-161	219	64	.	.	PROPN
aji-161	219	65	1989	1989	NUM
aji-161	219	66	)	)	PUNCT
aji-161	219	67	.	.	PUNCT
aji-161	220	1	ige	ige	PROPN
aji-161	220	2	-	-	PUNCT
aji-161	220	3	mediated	mediate	VERB
aji-161	220	4	sensitization	sensitization	NOUN
aji-161	220	5	against	against	ADP
aji-161	220	6	formaldehyde	formaldehyde	NOUN
aji-161	220	7	is	be	AUX
aji-161	220	8	not	not	PART
aji-161	220	9	an	an	DET
aji-161	220	10	easy	easy	ADJ
aji-161	220	11	diagnosis	diagnosis	NOUN
aji-161	220	12	but	but	CCONJ
aji-161	220	13	has	have	AUX
aji-161	220	14	already	already	ADV
aji-161	220	15	been	be	AUX
aji-161	220	16	described	describe	VERB
aji-161	220	17	in	in	ADP
aji-161	220	18	children	child	NOUN
aji-161	220	19	exposed	expose	VERB
aji-161	220	20	to	to	ADP
aji-161	220	21	gaseous	gaseous	ADJ
aji-161	220	22	formaldehyde	formaldehyde	NOUN
aji-161	220	23	(	(	PUNCT
aji-161	220	24	kramps	kramp	NOUN
aji-161	220	25	et	et	PROPN
aji-161	220	26	al	al	PROPN
aji-161	220	27	.	.	PROPN
aji-161	220	28	1989	1989	NUM
aji-161	220	29	,	,	PUNCT
aji-161	220	30	wantke	wantke	PROPN
aji-161	220	31	et	et	PROPN
aji-161	220	32	al	al	PROPN
aji-161	220	33	.	.	PROPN
aji-161	220	34	1996a	1996a	NUM
aji-161	220	35	,	,	PUNCT
aji-161	220	36	wantke	wantke	PROPN
aji-161	220	37	et	et	PROPN
aji-161	220	38	al	al	PROPN
aji-161	220	39	.	.	PROPN
aji-161	220	40	1996b	1996b	NUM
aji-161	220	41	,	,	PUNCT
aji-161	220	42	mizuki	mizuki	PROPN
aji-161	220	43	&	&	CCONJ
aji-161	220	44	tsuda	tsuda	NOUN
aji-161	220	45	2001	2001	NUM
aji-161	220	46	)	)	PUNCT
aji-161	220	47	.	.	PUNCT
aji-161	221	1	additionally	additionally	ADV
aji-161	221	2	,	,	PUNCT
aji-161	221	3	to	to	ADP
aji-161	221	4	the	the	DET
aji-161	221	5	capacity	capacity	NOUN
aji-161	221	6	to	to	PART
aji-161	221	7	produce	produce	VERB
aji-161	221	8	antibodies	antibody	NOUN
aji-161	221	9	against	against	ADP
aji-161	221	10	the	the	DET
aji-161	221	11	formaldehyde	formaldehyde	NOUN
aji-161	221	12	-	-	PUNCT
aji-161	221	13	has	have	AUX
aji-161	221	14	conjugated	conjugate	VERB
aji-161	221	15	,	,	PUNCT
aji-161	221	16	analysis	analysis	NOUN
aji-161	221	17	of	of	ADP
aji-161	221	18	individuals	individual	NOUN
aji-161	221	19	occupationally	occupationally	ADV
aji-161	221	20	exposed	expose	VERB
aji-161	221	21	to	to	ADP
aji-161	221	22	formaldehyde	formaldehyde	NOUN
aji-161	221	23	demonstrated	demonstrate	VERB
aji-161	221	24	elevated	elevate	VERB
aji-161	221	25	t	t	NOUN
aji-161	221	26	antigen	antigen	NOUN
aji-161	221	27	memory	memory	NOUN
aji-161	221	28	cells	cell	NOUN
aji-161	221	29	and	and	CCONJ
aji-161	221	30	lymphocyte	lymphocyte	ADJ
aji-161	221	31	subpopulations	subpopulation	NOUN
aji-161	221	32	of	of	ADP
aji-161	221	33	t	t	PROPN
aji-161	221	34	-	-	PUNCT
aji-161	221	35	helper	helper	NOUN
aji-161	221	36	/	/	SYM
aji-161	221	37	suppressor	suppressor	NOUN
aji-161	221	38	(	(	PUNCT
aji-161	221	39	h	h	NOUN
aji-161	221	40	/	/	SYM
aji-161	221	41	s	s	NOUN
aji-161	221	42	)	)	PUNCT
aji-161	221	43	ratios	ratio	NOUN
aji-161	221	44	ranging	range	VERB
aji-161	221	45	from	from	ADP
aji-161	221	46	0.8	0.8	NUM
aji-161	221	47	to	to	ADP
aji-161	221	48	3.3	3.3	NUM
aji-161	221	49	,	,	PUNCT
aji-161	221	50	suggesting	suggest	VERB
aji-161	221	51	chronic	chronic	ADJ
aji-161	221	52	antigenic	antigenic	ADJ
aji-161	221	53	stimulation	stimulation	NOUN
aji-161	221	54	by	by	ADP
aji-161	221	55	formaldehyde	formaldehyde	NOUN
aji-161	221	56	(	(	PUNCT
aji-161	221	57	thrasher	thrasher	NOUN
aji-161	221	58	et	et	PROPN
aji-161	221	59	al	al	PROPN
aji-161	221	60	.	.	PROPN
aji-161	221	61	,	,	PUNCT
aji-161	221	62	1988	1988	NUM
aji-161	221	63	)	)	PUNCT
aji-161	221	64	.	.	PUNCT
aji-161	222	1	there	there	PRON
aji-161	222	2	is	be	VERB
aji-161	222	3	no	no	DET
aji-161	222	4	standardized	standardized	ADJ
aji-161	222	5	lab	lab	NOUN
aji-161	222	6	examination	examination	NOUN
aji-161	222	7	to	to	AUX
aji-161	222	8	(	(	PUNCT
aji-161	222	9	unequivocally	unequivocally	ADV
aji-161	222	10	)	)	PUNCT
aji-161	222	11	diagnose	diagnose	NOUN
aji-161	222	12	non	non	PROPN
aji-161	222	13	–	–	PUNCT
aji-161	222	14	ige	ige	ADJ
aji-161	222	15	-	-	PUNCT
aji-161	222	16	mediated	mediate	VERB
aji-161	222	17	formaldehyde	formaldehyde	NOUN
aji-161	222	18	hypersensitivity	hypersensitivity	NOUN
aji-161	222	19	or	or	CCONJ
aji-161	222	20	to	to	PART
aji-161	222	21	suggest	suggest	VERB
aji-161	222	22	formaldehyde	formaldehyde	NOUN
aji-161	222	23	immunoreactivity	immunoreactivity	NOUN
aji-161	222	24	.	.	PUNCT
aji-161	223	1	however	however	ADV
aji-161	223	2	,	,	PUNCT
aji-161	223	3	endotyping	endotype	VERB
aji-161	223	4	the	the	DET
aji-161	223	5	mechanisms	mechanism	NOUN
aji-161	223	6	responsible	responsible	ADJ
aji-161	223	7	for	for	ADP
aji-161	223	8	allergic	allergic	ADJ
aji-161	223	9	phenotypes	phenotype	NOUN
aji-161	223	10	is	be	AUX
aji-161	223	11	crucial	crucial	ADJ
aji-161	223	12	for	for	ADP
aji-161	223	13	diagnosing	diagnose	VERB
aji-161	223	14	and	and	CCONJ
aji-161	223	15	supervising	supervise	VERB
aji-161	223	16	treatments	treatment	NOUN
aji-161	223	17	under	under	ADP
aji-161	223	18	personalized	personalized	ADJ
aji-161	223	19	medicine	medicine	NOUN
aji-161	223	20	and	and	CCONJ
aji-161	223	21	recognizing	recognize	VERB
aji-161	223	22	differential	differential	ADJ
aji-161	223	23	diagnoses	diagnosis	NOUN
aji-161	223	24	among	among	ADP
aji-161	223	25	phenotypes	phenotype	NOUN
aji-161	223	26	(	(	PUNCT
aji-161	223	27	olivier	olivier	NOUN
aji-161	223	28	.	.	PUNCT
aji-161	224	1	2024	2024	NUM
aji-161	224	2	)	)	PUNCT
aji-161	224	3	.	.	PUNCT
aji-161	225	1	several	several	ADJ
aji-161	225	2	phenotypes	phenotype	NOUN
aji-161	225	3	have	have	AUX
aji-161	225	4	been	be	AUX
aji-161	225	5	described	describe	VERB
aji-161	225	6	;	;	PUNCT
aji-161	225	7	however	however	ADV
aji-161	225	8	,	,	PUNCT
aji-161	225	9	the	the	DET
aji-161	225	10	endotypes	endotype	NOUN
aji-161	225	11	have	have	AUX
aji-161	225	12	been	be	AUX
aji-161	225	13	poorly	poorly	ADV
aji-161	225	14	explored	explore	VERB
aji-161	225	15	since	since	SCONJ
aji-161	225	16	the	the	DET
aji-161	225	17	main	main	ADJ
aji-161	225	18	clinical	clinical	ADJ
aji-161	225	19	tools	tool	NOUN
aji-161	225	20	to	to	PART
aji-161	225	21	verify	verify	VERB
aji-161	225	22	hypersensitivity	hypersensitivity	NOUN
aji-161	225	23	against	against	ADP
aji-161	225	24	formaldehyde	formaldehyde	NOUN
aji-161	225	25	are	be	AUX
aji-161	225	26	still	still	ADV
aji-161	225	27	the	the	DET
aji-161	225	28	cutaneous	cutaneous	ADJ
aji-161	225	29	tests	test	NOUN
aji-161	225	30	.	.	PUNCT
aji-161	226	1	as	as	ADP
aji-161	226	2	a	a	DET
aji-161	226	3	proof	proof	NOUN
aji-161	226	4	-	-	PUNCT
aji-161	226	5	of	of	ADP
aji-161	226	6	-	-	PUNCT
aji-161	226	7	concept	concept	NOUN
aji-161	226	8	,	,	PUNCT
aji-161	226	9	we	we	PRON
aji-161	226	10	submitted	submit	VERB
aji-161	226	11	formaldehyde	formaldehyde	NOUN
aji-161	226	12	to	to	ADP
aji-161	226	13	an	an	DET
aji-161	226	14	ex	ex	X
aji-161	226	15	vivo	vivo	NOUN
aji-161	226	16	challenge	challenge	NOUN
aji-161	226	17	monitored	monitor	VERB
aji-161	226	18	by	by	ADP
aji-161	226	19	the	the	DET
aji-161	226	20	lait	lait	NOUN
aji-161	226	21	to	to	PART
aji-161	226	22	demonstrate	demonstrate	VERB
aji-161	226	23	cellular	cellular	ADJ
aji-161	226	24	immunoreactivity	immunoreactivity	NOUN
aji-161	226	25	.	.	PUNCT
aji-161	227	1	in	in	ADP
aji-161	227	2	the	the	DET
aji-161	227	3	same	same	ADJ
aji-161	227	4	proof	proof	NOUN
aji-161	227	5	-	-	PUNCT
aji-161	227	6	of	of	ADP
aji-161	227	7	-	-	PUNCT
aji-161	227	8	concept	concept	NOUN
aji-161	227	9	mentality	mentality	NOUN
aji-161	227	10	,	,	PUNCT
aji-161	227	11	we	we	PRON
aji-161	227	12	titrated	titrate	VERB
aji-161	227	13	precipitins	precipitin	NOUN
aji-161	227	14	against	against	ADP
aji-161	227	15	formaldehyde	formaldehyde	NOUN
aji-161	227	16	to	to	PART
aji-161	227	17	demonstrate	demonstrate	VERB
aji-161	227	18	humoral	humoral	ADJ
aji-161	227	19	olivier	olivier	NOUN
aji-161	227	20	et	et	PROPN
aji-161	227	21	al	al	PROPN
aji-161	227	22	.	.	PROPN
aji-161	227	23	;	;	PUNCT
aji-161	228	1	asian	asian	PROPN
aji-161	228	2	j.	j.	PROPN
aji-161	228	3	immunol	immunol	PROPN
aji-161	228	4	.	.	PROPN
aji-161	228	5	,	,	PUNCT
aji-161	228	6	vol	vol	NOUN
aji-161	228	7	.	.	PROPN
aji-161	228	8	8	8	NUM
aji-161	228	9	,	,	PUNCT
aji-161	228	10	no	no	INTJ
aji-161	228	11	.	.	NOUN
aji-161	228	12	1	1	NUM
aji-161	228	13	,	,	PUNCT
aji-161	228	14	pp	pp	ADJ
aji-161	228	15	.	.	PUNCT
aji-161	229	1	70	70	NUM
aji-161	229	2	-	-	SYM
aji-161	229	3	81	81	NUM
aji-161	229	4	,	,	PUNCT
aji-161	229	5	2025	2025	NUM
aji-161	229	6	;	;	PUNCT
aji-161	229	7	article	article	NOUN
aji-161	229	8	no.aji.134825	no.aji.134825	VERB
aji-161	229	9	76	76	NUM
aji-161	229	10	immunoreactivity	immunoreactivity	NOUN
aji-161	229	11	.	.	PUNCT
aji-161	230	1	despite	despite	SCONJ
aji-161	230	2	non	non	ADJ
aji-161	230	3	-	-	ADJ
aji-161	230	4	reactive	reactive	ADJ
aji-161	230	5	or	or	CCONJ
aji-161	230	6	inconclusive	inconclusive	ADJ
aji-161	230	7	skin	skin	NOUN
aji-161	230	8	tests	test	NOUN
aji-161	230	9	,	,	PUNCT
aji-161	230	10	we	we	PRON
aji-161	230	11	propose	propose	VERB
aji-161	230	12	these	these	DET
aji-161	230	13	procedures	procedure	NOUN
aji-161	230	14	to	to	ADP
aji-161	230	15	patients	patient	NOUN
aji-161	230	16	with	with	ADP
aji-161	230	17	atopic	atopic	NOUN
aji-161	230	18	dermatitis	dermatitis	NOUN
aji-161	230	19	and/or	and/or	CCONJ
aji-161	230	20	contact	contact	NOUN
aji-161	230	21	dermatitis	dermatitis	NOUN
aji-161	230	22	with	with	ADP
aji-161	230	23	a	a	DET
aji-161	230	24	strong	strong	ADJ
aji-161	230	25	clinical	clinical	ADJ
aji-161	230	26	suspicion	suspicion	NOUN
aji-161	230	27	of	of	ADP
aji-161	230	28	hypersensitivity	hypersensitivity	NOUN
aji-161	230	29	to	to	ADP
aji-161	230	30	formaldehyde	formaldehyde	NOUN
aji-161	230	31	.	.	PUNCT
aji-161	231	1	the	the	DET
aji-161	231	2	clinical	clinical	ADJ
aji-161	231	3	reasoning	reasoning	NOUN
aji-161	231	4	to	to	PART
aji-161	231	5	indicate	indicate	VERB
aji-161	231	6	these	these	DET
aji-161	231	7	tests	test	NOUN
aji-161	231	8	is	be	AUX
aji-161	231	9	in	in	ADP
aji-161	231	10	the	the	DET
aji-161	231	11	assumption	assumption	NOUN
aji-161	231	12	that	that	SCONJ
aji-161	231	13	these	these	DET
aji-161	231	14	immunoassays	immunoassay	NOUN
aji-161	231	15	may	may	AUX
aji-161	231	16	function	function	VERB
aji-161	231	17	as	as	ADP
aji-161	231	18	triage	triage	NOUN
aji-161	231	19	tests	test	NOUN
aji-161	231	20	to	to	PART
aji-161	231	21	reinforce	reinforce	VERB
aji-161	231	22	the	the	DET
aji-161	231	23	need	need	NOUN
aji-161	231	24	for	for	ADP
aji-161	231	25	a	a	DET
aji-161	231	26	more	more	ADV
aji-161	231	27	exhaustive	exhaustive	ADJ
aji-161	231	28	diagnostic	diagnostic	ADJ
aji-161	231	29	exclusionprovocation	exclusionprovocation	NOUN
aji-161	231	30	test	test	NOUN
aji-161	231	31	(	(	PUNCT
aji-161	231	32	when	when	SCONJ
aji-161	231	33	the	the	DET
aji-161	231	34	patient	patient	NOUN
aji-161	231	35	excludes	exclude	VERB
aji-161	231	36	the	the	DET
aji-161	231	37	suspected	suspect	VERB
aji-161	231	38	allergen	allergen	NOUN
aji-161	231	39	until	until	SCONJ
aji-161	231	40	the	the	DET
aji-161	231	41	symptoms	symptom	NOUN
aji-161	231	42	disappear	disappear	VERB
aji-161	231	43	and	and	CCONJ
aji-161	231	44	then	then	ADV
aji-161	231	45	re	re	VERB
aji-161	231	46	-	-	NOUN
aji-161	231	47	introduces	introduce	VERB
aji-161	231	48	the	the	DET
aji-161	231	49	allergen	allergen	NOUN
aji-161	231	50	to	to	PART
aji-161	231	51	observe	observe	VERB
aji-161	231	52	the	the	DET
aji-161	231	53	reactions	reaction	NOUN
aji-161	231	54	)	)	PUNCT
aji-161	231	55	.	.	PUNCT
aji-161	232	1	as	as	ADP
aji-161	232	2	a	a	DET
aji-161	232	3	retrospective	retrospective	ADJ
aji-161	232	4	cohort	cohort	NOUN
aji-161	232	5	analysis	analysis	NOUN
aji-161	232	6	,	,	PUNCT
aji-161	232	7	there	there	PRON
aji-161	232	8	was	be	VERB
aji-161	232	9	no	no	DET
aji-161	232	10	prospective	prospective	ADJ
aji-161	232	11	plan	plan	NOUN
aji-161	232	12	.	.	PUNCT
aji-161	233	1	we	we	PRON
aji-161	233	2	spreadsheeted	spreadsheete	VERB
aji-161	233	3	a	a	DET
aji-161	233	4	compilation	compilation	NOUN
aji-161	233	5	of	of	ADP
aji-161	233	6	registered	register	VERB
aji-161	233	7	results	result	NOUN
aji-161	233	8	produced	produce	VERB
aji-161	233	9	by	by	ADP
aji-161	233	10	ttp	ttp	PROPN
aji-161	233	11	and	and	CCONJ
aji-161	233	12	lait	lait	PROPN
aji-161	233	13	,	,	PUNCT
aji-161	233	14	exploring	explore	VERB
aji-161	233	15	humoral	humoral	ADJ
aji-161	233	16	and	and	CCONJ
aji-161	233	17	cellular	cellular	ADJ
aji-161	233	18	immunoreactivity	immunoreactivity	NOUN
aji-161	233	19	against	against	ADP
aji-161	233	20	formaldehyde	formaldehyde	NOUN
aji-161	233	21	.	.	PUNCT
aji-161	234	1	these	these	DET
aji-161	234	2	assays	assay	NOUN
aji-161	234	3	provide	provide	VERB
aji-161	234	4	clues	clue	NOUN
aji-161	234	5	about	about	ADP
aji-161	234	6	humoral	humoral	ADJ
aji-161	234	7	and	and	CCONJ
aji-161	234	8	cellular	cellular	ADJ
aji-161	234	9	immunoreactivity	immunoreactivity	NOUN
aji-161	234	10	,	,	PUNCT
aji-161	234	11	and	and	CCONJ
aji-161	234	12	the	the	DET
aji-161	234	13	results	result	NOUN
aji-161	234	14	are	be	AUX
aji-161	234	15	distributed	distribute	VERB
aji-161	234	16	in	in	ADP
aji-161	234	17	an	an	DET
aji-161	234	18	extensive	extensive	ADJ
aji-161	234	19	spectral	spectral	ADJ
aji-161	234	20	range	range	NOUN
aji-161	234	21	,	,	PUNCT
aji-161	234	22	presumably	presumably	ADV
aji-161	234	23	between	between	ADP
aji-161	234	24	immune	immune	ADJ
aji-161	234	25	tolerance	tolerance	NOUN
aji-161	234	26	and	and	CCONJ
aji-161	234	27	symptomatic	symptomatic	ADJ
aji-161	234	28	hypersensitivity	hypersensitivity	NOUN
aji-161	234	29	.	.	PUNCT
aji-161	235	1	results	result	NOUN
aji-161	235	2	provided	provide	VERB
aji-161	235	3	by	by	ADP
aji-161	235	4	lait	lait	NOUN
aji-161	235	5	and	and	CCONJ
aji-161	235	6	ttp	ttp	PROPN
aji-161	235	7	were	be	AUX
aji-161	235	8	interpreted	interpret	VERB
aji-161	235	9	as	as	ADP
aji-161	235	10	markers	marker	NOUN
aji-161	235	11	of	of	ADP
aji-161	235	12	the	the	DET
aji-161	235	13	immune	immune	ADJ
aji-161	235	14	response	response	NOUN
aji-161	235	15	after	after	ADP
aji-161	235	16	contact	contact	NOUN
aji-161	235	17	with	with	ADP
aji-161	235	18	the	the	DET
aji-161	235	19	specific	specific	ADJ
aji-161	235	20	antigen	antigen	NOUN
aji-161	235	21	,	,	PUNCT
aji-161	235	22	configuring	configure	VERB
aji-161	235	23	themselves	themselves	PRON
aji-161	235	24	as	as	ADP
aji-161	235	25	techniques	technique	NOUN
aji-161	235	26	to	to	PART
aji-161	235	27	identify	identify	VERB
aji-161	235	28	exposition	exposition	NOUN
aji-161	235	29	to	to	ADP
aji-161	235	30	the	the	DET
aji-161	235	31	antigen	antigen	NOUN
aji-161	235	32	,	,	PUNCT
aji-161	235	33	immune	immune	ADJ
aji-161	235	34	stimulation	stimulation	NOUN
aji-161	235	35	,	,	PUNCT
aji-161	235	36	and	and	CCONJ
aji-161	235	37	immunoreactivity	immunoreactivity	NOUN
aji-161	235	38	,	,	PUNCT
aji-161	235	39	as	as	SCONJ
aji-161	235	40	proposed	propose	VERB
aji-161	235	41	by	by	ADP
aji-161	235	42	the	the	DET
aji-161	235	43	exposome	exposome	NOUN
aji-161	235	44	-	-	PUNCT
aji-161	235	45	wide	wide	ADJ
aji-161	235	46	association	association	NOUN
aji-161	235	47	study	study	NOUN
aji-161	235	48	(	(	PUNCT
aji-161	235	49	chung	chung	PROPN
aji-161	235	50	et	et	PROPN
aji-161	235	51	al	al	PROPN
aji-161	235	52	.	.	PROPN
aji-161	235	53	2024	2024	NUM
aji-161	235	54	)	)	PUNCT
aji-161	235	55	.	.	PUNCT
aji-161	236	1	at	at	ADP
aji-161	236	2	the	the	DET
aji-161	236	3	clinical	clinical	ADJ
aji-161	236	4	set	set	NOUN
aji-161	236	5	,	,	PUNCT
aji-161	236	6	the	the	DET
aji-161	236	7	diagnosis	diagnosis	NOUN
aji-161	236	8	of	of	ADP
aji-161	236	9	formaldehyde	formaldehyde	NOUN
aji-161	236	10	allergy	allergy	NOUN
aji-161	236	11	is	be	AUX
aji-161	236	12	accomplished	accomplish	VERB
aji-161	236	13	by	by	ADP
aji-161	236	14	anamnesis	anamnesis	NOUN
aji-161	236	15	,	,	PUNCT
aji-161	236	16	skin	skin	NOUN
aji-161	236	17	tests	test	NOUN
aji-161	236	18	,	,	PUNCT
aji-161	236	19	and	and	CCONJ
aji-161	236	20	in	in	ADP
aji-161	236	21	vivo	vivo	ADJ
aji-161	236	22	provocation	provocation	NOUN
aji-161	236	23	tests	test	NOUN
aji-161	236	24	;	;	PUNCT
aji-161	236	25	however	however	ADV
aji-161	236	26	,	,	PUNCT
aji-161	236	27	when	when	SCONJ
aji-161	236	28	employing	employ	VERB
aji-161	236	29	a	a	DET
aji-161	236	30	multi	multi	ADJ
aji-161	236	31	-	-	ADJ
aji-161	236	32	omics	omics	ADJ
aji-161	236	33	approach	approach	NOUN
aji-161	236	34	,	,	PUNCT
aji-161	236	35	several	several	ADJ
aji-161	236	36	clinical	clinical	ADJ
aji-161	236	37	phenotypes	phenotype	NOUN
aji-161	236	38	and	and	CCONJ
aji-161	236	39	endotypes	endotype	NOUN
aji-161	236	40	may	may	AUX
aji-161	236	41	be	be	AUX
aji-161	236	42	differentiated	differentiate	VERB
aji-161	236	43	(	(	PUNCT
aji-161	236	44	yoon	yoon	PROPN
aji-161	236	45	&	&	CCONJ
aji-161	236	46	bunyavanich	bunyavanich	PROPN
aji-161	236	47	2025	2025	NUM
aji-161	236	48	)	)	PUNCT
aji-161	236	49	.	.	PUNCT
aji-161	237	1	this	this	DET
aji-161	237	2	retrospective	retrospective	ADJ
aji-161	237	3	survey	survey	NOUN
aji-161	237	4	demonstrated	demonstrate	VERB
aji-161	237	5	that	that	SCONJ
aji-161	237	6	the	the	DET
aji-161	237	7	ttp	ttp	NOUN
aji-161	237	8	and	and	CCONJ
aji-161	237	9	the	the	DET
aji-161	237	10	ex	ex	X
aji-161	237	11	vivo	vivo	NOUN
aji-161	237	12	challenge	challenge	NOUN
aji-161	237	13	test	test	NOUN
aji-161	237	14	monitored	monitor	VERB
aji-161	237	15	by	by	ADP
aji-161	237	16	lait	lait	NOUN
aji-161	237	17	against	against	ADP
aji-161	237	18	formaldehyde	formaldehyde	NOUN
aji-161	237	19	can	can	AUX
aji-161	237	20	demonstrate	demonstrate	VERB
aji-161	237	21	significant	significant	ADJ
aji-161	237	22	cellular	cellular	ADJ
aji-161	237	23	and	and	CCONJ
aji-161	237	24	humoral	humoral	ADJ
aji-161	237	25	immunoreactivity	immunoreactivity	NOUN
aji-161	237	26	in	in	ADP
aji-161	237	27	patients	patient	NOUN
aji-161	237	28	diagnosed	diagnose	VERB
aji-161	237	29	with	with	ADP
aji-161	237	30	atopic	atopic	NOUN
aji-161	237	31	and/or	and/or	CCONJ
aji-161	237	32	contact	contact	NOUN
aji-161	237	33	dermatitis	dermatitis	NOUN
aji-161	237	34	.	.	PUNCT
aji-161	238	1	however	however	ADV
aji-161	238	2	,	,	PUNCT
aji-161	238	3	these	these	DET
aji-161	238	4	immunoassays	immunoassay	NOUN
aji-161	238	5	did	do	AUX
aji-161	238	6	not	not	PART
aji-161	238	7	prove	prove	VERB
aji-161	238	8	per	per	ADP
aji-161	238	9	se	se	ADV
aji-161	238	10	that	that	DET
aji-161	238	11	hypersensitivity	hypersensitivity	NOUN
aji-161	238	12	to	to	ADP
aji-161	238	13	formaldehyde	formaldehyde	NOUN
aji-161	238	14	is	be	AUX
aji-161	238	15	responsible	responsible	ADJ
aji-161	238	16	for	for	ADP
aji-161	238	17	these	these	DET
aji-161	238	18	patients	patient	NOUN
aji-161	238	19	'	'	PART
aji-161	238	20	symptoms	symptom	NOUN
aji-161	238	21	.	.	PUNCT
aji-161	239	1	this	this	DET
aji-161	239	2	association	association	NOUN
aji-161	239	3	may	may	AUX
aji-161	239	4	only	only	ADV
aji-161	239	5	be	be	AUX
aji-161	239	6	confirmed	confirm	VERB
aji-161	239	7	by	by	ADP
aji-161	239	8	further	far	ADV
aji-161	239	9	in	in	ADP
aji-161	239	10	vivo	vivo	ADJ
aji-161	239	11	provocation	provocation	NOUN
aji-161	239	12	studies	study	NOUN
aji-161	239	13	.	.	PUNCT
aji-161	240	1	none	none	NOUN
aji-161	240	2	of	of	ADP
aji-161	240	3	our	our	PRON
aji-161	240	4	patients	patient	NOUN
aji-161	240	5	presented	present	VERB
aji-161	240	6	an	an	DET
aji-161	240	7	exclusive	exclusive	ADJ
aji-161	240	8	reaction	reaction	NOUN
aji-161	240	9	to	to	ADP
aji-161	240	10	formaldehyde	formaldehyde	NOUN
aji-161	240	11	.	.	PUNCT
aji-161	241	1	we	we	PRON
aji-161	241	2	assessed	assess	VERB
aji-161	241	3	every	every	DET
aji-161	241	4	patient	patient	NOUN
aji-161	241	5	simultaneously	simultaneously	ADV
aji-161	241	6	with	with	ADP
aji-161	241	7	several	several	ADJ
aji-161	241	8	chemical	chemical	ADJ
aji-161	241	9	and	and	CCONJ
aji-161	241	10	biological	biological	ADJ
aji-161	241	11	allergens	allergen	NOUN
aji-161	241	12	,	,	PUNCT
aji-161	241	13	demonstrating	demonstrate	VERB
aji-161	241	14	positive	positive	ADJ
aji-161	241	15	results	result	NOUN
aji-161	241	16	for	for	ADP
aji-161	241	17	some	some	PRON
aji-161	241	18	of	of	ADP
aji-161	241	19	them	they	PRON
aji-161	241	20	,	,	PUNCT
aji-161	241	21	according	accord	VERB
aji-161	241	22	to	to	ADP
aji-161	241	23	clinical	clinical	ADJ
aji-161	241	24	suspicions	suspicion	NOUN
aji-161	241	25	.	.	PUNCT
aji-161	242	1	the	the	DET
aji-161	242	2	most	most	ADV
aji-161	242	3	vital	vital	ADJ
aji-161	242	4	suggestion	suggestion	NOUN
aji-161	242	5	driven	drive	VERB
aji-161	242	6	by	by	ADP
aji-161	242	7	the	the	DET
aji-161	242	8	results	result	NOUN
aji-161	242	9	is	be	AUX
aji-161	242	10	that	that	SCONJ
aji-161	242	11	allergic	allergic	ADJ
aji-161	242	12	patients	patient	NOUN
aji-161	242	13	may	may	AUX
aji-161	242	14	impair	impair	VERB
aji-161	242	15	their	their	PRON
aji-161	242	16	symptoms	symptom	NOUN
aji-161	242	17	by	by	ADP
aji-161	242	18	using	use	VERB
aji-161	242	19	creams	cream	NOUN
aji-161	242	20	or	or	CCONJ
aji-161	242	21	cosmetics	cosmetic	NOUN
aji-161	242	22	contaminated	contaminate	VERB
aji-161	242	23	with	with	ADP
aji-161	242	24	formaldehyde	formaldehyde	NOUN
aji-161	242	25	.	.	PUNCT
aji-161	243	1	in	in	ADP
aji-161	243	2	our	our	PRON
aji-161	243	3	practice	practice	NOUN
aji-161	243	4	,	,	PUNCT
aji-161	243	5	when	when	SCONJ
aji-161	243	6	preceding	precede	VERB
aji-161	243	7	in	in	ADP
aji-161	243	8	vivo	vivo	ADJ
aji-161	243	9	cutaneous	cutaneous	ADJ
aji-161	243	10	tests	test	NOUN
aji-161	243	11	with	with	ADP
aji-161	243	12	formaldehyde	formaldehyde	NOUN
aji-161	243	13	,	,	PUNCT
aji-161	243	14	we	we	PRON
aji-161	243	15	observe	observe	VERB
aji-161	243	16	immediate	immediate	ADJ
aji-161	243	17	cutaneous	cutaneous	ADJ
aji-161	243	18	reactions	reaction	NOUN
aji-161	243	19	(	(	PUNCT
aji-161	243	20	obtained	obtain	VERB
aji-161	243	21	by	by	ADP
aji-161	243	22	the	the	DET
aji-161	243	23	skin	skin	NOUN
aji-161	243	24	scrape	scrape	NOUN
aji-161	243	25	test	test	NOUN
aji-161	243	26	)	)	PUNCT
aji-161	243	27	and	and	CCONJ
aji-161	243	28	delayed	delay	VERB
aji-161	243	29	reactions	reaction	NOUN
aji-161	243	30	obtained	obtain	VERB
aji-161	243	31	by	by	ADP
aji-161	243	32	a	a	DET
aji-161	243	33	forty	forty	NUM
aji-161	243	34	-	-	PUNCT
aji-161	243	35	eight	eight	NUM
aji-161	243	36	-	-	PUNCT
aji-161	243	37	hour	hour	NOUN
aji-161	243	38	contact	contact	NOUN
aji-161	243	39	test	test	NOUN
aji-161	243	40	or	or	CCONJ
aji-161	243	41	a	a	DET
aji-161	243	42	photosensitized	photosensitized	ADJ
aji-161	243	43	ninety	ninety	NUM
aji-161	243	44	-	-	PUNCT
aji-161	243	45	six	six	NUM
aji-161	243	46	-	-	PUNCT
aji-161	243	47	hour	hour	NOUN
aji-161	243	48	contact	contact	NOUN
aji-161	243	49	test	test	NOUN
aji-161	243	50	(	(	PUNCT
aji-161	243	51	patch	patch	NOUN
aji-161	243	52	test	test	NOUN
aji-161	243	53	)	)	PUNCT
aji-161	243	54	.	.	PUNCT
aji-161	244	1	based	base	VERB
aji-161	244	2	on	on	ADP
aji-161	244	3	this	this	DET
aji-161	244	4	clinical	clinical	ADJ
aji-161	244	5	experience	experience	NOUN
aji-161	244	6	,	,	PUNCT
aji-161	244	7	we	we	PRON
aji-161	244	8	can	can	AUX
aji-161	244	9	hypothesize	hypothesize	VERB
aji-161	244	10	that	that	SCONJ
aji-161	244	11	at	at	ADV
aji-161	244	12	least	least	ADV
aji-161	244	13	three	three	NUM
aji-161	244	14	endotypes	endotype	NOUN
aji-161	244	15	are	be	AUX
aji-161	244	16	associated	associate	VERB
aji-161	244	17	with	with	ADP
aji-161	244	18	formaldehyde	formaldehyde	NOUN
aji-161	244	19	hypersensitivity	hypersensitivity	NOUN
aji-161	244	20	,	,	PUNCT
aji-161	244	21	which	which	PRON
aji-161	244	22	may	may	AUX
aji-161	244	23	be	be	AUX
aji-161	244	24	produced	produce	VERB
aji-161	244	25	by	by	ADP
aji-161	244	26	at	at	ADV
aji-161	244	27	least	least	ADV
aji-161	244	28	three	three	NUM
aji-161	244	29	mechanisms	mechanism	NOUN
aji-161	244	30	:	:	PUNCT
aji-161	244	31	a	a	DET
aji-161	244	32	predominantly	predominantly	ADV
aji-161	244	33	humoral	humoral	ADJ
aji-161	244	34	,	,	PUNCT
aji-161	244	35	a	a	DET
aji-161	244	36	predominantly	predominantly	ADV
aji-161	244	37	cellular	cellular	ADJ
aji-161	244	38	,	,	PUNCT
aji-161	244	39	and	and	CCONJ
aji-161	244	40	a	a	DET
aji-161	244	41	compound	compound	NOUN
aji-161	244	42	of	of	ADP
aji-161	244	43	both	both	PRON
aji-161	244	44	.	.	PUNCT
aji-161	245	1	integrating	integrate	VERB
aji-161	245	2	ttp	ttp	PROPN
aji-161	245	3	and	and	CCONJ
aji-161	245	4	lait	lait	NOUN
aji-161	245	5	into	into	ADP
aji-161	245	6	clinical	clinical	ADJ
aji-161	245	7	workflows	workflow	NOUN
aji-161	245	8	may	may	AUX
aji-161	245	9	guide	guide	VERB
aji-161	245	10	clinicians	clinician	NOUN
aji-161	245	11	in	in	ADP
aji-161	245	12	identifying	identify	VERB
aji-161	245	13	hidden	hidden	ADJ
aji-161	245	14	hypersensitivity	hypersensitivity	NOUN
aji-161	245	15	due	due	ADP
aji-161	245	16	to	to	ADP
aji-161	245	17	formaldehyde	formaldehyde	NOUN
aji-161	245	18	exposure	exposure	NOUN
aji-161	245	19	in	in	ADP
aji-161	245	20	products	product	NOUN
aji-161	245	21	and	and	CCONJ
aji-161	245	22	inform	inform	VERB
aji-161	245	23	safer	safe	ADJ
aji-161	245	24	therapeutic	therapeutic	ADJ
aji-161	245	25	strategies	strategy	NOUN
aji-161	245	26	for	for	ADP
aji-161	245	27	sensitized	sensitize	VERB
aji-161	245	28	patients	patient	NOUN
aji-161	245	29	.	.	PUNCT
aji-161	246	1	5	5	X
aji-161	246	2	.	.	X
aji-161	246	3	conclusion	conclusion	NOUN
aji-161	246	4	our	our	PRON
aji-161	246	5	preliminary	preliminary	ADJ
aji-161	246	6	results	result	NOUN
aji-161	246	7	show	show	VERB
aji-161	246	8	that	that	SCONJ
aji-161	246	9	the	the	DET
aji-161	246	10	lait	lait	NOUN
aji-161	246	11	and	and	CCONJ
aji-161	246	12	ttp	ttp	PROPN
aji-161	246	13	may	may	AUX
aji-161	246	14	differentiate	differentiate	VERB
aji-161	246	15	diverse	diverse	ADJ
aji-161	246	16	cellular	cellular	ADJ
aji-161	246	17	and	and	CCONJ
aji-161	246	18	humoral	humoral	ADJ
aji-161	246	19	immunoreactivity	immunoreactivity	NOUN
aji-161	246	20	degrees	degree	NOUN
aji-161	246	21	against	against	ADP
aji-161	246	22	formaldehyde	formaldehyde	NOUN
aji-161	246	23	in	in	ADP
aji-161	246	24	patients	patient	NOUN
aji-161	246	25	clinically	clinically	ADV
aji-161	246	26	diagnosed	diagnose	VERB
aji-161	246	27	with	with	ADP
aji-161	246	28	non	non	ADJ
aji-161	246	29	–	–	PUNCT
aji-161	246	30	ige	ige	ADJ
aji-161	246	31	-	-	PUNCT
aji-161	246	32	mediated	mediate	VERB
aji-161	246	33	allergies	allergy	NOUN
aji-161	246	34	.	.	PUNCT
aji-161	247	1	lait	lait	PROPN
aji-161	247	2	and	and	CCONJ
aji-161	247	3	ttp	ttp	PROPN
aji-161	247	4	are	be	AUX
aji-161	247	5	inexpensive	inexpensive	ADJ
aji-161	247	6	,	,	PUNCT
aji-161	247	7	can	can	AUX
aji-161	247	8	be	be	AUX
aji-161	247	9	performed	perform	VERB
aji-161	247	10	with	with	ADP
aji-161	247	11	minimum	minimum	ADJ
aji-161	247	12	laboratory	laboratory	NOUN
aji-161	247	13	equipment	equipment	NOUN
aji-161	247	14	,	,	PUNCT
aji-161	247	15	and	and	CCONJ
aji-161	247	16	can	can	AUX
aji-161	247	17	be	be	AUX
aji-161	247	18	incorporated	incorporate	VERB
aji-161	247	19	into	into	ADP
aji-161	247	20	strategies	strategy	NOUN
aji-161	247	21	to	to	PART
aji-161	247	22	address	address	VERB
aji-161	247	23	health	health	NOUN
aji-161	247	24	disparities	disparity	NOUN
aji-161	247	25	in	in	ADP
aji-161	247	26	respiratory	respiratory	ADJ
aji-161	247	27	and	and	CCONJ
aji-161	247	28	food	food	NOUN
aji-161	247	29	allergies	allergy	NOUN
aji-161	247	30	(	(	PUNCT
aji-161	247	31	anagnostou	anagnostou	PROPN
aji-161	247	32	et	et	PROPN
aji-161	247	33	al	al	PROPN
aji-161	247	34	.	.	PROPN
aji-161	247	35	,	,	PUNCT
aji-161	247	36	2025	2025	NUM
aji-161	247	37	)	)	PUNCT
aji-161	247	38	.	.	PUNCT
aji-161	248	1	as	as	ADP
aji-161	248	2	a	a	DET
aji-161	248	3	preliminary	preliminary	ADJ
aji-161	248	4	report	report	NOUN
aji-161	248	5	,	,	PUNCT
aji-161	248	6	the	the	DET
aji-161	248	7	propaedeutic	propaedeutic	ADJ
aji-161	248	8	meaning	meaning	NOUN
aji-161	248	9	of	of	ADP
aji-161	248	10	the	the	DET
aji-161	248	11	presented	present	VERB
aji-161	248	12	results	result	NOUN
aji-161	248	13	and	and	CCONJ
aji-161	248	14	the	the	DET
aji-161	248	15	possibility	possibility	NOUN
aji-161	248	16	of	of	ADP
aji-161	248	17	interferents	interferent	NOUN
aji-161	248	18	must	must	AUX
aji-161	248	19	be	be	AUX
aji-161	248	20	yet	yet	ADV
aji-161	248	21	established	establish	VERB
aji-161	248	22	(	(	PUNCT
aji-161	248	23	anouar	anouar	NOUN
aji-161	248	24	et	et	PROPN
aji-161	248	25	al	al	PROPN
aji-161	248	26	.	.	PROPN
aji-161	248	27	,	,	PUNCT
aji-161	248	28	2024	2024	NUM
aji-161	248	29	)	)	PUNCT
aji-161	248	30	.	.	PUNCT
aji-161	249	1	more	more	ADJ
aji-161	249	2	studies	study	NOUN
aji-161	249	3	focused	focus	VERB
aji-161	249	4	on	on	ADP
aji-161	249	5	the	the	DET
aji-161	249	6	quality	quality	NOUN
aji-161	249	7	-	-	PUNCT
aji-161	249	8	by	by	ADP
aji-161	249	9	-	-	PUNCT
aji-161	249	10	design	design	NOUN
aji-161	249	11	approach	approach	NOUN
aji-161	249	12	with	with	ADP
aji-161	249	13	prospective	prospective	ADJ
aji-161	249	14	larger	large	ADJ
aji-161	249	15	double	double	ADJ
aji-161	249	16	-	-	PUNCT
aji-161	249	17	blind	blind	ADJ
aji-161	249	18	cohorts	cohort	NOUN
aji-161	249	19	need	need	VERB
aji-161	249	20	to	to	PART
aji-161	249	21	evaluate	evaluate	VERB
aji-161	249	22	the	the	DET
aji-161	249	23	potential	potential	ADJ
aji-161	249	24	contribution	contribution	NOUN
aji-161	249	25	of	of	ADP
aji-161	249	26	lait	lait	NOUN
aji-161	249	27	and	and	CCONJ
aji-161	249	28	ttp	ttp	NOUN
aji-161	249	29	for	for	ADP
aji-161	249	30	endotyping	endotype	VERB
aji-161	249	31	immunoreactivity	immunoreactivity	NOUN
aji-161	249	32	of	of	ADP
aji-161	249	33	patients	patient	NOUN
aji-161	249	34	suspected	suspect	VERB
aji-161	249	35	of	of	ADP
aji-161	249	36	symptomatic	symptomatic	ADJ
aji-161	249	37	hypersensitivity	hypersensitivity	NOUN
aji-161	249	38	against	against	ADP
aji-161	249	39	formaldehyde	formaldehyde	NOUN
aji-161	249	40	and	and	CCONJ
aji-161	249	41	other	other	ADJ
aji-161	249	42	similar	similar	ADJ
aji-161	249	43	preservatives	preservative	NOUN
aji-161	249	44	(	(	PUNCT
aji-161	249	45	chiarentin	chiarentin	NOUN
aji-161	249	46	et	et	PROPN
aji-161	249	47	al	al	PROPN
aji-161	249	48	.	.	PROPN
aji-161	249	49	,	,	PUNCT
aji-161	249	50	2023	2023	NUM
aji-161	249	51	)	)	PUNCT
aji-161	249	52	.	.	PUNCT
aji-161	250	1	6	6	X
aji-161	250	2	.	.	X
aji-161	250	3	limitations	limitation	NOUN
aji-161	250	4	this	this	DET
aji-161	250	5	study	study	NOUN
aji-161	250	6	is	be	AUX
aji-161	250	7	a	a	DET
aji-161	250	8	retrospective	retrospective	ADJ
aji-161	250	9	analysis	analysis	NOUN
aji-161	250	10	of	of	ADP
aji-161	250	11	data	datum	NOUN
aji-161	250	12	collected	collect	VERB
aji-161	250	13	over	over	ADP
aji-161	250	14	six	six	NUM
aji-161	250	15	years	year	NOUN
aji-161	250	16	.	.	PUNCT
aji-161	251	1	there	there	PRON
aji-161	251	2	was	be	VERB
aji-161	251	3	no	no	DET
aji-161	251	4	protocol	protocol	NOUN
aji-161	251	5	research	research	NOUN
aji-161	251	6	,	,	PUNCT
aji-161	251	7	no	no	DET
aji-161	251	8	control	control	NOUN
aji-161	251	9	group	group	NOUN
aji-161	251	10	,	,	PUNCT
aji-161	251	11	and	and	CCONJ
aji-161	251	12	the	the	DET
aji-161	251	13	subject	subject	NOUN
aji-161	251	14	's	's	PART
aji-161	251	15	data	datum	NOUN
aji-161	251	16	were	be	AUX
aji-161	251	17	limited	limit	VERB
aji-161	251	18	to	to	ADP
aji-161	251	19	the	the	DET
aji-161	251	20	essentials	essential	NOUN
aji-161	251	21	available	available	ADJ
aji-161	251	22	on	on	ADP
aji-161	251	23	our	our	PRON
aji-161	251	24	electronic	electronic	ADJ
aji-161	251	25	sheets	sheet	NOUN
aji-161	251	26	.	.	PUNCT
aji-161	252	1	therefore	therefore	ADV
aji-161	252	2	,	,	PUNCT
aji-161	252	3	we	we	PRON
aji-161	252	4	could	could	AUX
aji-161	252	5	not	not	PART
aji-161	252	6	establish	establish	VERB
aji-161	252	7	a	a	DET
aji-161	252	8	cross	cross	NOUN
aji-161	252	9	-	-	NOUN
aji-161	252	10	comparison	comparison	NOUN
aji-161	252	11	between	between	ADP
aji-161	252	12	positive	positive	ADJ
aji-161	252	13	and	and	CCONJ
aji-161	252	14	negative	negative	ADJ
aji-161	252	15	controls	control	NOUN
aji-161	252	16	to	to	PART
aji-161	252	17	validate	validate	VERB
aji-161	252	18	the	the	DET
aji-161	252	19	results	result	NOUN
aji-161	252	20	.	.	PUNCT
aji-161	253	1	the	the	DET
aji-161	253	2	number	number	NOUN
aji-161	253	3	of	of	ADP
aji-161	253	4	subjects	subject	NOUN
aji-161	253	5	is	be	AUX
aji-161	253	6	appropriate	appropriate	ADJ
aji-161	253	7	for	for	ADP
aji-161	253	8	a	a	DET
aji-161	253	9	preliminary	preliminary	ADJ
aji-161	253	10	study	study	NOUN
aji-161	253	11	;	;	PUNCT
aji-161	253	12	however	however	ADV
aji-161	253	13	,	,	PUNCT
aji-161	253	14	future	future	ADJ
aji-161	253	15	studies	study	NOUN
aji-161	253	16	must	must	AUX
aji-161	253	17	be	be	AUX
aji-161	253	18	more	more	ADV
aji-161	253	19	comprehensive	comprehensive	ADJ
aji-161	253	20	.	.	PUNCT
aji-161	254	1	the	the	DET
aji-161	254	2	lack	lack	NOUN
aji-161	254	3	of	of	ADP
aji-161	254	4	a	a	DET
aji-161	254	5	research	research	NOUN
aji-161	254	6	olivier	olivier	NOUN
aji-161	254	7	et	et	PROPN
aji-161	254	8	al	al	PROPN
aji-161	254	9	.	.	PROPN
aji-161	254	10	;	;	PUNCT
aji-161	254	11	asian	asian	PROPN
aji-161	254	12	j.	j.	PROPN
aji-161	254	13	immunol	immunol	PROPN
aji-161	254	14	.	.	PROPN
aji-161	254	15	,	,	PUNCT
aji-161	254	16	vol	vol	NOUN
aji-161	254	17	.	.	PROPN
aji-161	254	18	8	8	NUM
aji-161	254	19	,	,	PUNCT
aji-161	254	20	no	no	INTJ
aji-161	254	21	.	.	NOUN
aji-161	254	22	1	1	NUM
aji-161	254	23	,	,	PUNCT
aji-161	254	24	pp	pp	ADJ
aji-161	254	25	.	.	PUNCT
aji-161	255	1	70	70	NUM
aji-161	255	2	-	-	SYM
aji-161	255	3	81	81	NUM
aji-161	255	4	,	,	PUNCT
aji-161	255	5	2025	2025	NUM
aji-161	255	6	;	;	PUNCT
aji-161	255	7	article	article	NOUN
aji-161	255	8	no.aji.134825	no.aji.134825	VERB
aji-161	255	9	77	77	NUM
aji-161	255	10	protocol	protocol	NOUN
aji-161	255	11	implies	imply	VERB
aji-161	255	12	the	the	DET
aji-161	255	13	possibility	possibility	NOUN
aji-161	255	14	of	of	ADP
aji-161	255	15	a	a	DET
aji-161	255	16	bias	bias	NOUN
aji-161	255	17	produced	produce	VERB
aji-161	255	18	by	by	ADP
aji-161	255	19	the	the	DET
aji-161	255	20	physician	physician	NOUN
aji-161	255	21	's	's	PART
aji-161	255	22	point	point	NOUN
aji-161	255	23	of	of	ADP
aji-161	255	24	view	view	NOUN
aji-161	255	25	,	,	PUNCT
aji-161	255	26	who	who	PRON
aji-161	255	27	suggested	suggest	VERB
aji-161	255	28	the	the	DET
aji-161	255	29	exam	exam	NOUN
aji-161	255	30	barely	barely	ADV
aji-161	255	31	on	on	ADP
aji-161	255	32	clinical	clinical	ADJ
aji-161	255	33	suspicion	suspicion	NOUN
aji-161	255	34	led	lead	VERB
aji-161	255	35	purely	purely	ADV
aji-161	255	36	by	by	ADP
aji-161	255	37	the	the	DET
aji-161	255	38	anamnesis	anamnesis	NOUN
aji-161	255	39	and	and	CCONJ
aji-161	255	40	physical	physical	ADJ
aji-161	255	41	examination	examination	NOUN
aji-161	255	42	.	.	PUNCT
aji-161	256	1	the	the	DET
aji-161	256	2	study	study	NOUN
aji-161	256	3	lost	lose	VERB
aji-161	256	4	many	many	ADJ
aji-161	256	5	of	of	ADP
aji-161	256	6	these	these	DET
aji-161	256	7	patients	patient	NOUN
aji-161	256	8	to	to	PART
aji-161	256	9	follow	follow	VERB
aji-161	256	10	-	-	PUNCT
aji-161	256	11	up	up	NOUN
aji-161	256	12	,	,	PUNCT
aji-161	256	13	so	so	ADV
aji-161	256	14	assuring	assure	VERB
aji-161	256	15	the	the	DET
aji-161	256	16	relationship	relationship	NOUN
aji-161	256	17	between	between	ADP
aji-161	256	18	the	the	DET
aji-161	256	19	immunoassays	immunoassay	NOUN
aji-161	256	20	'	'	PART
aji-161	256	21	results	result	NOUN
aji-161	256	22	and	and	CCONJ
aji-161	256	23	the	the	DET
aji-161	256	24	patient	patient	NOUN
aji-161	256	25	's	's	PART
aji-161	256	26	clinical	clinical	ADJ
aji-161	256	27	outcome	outcome	NOUN
aji-161	256	28	is	be	AUX
aji-161	256	29	impossible	impossible	ADJ
aji-161	256	30	.	.	PUNCT
aji-161	257	1	7	7	X
aji-161	257	2	.	.	X
aji-161	257	3	future	future	ADJ
aji-161	257	4	directions	direction	NOUN
aji-161	257	5	and	and	CCONJ
aji-161	257	6	recommendations	recommendation	NOUN
aji-161	257	7	for	for	ADP
aji-161	257	8	clinical	clinical	ADJ
aji-161	257	9	practice	practice	NOUN
aji-161	257	10	the	the	DET
aji-161	257	11	primary	primary	ADJ
aji-161	257	12	intended	intend	VERB
aji-161	257	13	use	use	NOUN
aji-161	257	14	of	of	ADP
aji-161	257	15	in	in	ADP
aji-161	257	16	vitro	vitro	X
aji-161	257	17	or	or	CCONJ
aji-161	257	18	ex	ex	PRON
aji-161	257	19	vivo	vivo	NOUN
aji-161	257	20	allergen	allergen	NOUN
aji-161	257	21	challenge	challenge	NOUN
aji-161	257	22	tests	test	NOUN
aji-161	257	23	is	be	AUX
aji-161	257	24	to	to	PART
aji-161	257	25	spare	spare	VERB
aji-161	257	26	the	the	DET
aji-161	257	27	patients	patient	NOUN
aji-161	257	28	from	from	ADP
aji-161	257	29	being	be	AUX
aji-161	257	30	submitted	submit	VERB
aji-161	257	31	to	to	ADP
aji-161	257	32	unnecessary	unnecessary	ADJ
aji-161	257	33	,	,	PUNCT
aji-161	257	34	exhaustive	exhaustive	ADJ
aji-161	257	35	,	,	PUNCT
aji-161	257	36	and	and	CCONJ
aji-161	257	37	dangerous	dangerous	ADJ
aji-161	257	38	in	in	ADP
aji-161	257	39	vivo	vivo	ADJ
aji-161	257	40	challenge	challenge	NOUN
aji-161	257	41	tests	test	NOUN
aji-161	257	42	.	.	PUNCT
aji-161	258	1	exploring	explore	VERB
aji-161	258	2	the	the	DET
aji-161	258	3	humoral	humoral	ADJ
aji-161	258	4	and	and	CCONJ
aji-161	258	5	the	the	DET
aji-161	258	6	cellular	cellular	ADJ
aji-161	258	7	arms	arm	NOUN
aji-161	258	8	of	of	ADP
aji-161	258	9	immune	immune	ADJ
aji-161	258	10	systems	system	NOUN
aji-161	258	11	,	,	PUNCT
aji-161	258	12	the	the	DET
aji-161	258	13	ttp	ttp	NOUN
aji-161	258	14	and	and	CCONJ
aji-161	258	15	lait	lait	NOUN
aji-161	258	16	alone	alone	ADJ
aji-161	258	17	or	or	CCONJ
aji-161	258	18	combined	combine	VERB
aji-161	258	19	may	may	AUX
aji-161	258	20	represent	represent	VERB
aji-161	258	21	,	,	PUNCT
aji-161	258	22	in	in	ADP
aji-161	258	23	the	the	DET
aji-161	258	24	near	near	ADJ
aji-161	258	25	future	future	NOUN
aji-161	258	26	,	,	PUNCT
aji-161	258	27	a	a	DET
aji-161	258	28	tool	tool	NOUN
aji-161	258	29	for	for	ADP
aji-161	258	30	allergists	allergist	NOUN
aji-161	258	31	to	to	PART
aji-161	258	32	construct	construct	VERB
aji-161	258	33	an	an	DET
aji-161	258	34	etiologic	etiologic	ADJ
aji-161	258	35	diagnosis	diagnosis	NOUN
aji-161	258	36	from	from	ADP
aji-161	258	37	their	their	PRON
aji-161	258	38	patients	patient	NOUN
aji-161	258	39	,	,	PUNCT
aji-161	258	40	as	as	ADV
aji-161	258	41	well	well	ADV
aji-161	258	42	as	as	ADP
aji-161	258	43	determine	determine	VERB
aji-161	258	44	the	the	DET
aji-161	258	45	endotypes	endotype	NOUN
aji-161	258	46	(	(	PUNCT
aji-161	258	47	mechanisms	mechanism	NOUN
aji-161	258	48	)	)	PUNCT
aji-161	258	49	of	of	ADP
aji-161	258	50	hypersensitivity	hypersensitivity	NOUN
aji-161	258	51	,	,	PUNCT
aji-161	258	52	in	in	ADP
aji-161	258	53	order	order	NOUN
aji-161	258	54	to	to	PART
aji-161	258	55	choose	choose	VERB
aji-161	258	56	more	more	ADV
aji-161	258	57	convenient	convenient	ADJ
aji-161	258	58	and	and	CCONJ
aji-161	258	59	personalized	personalized	ADJ
aji-161	258	60	therapies	therapy	NOUN
aji-161	258	61	for	for	ADP
aji-161	258	62	them	they	PRON
aji-161	258	63	.	.	PUNCT
aji-161	259	1	adding	add	VERB
aji-161	259	2	data	datum	NOUN
aji-161	259	3	provided	provide	VERB
aji-161	259	4	by	by	ADP
aji-161	259	5	ttp	ttp	PROPN
aji-161	259	6	and	and	CCONJ
aji-161	259	7	lait	lait	PROPN
aji-161	259	8	may	may	AUX
aji-161	259	9	also	also	ADV
aji-161	259	10	contribute	contribute	VERB
aji-161	259	11	to	to	ADP
aji-161	259	12	streamlining	streamline	VERB
aji-161	259	13	biomedical	biomedical	ADJ
aji-161	259	14	research	research	NOUN
aji-161	259	15	and	and	CCONJ
aji-161	259	16	improving	improve	VERB
aji-161	259	17	tools	tool	NOUN
aji-161	259	18	such	such	ADJ
aji-161	259	19	as	as	ADP
aji-161	259	20	large	large	ADJ
aji-161	259	21	language	language	NOUN
aji-161	259	22	models	model	NOUN
aji-161	259	23	,	,	PUNCT
aji-161	259	24	usually	usually	ADV
aji-161	259	25	used	use	VERB
aji-161	259	26	by	by	ADP
aji-161	259	27	clinicians	clinician	NOUN
aji-161	259	28	as	as	ADP
aji-161	259	29	a	a	DET
aji-161	259	30	decision	decision	NOUN
aji-161	259	31	support	support	NOUN
aji-161	259	32	system	system	NOUN
aji-161	259	33	to	to	PART
aji-161	259	34	enhance	enhance	VERB
aji-161	259	35	diagnostic	diagnostic	ADJ
aji-161	259	36	accuracy	accuracy	NOUN
aji-161	259	37	(	(	PUNCT
aji-161	259	38	abers	aber	NOUN
aji-161	259	39	&	&	CCONJ
aji-161	259	40	mathias	mathias	PROPN
aji-161	259	41	2025	2025	NUM
aji-161	259	42	)	)	PUNCT
aji-161	259	43	.	.	PUNCT
aji-161	260	1	consent	consent	NOUN
aji-161	260	2	as	as	ADP
aji-161	260	3	a	a	DET
aji-161	260	4	retrospective	retrospective	ADJ
aji-161	260	5	survey	survey	NOUN
aji-161	260	6	of	of	ADP
aji-161	260	7	results	result	NOUN
aji-161	260	8	recorded	record	VERB
aji-161	260	9	in	in	ADP
aji-161	260	10	cognito	cognito	PROPN
aji-161	260	11	,	,	PUNCT
aji-161	260	12	consent	consent	NOUN
aji-161	260	13	was	be	AUX
aji-161	260	14	given	give	VERB
aji-161	260	15	collectively	collectively	ADV
aji-161	260	16	by	by	ADP
aji-161	260	17	the	the	DET
aji-161	260	18	institution	institution	NOUN
aji-161	260	19	's	's	PART
aji-161	260	20	ethics	ethic	NOUN
aji-161	260	21	committee	committee	NOUN
aji-161	260	22	following	follow	VERB
aji-161	260	23	the	the	DET
aji-161	260	24	principles	principle	NOUN
aji-161	260	25	of	of	ADP
aji-161	260	26	the	the	DET
aji-161	260	27	declaration	declaration	NOUN
aji-161	260	28	of	of	ADP
aji-161	260	29	helsinki	helsinki	PROPN
aji-161	260	30	(	(	PUNCT
aji-161	260	31	wma	wma	PROPN
aji-161	260	32	,	,	PUNCT
aji-161	260	33	2013	2013	NUM
aji-161	260	34	)	)	PUNCT
aji-161	260	35	.	.	PUNCT
aji-161	261	1	ethical	ethical	ADJ
aji-161	261	2	approvals	approval	NOUN
aji-161	261	3	the	the	DET
aji-161	261	4	authors	author	NOUN
aji-161	261	5	have	have	AUX
aji-161	261	6	collected	collect	VERB
aji-161	261	7	and	and	CCONJ
aji-161	261	8	preserved	preserve	VERB
aji-161	261	9	written	write	VERB
aji-161	261	10	ethical	ethical	ADJ
aji-161	261	11	approval	approval	NOUN
aji-161	261	12	per	per	ADP
aji-161	261	13	international	international	ADJ
aji-161	261	14	standards	standard	NOUN
aji-161	261	15	.	.	PUNCT
aji-161	262	1	disclaimer	disclaimer	NOUN
aji-161	262	2	(	(	PUNCT
aji-161	262	3	artificial	artificial	ADJ
aji-161	262	4	intelligence	intelligence	NOUN
aji-161	262	5	)	)	PUNCT
aji-161	262	6	author(s	author(s	NOUN
aji-161	262	7	)	)	PUNCT
aji-161	262	8	hereby	hereby	ADV
aji-161	262	9	declare	declare	VERB
aji-161	262	10	that	that	SCONJ
aji-161	262	11	no	no	DET
aji-161	262	12	generative	generative	NOUN
aji-161	262	13	ai	ai	VERB
aji-161	262	14	technologies	technology	NOUN
aji-161	262	15	such	such	ADJ
aji-161	262	16	as	as	ADP
aji-161	262	17	large	large	ADJ
aji-161	262	18	language	language	NOUN
aji-161	262	19	models	model	NOUN
aji-161	262	20	(	(	PUNCT
aji-161	262	21	chatgpt	chatgpt	NOUN
aji-161	262	22	,	,	PUNCT
aji-161	262	23	copilot	copilot	NOUN
aji-161	262	24	,	,	PUNCT
aji-161	262	25	etc	etc	X
aji-161	262	26	.	.	X
aji-161	262	27	)	)	PUNCT
aji-161	262	28	and	and	CCONJ
aji-161	262	29	text	text	NOUN
aji-161	262	30	-	-	PUNCT
aji-161	262	31	to	to	ADP
aji-161	262	32	-	-	PUNCT
aji-161	262	33	image	image	NOUN
aji-161	262	34	generators	generator	NOUN
aji-161	262	35	have	have	AUX
aji-161	262	36	been	be	AUX
aji-161	262	37	used	use	VERB
aji-161	262	38	during	during	ADP
aji-161	262	39	the	the	DET
aji-161	262	40	writing	writing	NOUN
aji-161	262	41	or	or	CCONJ
aji-161	262	42	editing	editing	NOUN
aji-161	262	43	of	of	ADP
aji-161	262	44	this	this	DET
aji-161	262	45	manuscript	manuscript	NOUN
aji-161	262	46	.	.	PUNCT
aji-161	263	1	acknowledgements	acknowledgement	VERB
aji-161	263	2	the	the	DET
aji-161	263	3	instituto	instituto	PROPN
aji-161	263	4	alergoimuno	alergoimuno	PROPN
aji-161	263	5	de	de	PROPN
aji-161	263	6	americana	americana	PROPN
aji-161	263	7	funded	fund	VERB
aji-161	263	8	this	this	DET
aji-161	263	9	work	work	NOUN
aji-161	263	10	.	.	PUNCT
aji-161	264	1	we	we	PRON
aji-161	264	2	want	want	VERB
aji-161	264	3	to	to	PART
aji-161	264	4	thank	thank	VERB
aji-161	264	5	the	the	DET
aji-161	264	6	laboratory	laboratory	NOUN
aji-161	264	7	technicians	technician	NOUN
aji-161	264	8	alessandra	alessandra	PROPN
aji-161	264	9	vieira	vieira	PROPN
aji-161	264	10	de	de	PROPN
aji-161	264	11	oliveira	oliveira	PROPN
aji-161	264	12	and	and	CCONJ
aji-161	264	13	luciana	luciana	PROPN
aji-161	264	14	sacilotto	sacilotto	PROPN
aji-161	264	15	carvalho	carvalho	PROPN
aji-161	264	16	for	for	ADP
aji-161	264	17	their	their	PRON
aji-161	264	18	help	help	NOUN
aji-161	264	19	with	with	ADP
aji-161	264	20	the	the	DET
aji-161	264	21	exams	exam	NOUN
aji-161	264	22	.	.	PUNCT
aji-161	265	1	competing	compete	VERB
aji-161	265	2	interests	interest	NOUN
aji-161	265	3	authors	author	NOUN
aji-161	265	4	have	have	AUX
aji-161	265	5	declared	declare	VERB
aji-161	265	6	that	that	SCONJ
aji-161	265	7	they	they	PRON
aji-161	265	8	have	have	VERB
aji-161	265	9	no	no	DET
aji-161	265	10	known	know	VERB
aji-161	265	11	competing	compete	VERB
aji-161	265	12	financial	financial	ADJ
aji-161	265	13	interests	interest	NOUN
aji-161	265	14	or	or	CCONJ
aji-161	265	15	non	non	ADJ
aji-161	265	16	-	-	ADJ
aji-161	265	17	financial	financial	ADJ
aji-161	265	18	interests	interest	NOUN
aji-161	265	19	or	or	CCONJ
aji-161	265	20	personal	personal	ADJ
aji-161	265	21	relationships	relationship	NOUN
aji-161	265	22	that	that	PRON
aji-161	265	23	could	could	AUX
aji-161	265	24	have	have	AUX
aji-161	265	25	appeared	appear	VERB
aji-161	265	26	to	to	PART
aji-161	265	27	influence	influence	VERB
aji-161	265	28	the	the	DET
aji-161	265	29	work	work	NOUN
aji-161	265	30	reported	report	VERB
aji-161	265	31	in	in	ADP
aji-161	265	32	this	this	DET
aji-161	265	33	paper	paper	NOUN
aji-161	265	34	.	.	PUNCT
aji-161	266	1	references	reference	NOUN
aji-161	266	2	abers	aber	NOUN
aji-161	266	3	,	,	PUNCT
aji-161	266	4	m.	m.	NOUN
aji-161	266	5	s.	s.	PROPN
aji-161	266	6	,	,	PUNCT
aji-161	266	7	&	&	CCONJ
aji-161	266	8	mathias	mathias	PROPN
aji-161	266	9	,	,	PUNCT
aji-161	266	10	r.	r.	PROPN
aji-161	266	11	a.	a.	PROPN
aji-161	266	12	(	(	PUNCT
aji-161	266	13	2025	2025	NUM
aji-161	266	14	)	)	PUNCT
aji-161	266	15	.	.	PUNCT
aji-161	267	1	novel	novel	ADJ
aji-161	267	2	applications	application	NOUN
aji-161	267	3	of	of	ADP
aji-161	267	4	large	large	ADJ
aji-161	267	5	language	language	NOUN
aji-161	267	6	models	model	NOUN
aji-161	267	7	in	in	ADP
aji-161	267	8	clinical	clinical	ADJ
aji-161	267	9	research	research	NOUN
aji-161	267	10	.	.	PUNCT
aji-161	268	1	journal	journal	PROPN
aji-161	268	2	of	of	ADP
aji-161	268	3	allergy	allergy	NOUN
aji-161	268	4	and	and	CCONJ
aji-161	268	5	clinical	clinical	ADJ
aji-161	268	6	immunology	immunology	NOUN
aji-161	268	7	,	,	PUNCT
aji-161	268	8	155(3	155(3	NUM
aji-161	268	9	)	)	PUNCT
aji-161	268	10	,	,	PUNCT
aji-161	268	11	813–814	813–814	NUM
aji-161	268	12	.	.	PUNCT
aji-161	269	1	anagnostou	anagnostou	PROPN
aji-161	269	2	,	,	PUNCT
aji-161	269	3	a.	a.	PROPN
aji-161	269	4	,	,	PUNCT
aji-161	269	5	wang	wang	PROPN
aji-161	269	6	,	,	PUNCT
aji-161	269	7	j.	j.	PROPN
aji-161	269	8	,	,	PUNCT
aji-161	269	9	chinthrajah	chinthrajah	PROPN
aji-161	269	10	,	,	PUNCT
aji-161	269	11	s.	s.	PROPN
aji-161	269	12	,	,	PUNCT
aji-161	269	13	gupta	gupta	PROPN
aji-161	269	14	,	,	PUNCT
aji-161	269	15	r.	r.	PROPN
aji-161	269	16	,	,	PUNCT
aji-161	269	17	davis	davis	PROPN
aji-161	269	18	,	,	PUNCT
aji-161	269	19	c.	c.	PROPN
aji-161	269	20	m.	m.	PROPN
aji-161	269	21	,	,	PUNCT
aji-161	269	22	parrish	parrish	PROPN
aji-161	269	23	,	,	PUNCT
aji-161	269	24	c.	c.	PROPN
aji-161	269	25	,	,	PUNCT
aji-161	269	26	et	et	PROPN
aji-161	269	27	al	al	PROPN
aji-161	269	28	.	.	PROPN
aji-161	269	29	(	(	PUNCT
aji-161	269	30	2025	2025	NUM
aji-161	269	31	)	)	PUNCT
aji-161	269	32	.	.	PUNCT
aji-161	270	1	addressing	address	VERB
aji-161	270	2	health	health	NOUN
aji-161	270	3	disparities	disparity	NOUN
aji-161	270	4	in	in	ADP
aji-161	270	5	food	food	NOUN
aji-161	270	6	allergy	allergy	NOUN
aji-161	270	7	:	:	PUNCT
aji-161	270	8	a	a	DET
aji-161	270	9	position	position	NOUN
aji-161	270	10	statement	statement	NOUN
aji-161	270	11	of	of	ADP
aji-161	270	12	the	the	DET
aji-161	270	13	aaaai	aaaai	NOUN
aji-161	270	14	prior	prior	ADJ
aji-161	270	15	authorization	authorization	NOUN
aji-161	270	16	task	task	NOUN
aji-161	270	17	force	force	NOUN
aji-161	270	18	.	.	PUNCT
aji-161	271	1	journal	journal	PROPN
aji-161	271	2	of	of	ADP
aji-161	271	3	allergy	allergy	NOUN
aji-161	271	4	and	and	CCONJ
aji-161	271	5	clinical	clinical	ADJ
aji-161	271	6	immunology	immunology	NOUN
aji-161	271	7	,	,	PUNCT
aji-161	271	8	155(1	155(1	NUM
aji-161	271	9	)	)	PUNCT
aji-161	271	10	,	,	PUNCT
aji-161	271	11	53–61	53–61	NUM
aji-161	271	12	.	.	PUNCT
aji-161	271	13	anouar	anouar	PROPN
aji-161	271	14	,	,	PUNCT
aji-161	271	15	s.	s.	PROPN
aji-161	271	16	,	,	PUNCT
aji-161	271	17	hazim	hazim	PROPN
aji-161	271	18	,	,	PUNCT
aji-161	271	19	r.	r.	PROPN
aji-161	271	20	,	,	PUNCT
aji-161	271	21	&	&	CCONJ
aji-161	271	22	brahim	brahim	PROPN
aji-161	271	23	,	,	PUNCT
aji-161	271	24	a.	a.	NOUN
aji-161	271	25	(	(	PUNCT
aji-161	271	26	2024	2024	NUM
aji-161	271	27	)	)	PUNCT
aji-161	271	28	.	.	PUNCT
aji-161	272	1	interferences	interference	NOUN
aji-161	272	2	in	in	ADP
aji-161	272	3	immunological	immunological	ADJ
aji-161	272	4	assays	assay	NOUN
aji-161	272	5	:	:	PUNCT
aji-161	272	6	causes	cause	NOUN
aji-161	272	7	,	,	PUNCT
aji-161	272	8	detection	detection	NOUN
aji-161	272	9	,	,	PUNCT
aji-161	272	10	and	and	CCONJ
aji-161	272	11	prevention	prevention	NOUN
aji-161	272	12	.	.	PUNCT
aji-161	273	1	asian	asian	PROPN
aji-161	273	2	j	j	PROPN
aji-161	273	3	immunol	immunol	NOUN
aji-161	273	4	.	.	PROPN
aji-161	273	5	,	,	PUNCT
aji-161	273	6	7(1	7(1	NUM
aji-161	273	7	)	)	PUNCT
aji-161	273	8	,	,	PUNCT
aji-161	273	9	71–78	71–78	NUM
aji-161	273	10	.	.	PUNCT
aji-161	274	1	bardana	bardana	PROPN
aji-161	274	2	,	,	PUNCT
aji-161	274	3	e.	e.	PROPN
aji-161	274	4	j.	j.	PROPN
aji-161	274	5	,	,	PUNCT
aji-161	274	6	jr	jr	PROPN
aji-161	274	7	.	.	PROPN
aji-161	274	8	,	,	PUNCT
aji-161	274	9	&	&	CCONJ
aji-161	274	10	montanaro	montanaro	PROPN
aji-161	274	11	,	,	PUNCT
aji-161	274	12	a.	a.	NOUN
aji-161	274	13	(	(	PUNCT
aji-161	274	14	1991	1991	NUM
aji-161	274	15	)	)	PUNCT
aji-161	274	16	.	.	PUNCT
aji-161	275	1	formaldehyde	formaldehyde	NOUN
aji-161	275	2	:	:	PUNCT
aji-161	275	3	an	an	DET
aji-161	275	4	analysis	analysis	NOUN
aji-161	275	5	of	of	ADP
aji-161	275	6	its	its	PRON
aji-161	275	7	respiratory	respiratory	ADJ
aji-161	275	8	,	,	PUNCT
aji-161	275	9	cutaneous	cutaneous	ADJ
aji-161	275	10	,	,	PUNCT
aji-161	275	11	and	and	CCONJ
aji-161	275	12	immunologic	immunologic	ADJ
aji-161	275	13	effects	effect	NOUN
aji-161	275	14	.	.	PUNCT
aji-161	276	1	ann	ann	PROPN
aji-161	276	2	allergy	allergy	PROPN
aji-161	276	3	,	,	PUNCT
aji-161	276	4	66(6	66(6	NUM
aji-161	276	5	)	)	PUNCT
aji-161	276	6	,	,	PUNCT
aji-161	276	7	441–452	441–452	NUM
aji-161	276	8	.	.	PUNCT
aji-161	277	1	bergh	bergh	PROPN
aji-161	277	2	,	,	PUNCT
aji-161	277	3	m.	m.	NOUN
aji-161	277	4	,	,	PUNCT
aji-161	277	5	magnusson	magnusson	PROPN
aji-161	277	6	,	,	PUNCT
aji-161	277	7	k.	k.	PROPN
aji-161	277	8	,	,	PUNCT
aji-161	277	9	nilsson	nilsson	PROPN
aji-161	277	10	,	,	PUNCT
aji-161	277	11	j.	j.	PROPN
aji-161	277	12	l.	l.	PROPN
aji-161	277	13	,	,	PUNCT
aji-161	277	14	&	&	CCONJ
aji-161	277	15	karlberg	karlberg	PROPN
aji-161	277	16	,	,	PUNCT
aji-161	277	17	a.	a.	NOUN
aji-161	277	18	t.	t.	PROPN
aji-161	277	19	(	(	PUNCT
aji-161	277	20	1998	1998	NUM
aji-161	277	21	)	)	PUNCT
aji-161	277	22	.	.	PUNCT
aji-161	278	1	formation	formation	NOUN
aji-161	278	2	of	of	ADP
aji-161	278	3	formaldehyde	formaldehyde	NOUN
aji-161	278	4	and	and	CCONJ
aji-161	278	5	peroxides	peroxide	NOUN
aji-161	278	6	by	by	ADP
aji-161	278	7	air	air	NOUN
aji-161	278	8	oxidation	oxidation	NOUN
aji-161	278	9	of	of	ADP
aji-161	278	10	high	high	ADJ
aji-161	278	11	purity	purity	NOUN
aji-161	278	12	polyoxyethylene	polyoxyethylene	NOUN
aji-161	278	13	surfactants	surfactant	NOUN
aji-161	278	14	.	.	PUNCT
aji-161	279	1	contact	contact	PROPN
aji-161	279	2	dermatitis	dermatitis	PROPN
aji-161	279	3	,	,	PUNCT
aji-161	279	4	39(1	39(1	NUM
aji-161	279	5	)	)	PUNCT
aji-161	279	6	,	,	PUNCT
aji-161	279	7	14	14	NUM
aji-161	279	8	–	–	SYM
aji-161	279	9	20	20	NUM
aji-161	279	10	.	.	PUNCT
aji-161	279	11	braun	braun	PROPN
aji-161	279	12	,	,	PUNCT
aji-161	279	13	d.	d.	PROPN
aji-161	279	14	,	,	PUNCT
aji-161	279	15	cherdron	cherdron	PROPN
aji-161	279	16	,	,	PUNCT
aji-161	279	17	h.	h.	PROPN
aji-161	279	18	,	,	PUNCT
aji-161	279	19	rehahn	rehahn	NOUN
aji-161	279	20	,	,	PUNCT
aji-161	279	21	m.	m.	NOUN
aji-161	279	22	,	,	PUNCT
aji-161	279	23	ritter	ritter	PROPN
aji-161	279	24	,	,	PUNCT
aji-161	279	25	h.	h.	PROPN
aji-161	279	26	,	,	PUNCT
aji-161	279	27	&	&	CCONJ
aji-161	279	28	voit	voit	PROPN
aji-161	279	29	,	,	PUNCT
aji-161	279	30	b.	b.	PROPN
aji-161	279	31	(	(	PUNCT
aji-161	279	32	2013	2013	NUM
aji-161	279	33	)	)	PUNCT
aji-161	279	34	.	.	PUNCT
aji-161	280	1	polymer	polymer	NOUN
aji-161	280	2	synthesis	synthesis	NOUN
aji-161	280	3	:	:	PUNCT
aji-161	280	4	theory	theory	NOUN
aji-161	280	5	and	and	CCONJ
aji-161	280	6	practice	practice	NOUN
aji-161	280	7	.	.	PUNCT
aji-161	281	1	springer	springer	PROPN
aji-161	281	2	berlin	berlin	PROPN
aji-161	281	3	heidelberg	heidelberg	PROPN
aji-161	281	4	.	.	PUNCT
aji-161	282	1	bruynzeel	bruynzeel	PROPN
aji-161	282	2	,	,	PUNCT
aji-161	282	3	d.	d.	PROPN
aji-161	282	4	p.	p.	PROPN
aji-161	282	5	,	,	PUNCT
aji-161	282	6	andersen	andersen	PROPN
aji-161	282	7	,	,	PUNCT
aji-161	282	8	k.	k.	PROPN
aji-161	282	9	e.	e.	PROPN
aji-161	282	10	,	,	PUNCT
aji-161	282	11	camarasa	camarasa	PROPN
aji-161	282	12	,	,	PUNCT
aji-161	282	13	j.	j.	PROPN
aji-161	282	14	g.	g.	PROPN
aji-161	282	15	,	,	PUNCT
aji-161	282	16	lachapelle	lachapelle	PROPN
aji-161	282	17	,	,	PUNCT
aji-161	282	18	j.-m	j.-m	PROPN
aji-161	282	19	.	.	PUNCT
aji-161	282	20	,	,	PUNCT
aji-161	282	21	menné	menné	NOUN
aji-161	282	22	,	,	PUNCT
aji-161	282	23	t.	t.	PROPN
aji-161	282	24	,	,	PUNCT
aji-161	282	25	&	&	CCONJ
aji-161	282	26	white	white	PROPN
aji-161	282	27	,	,	PUNCT
aji-161	282	28	i.	i.	PROPN
aji-161	282	29	r.	r.	PROPN
aji-161	282	30	(	(	PUNCT
aji-161	282	31	1995	1995	NUM
aji-161	282	32	)	)	PUNCT
aji-161	282	33	.	.	PUNCT
aji-161	283	1	the	the	DET
aji-161	283	2	european	european	PROPN
aji-161	283	3	standard	standard	PROPN
aji-161	283	4	series	series	PROPN
aji-161	283	5	.	.	PUNCT
aji-161	284	1	contact	contact	PROPN
aji-161	284	2	dermatitis	dermatitis	PROPN
aji-161	284	3	,	,	PUNCT
aji-161	284	4	33(3	33(3	NOUN
aji-161	284	5	)	)	PUNCT
aji-161	284	6	,	,	PUNCT
aji-161	284	7	145–148	145–148	NUM
aji-161	284	8	.	.	PUNCT
aji-161	285	1	castanedo	castanedo	PROPN
aji-161	285	2	-	-	PUNCT
aji-161	285	3	tardan	tardan	ADJ
aji-161	285	4	,	,	PUNCT
aji-161	285	5	m.	m.	NOUN
aji-161	285	6	p.	p.	PROPN
aji-161	285	7	,	,	PUNCT
aji-161	285	8	gonzález	gonzález	PROPN
aji-161	285	9	,	,	PUNCT
aji-161	285	10	m.	m.	PROPN
aji-161	285	11	e.	e.	PROPN
aji-161	285	12	,	,	PUNCT
aji-161	285	13	connelly	connelly	PROPN
aji-161	285	14	,	,	PUNCT
aji-161	285	15	e.	e.	PROPN
aji-161	285	16	a.	a.	PROPN
aji-161	285	17	,	,	PUNCT
aji-161	285	18	giordano	giordano	PROPN
aji-161	285	19	,	,	PUNCT
aji-161	285	20	k.	k.	PROPN
aji-161	285	21	,	,	PUNCT
aji-161	285	22	&	&	CCONJ
aji-161	285	23	jacob	jacob	PROPN
aji-161	285	24	,	,	PUNCT
aji-161	285	25	s.	s.	PROPN
aji-161	285	26	e.	e.	PROPN
aji-161	285	27	(	(	PUNCT
aji-161	285	28	2009	2009	NUM
aji-161	285	29	)	)	PUNCT
aji-161	285	30	.	.	PUNCT
aji-161	286	1	systematized	systematize	VERB
aji-161	286	2	contact	contact	NOUN
aji-161	286	3	dermatitis	dermatitis	NOUN
aji-161	286	4	and	and	CCONJ
aji-161	286	5	montelukast	montelukast	NOUN
aji-161	286	6	in	in	ADP
aji-161	286	7	an	an	DET
aji-161	286	8	atopic	atopic	NOUN
aji-161	286	9	boy	boy	NOUN
aji-161	286	10	.	.	PUNCT
aji-161	287	1	pediatric	pediatric	ADJ
aji-161	287	2	dermatology	dermatology	NOUN
aji-161	287	3	,	,	PUNCT
aji-161	287	4	26(6	26(6	NUM
aji-161	287	5	)	)	PUNCT
aji-161	287	6	,	,	PUNCT
aji-161	287	7	739–743	739–743	NUM
aji-161	287	8	.	.	PUNCT
aji-161	288	1	chiarentin	chiarentin	PROPN
aji-161	288	2	,	,	PUNCT
aji-161	288	3	l.	l.	PROPN
aji-161	288	4	,	,	PUNCT
aji-161	288	5	gonçalves	gonçalves	PROPN
aji-161	288	6	,	,	PUNCT
aji-161	288	7	c.	c.	PROPN
aji-161	288	8	,	,	PUNCT
aji-161	288	9	augusto	augusto	NOUN
aji-161	288	10	,	,	PUNCT
aji-161	288	11	c.	c.	PROPN
aji-161	288	12	,	,	PUNCT
aji-161	288	13	miranda	miranda	PROPN
aji-161	288	14	,	,	PUNCT
aji-161	288	15	m.	m.	NOUN
aji-161	288	16	,	,	PUNCT
aji-161	288	17	cardoso	cardoso	PROPN
aji-161	288	18	,	,	PUNCT
aji-161	288	19	c.	c.	PROPN
aji-161	288	20	,	,	PUNCT
aji-161	288	21	&	&	CCONJ
aji-161	288	22	vitorino	vitorino	PROPN
aji-161	288	23	,	,	PUNCT
aji-161	288	24	c.	c.	PROPN
aji-161	288	25	(	(	PUNCT
aji-161	288	26	2023	2023	NUM
aji-161	288	27	)	)	PUNCT
aji-161	288	28	.	.	PUNCT
aji-161	289	1	drilling	drill	VERB
aji-161	289	2	into	into	ADP
aji-161	289	3	"	"	PUNCT
aji-161	289	4	quality	quality	NOUN
aji-161	289	5	by	by	ADP
aji-161	289	6	design	design	NOUN
aji-161	289	7	"	"	PUNCT
aji-161	289	8	approach	approach	NOUN
aji-161	289	9	for	for	ADP
aji-161	289	10	analytical	analytical	ADJ
aji-161	289	11	methods	method	NOUN
aji-161	289	12	.	.	PUNCT
aji-161	290	1	critical	critical	ADJ
aji-161	290	2	reviews	review	NOUN
aji-161	290	3	in	in	ADP
aji-161	290	4	analytical	analytical	ADJ
aji-161	290	5	chemistry	chemistry	NOUN
aji-161	290	6	,	,	PUNCT
aji-161	290	7	1–42	1–42	PROPN
aji-161	290	8	.	.	PUNCT
aji-161	291	1	olivier	olivier	PROPN
aji-161	291	2	et	et	PROPN
aji-161	291	3	al	al	PROPN
aji-161	291	4	.	.	PROPN
aji-161	291	5	;	;	PUNCT
aji-161	291	6	asian	asian	PROPN
aji-161	291	7	j.	j.	PROPN
aji-161	291	8	immunol	immunol	PROPN
aji-161	291	9	.	.	PROPN
aji-161	291	10	,	,	PUNCT
aji-161	291	11	vol	vol	NOUN
aji-161	291	12	.	.	PROPN
aji-161	291	13	8	8	NUM
aji-161	291	14	,	,	PUNCT
aji-161	291	15	no	no	INTJ
aji-161	291	16	.	.	NOUN
aji-161	291	17	1	1	NUM
aji-161	291	18	,	,	PUNCT
aji-161	291	19	pp	pp	ADJ
aji-161	291	20	.	.	PUNCT
aji-161	292	1	70	70	NUM
aji-161	292	2	-	-	SYM
aji-161	292	3	81	81	NUM
aji-161	292	4	,	,	PUNCT
aji-161	292	5	2025	2025	NUM
aji-161	292	6	;	;	PUNCT
aji-161	292	7	article	article	NOUN
aji-161	292	8	no.aji.134825	no.aji.134825	VERB
aji-161	292	9	78	78	NUM
aji-161	292	10	chung	chung	NOUN
aji-161	292	11	,	,	PUNCT
aji-161	292	12	m.	m.	NOUN
aji-161	292	13	k.	k.	PROPN
aji-161	292	14	,	,	PUNCT
aji-161	292	15	house	house	PROPN
aji-161	292	16	,	,	PUNCT
aji-161	292	17	j.	j.	PROPN
aji-161	292	18	s.	s.	PROPN
aji-161	292	19	,	,	PUNCT
aji-161	292	20	akhtari	akhtari	PROPN
aji-161	292	21	,	,	PUNCT
aji-161	292	22	f.	f.	PROPN
aji-161	292	23	s.	s.	PROPN
aji-161	292	24	,	,	PUNCT
aji-161	292	25	makris	makris	PROPN
aji-161	292	26	,	,	PUNCT
aji-161	292	27	k.	k.	PROPN
aji-161	292	28	c.	c.	PROPN
aji-161	292	29	,	,	PUNCT
aji-161	292	30	langston	langston	PROPN
aji-161	292	31	,	,	PUNCT
aji-161	292	32	m.	m.	NOUN
aji-161	292	33	a.	a.	PROPN
aji-161	292	34	,	,	PUNCT
aji-161	292	35	islam	islam	PROPN
aji-161	292	36	,	,	PUNCT
aji-161	292	37	k.	k.	PROPN
aji-161	292	38	t.	t.	PROPN
aji-161	292	39	,	,	PUNCT
aji-161	292	40	et	et	PROPN
aji-161	292	41	al	al	PROPN
aji-161	292	42	.	.	PUNCT
aji-161	293	1	(	(	PUNCT
aji-161	293	2	2024	2024	NUM
aji-161	293	3	)	)	PUNCT
aji-161	293	4	.	.	PUNCT
aji-161	294	1	decoding	decode	VERB
aji-161	294	2	the	the	DET
aji-161	294	3	exposome	exposome	NOUN
aji-161	294	4	:	:	PUNCT
aji-161	294	5	data	datum	NOUN
aji-161	294	6	science	science	NOUN
aji-161	294	7	methodologies	methodology	NOUN
aji-161	294	8	and	and	CCONJ
aji-161	294	9	implications	implication	NOUN
aji-161	294	10	in	in	ADP
aji-161	294	11	exposome	exposome	NOUN
aji-161	294	12	-	-	PUNCT
aji-161	294	13	wide	wide	ADJ
aji-161	294	14	association	association	NOUN
aji-161	294	15	studies	study	NOUN
aji-161	294	16	(	(	PUNCT
aji-161	294	17	exwass	exwass	PROPN
aji-161	294	18	)	)	PUNCT
aji-161	294	19	.	.	PUNCT
aji-161	295	1	exposome	exposome	NOUN
aji-161	295	2	,	,	PUNCT
aji-161	295	3	4(1	4(1	NOUN
aji-161	295	4	)	)	PUNCT
aji-161	295	5	,	,	PUNCT
aji-161	295	6	osae001	osae001	PROPN
aji-161	295	7	.	.	PUNCT
aji-161	295	8	commission	commission	PROPN
aji-161	295	9	for	for	ADP
aji-161	295	10	the	the	DET
aji-161	295	11	regulation	regulation	NOUN
aji-161	295	12	of	of	ADP
aji-161	295	13	the	the	DET
aji-161	295	14	council	council	NOUN
aji-161	295	15	on	on	ADP
aji-161	295	16	cosmetic	cosmetic	ADJ
aji-161	295	17	products	product	NOUN
aji-161	295	18	.	.	PUNCT
aji-161	296	1	(	(	PUNCT
aji-161	296	2	2019	2019	NUM
aji-161	296	3	)	)	PUNCT
aji-161	296	4	.	.	PUNCT
aji-161	297	1	commission	commission	NOUN
aji-161	297	2	regulation	regulation	NOUN
aji-161	297	3	number	number	NOUN
aji-161	297	4	2019/831	2019/831	NUM
aji-161	297	5	of	of	ADP
aji-161	297	6	the	the	DET
aji-161	297	7	european	european	ADJ
aji-161	297	8	parliament	parliament	NOUN
aji-161	297	9	and	and	CCONJ
aji-161	297	10	the	the	DET
aji-161	297	11	council	council	NOUN
aji-161	297	12	on	on	ADP
aji-161	297	13	cosmetic	cosmetic	ADJ
aji-161	297	14	products	product	NOUN
aji-161	297	15	.	.	PUNCT
aji-161	298	1	official	official	ADJ
aji-161	298	2	journal	journal	NOUN
aji-161	298	3	of	of	ADP
aji-161	298	4	the	the	DET
aji-161	298	5	european	european	PROPN
aji-161	298	6	union	union	PROPN
aji-161	298	7	,	,	PUNCT
aji-161	298	8	62	62	NUM
aji-161	298	9	,	,	PUNCT
aji-161	298	10	29–63	29–63	NUM
aji-161	298	11	.	.	PUNCT
aji-161	299	1	commission	commission	NOUN
aji-161	299	2	of	of	ADP
aji-161	299	3	the	the	DET
aji-161	299	4	15th	15th	ADJ
aji-161	299	5	report	report	NOUN
aji-161	299	6	on	on	ADP
aji-161	299	7	carcinogens	carcinogen	NOUN
aji-161	299	8	.	.	PUNCT
aji-161	300	1	(	(	PUNCT
aji-161	300	2	2021	2021	NUM
aji-161	300	3	)	)	PUNCT
aji-161	300	4	.	.	PUNCT
aji-161	301	1	report	report	NOUN
aji-161	301	2	on	on	ADP
aji-161	301	3	carcinogens	carcinogen	NOUN
aji-161	301	4	:	:	PUNCT
aji-161	301	5	carcinogen	carcinogen	NOUN
aji-161	301	6	profiles	profile	NOUN
aji-161	301	7	(	(	PUNCT
aji-161	301	8	2021/12/21	2021/12/21	NUM
aji-161	301	9	ed	ed	NOUN
aji-161	301	10	.	.	PUNCT
aji-161	301	11	,	,	PUNCT
aji-161	301	12	vol	vol	NOUN
aji-161	301	13	.	.	PROPN
aji-161	301	14	15	15	NUM
aji-161	301	15	)	)	PUNCT
aji-161	301	16	.	.	PUNCT
aji-161	302	1	commission	commission	PROPN
aji-161	302	2	of	of	ADP
aji-161	302	3	the	the	DET
aji-161	302	4	national	national	ADJ
aji-161	302	5	center	center	NOUN
aji-161	302	6	for	for	ADP
aji-161	302	7	biotechnology	biotechnology	NOUN
aji-161	302	8	information	information	NOUN
aji-161	302	9	.	.	PUNCT
aji-161	303	1	(	(	PUNCT
aji-161	303	2	2024	2024	NUM
aji-161	303	3	)	)	PUNCT
aji-161	303	4	.	.	PUNCT
aji-161	304	1	pubchem	pubchem	PROPN
aji-161	304	2	compound	compound	NOUN
aji-161	304	3	summary	summary	NOUN
aji-161	304	4	for	for	ADP
aji-161	304	5	cid	cid	NOUN
aji-161	304	6	712	712	NUM
aji-161	304	7	,	,	PUNCT
aji-161	304	8	formaldehyde	formaldehyde	NOUN
aji-161	304	9	.	.	PUNCT
aji-161	305	1	https://pubchem.ncbi.nlm.nih.gov/compoun	https://pubchem.ncbi.nlm.nih.gov/compoun	PUNCT
aji-161	305	2	d	d	X
aji-161	305	3	/	/	SYM
aji-161	305	4	formaldehyde	formaldehyde	NOUN
aji-161	305	5	dahlquist	dahlquist	NOUN
aji-161	305	6	,	,	PUNCT
aji-161	305	7	i.	i.	PROPN
aji-161	305	8	,	,	PUNCT
aji-161	305	9	&	&	CCONJ
aji-161	305	10	fregert	fregert	PROPN
aji-161	305	11	,	,	PUNCT
aji-161	305	12	s.	s.	PROPN
aji-161	305	13	(	(	PUNCT
aji-161	305	14	1978	1978	NUM
aji-161	305	15	)	)	PUNCT
aji-161	305	16	.	.	PUNCT
aji-161	306	1	formaldehyde	formaldehyde	NOUN
aji-161	306	2	releasers	releaser	NOUN
aji-161	306	3	.	.	PUNCT
aji-161	307	1	contact	contact	PROPN
aji-161	307	2	dermatitis	dermatitis	PROPN
aji-161	307	3	,	,	PUNCT
aji-161	307	4	4(3	4(3	NUM
aji-161	307	5	)	)	PUNCT
aji-161	307	6	,	,	PUNCT
aji-161	307	7	173	173	NUM
aji-161	307	8	.	.	PUNCT
aji-161	307	9	dahlquist	dahlquist	PROPN
aji-161	307	10	,	,	PUNCT
aji-161	307	11	i.	i.	PROPN
aji-161	307	12	,	,	PUNCT
aji-161	307	13	fregert	fregert	PROPN
aji-161	307	14	,	,	PUNCT
aji-161	307	15	s.	s.	PROPN
aji-161	307	16	,	,	PUNCT
aji-161	307	17	&	&	CCONJ
aji-161	307	18	gruvberger	gruvberger	PROPN
aji-161	307	19	,	,	PUNCT
aji-161	307	20	b.	b.	PROPN
aji-161	307	21	(	(	PUNCT
aji-161	307	22	1980	1980	NUM
aji-161	307	23	)	)	PUNCT
aji-161	307	24	.	.	PUNCT
aji-161	308	1	detection	detection	NOUN
aji-161	308	2	of	of	ADP
aji-161	308	3	formaldehyde	formaldehyde	NOUN
aji-161	308	4	in	in	ADP
aji-161	308	5	corticoid	corticoid	PROPN
aji-161	308	6	creams	cream	NOUN
aji-161	308	7	.	.	PUNCT
aji-161	309	1	contact	contact	PROPN
aji-161	309	2	dermatitis	dermatitis	PROPN
aji-161	309	3	,	,	PUNCT
aji-161	309	4	6(7	6(7	NUM
aji-161	309	5	)	)	PUNCT
aji-161	309	6	,	,	PUNCT
aji-161	309	7	494	494	NUM
aji-161	309	8	.	.	X
aji-161	309	9	dankelman	dankelman	PROPN
aji-161	309	10	,	,	PUNCT
aji-161	309	11	w.	w.	PROPN
aji-161	309	12	,	,	PUNCT
aji-161	309	13	&	&	CCONJ
aji-161	309	14	daemen	daemen	PROPN
aji-161	309	15	,	,	PUNCT
aji-161	309	16	j.	j.	PROPN
aji-161	309	17	m.	m.	PROPN
aji-161	309	18	h.	h.	PROPN
aji-161	309	19	(	(	PUNCT
aji-161	309	20	1976	1976	NUM
aji-161	309	21	)	)	PUNCT
aji-161	309	22	.	.	PUNCT
aji-161	310	1	gas	gas	NOUN
aji-161	310	2	chromatographic	chromatographic	ADJ
aji-161	310	3	and	and	CCONJ
aji-161	310	4	nuclear	nuclear	ADJ
aji-161	310	5	magnetic	magnetic	ADJ
aji-161	310	6	resonance	resonance	NOUN
aji-161	310	7	determination	determination	NOUN
aji-161	310	8	of	of	ADP
aji-161	310	9	linear	linear	ADJ
aji-161	310	10	formaldehyde	formaldehyde	NOUN
aji-161	310	11	oligomers	oligomer	NOUN
aji-161	310	12	in	in	ADP
aji-161	310	13	formalin	formalin	NOUN
aji-161	310	14	.	.	PUNCT
aji-161	311	1	analytical	analytical	ADJ
aji-161	311	2	chemistry	chemistry	NOUN
aji-161	311	3	,	,	PUNCT
aji-161	311	4	48(2	48(2	NUM
aji-161	311	5	)	)	PUNCT
aji-161	311	6	,	,	PUNCT
aji-161	311	7	401–404	401–404	NUM
aji-161	311	8	.	.	PUNCT
aji-161	312	1	de	de	PROPN
aji-161	312	2	groot	groot	PROPN
aji-161	312	3	,	,	PUNCT
aji-161	312	4	a.	a.	PROPN
aji-161	312	5	c.	c.	PROPN
aji-161	312	6	,	,	PUNCT
aji-161	312	7	flyvholm	flyvholm	NOUN
aji-161	312	8	,	,	PUNCT
aji-161	312	9	m.-a	m.-a	NOUN
aji-161	312	10	.	.	PROPN
aji-161	312	11	,	,	PUNCT
aji-161	312	12	lensen	lensen	PROPN
aji-161	312	13	,	,	PUNCT
aji-161	312	14	g.	g.	PROPN
aji-161	312	15	,	,	PUNCT
aji-161	312	16	menné	menné	NOUN
aji-161	312	17	,	,	PUNCT
aji-161	312	18	t.	t.	PROPN
aji-161	312	19	,	,	PUNCT
aji-161	312	20	&	&	CCONJ
aji-161	312	21	coenraads	coenraad	NOUN
aji-161	312	22	,	,	PUNCT
aji-161	312	23	p.-j	p.-j	NOUN
aji-161	312	24	.	.	PUNCT
aji-161	313	1	(	(	PUNCT
aji-161	313	2	2009	2009	NUM
aji-161	313	3	)	)	PUNCT
aji-161	313	4	.	.	PUNCT
aji-161	314	1	formaldehyde	formaldehyde	NOUN
aji-161	314	2	-	-	PUNCT
aji-161	314	3	releasers	releaser	NOUN
aji-161	314	4	:	:	PUNCT
aji-161	314	5	relationship	relationship	NOUN
aji-161	314	6	to	to	ADP
aji-161	314	7	formaldehyde	formaldehyde	NOUN
aji-161	314	8	contact	contact	NOUN
aji-161	314	9	allergy	allergy	NOUN
aji-161	314	10	.	.	PUNCT
aji-161	315	1	contact	contact	NOUN
aji-161	315	2	allergy	allergy	NOUN
aji-161	315	3	to	to	ADP
aji-161	315	4	formaldehyde	formaldehyde	NOUN
aji-161	315	5	and	and	CCONJ
aji-161	315	6	inventory	inventory	NOUN
aji-161	315	7	of	of	ADP
aji-161	315	8	formaldehyde	formaldehyde	NOUN
aji-161	315	9	-	-	PUNCT
aji-161	315	10	releasers	releaser	NOUN
aji-161	315	11	.	.	PUNCT
aji-161	316	1	contact	contact	PROPN
aji-161	316	2	dermatitis	dermatitis	PROPN
aji-161	316	3	,	,	PUNCT
aji-161	316	4	61(2	61(2	NUM
aji-161	316	5	)	)	PUNCT
aji-161	316	6	,	,	PUNCT
aji-161	316	7	63–85	63–85	NUM
aji-161	316	8	.	.	PUNCT
aji-161	317	1	dias	dias	PROPN
aji-161	317	2	,	,	PUNCT
aji-161	317	3	v.	v.	PROPN
aji-161	317	4	,	,	PUNCT
aji-161	317	5	duynslaegher	duynslaegher	NOUN
aji-161	317	6	,	,	PUNCT
aji-161	317	7	c.	c.	PROPN
aji-161	317	8	,	,	PUNCT
aji-161	317	9	contino	contino	PROPN
aji-161	317	10	,	,	PUNCT
aji-161	317	11	f.	f.	PROPN
aji-161	317	12	,	,	PUNCT
aji-161	317	13	vandooren	vandooren	PROPN
aji-161	317	14	,	,	PUNCT
aji-161	317	15	j.	j.	PROPN
aji-161	317	16	,	,	PUNCT
aji-161	317	17	&	&	CCONJ
aji-161	317	18	jeanmart	jeanmart	PROPN
aji-161	317	19	,	,	PUNCT
aji-161	317	20	h.	h.	PROPN
aji-161	317	21	(	(	PUNCT
aji-161	317	22	2012	2012	NUM
aji-161	317	23	)	)	PUNCT
aji-161	317	24	.	.	PUNCT
aji-161	318	1	experimental	experimental	ADJ
aji-161	318	2	and	and	CCONJ
aji-161	318	3	modeling	modeling	NOUN
aji-161	318	4	study	study	NOUN
aji-161	318	5	of	of	ADP
aji-161	318	6	formaldehyde	formaldehyde	NOUN
aji-161	318	7	combustion	combustion	NOUN
aji-161	318	8	in	in	ADP
aji-161	318	9	flames	flame	NOUN
aji-161	318	10	.	.	PUNCT
aji-161	319	1	combustion	combustion	NOUN
aji-161	319	2	and	and	CCONJ
aji-161	319	3	flame	flame	NOUN
aji-161	319	4	,	,	PUNCT
aji-161	319	5	159(5	159(5	NUM
aji-161	319	6	)	)	PUNCT
aji-161	319	7	,	,	PUNCT
aji-161	319	8	1814	1814	NUM
aji-161	319	9	–	–	PUNCT
aji-161	319	10	1820	1820	NUM
aji-161	319	11	.	.	PUNCT
aji-161	320	1	flyvholm	flyvholm	NOUN
aji-161	320	2	,	,	PUNCT
aji-161	320	3	m.	m.	NOUN
aji-161	320	4	a.	a.	PROPN
aji-161	320	5	,	,	PUNCT
aji-161	320	6	&	&	CCONJ
aji-161	320	7	andersen	andersen	PROPN
aji-161	320	8	,	,	PUNCT
aji-161	320	9	p.	p.	NOUN
aji-161	320	10	(	(	PUNCT
aji-161	320	11	1993	1993	NUM
aji-161	320	12	)	)	PUNCT
aji-161	320	13	.	.	PUNCT
aji-161	321	1	identification	identification	NOUN
aji-161	321	2	of	of	ADP
aji-161	321	3	formaldehyde	formaldehyde	NOUN
aji-161	321	4	releasers	releaser	NOUN
aji-161	321	5	and	and	CCONJ
aji-161	321	6	occurrence	occurrence	NOUN
aji-161	321	7	of	of	ADP
aji-161	321	8	formaldehyde	formaldehyde	NOUN
aji-161	321	9	and	and	CCONJ
aji-161	321	10	formaldehyde	formaldehyde	NOUN
aji-161	321	11	releasers	releaser	NOUN
aji-161	321	12	in	in	ADP
aji-161	321	13	registered	register	VERB
aji-161	321	14	chemical	chemical	NOUN
aji-161	321	15	products	product	NOUN
aji-161	321	16	.	.	PUNCT
aji-161	322	1	american	american	ADJ
aji-161	322	2	journal	journal	PROPN
aji-161	322	3	of	of	ADP
aji-161	322	4	industrial	industrial	ADJ
aji-161	322	5	medicine	medicine	NOUN
aji-161	322	6	,	,	PUNCT
aji-161	322	7	24(5	24(5	NOUN
aji-161	322	8	)	)	PUNCT
aji-161	322	9	,	,	PUNCT
aji-161	322	10	533–552	533–552	NUM
aji-161	322	11	.	.	PUNCT
aji-161	322	12	fraenkel	fraenkel	NOUN
aji-161	322	13	-	-	PUNCT
aji-161	322	14	conrat	conrat	NOUN
aji-161	322	15	,	,	PUNCT
aji-161	322	16	h.	h.	PROPN
aji-161	322	17	,	,	PUNCT
aji-161	322	18	&	&	CCONJ
aji-161	322	19	olcott	olcott	PROPN
aji-161	322	20	,	,	PUNCT
aji-161	322	21	h.	h.	PROPN
aji-161	322	22	s.	s.	PROPN
aji-161	322	23	(	(	PUNCT
aji-161	322	24	1948a	1948a	NUM
aji-161	322	25	)	)	PUNCT
aji-161	322	26	.	.	PUNCT
aji-161	323	1	the	the	DET
aji-161	323	2	reaction	reaction	NOUN
aji-161	323	3	of	of	ADP
aji-161	323	4	formaldehyde	formaldehyde	NOUN
aji-161	323	5	with	with	ADP
aji-161	323	6	proteins	protein	NOUN
aji-161	323	7	;	;	PUNCT
aji-161	323	8	cross	cross	NOUN
aji-161	323	9	-	-	ADJ
aji-161	323	10	linking	link	VERB
aji-161	323	11	between	between	ADP
aji-161	323	12	amino	amino	NOUN
aji-161	323	13	and	and	CCONJ
aji-161	323	14	primary	primary	ADJ
aji-161	323	15	amide	amide	NOUN
aji-161	323	16	or	or	CCONJ
aji-161	323	17	guanidyl	guanidyl	ADJ
aji-161	323	18	groups	group	NOUN
aji-161	323	19	.	.	PUNCT
aji-161	324	1	journal	journal	NOUN
aji-161	324	2	of	of	ADP
aji-161	324	3	the	the	DET
aji-161	324	4	american	american	PROPN
aji-161	324	5	chemical	chemical	PROPN
aji-161	324	6	society	society	PROPN
aji-161	324	7	,	,	PUNCT
aji-161	324	8	70(8	70(8	NUM
aji-161	324	9	)	)	PUNCT
aji-161	324	10	,	,	PUNCT
aji-161	324	11	2673	2673	NUM
aji-161	324	12	–	–	PUNCT
aji-161	324	13	2684	2684	NUM
aji-161	324	14	.	.	PUNCT
aji-161	325	1	fraenkel	fraenkel	NOUN
aji-161	325	2	-	-	PUNCT
aji-161	325	3	conrat	conrat	NOUN
aji-161	325	4	,	,	PUNCT
aji-161	325	5	h.	h.	PROPN
aji-161	325	6	,	,	PUNCT
aji-161	325	7	&	&	CCONJ
aji-161	325	8	olcott	olcott	PROPN
aji-161	325	9	,	,	PUNCT
aji-161	325	10	h.	h.	PROPN
aji-161	325	11	s.	s.	PROPN
aji-161	325	12	(	(	PUNCT
aji-161	325	13	1948b	1948b	NUM
aji-161	325	14	)	)	PUNCT
aji-161	325	15	.	.	PUNCT
aji-161	326	1	reaction	reaction	NOUN
aji-161	326	2	of	of	ADP
aji-161	326	3	formaldehyde	formaldehyde	NOUN
aji-161	326	4	with	with	ADP
aji-161	326	5	proteins	protein	NOUN
aji-161	326	6	;	;	PUNCT
aji-161	326	7	cross	cross	NOUN
aji-161	326	8	-	-	ADJ
aji-161	326	9	linking	linking	NOUN
aji-161	326	10	of	of	ADP
aji-161	326	11	amino	amino	ADJ
aji-161	326	12	groups	group	NOUN
aji-161	326	13	with	with	ADP
aji-161	326	14	phenol	phenol	NOUN
aji-161	326	15	,	,	PUNCT
aji-161	326	16	imidazole	imidazole	NOUN
aji-161	326	17	,	,	PUNCT
aji-161	326	18	or	or	CCONJ
aji-161	326	19	indole	indole	ADJ
aji-161	326	20	groups	group	NOUN
aji-161	326	21	.	.	PUNCT
aji-161	327	1	the	the	DET
aji-161	327	2	journal	journal	NOUN
aji-161	327	3	of	of	ADP
aji-161	327	4	biological	biological	ADJ
aji-161	327	5	chemistry	chemistry	NOUN
aji-161	327	6	,	,	PUNCT
aji-161	327	7	174(3	174(3	NUM
aji-161	327	8	)	)	PUNCT
aji-161	327	9	,	,	PUNCT
aji-161	327	10	827–843	827–843	NUM
aji-161	327	11	.	.	PUNCT
aji-161	327	12	fraenkel	fraenkel	NOUN
aji-161	327	13	-	-	PUNCT
aji-161	327	14	conrat	conrat	NOUN
aji-161	327	15	,	,	PUNCT
aji-161	327	16	h.	h.	PROPN
aji-161	327	17	,	,	PUNCT
aji-161	327	18	brandon	brandon	PROPN
aji-161	327	19	,	,	PUNCT
aji-161	327	20	b.	b.	PROPN
aji-161	327	21	a.	a.	PROPN
aji-161	327	22	,	,	PUNCT
aji-161	327	23	&	&	CCONJ
aji-161	327	24	olcott	olcott	PROPN
aji-161	327	25	,	,	PUNCT
aji-161	327	26	h.	h.	PROPN
aji-161	327	27	s.	s.	PROPN
aji-161	327	28	(	(	PUNCT
aji-161	327	29	1947	1947	NUM
aji-161	327	30	)	)	PUNCT
aji-161	327	31	.	.	PUNCT
aji-161	328	1	the	the	DET
aji-161	328	2	reaction	reaction	NOUN
aji-161	328	3	of	of	ADP
aji-161	328	4	formaldehyde	formaldehyde	NOUN
aji-161	328	5	with	with	ADP
aji-161	328	6	proteins	protein	NOUN
aji-161	328	7	;	;	PUNCT
aji-161	328	8	participation	participation	NOUN
aji-161	328	9	of	of	ADP
aji-161	328	10	indole	indole	ADJ
aji-161	328	11	groups	group	NOUN
aji-161	328	12	;	;	PUNCT
aji-161	328	13	gramicidin	gramicidin	VERB
aji-161	328	14	.	.	PUNCT
aji-161	329	1	the	the	DET
aji-161	329	2	journal	journal	NOUN
aji-161	329	3	of	of	ADP
aji-161	329	4	biological	biological	ADJ
aji-161	329	5	chemistry	chemistry	NOUN
aji-161	329	6	,	,	PUNCT
aji-161	329	7	168(1	168(1	NUM
aji-161	329	8	)	)	PUNCT
aji-161	329	9	,	,	PUNCT
aji-161	329	10	99–118	99–118	X
aji-161	329	11	.	.	PUNCT
aji-161	329	12	gerberich	gerberich	PROPN
aji-161	329	13	,	,	PUNCT
aji-161	329	14	h.	h.	PROPN
aji-161	329	15	r.	r.	PROPN
aji-161	329	16	,	,	PUNCT
aji-161	329	17	&	&	CCONJ
aji-161	329	18	seaman	seaman	PROPN
aji-161	329	19	,	,	PUNCT
aji-161	329	20	g.	g.	PROPN
aji-161	329	21	c.	c.	PROPN
aji-161	329	22	(	(	PUNCT
aji-161	329	23	2013	2013	NUM
aji-161	329	24	)	)	PUNCT
aji-161	329	25	.	.	PUNCT
aji-161	330	1	formaldehyde	formaldehyde	NOUN
aji-161	330	2	.	.	PUNCT
aji-161	331	1	in	in	ADP
aji-161	331	2	kirk‐othmer	kirk‐othmer	ADJ
aji-161	331	3	encyclopedia	encyclopedia	NOUN
aji-161	331	4	of	of	ADP
aji-161	331	5	chemical	chemical	ADJ
aji-161	331	6	technology	technology	NOUN
aji-161	331	7	(	(	PUNCT
aji-161	331	8	pp	pp	ADJ
aji-161	331	9	.	.	PUNCT
aji-161	332	1	1–22	1–22	PROPN
aji-161	332	2	)	)	PUNCT
aji-161	332	3	.	.	PUNCT
aji-161	333	1	goossens	goossens	PROPN
aji-161	333	2	,	,	PUNCT
aji-161	333	3	a.	a.	NOUN
aji-161	333	4	,	,	PUNCT
aji-161	333	5	&	&	CCONJ
aji-161	333	6	aerts	aert	NOUN
aji-161	333	7	,	,	PUNCT
aji-161	333	8	o.	o.	NOUN
aji-161	333	9	(	(	PUNCT
aji-161	333	10	2022	2022	NUM
aji-161	333	11	)	)	PUNCT
aji-161	333	12	.	.	PUNCT
aji-161	334	1	contact	contact	NOUN
aji-161	334	2	allergy	allergy	NOUN
aji-161	334	3	to	to	ADP
aji-161	334	4	and	and	CCONJ
aji-161	334	5	allergic	allergic	ADJ
aji-161	334	6	contact	contact	NOUN
aji-161	334	7	dermatitis	dermatitis	NOUN
aji-161	334	8	from	from	ADP
aji-161	334	9	formaldehyde	formaldehyde	NOUN
aji-161	334	10	and	and	CCONJ
aji-161	334	11	formaldehyde	formaldehyde	NOUN
aji-161	334	12	releasers	releaser	NOUN
aji-161	334	13	:	:	PUNCT
aji-161	334	14	a	a	DET
aji-161	334	15	clinical	clinical	ADJ
aji-161	334	16	review	review	NOUN
aji-161	334	17	and	and	CCONJ
aji-161	334	18	update	update	VERB
aji-161	334	19	.	.	PUNCT
aji-161	335	1	contact	contact	PROPN
aji-161	335	2	dermatitis	dermatitis	PROPN
aji-161	335	3	,	,	PUNCT
aji-161	335	4	87(1	87(1	PROPN
aji-161	335	5	)	)	PUNCT
aji-161	335	6	,	,	PUNCT
aji-161	335	7	20–27	20–27	NUM
aji-161	335	8	.	.	PUNCT
aji-161	336	1	hill	hill	PROPN
aji-161	336	2	,	,	PUNCT
aji-161	336	3	a.	a.	NOUN
aji-161	336	4	m.	m.	NOUN
aji-161	336	5	,	,	PUNCT
aji-161	336	6	&	&	CCONJ
aji-161	336	7	belsito	belsito	PROPN
aji-161	336	8	,	,	PUNCT
aji-161	336	9	d.	d.	PROPN
aji-161	336	10	v.	v.	PROPN
aji-161	336	11	(	(	PUNCT
aji-161	336	12	2003	2003	NUM
aji-161	336	13	)	)	PUNCT
aji-161	336	14	.	.	PUNCT
aji-161	337	1	systemic	systemic	ADJ
aji-161	337	2	contact	contact	NOUN
aji-161	337	3	dermatitis	dermatitis	PROPN
aji-161	337	4	of	of	ADP
aji-161	337	5	the	the	DET
aji-161	337	6	eyelids	eyelid	NOUN
aji-161	337	7	caused	cause	VERB
aji-161	337	8	by	by	ADP
aji-161	337	9	formaldehyde	formaldehyde	NOUN
aji-161	337	10	derived	derive	VERB
aji-161	337	11	from	from	ADP
aji-161	337	12	aspartame	aspartame	NOUN
aji-161	337	13	?	?	PUNCT
aji-161	338	1	contact	contact	PROPN
aji-161	338	2	dermatitis	dermatitis	NOUN
aji-161	338	3	,	,	PUNCT
aji-161	338	4	49(5	49(5	NUM
aji-161	338	5	)	)	PUNCT
aji-161	338	6	,	,	PUNCT
aji-161	338	7	258–259	258–259	NUM
aji-161	338	8	.	.	PUNCT
aji-161	339	1	kramps	kramps	PROPN
aji-161	339	2	,	,	PUNCT
aji-161	339	3	j.	j.	PROPN
aji-161	339	4	a.	a.	PROPN
aji-161	339	5	,	,	PUNCT
aji-161	339	6	peltenburg	peltenburg	PROPN
aji-161	339	7	,	,	PUNCT
aji-161	339	8	l.	l.	PROPN
aji-161	339	9	t.	t.	PROPN
aji-161	339	10	,	,	PUNCT
aji-161	339	11	kerklaan	kerklaan	PROPN
aji-161	339	12	,	,	PUNCT
aji-161	339	13	p.	p.	PROPN
aji-161	339	14	r.	r.	PROPN
aji-161	339	15	,	,	PUNCT
aji-161	339	16	spieksma	spieksma	VERB
aji-161	339	17	,	,	PUNCT
aji-161	339	18	f.	f.	PROPN
aji-161	339	19	t.	t.	PROPN
aji-161	339	20	,	,	PUNCT
aji-161	339	21	valentijn	valentijn	PROPN
aji-161	339	22	,	,	PUNCT
aji-161	339	23	r.	r.	PROPN
aji-161	339	24	m.	m.	PROPN
aji-161	339	25	,	,	PUNCT
aji-161	339	26	&	&	CCONJ
aji-161	339	27	dijkman	dijkman	PROPN
aji-161	339	28	,	,	PUNCT
aji-161	339	29	j.	j.	PROPN
aji-161	339	30	h.	h.	PROPN
aji-161	339	31	(	(	PUNCT
aji-161	339	32	1989	1989	NUM
aji-161	339	33	)	)	PUNCT
aji-161	339	34	.	.	PUNCT
aji-161	340	1	measurement	measurement	NOUN
aji-161	340	2	of	of	ADP
aji-161	340	3	specific	specific	ADJ
aji-161	340	4	ige	ige	PROPN
aji-161	340	5	antibodies	antibody	NOUN
aji-161	340	6	in	in	ADP
aji-161	340	7	individuals	individual	NOUN
aji-161	340	8	exposed	expose	VERB
aji-161	340	9	to	to	ADP
aji-161	340	10	formaldehyde	formaldehyde	NOUN
aji-161	340	11	.	.	PUNCT
aji-161	341	1	clinical	clinical	ADJ
aji-161	341	2	and	and	CCONJ
aji-161	341	3	experimental	experimental	ADJ
aji-161	341	4	allergy	allergy	NOUN
aji-161	341	5	,	,	PUNCT
aji-161	341	6	19(5	19(5	NUM
aji-161	341	7	)	)	PUNCT
aji-161	341	8	,	,	PUNCT
aji-161	341	9	509–514	509–514	NUM
aji-161	341	10	.	.	PUNCT
aji-161	342	1	kuratsuji	kuratsuji	PROPN
aji-161	342	2	,	,	PUNCT
aji-161	342	3	t.	t.	PROPN
aji-161	342	4	(	(	PUNCT
aji-161	342	5	1981	1981	NUM
aji-161	342	6	)	)	PUNCT
aji-161	342	7	.	.	PUNCT
aji-161	343	1	studies	study	NOUN
aji-161	343	2	on	on	ADP
aji-161	343	3	leukocyte	leukocyte	ADJ
aji-161	343	4	adherence	adherence	NOUN
aji-161	343	5	inhibition	inhibition	NOUN
aji-161	343	6	test	test	NOUN
aji-161	343	7	.	.	PUNCT
aji-161	344	1	part	part	NOUN
aji-161	344	2	i.	i.	PROPN
aji-161	344	3	studies	study	NOUN
aji-161	344	4	on	on	ADP
aji-161	344	5	mechanisms	mechanism	NOUN
aji-161	344	6	of	of	ADP
aji-161	344	7	leukocyte	leukocyte	NOUN
aji-161	344	8	adherence	adherence	NOUN
aji-161	344	9	inhibition	inhibition	NOUN
aji-161	344	10	.	.	PUNCT
aji-161	345	1	keio	keio	PROPN
aji-161	345	2	journal	journal	PROPN
aji-161	345	3	of	of	ADP
aji-161	345	4	medicine	medicine	NOUN
aji-161	345	5	,	,	PUNCT
aji-161	345	6	30(2	30(2	NUM
aji-161	345	7	)	)	PUNCT
aji-161	345	8	,	,	PUNCT
aji-161	345	9	53–63	53–63	NUM
aji-161	345	10	.	.	PUNCT
aji-161	346	1	lazarov	lazarov	PROPN
aji-161	346	2	,	,	PUNCT
aji-161	346	3	a.	a.	PROPN
aji-161	346	4	,	,	PUNCT
aji-161	346	5	cordoba	cordoba	PROPN
aji-161	346	6	,	,	PUNCT
aji-161	346	7	m.	m.	NOUN
aji-161	346	8	,	,	PUNCT
aji-161	346	9	plosk	plosk	PROPN
aji-161	346	10	,	,	PUNCT
aji-161	346	11	n.	n.	NOUN
aji-161	346	12	,	,	PUNCT
aji-161	346	13	&	&	CCONJ
aji-161	346	14	abraham	abraham	PROPN
aji-161	346	15	,	,	PUNCT
aji-161	346	16	d.	d.	PROPN
aji-161	346	17	(	(	PUNCT
aji-161	346	18	2003	2003	NUM
aji-161	346	19	)	)	PUNCT
aji-161	346	20	.	.	PUNCT
aji-161	347	1	atypical	atypical	ADJ
aji-161	347	2	and	and	CCONJ
aji-161	347	3	unusual	unusual	ADJ
aji-161	347	4	clinical	clinical	ADJ
aji-161	347	5	manifestations	manifestation	NOUN
aji-161	347	6	of	of	ADP
aji-161	347	7	contact	contact	NOUN
aji-161	347	8	dermatitis	dermatitis	NOUN
aji-161	347	9	to	to	ADP
aji-161	347	10	clothing	clothing	NOUN
aji-161	347	11	(	(	PUNCT
aji-161	347	12	textile	textile	NOUN
aji-161	347	13	contact	contact	NOUN
aji-161	347	14	dermatitis	dermatitis	PROPN
aji-161	347	15	):	):	PUNCT
aji-161	347	16	case	case	NOUN
aji-161	347	17	presentation	presentation	NOUN
aji-161	347	18	and	and	CCONJ
aji-161	347	19	review	review	NOUN
aji-161	347	20	of	of	ADP
aji-161	347	21	the	the	DET
aji-161	347	22	literature	literature	NOUN
aji-161	347	23	.	.	PUNCT
aji-161	348	1	dermatology	dermatology	NOUN
aji-161	348	2	online	online	PROPN
aji-161	348	3	journal	journal	PROPN
aji-161	348	4	,	,	PUNCT
aji-161	348	5	9(3	9(3	NUM
aji-161	348	6	)	)	PUNCT
aji-161	348	7	,	,	PUNCT
aji-161	348	8	1	1	X
aji-161	348	9	.	.	PUNCT
aji-161	348	10	liou	liou	NOUN
aji-161	348	11	,	,	PUNCT
aji-161	348	12	y.	y.	PROPN
aji-161	348	13	l.	l.	PROPN
aji-161	348	14	,	,	PUNCT
aji-161	348	15	voller	voller	PROPN
aji-161	348	16	,	,	PUNCT
aji-161	348	17	l.	l.	PROPN
aji-161	348	18	m.	m.	PROPN
aji-161	348	19	,	,	PUNCT
aji-161	348	20	liszewski	liszewski	PROPN
aji-161	348	21	,	,	PUNCT
aji-161	348	22	w.	w.	PROPN
aji-161	348	23	,	,	PUNCT
aji-161	348	24	ericson	ericson	PROPN
aji-161	348	25	,	,	PUNCT
aji-161	348	26	m.	m.	PROPN
aji-161	348	27	e.	e.	PROPN
aji-161	348	28	,	,	PUNCT
aji-161	348	29	siegel	siegel	PROPN
aji-161	348	30	,	,	PUNCT
aji-161	348	31	p.	p.	PROPN
aji-161	348	32	d.	d.	PROPN
aji-161	348	33	,	,	PUNCT
aji-161	348	34	&	&	CCONJ
aji-161	348	35	warshaw	warshaw	PROPN
aji-161	348	36	,	,	PUNCT
aji-161	348	37	e.	e.	PROPN
aji-161	348	38	m.	m.	PROPN
aji-161	348	39	(	(	PUNCT
aji-161	348	40	2021	2021	NUM
aji-161	348	41	)	)	PUNCT
aji-161	348	42	.	.	PUNCT
aji-161	349	1	formaldehyde	formaldehyde	NOUN
aji-161	349	2	release	release	NOUN
aji-161	349	3	from	from	ADP
aji-161	349	4	predispersed	predisperse	VERB
aji-161	349	5	tattoo	tattoo	ADJ
aji-161	349	6	inks	ink	NOUN
aji-161	349	7	:	:	PUNCT
aji-161	349	8	analysis	analysis	NOUN
aji-161	349	9	using	use	VERB
aji-161	349	10	the	the	DET
aji-161	349	11	chromotropic	chromotropic	ADJ
aji-161	349	12	acid	acid	NOUN
aji-161	349	13	method	method	NOUN
aji-161	349	14	.	.	PUNCT
aji-161	350	1	dermatitis	dermatitis	NOUN
aji-161	350	2	,	,	PUNCT
aji-161	350	3	32(5	32(5	NUM
aji-161	350	4	)	)	PUNCT
aji-161	350	5	,	,	PUNCT
aji-161	350	6	327–332	327–332	NUM
aji-161	350	7	.	.	PUNCT
aji-161	351	1	mizuki	mizuki	PROPN
aji-161	351	2	,	,	PUNCT
aji-161	351	3	m.	m.	NOUN
aji-161	351	4	,	,	PUNCT
aji-161	351	5	&	&	CCONJ
aji-161	351	6	tsuda	tsuda	NOUN
aji-161	351	7	,	,	PUNCT
aji-161	351	8	t.	t.	PROPN
aji-161	351	9	(	(	PUNCT
aji-161	351	10	2001	2001	NUM
aji-161	351	11	)	)	PUNCT
aji-161	351	12	.	.	PUNCT
aji-161	352	1	[	[	X
aji-161	352	2	relationship	relationship	NOUN
aji-161	352	3	between	between	ADP
aji-161	352	4	atopic	atopic	NOUN
aji-161	352	5	factors	factor	NOUN
aji-161	352	6	and	and	CCONJ
aji-161	352	7	physical	physical	ADJ
aji-161	352	8	symptoms	symptom	NOUN
aji-161	352	9	induced	induce	VERB
aji-161	352	10	by	by	ADP
aji-161	352	11	gaseous	gaseous	ADJ
aji-161	352	12	formaldehyde	formaldehyde	NOUN
aji-161	352	13	exposure	exposure	NOUN
aji-161	352	14	during	during	ADP
aji-161	352	15	an	an	DET
aji-161	352	16	anatomy	anatomy	NOUN
aji-161	352	17	dissection	dissection	NOUN
aji-161	352	18	course	course	NOUN
aji-161	352	19	]	]	PUNCT
aji-161	352	20	.	.	PUNCT
aji-161	353	1	arerugi	arerugi	PROPN
aji-161	353	2	,	,	PUNCT
aji-161	353	3	50(1	50(1	NUM
aji-161	353	4	)	)	PUNCT
aji-161	353	5	,	,	PUNCT
aji-161	353	6	21–28	21–28	NUM
aji-161	353	7	.	.	PUNCT
aji-161	354	1	olivier	olivier	PROPN
aji-161	354	2	,	,	PUNCT
aji-161	354	3	c.	c.	PROPN
aji-161	354	4	e.	e.	PROPN
aji-161	354	5	(	(	PUNCT
aji-161	354	6	2024	2024	NUM
aji-161	354	7	)	)	PUNCT
aji-161	354	8	.	.	PUNCT
aji-161	355	1	allergic	allergic	ADJ
aji-161	355	2	sinusitis	sinusitis	NOUN
aji-161	355	3	,	,	PUNCT
aji-161	355	4	allergic	allergic	ADJ
aji-161	355	5	migraine	migraine	NOUN
aji-161	355	6	,	,	PUNCT
aji-161	355	7	and	and	CCONJ
aji-161	355	8	sinus	sinus	NOUN
aji-161	355	9	headaches	headache	NOUN
aji-161	355	10	.	.	PUNCT
aji-161	356	1	online	online	ADJ
aji-161	356	2	olivier	olivier	PROPN
aji-161	356	3	et	et	PROPN
aji-161	356	4	al	al	PROPN
aji-161	356	5	.	.	PROPN
aji-161	356	6	;	;	PUNCT
aji-161	356	7	asian	asian	PROPN
aji-161	356	8	j.	j.	PROPN
aji-161	356	9	immunol	immunol	PROPN
aji-161	356	10	.	.	PROPN
aji-161	356	11	,	,	PUNCT
aji-161	356	12	vol	vol	NOUN
aji-161	356	13	.	.	PROPN
aji-161	356	14	8	8	NUM
aji-161	356	15	,	,	PUNCT
aji-161	356	16	no	no	INTJ
aji-161	356	17	.	.	NOUN
aji-161	356	18	1	1	NUM
aji-161	356	19	,	,	PUNCT
aji-161	356	20	pp	pp	ADJ
aji-161	356	21	.	.	PUNCT
aji-161	357	1	70	70	NUM
aji-161	357	2	-	-	SYM
aji-161	357	3	81	81	NUM
aji-161	357	4	,	,	PUNCT
aji-161	357	5	2025	2025	NUM
aji-161	357	6	;	;	PUNCT
aji-161	357	7	article	article	NOUN
aji-161	357	8	no.aji.134825	no.aji.134825	X
aji-161	357	9	79	79	NUM
aji-161	357	10	journal	journal	NOUN
aji-161	357	11	of	of	ADP
aji-161	357	12	otolaryngology	otolaryngology	NOUN
aji-161	357	13	and	and	CCONJ
aji-161	357	14	rhinology	rhinology	NOUN
aji-161	357	15	,	,	PUNCT
aji-161	357	16	7(1	7(1	NUM
aji-161	357	17	)	)	PUNCT
aji-161	357	18	,	,	PUNCT
aji-161	358	1	ojor.ms.id.000652	ojor.ms.id.000652	PROPN
aji-161	358	2	.	.	PUNCT
aji-161	358	3	olivier	olivier	PROPN
aji-161	358	4	,	,	PUNCT
aji-161	358	5	c.	c.	PROPN
aji-161	358	6	e.	e.	PROPN
aji-161	358	7	,	,	PUNCT
aji-161	358	8	argentão	argentão	PROPN
aji-161	358	9	,	,	PUNCT
aji-161	358	10	d.	d.	PROPN
aji-161	358	11	g.	g.	PROPN
aji-161	358	12	p.	p.	PROPN
aji-161	358	13	,	,	PUNCT
aji-161	358	14	santos	santos	PROPN
aji-161	358	15	,	,	PUNCT
aji-161	358	16	r.	r.	PROPN
aji-161	358	17	a.	a.	PROPN
aji-161	358	18	p.	p.	PROPN
aji-161	358	19	g.	g.	PROPN
aji-161	358	20	,	,	PUNCT
aji-161	358	21	silva	silva	PROPN
aji-161	358	22	,	,	PUNCT
aji-161	358	23	m.	m.	NOUN
aji-161	358	24	d.	d.	PROPN
aji-161	358	25	,	,	PUNCT
aji-161	358	26	lima	lima	PROPN
aji-161	358	27	,	,	PUNCT
aji-161	358	28	r.	r.	PROPN
aji-161	358	29	p.	p.	PROPN
aji-161	358	30	s.	s.	PROPN
aji-161	358	31	,	,	PUNCT
aji-161	358	32	&	&	CCONJ
aji-161	358	33	zollner	zollner	PROPN
aji-161	358	34	,	,	PUNCT
aji-161	358	35	r.	r.	PROPN
aji-161	358	36	l.	l.	PROPN
aji-161	358	37	(	(	PUNCT
aji-161	358	38	2013	2013	NUM
aji-161	358	39	)	)	PUNCT
aji-161	358	40	.	.	PUNCT
aji-161	359	1	skin	skin	NOUN
aji-161	359	2	scrape	scrape	PROPN
aji-161	359	3	test	test	NOUN
aji-161	359	4	:	:	PUNCT
aji-161	359	5	an	an	DET
aji-161	359	6	inexpensive	inexpensive	ADJ
aji-161	359	7	and	and	CCONJ
aji-161	359	8	painless	painless	ADJ
aji-161	359	9	skin	skin	NOUN
aji-161	359	10	test	test	NOUN
aji-161	359	11	for	for	ADP
aji-161	359	12	recognition	recognition	NOUN
aji-161	359	13	of	of	ADP
aji-161	359	14	immediate	immediate	ADJ
aji-161	359	15	hypersensitivity	hypersensitivity	NOUN
aji-161	359	16	in	in	ADP
aji-161	359	17	children	child	NOUN
aji-161	359	18	and	and	CCONJ
aji-161	359	19	adults	adult	NOUN
aji-161	359	20	.	.	PUNCT
aji-161	360	1	the	the	DET
aji-161	360	2	open	open	ADJ
aji-161	360	3	allergy	allergy	NOUN
aji-161	360	4	journal	journal	PROPN
aji-161	360	5	,	,	PUNCT
aji-161	360	6	6	6	NUM
aji-161	360	7	,	,	PUNCT
aji-161	360	8	9–17	9–17	NOUN
aji-161	360	9	.	.	PUNCT
aji-161	361	1	olivier	olivier	PROPN
aji-161	361	2	,	,	PUNCT
aji-161	361	3	c.	c.	PROPN
aji-161	361	4	e.	e.	PROPN
aji-161	361	5	,	,	PUNCT
aji-161	361	6	lima	lima	PROPN
aji-161	361	7	,	,	PUNCT
aji-161	361	8	r.	r.	PROPN
aji-161	361	9	p.	p.	PROPN
aji-161	361	10	s.	s.	PROPN
aji-161	361	11	,	,	PUNCT
aji-161	361	12	pinto	pinto	NOUN
aji-161	361	13	,	,	PUNCT
aji-161	361	14	d.	d.	PROPN
aji-161	361	15	g.	g.	PROPN
aji-161	361	16	,	,	PUNCT
aji-161	361	17	santos	santos	PROPN
aji-161	361	18	,	,	PUNCT
aji-161	361	19	r.	r.	PROPN
aji-161	361	20	a.	a.	PROPN
aji-161	361	21	p.	p.	PROPN
aji-161	361	22	g.	g.	PROPN
aji-161	361	23	,	,	PUNCT
aji-161	361	24	silva	silva	PROPN
aji-161	361	25	,	,	PUNCT
aji-161	361	26	g.	g.	PROPN
aji-161	361	27	k.	k.	PROPN
aji-161	361	28	m.	m.	PROPN
aji-161	361	29	,	,	PUNCT
aji-161	361	30	lorena	lorena	PROPN
aji-161	361	31	,	,	PUNCT
aji-161	361	32	s.	s.	PROPN
aji-161	361	33	l.	l.	PROPN
aji-161	361	34	s.	s.	PROPN
aji-161	361	35	,	,	PUNCT
aji-161	361	36	et	et	PROPN
aji-161	361	37	al	al	PROPN
aji-161	361	38	.	.	PUNCT
aji-161	361	39	(	(	PUNCT
aji-161	361	40	2012	2012	NUM
aji-161	361	41	)	)	PUNCT
aji-161	361	42	.	.	PUNCT
aji-161	362	1	in	in	ADP
aji-161	362	2	search	search	NOUN
aji-161	362	3	of	of	ADP
aji-161	362	4	a	a	DET
aji-161	362	5	tolerance	tolerance	NOUN
aji-161	362	6	-	-	PUNCT
aji-161	362	7	induction	induction	NOUN
aji-161	362	8	strategy	strategy	NOUN
aji-161	362	9	for	for	ADP
aji-161	362	10	cow	cow	NOUN
aji-161	362	11	's	's	PART
aji-161	362	12	milk	milk	NOUN
aji-161	362	13	allergies	allergy	NOUN
aji-161	362	14	:	:	PUNCT
aji-161	362	15	significant	significant	ADJ
aji-161	362	16	reduction	reduction	NOUN
aji-161	362	17	of	of	ADP
aji-161	362	18	betalactoglobulin	betalactoglobulin	ADJ
aji-161	362	19	allergenicity	allergenicity	NOUN
aji-161	362	20	via	via	ADP
aji-161	362	21	transglutaminase	transglutaminase	NOUN
aji-161	362	22	/	/	SYM
aji-161	362	23	cysteine	cysteine	NOUN
aji-161	362	24	polymerization	polymerization	NOUN
aji-161	362	25	.	.	PUNCT
aji-161	363	1	clinics	clinic	NOUN
aji-161	363	2	,	,	PUNCT
aji-161	363	3	67(10	67(10	NUM
aji-161	363	4	)	)	PUNCT
aji-161	363	5	,	,	PUNCT
aji-161	363	6	1171–1179	1171–1179	NUM
aji-161	363	7	.	.	PUNCT
aji-161	364	1	olivier	olivier	PROPN
aji-161	364	2	,	,	PUNCT
aji-161	364	3	c.	c.	PROPN
aji-161	364	4	e.	e.	PROPN
aji-161	364	5	,	,	PUNCT
aji-161	364	6	pinto	pinto	PROPN
aji-161	364	7	,	,	PUNCT
aji-161	364	8	d.	d.	PROPN
aji-161	364	9	g.	g.	PROPN
aji-161	364	10	,	,	PUNCT
aji-161	364	11	lima	lima	PROPN
aji-161	364	12	,	,	PUNCT
aji-161	364	13	r.	r.	PROPN
aji-161	364	14	p.	p.	PROPN
aji-161	364	15	s.	s.	PROPN
aji-161	364	16	,	,	PUNCT
aji-161	364	17	silva	silva	PROPN
aji-161	364	18	,	,	PUNCT
aji-161	364	19	m.	m.	PROPN
aji-161	364	20	d.	d.	PROPN
aji-161	364	21	d.	d.	PROPN
aji-161	364	22	,	,	PUNCT
aji-161	364	23	santos	santos	PROPN
aji-161	364	24	,	,	PUNCT
aji-161	364	25	r.	r.	PROPN
aji-161	364	26	a.	a.	PROPN
aji-161	364	27	p.	p.	PROPN
aji-161	364	28	g.	g.	PROPN
aji-161	364	29	,	,	PUNCT
aji-161	364	30	teixeira	teixeira	PROPN
aji-161	364	31	,	,	PUNCT
aji-161	364	32	a.	a.	NOUN
aji-161	364	33	p.	p.	NOUN
aji-161	364	34	m.	m.	NOUN
aji-161	364	35	,	,	PUNCT
aji-161	364	36	et	et	PROPN
aji-161	364	37	al	al	PROPN
aji-161	364	38	.	.	PROPN
aji-161	364	39	(	(	PUNCT
aji-161	364	40	2021a	2021a	NUM
aji-161	364	41	)	)	PUNCT
aji-161	364	42	.	.	PUNCT
aji-161	365	1	assessment	assessment	NOUN
aji-161	365	2	of	of	ADP
aji-161	365	3	immunoreactivity	immunoreactivity	NOUN
aji-161	365	4	against	against	ADP
aji-161	365	5	therapeutic	therapeutic	ADJ
aji-161	365	6	options	option	NOUN
aji-161	365	7	employing	employ	VERB
aji-161	365	8	the	the	DET
aji-161	365	9	leukocyte	leukocyte	NOUN
aji-161	365	10	adherence	adherence	NOUN
aji-161	365	11	inhibition	inhibition	NOUN
aji-161	365	12	test	test	NOUN
aji-161	365	13	as	as	ADP
aji-161	365	14	a	a	DET
aji-161	365	15	tool	tool	NOUN
aji-161	365	16	for	for	ADP
aji-161	365	17	precision	precision	NOUN
aji-161	365	18	medicine	medicine	NOUN
aji-161	365	19	.	.	PUNCT
aji-161	366	1	european	european	ADJ
aji-161	366	2	journal	journal	PROPN
aji-161	366	3	of	of	ADP
aji-161	366	4	clinical	clinical	ADJ
aji-161	366	5	medicine	medicine	NOUN
aji-161	366	6	,	,	PUNCT
aji-161	366	7	2(3	2(3	NUM
aji-161	366	8	)	)	PUNCT
aji-161	366	9	,	,	PUNCT
aji-161	366	10	40–45	40–45	NUM
aji-161	366	11	.	.	PUNCT
aji-161	367	1	olivier	olivier	PROPN
aji-161	367	2	,	,	PUNCT
aji-161	367	3	c.	c.	PROPN
aji-161	367	4	e.	e.	PROPN
aji-161	367	5	,	,	PUNCT
aji-161	367	6	pinto	pinto	PROPN
aji-161	367	7	,	,	PUNCT
aji-161	367	8	d.	d.	PROPN
aji-161	367	9	g.	g.	PROPN
aji-161	367	10	,	,	PUNCT
aji-161	367	11	santos	santos	PROPN
aji-161	367	12	,	,	PUNCT
aji-161	367	13	r.	r.	PROPN
aji-161	367	14	a.	a.	PROPN
aji-161	367	15	p.	p.	PROPN
aji-161	367	16	g.	g.	PROPN
aji-161	367	17	,	,	PUNCT
aji-161	367	18	&	&	CCONJ
aji-161	367	19	lima	lima	PROPN
aji-161	367	20	,	,	PUNCT
aji-161	367	21	r.	r.	PROPN
aji-161	367	22	p.	p.	PROPN
aji-161	367	23	s.	s.	PROPN
aji-161	367	24	(	(	PUNCT
aji-161	367	25	2021b	2021b	NUM
aji-161	367	26	)	)	PUNCT
aji-161	367	27	.	.	PUNCT
aji-161	368	1	dextran	dextran	PROPN
aji-161	368	2	's	's	PART
aji-161	368	3	interference	interference	NOUN
aji-161	368	4	over	over	ADP
aji-161	368	5	the	the	DET
aji-161	368	6	leukocyte	leukocyte	NOUN
aji-161	368	7	adherence	adherence	NOUN
aji-161	368	8	inhibition	inhibition	NOUN
aji-161	368	9	test	test	NOUN
aji-161	368	10	.	.	PUNCT
aji-161	369	1	academia	academia	PROPN
aji-161	369	2	letter	letter	PROPN
aji-161	369	3	,	,	PUNCT
aji-161	369	4	article	article	NOUN
aji-161	369	5	3792	3792	NUM
aji-161	369	6	.	.	PUNCT
aji-161	370	1	olivier	olivier	PROPN
aji-161	370	2	,	,	PUNCT
aji-161	370	3	c.	c.	PROPN
aji-161	370	4	e.	e.	PROPN
aji-161	370	5	,	,	PUNCT
aji-161	370	6	pinto	pinto	PROPN
aji-161	370	7	,	,	PUNCT
aji-161	370	8	d.	d.	PROPN
aji-161	370	9	g.	g.	PROPN
aji-161	370	10	,	,	PUNCT
aji-161	370	11	teixeira	teixeira	PROPN
aji-161	370	12	,	,	PUNCT
aji-161	370	13	a.	a.	NOUN
aji-161	370	14	p.	p.	NOUN
aji-161	370	15	m.	m.	NOUN
aji-161	370	16	,	,	PUNCT
aji-161	370	17	miguel	miguel	PROPN
aji-161	370	18	,	,	PUNCT
aji-161	370	19	c.	c.	PROPN
aji-161	370	20	s.	s.	PROPN
aji-161	370	21	,	,	PUNCT
aji-161	370	22	santana	santana	PROPN
aji-161	370	23	,	,	PUNCT
aji-161	370	24	j.	j.	PROPN
aji-161	370	25	l.	l.	PROPN
aji-161	370	26	s.	s.	PROPN
aji-161	370	27	,	,	PUNCT
aji-161	370	28	santos	santos	PROPN
aji-161	370	29	,	,	PUNCT
aji-161	370	30	et	et	PROPN
aji-161	370	31	al	al	PROPN
aji-161	370	32	.	.	PROPN
aji-161	370	33	(	(	PUNCT
aji-161	370	34	2025a	2025a	NUM
aji-161	370	35	)	)	PUNCT
aji-161	370	36	.	.	PUNCT
aji-161	371	1	immunoreactivity	immunoreactivity	NOUN
aji-161	371	2	to	to	ADP
aji-161	371	3	cocoa	cocoa	NOUN
aji-161	371	4	and	and	CCONJ
aji-161	371	5	nickel	nickel	NOUN
aji-161	371	6	in	in	ADP
aji-161	371	7	atopic	atopic	NOUN
aji-161	371	8	and	and	CCONJ
aji-161	371	9	allergic	allergic	ADJ
aji-161	371	10	contact	contact	NOUN
aji-161	371	11	dermatitis	dermatitis	NOUN
aji-161	371	12	.	.	PUNCT
aji-161	372	1	asian	asian	ADJ
aji-161	372	2	journal	journal	NOUN
aji-161	372	3	of	of	ADP
aji-161	372	4	immunology	immunology	NOUN
aji-161	372	5	,	,	PUNCT
aji-161	372	6	8(1	8(1	NOUN
aji-161	372	7	)	)	PUNCT
aji-161	372	8	,	,	PUNCT
aji-161	372	9	35–49	35–49	NUM
aji-161	372	10	.	.	PUNCT
aji-161	373	1	olivier	olivier	PROPN
aji-161	373	2	,	,	PUNCT
aji-161	373	3	c.	c.	PROPN
aji-161	373	4	e.	e.	PROPN
aji-161	373	5	,	,	PUNCT
aji-161	373	6	pinto	pinto	PROPN
aji-161	373	7	,	,	PUNCT
aji-161	373	8	d.	d.	PROPN
aji-161	373	9	g.	g.	PROPN
aji-161	373	10	,	,	PUNCT
aji-161	373	11	teixeira	teixeira	PROPN
aji-161	373	12	,	,	PUNCT
aji-161	373	13	a.	a.	NOUN
aji-161	373	14	p.	p.	NOUN
aji-161	373	15	m.	m.	NOUN
aji-161	373	16	,	,	PUNCT
aji-161	373	17	miguel	miguel	PROPN
aji-161	373	18	,	,	PUNCT
aji-161	373	19	c.	c.	PROPN
aji-161	373	20	s.	s.	PROPN
aji-161	373	21	,	,	PUNCT
aji-161	373	22	santos	santos	PROPN
aji-161	373	23	,	,	PUNCT
aji-161	373	24	r.	r.	PROPN
aji-161	373	25	a.	a.	PROPN
aji-161	373	26	p.	p.	PROPN
aji-161	373	27	g.	g.	PROPN
aji-161	373	28	,	,	PUNCT
aji-161	373	29	rocha	rocha	PROPN
aji-161	373	30	,	,	PUNCT
aji-161	373	31	n.	n.	PROPN
aji-161	373	32	s.	s.	PROPN
aji-161	373	33	,	,	PUNCT
aji-161	373	34	&	&	CCONJ
aji-161	373	35	et	et	PROPN
aji-161	373	36	al	al	PROPN
aji-161	373	37	.	.	PROPN
aji-161	373	38	(	(	PUNCT
aji-161	373	39	2025b	2025b	NUM
aji-161	373	40	)	)	PUNCT
aji-161	373	41	.	.	PUNCT
aji-161	374	1	endotyping	endotype	VERB
aji-161	374	2	cellular	cellular	ADJ
aji-161	374	3	and	and	CCONJ
aji-161	374	4	humoral	humoral	ADJ
aji-161	374	5	immunoreactivity	immunoreactivity	NOUN
aji-161	374	6	against	against	ADP
aji-161	374	7	pollen	pollen	NOUN
aji-161	374	8	and	and	CCONJ
aji-161	374	9	citrus	citrus	NOUN
aji-161	374	10	fruits	fruit	NOUN
aji-161	374	11	in	in	ADP
aji-161	374	12	patients	patient	NOUN
aji-161	374	13	with	with	ADP
aji-161	374	14	nonige	nonige	NOUN
aji-161	374	15	mediated	mediate	VERB
aji-161	374	16	rhinoconjunctivitis	rhinoconjunctivitis	NOUN
aji-161	374	17	.	.	PUNCT
aji-161	375	1	asian	asian	ADJ
aji-161	375	2	journal	journal	PROPN
aji-161	375	3	of	of	ADP
aji-161	375	4	immunology	immunology	NOUN
aji-161	375	5	,	,	PUNCT
aji-161	375	6	8(1	8(1	NOUN
aji-161	375	7	)	)	PUNCT
aji-161	375	8	,	,	PUNCT
aji-161	375	9	8–25	8–25	NOUN
aji-161	375	10	.	.	PUNCT
aji-161	376	1	olivier	olivier	PROPN
aji-161	376	2	,	,	PUNCT
aji-161	376	3	c.	c.	PROPN
aji-161	376	4	e.	e.	PROPN
aji-161	376	5	,	,	PUNCT
aji-161	376	6	pinto	pinto	PROPN
aji-161	376	7	,	,	PUNCT
aji-161	376	8	d.	d.	PROPN
aji-161	376	9	g.	g.	PROPN
aji-161	376	10	,	,	PUNCT
aji-161	376	11	teixeira	teixeira	PROPN
aji-161	376	12	,	,	PUNCT
aji-161	376	13	a.	a.	NOUN
aji-161	376	14	p.	p.	NOUN
aji-161	376	15	m.	m.	NOUN
aji-161	376	16	,	,	PUNCT
aji-161	376	17	miguel	miguel	PROPN
aji-161	376	18	,	,	PUNCT
aji-161	376	19	c.	c.	PROPN
aji-161	376	20	s.	s.	PROPN
aji-161	376	21	,	,	PUNCT
aji-161	376	22	santos	santos	PROPN
aji-161	376	23	,	,	PUNCT
aji-161	376	24	r.	r.	PROPN
aji-161	376	25	a.	a.	PROPN
aji-161	376	26	p.	p.	PROPN
aji-161	376	27	g.	g.	PROPN
aji-161	376	28	,	,	PUNCT
aji-161	376	29	santana	santana	PROPN
aji-161	376	30	,	,	PUNCT
aji-161	376	31	j.	j.	PROPN
aji-161	376	32	l.	l.	PROPN
aji-161	376	33	s.	s.	PROPN
aji-161	376	34	,	,	PUNCT
aji-161	376	35	et	et	PROPN
aji-161	376	36	al	al	PROPN
aji-161	376	37	.	.	PROPN
aji-161	376	38	(	(	PUNCT
aji-161	376	39	2024a	2024a	NUM
aji-161	376	40	)	)	PUNCT
aji-161	376	41	.	.	PUNCT
aji-161	377	1	cellular	cellular	ADJ
aji-161	377	2	and	and	CCONJ
aji-161	377	3	humoral	humoral	ADJ
aji-161	377	4	immunoreactivity	immunoreactivity	NOUN
aji-161	377	5	against	against	ADP
aji-161	377	6	hen	hen	NOUN
aji-161	377	7	's	's	PART
aji-161	377	8	egg	egg	NOUN
aji-161	377	9	white	white	NOUN
aji-161	377	10	:	:	PUNCT
aji-161	377	11	relevance	relevance	NOUN
aji-161	377	12	in	in	ADP
aji-161	377	13	allergic	allergic	ADJ
aji-161	377	14	patients	patient	NOUN
aji-161	377	15	.	.	PUNCT
aji-161	378	1	asian	asian	ADJ
aji-161	378	2	journal	journal	NOUN
aji-161	378	3	of	of	ADP
aji-161	378	4	immunology	immunology	NOUN
aji-161	378	5	,	,	PUNCT
aji-161	378	6	7(1	7(1	NUM
aji-161	378	7	)	)	PUNCT
aji-161	378	8	,	,	PUNCT
aji-161	378	9	274–284	274–284	NUM
aji-161	378	10	.	.	PUNCT
aji-161	379	1	olivier	olivier	PROPN
aji-161	379	2	,	,	PUNCT
aji-161	379	3	c.	c.	PROPN
aji-161	379	4	e.	e.	PROPN
aji-161	379	5	,	,	PUNCT
aji-161	379	6	pinto	pinto	PROPN
aji-161	379	7	,	,	PUNCT
aji-161	379	8	d.	d.	PROPN
aji-161	379	9	g.	g.	PROPN
aji-161	379	10	,	,	PUNCT
aji-161	379	11	teixeira	teixeira	PROPN
aji-161	379	12	,	,	PUNCT
aji-161	379	13	a.	a.	NOUN
aji-161	379	14	p.	p.	NOUN
aji-161	379	15	m.	m.	NOUN
aji-161	379	16	,	,	PUNCT
aji-161	379	17	miguel	miguel	PROPN
aji-161	379	18	,	,	PUNCT
aji-161	379	19	c.	c.	PROPN
aji-161	379	20	s.	s.	PROPN
aji-161	379	21	,	,	PUNCT
aji-161	379	22	santos	santos	PROPN
aji-161	379	23	,	,	PUNCT
aji-161	379	24	r.	r.	PROPN
aji-161	379	25	a.	a.	PROPN
aji-161	379	26	p.	p.	PROPN
aji-161	379	27	g.	g.	PROPN
aji-161	379	28	,	,	PUNCT
aji-161	379	29	santana	santana	PROPN
aji-161	379	30	,	,	PUNCT
aji-161	379	31	j.	j.	PROPN
aji-161	379	32	l.	l.	PROPN
aji-161	379	33	s.	s.	PROPN
aji-161	379	34	,	,	PUNCT
aji-161	379	35	et	et	PROPN
aji-161	379	36	al	al	PROPN
aji-161	379	37	.	.	PROPN
aji-161	379	38	(	(	PUNCT
aji-161	379	39	2024b	2024b	NUM
aji-161	379	40	)	)	PUNCT
aji-161	379	41	.	.	PUNCT
aji-161	380	1	endotyping	endotype	VERB
aji-161	380	2	cellular	cellular	ADJ
aji-161	380	3	and	and	CCONJ
aji-161	380	4	humoral	humoral	ADJ
aji-161	380	5	immunoreactivity	immunoreactivity	NOUN
aji-161	380	6	against	against	ADP
aji-161	380	7	allium	allium	NOUN
aji-161	380	8	spices	spice	NOUN
aji-161	380	9	and	and	CCONJ
aji-161	380	10	sulfites	sulfite	NOUN
aji-161	380	11	preservatives	preservative	NOUN
aji-161	380	12	in	in	ADP
aji-161	380	13	allergic	allergic	ADJ
aji-161	380	14	patients	patient	NOUN
aji-161	380	15	:	:	PUNCT
aji-161	380	16	a	a	DET
aji-161	380	17	retrospective	retrospective	ADJ
aji-161	380	18	study	study	NOUN
aji-161	380	19	.	.	PUNCT
aji-161	381	1	asian	asian	ADJ
aji-161	381	2	journal	journal	NOUN
aji-161	381	3	of	of	ADP
aji-161	381	4	immunology	immunology	NOUN
aji-161	381	5	,	,	PUNCT
aji-161	381	6	7(1	7(1	NUM
aji-161	381	7	)	)	PUNCT
aji-161	381	8	,	,	PUNCT
aji-161	381	9	185–200	185–200	NUM
aji-161	381	10	.	.	PUNCT
aji-161	382	1	olivier	olivier	PROPN
aji-161	382	2	,	,	PUNCT
aji-161	382	3	c.	c.	PROPN
aji-161	382	4	e.	e.	PROPN
aji-161	382	5	,	,	PUNCT
aji-161	382	6	pinto	pinto	PROPN
aji-161	382	7	,	,	PUNCT
aji-161	382	8	d.	d.	PROPN
aji-161	382	9	g.	g.	PROPN
aji-161	382	10	,	,	PUNCT
aji-161	382	11	teixeira	teixeira	PROPN
aji-161	382	12	,	,	PUNCT
aji-161	382	13	a.	a.	NOUN
aji-161	382	14	p.	p.	NOUN
aji-161	382	15	m.	m.	NOUN
aji-161	382	16	,	,	PUNCT
aji-161	382	17	miguel	miguel	PROPN
aji-161	382	18	,	,	PUNCT
aji-161	382	19	c.	c.	PROPN
aji-161	382	20	s.	s.	PROPN
aji-161	382	21	,	,	PUNCT
aji-161	382	22	santos	santos	PROPN
aji-161	382	23	,	,	PUNCT
aji-161	382	24	r.	r.	PROPN
aji-161	382	25	a.	a.	PROPN
aji-161	382	26	p.	p.	PROPN
aji-161	382	27	g.	g.	PROPN
aji-161	382	28	,	,	PUNCT
aji-161	382	29	santana	santana	PROPN
aji-161	382	30	,	,	PUNCT
aji-161	382	31	j.	j.	PROPN
aji-161	382	32	l.	l.	PROPN
aji-161	382	33	s.	s.	PROPN
aji-161	382	34	,	,	PUNCT
aji-161	382	35	et	et	PROPN
aji-161	382	36	al	al	PROPN
aji-161	382	37	.	.	PROPN
aji-161	382	38	(	(	PUNCT
aji-161	382	39	2024c	2024c	NUM
aji-161	382	40	)	)	PUNCT
aji-161	382	41	.	.	PUNCT
aji-161	383	1	endotyping	endotype	VERB
aji-161	383	2	cellular	cellular	ADJ
aji-161	383	3	and	and	CCONJ
aji-161	383	4	humoral	humoral	ADJ
aji-161	383	5	immunoreactivity	immunoreactivity	NOUN
aji-161	383	6	against	against	ADP
aji-161	383	7	tartrazine	tartrazine	NOUN
aji-161	383	8	in	in	ADP
aji-161	383	9	allergic	allergic	ADJ
aji-161	383	10	patients	patient	NOUN
aji-161	383	11	:	:	PUNCT
aji-161	383	12	a	a	DET
aji-161	383	13	retrospective	retrospective	ADJ
aji-161	383	14	study	study	NOUN
aji-161	383	15	.	.	PUNCT
aji-161	384	1	asian	asian	ADJ
aji-161	384	2	journal	journal	NOUN
aji-161	384	3	of	of	ADP
aji-161	384	4	immunology	immunology	NOUN
aji-161	384	5	,	,	PUNCT
aji-161	384	6	7(1	7(1	NUM
aji-161	384	7	)	)	PUNCT
aji-161	384	8	,	,	PUNCT
aji-161	384	9	217	217	NUM
aji-161	384	10	–	–	PUNCT
aji-161	384	11	227	227	NUM
aji-161	384	12	.	.	PUNCT
aji-161	385	1	olivier	olivier	PROPN
aji-161	385	2	,	,	PUNCT
aji-161	385	3	c.	c.	PROPN
aji-161	385	4	e.	e.	PROPN
aji-161	385	5	,	,	PUNCT
aji-161	385	6	pinto	pinto	PROPN
aji-161	385	7	,	,	PUNCT
aji-161	385	8	d.	d.	PROPN
aji-161	385	9	g.	g.	PROPN
aji-161	385	10	,	,	PUNCT
aji-161	385	11	teixeira	teixeira	PROPN
aji-161	385	12	,	,	PUNCT
aji-161	385	13	a.	a.	NOUN
aji-161	385	14	p.	p.	NOUN
aji-161	385	15	m.	m.	NOUN
aji-161	385	16	,	,	PUNCT
aji-161	385	17	santana	santana	PROPN
aji-161	385	18	,	,	PUNCT
aji-161	385	19	j.	j.	PROPN
aji-161	385	20	l.	l.	PROPN
aji-161	385	21	s.	s.	PROPN
aji-161	385	22	,	,	PUNCT
aji-161	385	23	santos	santos	PROPN
aji-161	385	24	,	,	PUNCT
aji-161	385	25	r.	r.	PROPN
aji-161	385	26	a.	a.	PROPN
aji-161	385	27	p.	p.	PROPN
aji-161	385	28	g.	g.	PROPN
aji-161	385	29	,	,	PUNCT
aji-161	385	30	&	&	CCONJ
aji-161	385	31	lima	lima	PROPN
aji-161	385	32	,	,	PUNCT
aji-161	385	33	r.	r.	PROPN
aji-161	385	34	p.	p.	PROPN
aji-161	385	35	s.	s.	PROPN
aji-161	385	36	(	(	PUNCT
aji-161	385	37	2021c	2021c	NUM
aji-161	385	38	)	)	PUNCT
aji-161	385	39	.	.	PUNCT
aji-161	386	1	self	self	NOUN
aji-161	386	2	-	-	PUNCT
aji-161	386	3	imposed	impose	VERB
aji-161	386	4	food	food	NOUN
aji-161	386	5	restriction	restriction	NOUN
aji-161	386	6	and	and	CCONJ
aji-161	386	7	oral	oral	ADJ
aji-161	386	8	food	food	NOUN
aji-161	386	9	challenges	challenge	NOUN
aji-161	386	10	are	be	AUX
aji-161	386	11	correlated	correlate	VERB
aji-161	386	12	with	with	ADP
aji-161	386	13	precipitin	precipitin	PROPN
aji-161	386	14	's	's	PART
aji-161	386	15	accuracy	accuracy	NOUN
aji-161	386	16	in	in	ADP
aji-161	386	17	the	the	DET
aji-161	386	18	diagnosis	diagnosis	NOUN
aji-161	386	19	of	of	ADP
aji-161	386	20	non	non	ADJ
aji-161	386	21	-	-	ADJ
aji-161	386	22	ige	ige	ADJ
aji-161	386	23	-	-	PUNCT
aji-161	386	24	mediated	mediate	VERB
aji-161	386	25	foodrelated	foodrelated	ADJ
aji-161	386	26	adulthood	adulthood	NOUN
aji-161	386	27	acute	acute	NOUN
aji-161	386	28	episodes	episode	NOUN
aji-161	386	29	of	of	ADP
aji-161	386	30	urticaria	urticaria	PROPN
aji-161	386	31	.	.	PUNCT
aji-161	387	1	journal	journal	PROPN
aji-161	387	2	of	of	ADP
aji-161	387	3	allergy	allergy	PROPN
aji-161	387	4	&	&	CCONJ
aji-161	387	5	therapy	therapy	NOUN
aji-161	387	6	,	,	PUNCT
aji-161	387	7	12(8	12(8	NUM
aji-161	387	8	)	)	PUNCT
aji-161	387	9	,	,	PUNCT
aji-161	387	10	1–8	1–8	X
aji-161	387	11	.	.	PUNCT
aji-161	387	12	olivier	olivier	PROPN
aji-161	387	13	,	,	PUNCT
aji-161	387	14	c.	c.	PROPN
aji-161	387	15	e.	e.	PROPN
aji-161	387	16	,	,	PUNCT
aji-161	387	17	pinto	pinto	PROPN
aji-161	387	18	,	,	PUNCT
aji-161	387	19	d.	d.	PROPN
aji-161	387	20	g.	g.	PROPN
aji-161	387	21	,	,	PUNCT
aji-161	387	22	teixeira	teixeira	PROPN
aji-161	387	23	,	,	PUNCT
aji-161	387	24	a.	a.	NOUN
aji-161	387	25	p.	p.	NOUN
aji-161	387	26	m.	m.	NOUN
aji-161	387	27	,	,	PUNCT
aji-161	387	28	santana	santana	PROPN
aji-161	387	29	,	,	PUNCT
aji-161	387	30	j.	j.	PROPN
aji-161	387	31	l.	l.	PROPN
aji-161	387	32	s.	s.	PROPN
aji-161	387	33	,	,	PUNCT
aji-161	387	34	santos	santos	PROPN
aji-161	387	35	,	,	PUNCT
aji-161	387	36	r.	r.	PROPN
aji-161	387	37	a.	a.	PROPN
aji-161	387	38	p.	p.	PROPN
aji-161	387	39	g.	g.	PROPN
aji-161	387	40	,	,	PUNCT
aji-161	387	41	&	&	CCONJ
aji-161	387	42	lima	lima	PROPN
aji-161	387	43	,	,	PUNCT
aji-161	387	44	r.	r.	PROPN
aji-161	387	45	p.	p.	PROPN
aji-161	387	46	s.	s.	PROPN
aji-161	387	47	(	(	PUNCT
aji-161	387	48	2023a	2023a	NUM
aji-161	387	49	)	)	PUNCT
aji-161	387	50	.	.	PUNCT
aji-161	388	1	contribution	contribution	NOUN
aji-161	388	2	of	of	ADP
aji-161	388	3	the	the	DET
aji-161	388	4	leukocyte	leukocyte	NOUN
aji-161	388	5	adherence	adherence	NOUN
aji-161	388	6	inhibition	inhibition	NOUN
aji-161	388	7	test	test	NOUN
aji-161	388	8	to	to	ADP
aji-161	388	9	the	the	DET
aji-161	388	10	diagnosis	diagnosis	NOUN
aji-161	388	11	of	of	ADP
aji-161	388	12	immunoreactivity	immunoreactivity	NOUN
aji-161	388	13	against	against	ADP
aji-161	388	14	cobalt	cobalt	NOUN
aji-161	388	15	.	.	PUNCT
aji-161	389	1	asian	asian	ADJ
aji-161	389	2	journal	journal	NOUN
aji-161	389	3	of	of	ADP
aji-161	389	4	immunology	immunology	NOUN
aji-161	389	5	,	,	PUNCT
aji-161	389	6	6(1	6(1	NUM
aji-161	389	7	)	)	PUNCT
aji-161	389	8	,	,	PUNCT
aji-161	390	1	174–184	174–184	X
aji-161	390	2	.	.	PUNCT
aji-161	391	1	olivier	olivier	PROPN
aji-161	391	2	,	,	PUNCT
aji-161	391	3	c.	c.	PROPN
aji-161	391	4	e.	e.	PROPN
aji-161	391	5	,	,	PUNCT
aji-161	391	6	pinto	pinto	PROPN
aji-161	391	7	,	,	PUNCT
aji-161	391	8	d.	d.	PROPN
aji-161	391	9	g.	g.	PROPN
aji-161	391	10	,	,	PUNCT
aji-161	391	11	teixeira	teixeira	PROPN
aji-161	391	12	,	,	PUNCT
aji-161	391	13	a.	a.	NOUN
aji-161	391	14	p.	p.	NOUN
aji-161	391	15	m.	m.	NOUN
aji-161	391	16	,	,	PUNCT
aji-161	391	17	santana	santana	PROPN
aji-161	391	18	,	,	PUNCT
aji-161	391	19	j.	j.	PROPN
aji-161	391	20	l.	l.	PROPN
aji-161	391	21	s.	s.	PROPN
aji-161	391	22	,	,	PUNCT
aji-161	391	23	santos	santos	PROPN
aji-161	391	24	,	,	PUNCT
aji-161	391	25	r.	r.	PROPN
aji-161	391	26	a.	a.	PROPN
aji-161	391	27	p.	p.	PROPN
aji-161	391	28	g.	g.	PROPN
aji-161	391	29	,	,	PUNCT
aji-161	391	30	&	&	CCONJ
aji-161	391	31	lima	lima	PROPN
aji-161	391	32	,	,	PUNCT
aji-161	391	33	r.	r.	PROPN
aji-161	391	34	p.	p.	PROPN
aji-161	391	35	s.	s.	PROPN
aji-161	391	36	(	(	PUNCT
aji-161	391	37	2023b	2023b	NUM
aji-161	391	38	)	)	PUNCT
aji-161	391	39	.	.	PUNCT
aji-161	392	1	contributions	contribution	NOUN
aji-161	392	2	of	of	ADP
aji-161	392	3	the	the	DET
aji-161	392	4	leukocyte	leukocyte	NOUN
aji-161	392	5	adherence	adherence	NOUN
aji-161	392	6	inhibition	inhibition	NOUN
aji-161	392	7	test	test	NOUN
aji-161	392	8	to	to	ADP
aji-161	392	9	the	the	DET
aji-161	392	10	diagnosis	diagnosis	NOUN
aji-161	392	11	of	of	ADP
aji-161	392	12	hypersensitivity	hypersensitivity	NOUN
aji-161	392	13	reactions	reaction	NOUN
aji-161	392	14	produced	produce	VERB
aji-161	392	15	by	by	ADP
aji-161	392	16	nickel	nickel	NOUN
aji-161	392	17	.	.	PUNCT
aji-161	393	1	asian	asian	ADJ
aji-161	393	2	journal	journal	NOUN
aji-161	393	3	of	of	ADP
aji-161	393	4	immunology	immunology	NOUN
aji-161	393	5	,	,	PUNCT
aji-161	393	6	6(1	6(1	NUM
aji-161	393	7	)	)	PUNCT
aji-161	393	8	,	,	PUNCT
aji-161	393	9	120–128	120–128	NUM
aji-161	393	10	.	.	PUNCT
aji-161	394	1	olivier	olivier	PROPN
aji-161	394	2	,	,	PUNCT
aji-161	394	3	c.	c.	PROPN
aji-161	394	4	e.	e.	PROPN
aji-161	394	5	,	,	PUNCT
aji-161	394	6	pinto	pinto	PROPN
aji-161	394	7	,	,	PUNCT
aji-161	394	8	d.	d.	PROPN
aji-161	394	9	g.	g.	PROPN
aji-161	394	10	,	,	PUNCT
aji-161	394	11	teixeira	teixeira	PROPN
aji-161	394	12	,	,	PUNCT
aji-161	394	13	a.	a.	NOUN
aji-161	394	14	p.	p.	NOUN
aji-161	394	15	m.	m.	NOUN
aji-161	394	16	,	,	PUNCT
aji-161	394	17	santana	santana	PROPN
aji-161	394	18	,	,	PUNCT
aji-161	394	19	j.	j.	PROPN
aji-161	394	20	l.	l.	PROPN
aji-161	394	21	s.	s.	PROPN
aji-161	394	22	,	,	PUNCT
aji-161	394	23	santos	santos	PROPN
aji-161	394	24	,	,	PUNCT
aji-161	394	25	r.	r.	PROPN
aji-161	394	26	a.	a.	PROPN
aji-161	394	27	p.	p.	PROPN
aji-161	394	28	g.	g.	PROPN
aji-161	394	29	,	,	PUNCT
aji-161	394	30	&	&	CCONJ
aji-161	394	31	lima	lima	PROPN
aji-161	394	32	,	,	PUNCT
aji-161	394	33	r.	r.	PROPN
aji-161	394	34	p.	p.	PROPN
aji-161	394	35	s.	s.	PROPN
aji-161	394	36	(	(	PUNCT
aji-161	394	37	2024d	2024d	NUM
aji-161	394	38	)	)	PUNCT
aji-161	394	39	.	.	PUNCT
aji-161	395	1	endotyping	endotype	VERB
aji-161	395	2	cellular	cellular	ADJ
aji-161	395	3	and	and	CCONJ
aji-161	395	4	humoral	humoral	ADJ
aji-161	395	5	immunoreactivity	immunoreactivity	NOUN
aji-161	395	6	against	against	ADP
aji-161	395	7	aluminum	aluminum	NOUN
aji-161	395	8	in	in	ADP
aji-161	395	9	allergic	allergic	ADJ
aji-161	395	10	patients	patient	NOUN
aji-161	395	11	:	:	PUNCT
aji-161	395	12	a	a	DET
aji-161	395	13	retrospective	retrospective	ADJ
aji-161	395	14	study	study	NOUN
aji-161	395	15	.	.	PUNCT
aji-161	396	1	asian	asian	ADJ
aji-161	396	2	journal	journal	NOUN
aji-161	396	3	of	of	ADP
aji-161	396	4	immunology	immunology	NOUN
aji-161	396	5	,	,	PUNCT
aji-161	396	6	7(1	7(1	NUM
aji-161	396	7	)	)	PUNCT
aji-161	396	8	,	,	PUNCT
aji-161	396	9	149–158	149–158	NUM
aji-161	396	10	.	.	PUNCT
aji-161	397	1	olivier	olivier	PROPN
aji-161	397	2	,	,	PUNCT
aji-161	397	3	c.	c.	PROPN
aji-161	397	4	e.	e.	PROPN
aji-161	397	5	,	,	PUNCT
aji-161	397	6	pinto	pinto	PROPN
aji-161	397	7	,	,	PUNCT
aji-161	397	8	d.	d.	PROPN
aji-161	397	9	g.	g.	PROPN
aji-161	397	10	,	,	PUNCT
aji-161	397	11	teixeira	teixeira	PROPN
aji-161	397	12	,	,	PUNCT
aji-161	397	13	a.	a.	NOUN
aji-161	397	14	p.	p.	NOUN
aji-161	397	15	m.	m.	NOUN
aji-161	397	16	,	,	PUNCT
aji-161	397	17	santana	santana	PROPN
aji-161	397	18	,	,	PUNCT
aji-161	397	19	j.	j.	PROPN
aji-161	397	20	l.	l.	PROPN
aji-161	397	21	s.	s.	PROPN
aji-161	397	22	,	,	PUNCT
aji-161	397	23	santos	santos	PROPN
aji-161	397	24	,	,	PUNCT
aji-161	397	25	r.	r.	PROPN
aji-161	397	26	a.	a.	PROPN
aji-161	397	27	p.	p.	PROPN
aji-161	397	28	g.	g.	PROPN
aji-161	397	29	,	,	PUNCT
aji-161	397	30	&	&	CCONJ
aji-161	397	31	lima	lima	PROPN
aji-161	397	32	,	,	PUNCT
aji-161	397	33	r.	r.	PROPN
aji-161	397	34	p.	p.	PROPN
aji-161	397	35	s.	s.	PROPN
aji-161	397	36	(	(	PUNCT
aji-161	397	37	2024e	2024e	NUM
aji-161	397	38	)	)	PUNCT
aji-161	397	39	.	.	PUNCT
aji-161	398	1	endotyping	endotype	VERB
aji-161	398	2	nonige	nonige	NOUN
aji-161	398	3	-	-	PUNCT
aji-161	398	4	mediated	mediate	VERB
aji-161	398	5	immunoreactivity	immunoreactivity	NOUN
aji-161	398	6	to	to	ADP
aji-161	398	7	polyethylene	polyethylene	NOUN
aji-161	398	8	glycol	glycol	NOUN
aji-161	398	9	:	:	PUNCT
aji-161	398	10	implications	implication	NOUN
aji-161	398	11	for	for	ADP
aji-161	398	12	allergic	allergic	ADJ
aji-161	398	13	patients	patient	NOUN
aji-161	398	14	.	.	PUNCT
aji-161	399	1	asian	asian	ADJ
aji-161	399	2	journal	journal	NOUN
aji-161	399	3	of	of	ADP
aji-161	399	4	immunology	immunology	NOUN
aji-161	399	5	,	,	PUNCT
aji-161	399	6	7(1	7(1	NUM
aji-161	399	7	)	)	PUNCT
aji-161	399	8	,	,	PUNCT
aji-161	399	9	100–111	100–111	NUM
aji-161	399	10	.	.	PUNCT
aji-161	400	1	olivier	olivier	PROPN
aji-161	400	2	,	,	PUNCT
aji-161	400	3	c.	c.	PROPN
aji-161	400	4	e.	e.	PROPN
aji-161	400	5	,	,	PUNCT
aji-161	400	6	pinto	pinto	PROPN
aji-161	400	7	,	,	PUNCT
aji-161	400	8	d.	d.	PROPN
aji-161	400	9	g.	g.	PROPN
aji-161	400	10	,	,	PUNCT
aji-161	400	11	teixeira	teixeira	PROPN
aji-161	400	12	,	,	PUNCT
aji-161	400	13	a.	a.	NOUN
aji-161	400	14	p.	p.	NOUN
aji-161	400	15	m.	m.	NOUN
aji-161	400	16	,	,	PUNCT
aji-161	400	17	santana	santana	PROPN
aji-161	400	18	,	,	PUNCT
aji-161	400	19	j.	j.	PROPN
aji-161	400	20	l.	l.	PROPN
aji-161	400	21	s.	s.	PROPN
aji-161	400	22	,	,	PUNCT
aji-161	400	23	santos	santos	PROPN
aji-161	400	24	,	,	PUNCT
aji-161	400	25	r.	r.	PROPN
aji-161	400	26	a.	a.	PROPN
aji-161	400	27	p.	p.	PROPN
aji-161	400	28	g.	g.	PROPN
aji-161	400	29	,	,	PUNCT
aji-161	400	30	lima	lima	PROPN
aji-161	400	31	,	,	PUNCT
aji-161	400	32	r.	r.	PROPN
aji-161	400	33	p.	p.	PROPN
aji-161	400	34	s.	s.	PROPN
aji-161	400	35	,	,	PUNCT
aji-161	400	36	et	et	PROPN
aji-161	400	37	al	al	PROPN
aji-161	400	38	.	.	PROPN
aji-161	400	39	(	(	PUNCT
aji-161	400	40	2024f	2024f	NUM
aji-161	400	41	)	)	PUNCT
aji-161	400	42	.	.	PUNCT
aji-161	401	1	endotyping	endotype	VERB
aji-161	401	2	non	non	ADJ
aji-161	401	3	-	-	ADJ
aji-161	401	4	ige	ige	ADJ
aji-161	401	5	-	-	PUNCT
aji-161	401	6	mediated	mediate	VERB
aji-161	401	7	immunoreactivity	immunoreactivity	NOUN
aji-161	401	8	to	to	ADP
aji-161	401	9	dermatophagoides	dermatophagoide	NOUN
aji-161	401	10	farinae	farinae	NOUN
aji-161	401	11	:	:	PUNCT
aji-161	401	12	implications	implication	NOUN
aji-161	401	13	for	for	ADP
aji-161	401	14	allergic	allergic	ADJ
aji-161	401	15	patients	patient	NOUN
aji-161	401	16	.	.	PUNCT
aji-161	402	1	asian	asian	ADJ
aji-161	402	2	journal	journal	NOUN
aji-161	402	3	of	of	ADP
aji-161	402	4	immunology	immunology	NOUN
aji-161	402	5	,	,	PUNCT
aji-161	402	6	7(1	7(1	NUM
aji-161	402	7	)	)	PUNCT
aji-161	402	8	,	,	PUNCT
aji-161	402	9	90–99	90–99	NUM
aji-161	402	10	.	.	PUNCT
aji-161	403	1	olivier	olivier	PROPN
aji-161	403	2	,	,	PUNCT
aji-161	403	3	c.	c.	PROPN
aji-161	403	4	e.	e.	PROPN
aji-161	403	5	,	,	PUNCT
aji-161	403	6	pinto	pinto	PROPN
aji-161	403	7	,	,	PUNCT
aji-161	403	8	d.	d.	PROPN
aji-161	403	9	g.	g.	PROPN
aji-161	403	10	,	,	PUNCT
aji-161	403	11	teixeira	teixeira	PROPN
aji-161	403	12	,	,	PUNCT
aji-161	403	13	a.	a.	NOUN
aji-161	403	14	p.	p.	NOUN
aji-161	403	15	m.	m.	NOUN
aji-161	403	16	,	,	PUNCT
aji-161	403	17	santana	santana	PROPN
aji-161	403	18	,	,	PUNCT
aji-161	403	19	j.	j.	PROPN
aji-161	403	20	l.	l.	PROPN
aji-161	403	21	s.	s.	PROPN
aji-161	403	22	,	,	PUNCT
aji-161	403	23	santos	santos	PROPN
aji-161	403	24	,	,	PUNCT
aji-161	403	25	r.	r.	PROPN
aji-161	403	26	a.	a.	PROPN
aji-161	403	27	p.	p.	PROPN
aji-161	403	28	g.	g.	PROPN
aji-161	403	29	,	,	PUNCT
aji-161	403	30	&	&	CCONJ
aji-161	403	31	olivier	olivier	PROPN
aji-161	403	32	et	et	PROPN
aji-161	403	33	al	al	PROPN
aji-161	403	34	.	.	PROPN
aji-161	403	35	;	;	PUNCT
aji-161	403	36	asian	asian	PROPN
aji-161	403	37	j.	j.	PROPN
aji-161	403	38	immunol	immunol	PROPN
aji-161	403	39	.	.	PROPN
aji-161	403	40	,	,	PUNCT
aji-161	403	41	vol	vol	NOUN
aji-161	403	42	.	.	PROPN
aji-161	403	43	8	8	NUM
aji-161	403	44	,	,	PUNCT
aji-161	403	45	no	no	INTJ
aji-161	403	46	.	.	NOUN
aji-161	403	47	1	1	NUM
aji-161	403	48	,	,	PUNCT
aji-161	403	49	pp	pp	ADJ
aji-161	403	50	.	.	PUNCT
aji-161	404	1	70	70	NUM
aji-161	404	2	-	-	SYM
aji-161	404	3	81	81	NUM
aji-161	404	4	,	,	PUNCT
aji-161	404	5	2025	2025	NUM
aji-161	404	6	;	;	PUNCT
aji-161	404	7	article	article	NOUN
aji-161	404	8	no.aji.134825	no.aji.134825	VERB
aji-161	404	9	80	80	NUM
aji-161	404	10	lima	lima	NOUN
aji-161	404	11	,	,	PUNCT
aji-161	404	12	r.	r.	PROPN
aji-161	404	13	p.	p.	PROPN
aji-161	404	14	s.	s.	PROPN
aji-161	404	15	(	(	PUNCT
aji-161	404	16	2021d	2021d	NUM
aji-161	404	17	)	)	PUNCT
aji-161	404	18	.	.	PUNCT
aji-161	405	1	immunoreactivity	immunoreactivity	NOUN
aji-161	405	2	against	against	ADP
aji-161	405	3	dermatophagoides	dermatophagoide	NOUN
aji-161	405	4	pteronyssinus	pteronyssinus	NOUN
aji-161	405	5	assessed	assess	VERB
aji-161	405	6	by	by	ADP
aji-161	405	7	the	the	DET
aji-161	405	8	leukocyte	leukocyte	NOUN
aji-161	405	9	adherence	adherence	NOUN
aji-161	405	10	inhibition	inhibition	NOUN
aji-161	405	11	test	test	NOUN
aji-161	405	12	in	in	ADP
aji-161	405	13	patients	patient	NOUN
aji-161	405	14	with	with	ADP
aji-161	405	15	intrinsic	intrinsic	ADJ
aji-161	405	16	atopic	atopic	NOUN
aji-161	405	17	dermatitis	dermatitis	NOUN
aji-161	405	18	and	and	CCONJ
aji-161	405	19	correlated	correlate	VERB
aji-161	405	20	"	"	PUNCT
aji-161	405	21	intrinsic	intrinsic	ADJ
aji-161	405	22	"	"	PUNCT
aji-161	405	23	non	non	ADJ
aji-161	405	24	–	–	PUNCT
aji-161	405	25	ige	ige	ADJ
aji-161	405	26	-	-	PUNCT
aji-161	405	27	mediated	mediate	VERB
aji-161	405	28	allergic	allergic	ADJ
aji-161	405	29	conditions	condition	NOUN
aji-161	405	30	.	.	PUNCT
aji-161	406	1	european	european	ADJ
aji-161	406	2	journal	journal	PROPN
aji-161	406	3	of	of	ADP
aji-161	406	4	clinical	clinical	ADJ
aji-161	406	5	medicine	medicine	NOUN
aji-161	406	6	,	,	PUNCT
aji-161	406	7	2(6	2(6	NUM
aji-161	406	8	)	)	PUNCT
aji-161	406	9	,	,	PUNCT
aji-161	406	10	45–50	45–50	NOUN
aji-161	406	11	.	.	PUNCT
aji-161	407	1	olivier	olivier	PROPN
aji-161	407	2	,	,	PUNCT
aji-161	407	3	c.	c.	PROPN
aji-161	407	4	e.	e.	PROPN
aji-161	407	5	,	,	PUNCT
aji-161	407	6	pinto	pinto	PROPN
aji-161	407	7	,	,	PUNCT
aji-161	407	8	d.	d.	PROPN
aji-161	407	9	g.	g.	PROPN
aji-161	407	10	,	,	PUNCT
aji-161	407	11	teixeira	teixeira	PROPN
aji-161	407	12	,	,	PUNCT
aji-161	407	13	a.	a.	NOUN
aji-161	407	14	p.	p.	NOUN
aji-161	407	15	m.	m.	NOUN
aji-161	407	16	,	,	PUNCT
aji-161	407	17	santana	santana	PROPN
aji-161	407	18	,	,	PUNCT
aji-161	407	19	j.	j.	PROPN
aji-161	407	20	l.	l.	PROPN
aji-161	407	21	s.	s.	PROPN
aji-161	407	22	,	,	PUNCT
aji-161	407	23	santos	santos	PROPN
aji-161	407	24	,	,	PUNCT
aji-161	408	1	r.	r.	PROPN
aji-161	408	2	a.	a.	PROPN
aji-161	408	3	p.	p.	PROPN
aji-161	408	4	g.	g.	PROPN
aji-161	409	1	s.	s.	PROPN
aji-161	409	2	,	,	PUNCT
aji-161	409	3	&	&	CCONJ
aji-161	409	4	lima	lima	PROPN
aji-161	409	5	,	,	PUNCT
aji-161	409	6	r.	r.	PROPN
aji-161	409	7	p.	p.	PROPN
aji-161	409	8	s.	s.	PROPN
aji-161	409	9	(	(	PUNCT
aji-161	409	10	2021e	2021e	NUM
aji-161	409	11	)	)	PUNCT
aji-161	409	12	.	.	PUNCT
aji-161	410	1	intrinsic	intrinsic	ADJ
aji-161	410	2	atopic	atopic	NOUN
aji-161	410	3	dermatitis	dermatitis	NOUN
aji-161	410	4	:	:	PUNCT
aji-161	410	5	titration	titration	NOUN
aji-161	410	6	of	of	ADP
aji-161	410	7	precipitins	precipitin	NOUN
aji-161	410	8	in	in	ADP
aji-161	410	9	the	the	DET
aji-161	410	10	screening	screening	NOUN
aji-161	410	11	of	of	ADP
aji-161	410	12	food	food	NOUN
aji-161	410	13	allergens	allergen	NOUN
aji-161	410	14	for	for	ADP
aji-161	410	15	prescription	prescription	NOUN
aji-161	410	16	of	of	ADP
aji-161	410	17	elimination	elimination	NOUN
aji-161	410	18	diets	diet	NOUN
aji-161	410	19	and	and	CCONJ
aji-161	410	20	desensitization	desensitization	NOUN
aji-161	410	21	strategies	strategy	NOUN
aji-161	410	22	.	.	PUNCT
aji-161	411	1	european	european	ADJ
aji-161	411	2	journal	journal	PROPN
aji-161	411	3	of	of	ADP
aji-161	411	4	clinical	clinical	ADJ
aji-161	411	5	medicine	medicine	NOUN
aji-161	411	6	,	,	PUNCT
aji-161	411	7	2(6	2(6	NUM
aji-161	411	8	)	)	PUNCT
aji-161	411	9	,	,	PUNCT
aji-161	411	10	1–9	1–9	PROPN
aji-161	411	11	.	.	NOUN
aji-161	411	12	olivier	olivier	PROPN
aji-161	411	13	,	,	PUNCT
aji-161	411	14	c.	c.	PROPN
aji-161	411	15	e.	e.	PROPN
aji-161	411	16	,	,	PUNCT
aji-161	411	17	pinto	pinto	PROPN
aji-161	411	18	,	,	PUNCT
aji-161	411	19	d.	d.	PROPN
aji-161	411	20	g.	g.	PROPN
aji-161	411	21	,	,	PUNCT
aji-161	411	22	teixeira	teixeira	PROPN
aji-161	411	23	,	,	PUNCT
aji-161	411	24	a.	a.	NOUN
aji-161	411	25	p.	p.	NOUN
aji-161	411	26	m.	m.	NOUN
aji-161	411	27	,	,	PUNCT
aji-161	411	28	santana	santana	PROPN
aji-161	411	29	,	,	PUNCT
aji-161	411	30	j.	j.	PROPN
aji-161	411	31	l.	l.	PROPN
aji-161	411	32	s.	s.	PROPN
aji-161	411	33	,	,	PUNCT
aji-161	411	34	santos	santos	PROPN
aji-161	411	35	,	,	PUNCT
aji-161	412	1	r.	r.	PROPN
aji-161	412	2	a.	a.	PROPN
aji-161	412	3	p.	p.	PROPN
aji-161	412	4	g.	g.	PROPN
aji-161	413	1	s.	s.	PROPN
aji-161	413	2	,	,	PUNCT
aji-161	413	3	&	&	CCONJ
aji-161	413	4	lima	lima	PROPN
aji-161	413	5	,	,	PUNCT
aji-161	413	6	r.	r.	PROPN
aji-161	413	7	p.	p.	PROPN
aji-161	413	8	s.	s.	PROPN
aji-161	413	9	(	(	PUNCT
aji-161	413	10	2022a	2022a	NUM
aji-161	413	11	)	)	PUNCT
aji-161	413	12	.	.	PUNCT
aji-161	414	1	contribution	contribution	NOUN
aji-161	414	2	of	of	ADP
aji-161	414	3	the	the	DET
aji-161	414	4	leukocyte	leukocyte	NOUN
aji-161	414	5	adherence	adherence	NOUN
aji-161	414	6	inhibition	inhibition	NOUN
aji-161	414	7	test	test	NOUN
aji-161	414	8	for	for	ADP
aji-161	414	9	the	the	DET
aji-161	414	10	evaluation	evaluation	NOUN
aji-161	414	11	of	of	ADP
aji-161	414	12	immunoreactivity	immunoreactivity	NOUN
aji-161	414	13	against	against	ADP
aji-161	414	14	gluten	gluten	ADJ
aji-161	414	15	extracts	extract	NOUN
aji-161	414	16	in	in	ADP
aji-161	414	17	non	non	ADJ
aji-161	414	18	—	—	PUNCT
aji-161	414	19	ige	ige	ADJ
aji-161	414	20	-	-	PUNCT
aji-161	414	21	mediated	mediate	VERB
aji-161	414	22	/	/	SYM
aji-161	414	23	non	non	ADJ
aji-161	414	24	-	-	ADJ
aji-161	414	25	autoimmune	autoimmune	ADJ
aji-161	414	26	gluten	gluten	NOUN
aji-161	414	27	-	-	PUNCT
aji-161	414	28	related	relate	VERB
aji-161	414	29	disorders	disorder	NOUN
aji-161	414	30	.	.	PUNCT
aji-161	415	1	european	european	ADJ
aji-161	415	2	journal	journal	PROPN
aji-161	415	3	of	of	ADP
aji-161	415	4	clinical	clinical	ADJ
aji-161	415	5	medicine	medicine	NOUN
aji-161	415	6	,	,	PUNCT
aji-161	415	7	3(2	3(2	NUM
aji-161	415	8	)	)	PUNCT
aji-161	415	9	,	,	PUNCT
aji-161	415	10	1–7	1–7	X
aji-161	415	11	.	.	PUNCT
aji-161	415	12	olivier	olivier	PROPN
aji-161	415	13	,	,	PUNCT
aji-161	415	14	c.	c.	PROPN
aji-161	415	15	e.	e.	PROPN
aji-161	415	16	,	,	PUNCT
aji-161	415	17	pinto	pinto	PROPN
aji-161	415	18	,	,	PUNCT
aji-161	415	19	d.	d.	PROPN
aji-161	415	20	g.	g.	PROPN
aji-161	415	21	,	,	PUNCT
aji-161	415	22	teixeira	teixeira	PROPN
aji-161	415	23	,	,	PUNCT
aji-161	415	24	a.	a.	NOUN
aji-161	415	25	p.	p.	NOUN
aji-161	415	26	m.	m.	NOUN
aji-161	415	27	,	,	PUNCT
aji-161	415	28	santana	santana	PROPN
aji-161	415	29	,	,	PUNCT
aji-161	415	30	j.	j.	PROPN
aji-161	415	31	l.	l.	PROPN
aji-161	415	32	s.	s.	PROPN
aji-161	415	33	,	,	PUNCT
aji-161	415	34	santos	santos	PROPN
aji-161	415	35	,	,	PUNCT
aji-161	416	1	r.	r.	PROPN
aji-161	416	2	a.	a.	PROPN
aji-161	416	3	p.	p.	PROPN
aji-161	416	4	g.	g.	PROPN
aji-161	417	1	s.	s.	PROPN
aji-161	417	2	,	,	PUNCT
aji-161	417	3	&	&	CCONJ
aji-161	417	4	lima	lima	PROPN
aji-161	417	5	,	,	PUNCT
aji-161	417	6	r.	r.	PROPN
aji-161	417	7	p.	p.	PROPN
aji-161	417	8	s.	s.	PROPN
aji-161	417	9	(	(	PUNCT
aji-161	417	10	2022b	2022b	NUM
aji-161	417	11	)	)	PUNCT
aji-161	417	12	.	.	PUNCT
aji-161	418	1	contribution	contribution	NOUN
aji-161	418	2	of	of	ADP
aji-161	418	3	the	the	DET
aji-161	418	4	leukocyte	leukocyte	NOUN
aji-161	418	5	adherence	adherence	NOUN
aji-161	418	6	inhibition	inhibition	NOUN
aji-161	418	7	test	test	NOUN
aji-161	418	8	to	to	ADP
aji-161	418	9	the	the	DET
aji-161	418	10	evaluation	evaluation	NOUN
aji-161	418	11	of	of	ADP
aji-161	418	12	cellular	cellular	ADJ
aji-161	418	13	immunoreactivity	immunoreactivity	NOUN
aji-161	418	14	against	against	ADP
aji-161	418	15	latex	latex	NOUN
aji-161	418	16	extracts	extract	NOUN
aji-161	418	17	for	for	ADP
aji-161	418	18	non	non	ADJ
aji-161	418	19	—	—	ADJ
aji-161	418	20	igemediated	igemediate	VERB
aji-161	418	21	latex	latex	NOUN
aji-161	418	22	-	-	PUNCT
aji-161	418	23	fruit	fruit	NOUN
aji-161	418	24	-	-	PUNCT
aji-161	418	25	pollen	pollen	NOUN
aji-161	418	26	syndrome	syndrome	NOUN
aji-161	418	27	in	in	ADP
aji-161	418	28	allergic	allergic	ADJ
aji-161	418	29	candidates	candidate	NOUN
aji-161	418	30	to	to	PART
aji-161	418	31	exclusion	exclusion	VERB
aji-161	418	32	diets	diet	NOUN
aji-161	418	33	and	and	CCONJ
aji-161	418	34	allergic	allergic	ADJ
aji-161	418	35	desensitization	desensitization	NOUN
aji-161	418	36	.	.	PUNCT
aji-161	419	1	european	european	ADJ
aji-161	419	2	journal	journal	PROPN
aji-161	419	3	of	of	ADP
aji-161	419	4	clinical	clinical	ADJ
aji-161	419	5	medicine	medicine	NOUN
aji-161	419	6	,	,	PUNCT
aji-161	419	7	3(1	3(1	NUM
aji-161	419	8	)	)	PUNCT
aji-161	419	9	,	,	PUNCT
aji-161	419	10	11–17	11–17	NUM
aji-161	419	11	.	.	PUNCT
aji-161	420	1	olivier	olivier	PROPN
aji-161	420	2	,	,	PUNCT
aji-161	420	3	c.	c.	PROPN
aji-161	420	4	e.	e.	PROPN
aji-161	420	5	,	,	PUNCT
aji-161	420	6	pinto	pinto	PROPN
aji-161	420	7	,	,	PUNCT
aji-161	420	8	d.	d.	PROPN
aji-161	420	9	g.	g.	PROPN
aji-161	420	10	,	,	PUNCT
aji-161	420	11	teixeira	teixeira	PROPN
aji-161	420	12	,	,	PUNCT
aji-161	420	13	a.	a.	NOUN
aji-161	420	14	p.	p.	NOUN
aji-161	420	15	m.	m.	NOUN
aji-161	420	16	,	,	PUNCT
aji-161	420	17	santana	santana	PROPN
aji-161	420	18	,	,	PUNCT
aji-161	420	19	j.	j.	PROPN
aji-161	420	20	l.	l.	PROPN
aji-161	420	21	s.	s.	PROPN
aji-161	420	22	,	,	PUNCT
aji-161	420	23	santos	santos	PROPN
aji-161	420	24	,	,	PUNCT
aji-161	421	1	r.	r.	PROPN
aji-161	421	2	a.	a.	PROPN
aji-161	421	3	p.	p.	PROPN
aji-161	421	4	g.	g.	PROPN
aji-161	422	1	s.	s.	PROPN
aji-161	422	2	,	,	PUNCT
aji-161	422	3	&	&	CCONJ
aji-161	422	4	lima	lima	PROPN
aji-161	422	5	,	,	PUNCT
aji-161	422	6	r.	r.	PROPN
aji-161	422	7	p.	p.	PROPN
aji-161	422	8	s.	s.	PROPN
aji-161	422	9	(	(	PUNCT
aji-161	422	10	2022c	2022c	NUM
aji-161	422	11	)	)	PUNCT
aji-161	422	12	.	.	PUNCT
aji-161	423	1	leukocyte	leukocyte	NOUN
aji-161	423	2	adherence	adherence	NOUN
aji-161	423	3	inhibition	inhibition	NOUN
aji-161	423	4	test	test	NOUN
aji-161	423	5	to	to	ADP
aji-161	423	6	the	the	DET
aji-161	423	7	assessment	assessment	NOUN
aji-161	423	8	of	of	ADP
aji-161	423	9	immunoreactivity	immunoreactivity	NOUN
aji-161	423	10	against	against	ADP
aji-161	423	11	cow	cow	NOUN
aji-161	423	12	's	's	PART
aji-161	423	13	milk	milk	NOUN
aji-161	423	14	proteins	protein	NOUN
aji-161	423	15	in	in	ADP
aji-161	423	16	non	non	ADJ
aji-161	423	17	—	—	PUNCT
aji-161	423	18	ige	ige	ADJ
aji-161	423	19	-	-	PUNCT
aji-161	423	20	mediated	mediate	VERB
aji-161	423	21	gastrointestinal	gastrointestinal	ADJ
aji-161	423	22	food	food	NOUN
aji-161	423	23	allergy	allergy	NOUN
aji-161	423	24	.	.	PUNCT
aji-161	424	1	european	european	PROPN
aji-161	424	2	journal	journal	PROPN
aji-161	424	3	of	of	ADP
aji-161	424	4	clinical	clinical	ADJ
aji-161	424	5	medicine	medicine	NOUN
aji-161	424	6	,	,	PUNCT
aji-161	424	7	3(2	3(2	NUM
aji-161	424	8	)	)	PUNCT
aji-161	424	9	,	,	PUNCT
aji-161	424	10	38–43	38–43	NUM
aji-161	424	11	.	.	PUNCT
aji-161	425	1	olivier	olivier	PROPN
aji-161	425	2	,	,	PUNCT
aji-161	425	3	c.	c.	PROPN
aji-161	425	4	e.	e.	PROPN
aji-161	425	5	,	,	PUNCT
aji-161	425	6	pinto	pinto	PROPN
aji-161	425	7	,	,	PUNCT
aji-161	425	8	d.	d.	PROPN
aji-161	425	9	g.	g.	PROPN
aji-161	425	10	,	,	PUNCT
aji-161	425	11	teixeira	teixeira	PROPN
aji-161	425	12	,	,	PUNCT
aji-161	425	13	a.	a.	NOUN
aji-161	425	14	p.	p.	NOUN
aji-161	425	15	m.	m.	NOUN
aji-161	425	16	,	,	PUNCT
aji-161	425	17	santana	santana	PROPN
aji-161	425	18	,	,	PUNCT
aji-161	425	19	j.	j.	PROPN
aji-161	425	20	l.	l.	PROPN
aji-161	425	21	s.	s.	PROPN
aji-161	425	22	,	,	PUNCT
aji-161	425	23	santos	santos	PROPN
aji-161	425	24	,	,	PUNCT
aji-161	426	1	r.	r.	PROPN
aji-161	426	2	a.	a.	PROPN
aji-161	426	3	p.	p.	PROPN
aji-161	426	4	g.	g.	PROPN
aji-161	427	1	s.	s.	PROPN
aji-161	427	2	,	,	PUNCT
aji-161	427	3	&	&	CCONJ
aji-161	427	4	lima	lima	PROPN
aji-161	427	5	,	,	PUNCT
aji-161	427	6	r.	r.	PROPN
aji-161	427	7	p.	p.	PROPN
aji-161	427	8	s.	s.	PROPN
aji-161	427	9	(	(	PUNCT
aji-161	427	10	2023c	2023c	NUM
aji-161	427	11	)	)	PUNCT
aji-161	427	12	.	.	PUNCT
aji-161	428	1	antisaccharomyces	antisaccharomyce	NOUN
aji-161	428	2	cerevisiae	cerevisiae	NOUN
aji-161	428	3	antibodies	antibody	NOUN
aji-161	428	4	(	(	PUNCT
aji-161	428	5	asca	asca	PROPN
aji-161	428	6	)	)	PUNCT
aji-161	428	7	researched	research	VERB
aji-161	428	8	by	by	ADP
aji-161	428	9	tube	tube	NOUN
aji-161	428	10	precipitins	precipitin	NOUN
aji-161	428	11	are	be	AUX
aji-161	428	12	elevated	elevate	VERB
aji-161	428	13	in	in	ADP
aji-161	428	14	patients	patient	NOUN
aji-161	428	15	with	with	ADP
aji-161	428	16	dermatologic	dermatologic	ADJ
aji-161	428	17	and	and	CCONJ
aji-161	428	18	gastrointestinal	gastrointestinal	ADJ
aji-161	428	19	non	non	ADJ
aji-161	428	20	—	—	PUNCT
aji-161	428	21	ige	ige	ADJ
aji-161	428	22	-	-	PUNCT
aji-161	428	23	mediated	mediate	VERB
aji-161	428	24	hypersensitivity	hypersensitivity	NOUN
aji-161	428	25	.	.	PUNCT
aji-161	429	1	european	european	PROPN
aji-161	429	2	journal	journal	PROPN
aji-161	429	3	of	of	ADP
aji-161	429	4	clinical	clinical	ADJ
aji-161	429	5	medicine	medicine	NOUN
aji-161	429	6	,	,	PUNCT
aji-161	429	7	4(2	4(2	NUM
aji-161	429	8	)	)	PUNCT
aji-161	429	9	,	,	PUNCT
aji-161	429	10	25–30	25–30	NUM
aji-161	429	11	.	.	PUNCT
aji-161	430	1	olivier	olivier	PROPN
aji-161	430	2	,	,	PUNCT
aji-161	430	3	c.	c.	PROPN
aji-161	430	4	e.	e.	PROPN
aji-161	430	5	,	,	PUNCT
aji-161	430	6	santos	santos	PROPN
aji-161	430	7	,	,	PUNCT
aji-161	430	8	r.	r.	PROPN
aji-161	430	9	a.	a.	PROPN
aji-161	430	10	p.	p.	PROPN
aji-161	430	11	g.	g.	PROPN
aji-161	430	12	,	,	PUNCT
aji-161	430	13	lima	lima	PROPN
aji-161	430	14	,	,	PUNCT
aji-161	430	15	r.	r.	PROPN
aji-161	430	16	p.	p.	PROPN
aji-161	430	17	s.	s.	PROPN
aji-161	430	18	,	,	PUNCT
aji-161	430	19	argentão	argentão	PROPN
aji-161	430	20	,	,	PUNCT
aji-161	430	21	d.	d.	PROPN
aji-161	430	22	g.	g.	PROPN
aji-161	430	23	p.	p.	PROPN
aji-161	430	24	,	,	PUNCT
aji-161	430	25	silva	silva	PROPN
aji-161	430	26	,	,	PUNCT
aji-161	430	27	g.	g.	PROPN
aji-161	430	28	k.	k.	PROPN
aji-161	430	29	m.	m.	PROPN
aji-161	430	30	,	,	PUNCT
aji-161	430	31	&	&	CCONJ
aji-161	430	32	silva	silva	PROPN
aji-161	430	33	,	,	PUNCT
aji-161	430	34	m.	m.	PROPN
aji-161	430	35	d.	d.	PROPN
aji-161	430	36	(	(	PUNCT
aji-161	430	37	2014	2014	NUM
aji-161	430	38	)	)	PUNCT
aji-161	430	39	.	.	PUNCT
aji-161	431	1	a	a	DET
aji-161	431	2	novel	novel	ADJ
aji-161	431	3	utility	utility	NOUN
aji-161	431	4	for	for	ADP
aji-161	431	5	an	an	DET
aji-161	431	6	old	old	ADJ
aji-161	431	7	method	method	NOUN
aji-161	431	8	:	:	PUNCT
aji-161	431	9	the	the	DET
aji-161	431	10	leukocyte	leukocyte	NOUN
aji-161	431	11	adherence	adherence	NOUN
aji-161	431	12	inhibition	inhibition	NOUN
aji-161	431	13	test	test	NOUN
aji-161	431	14	is	be	AUX
aji-161	431	15	an	an	DET
aji-161	431	16	easy	easy	ADJ
aji-161	431	17	way	way	NOUN
aji-161	431	18	to	to	PART
aji-161	431	19	detect	detect	VERB
aji-161	431	20	the	the	DET
aji-161	431	21	immunoreactive	immunoreactive	ADJ
aji-161	431	22	interference	interference	NOUN
aji-161	431	23	of	of	ADP
aji-161	431	24	the	the	DET
aji-161	431	25	collection	collection	NOUN
aji-161	431	26	tube	tube	NOUN
aji-161	431	27	anticoagulant	anticoagulant	NOUN
aji-161	431	28	on	on	ADP
aji-161	431	29	cellular	cellular	ADJ
aji-161	431	30	immunoassays	immunoassay	NOUN
aji-161	431	31	.	.	PUNCT
aji-161	432	1	journal	journal	NOUN
aji-161	432	2	of	of	ADP
aji-161	432	3	cell	cell	NOUN
aji-161	432	4	adhesion	adhesion	NOUN
aji-161	432	5	,	,	PUNCT
aji-161	432	6	article	article	NOUN
aji-161	432	7	i	i	PROPN
aji-161	432	8	d	d	PROPN
aji-161	432	9	860427	860427	NUM
aji-161	432	10	.	.	PUNCT
aji-161	433	1	http://dx.doi.org/10.1155/2014/860427	http://dx.doi.org/10.1155/2014/860427	PROPN
aji-161	433	2	patterson	patterson	PROPN
aji-161	433	3	,	,	PUNCT
aji-161	433	4	r.	r.	PROPN
aji-161	433	5	,	,	PUNCT
aji-161	433	6	dykewicz	dykewicz	PROPN
aji-161	433	7	,	,	PUNCT
aji-161	433	8	m.	m.	NOUN
aji-161	433	9	s.	s.	PROPN
aji-161	433	10	,	,	PUNCT
aji-161	433	11	evans	evans	PROPN
aji-161	433	12	,	,	PUNCT
aji-161	433	13	r.	r.	PROPN
aji-161	433	14	,	,	PUNCT
aji-161	433	15	3rd	3rd	NOUN
aji-161	433	16	,	,	PUNCT
aji-161	433	17	grammer	grammer	PROPN
aji-161	433	18	,	,	PUNCT
aji-161	433	19	l.	l.	PROPN
aji-161	433	20	c.	c.	PROPN
aji-161	433	21	,	,	PUNCT
aji-161	433	22	greenberger	greenberger	NOUN
aji-161	433	23	,	,	PUNCT
aji-161	433	24	p.	p.	PROPN
aji-161	433	25	a.	a.	PROPN
aji-161	433	26	,	,	PUNCT
aji-161	433	27	harris	harris	PROPN
aji-161	433	28	,	,	PUNCT
aji-161	433	29	k.	k.	PROPN
aji-161	433	30	e.	e.	PROPN
aji-161	433	31	,	,	PUNCT
aji-161	433	32	et	et	PROPN
aji-161	433	33	al	al	PROPN
aji-161	433	34	.	.	PUNCT
aji-161	433	35	(	(	PUNCT
aji-161	433	36	1989	1989	NUM
aji-161	433	37	)	)	PUNCT
aji-161	433	38	.	.	PUNCT
aji-161	434	1	igg	igg	NOUN
aji-161	434	2	antibody	antibody	NOUN
aji-161	434	3	against	against	ADP
aji-161	434	4	formaldehyde	formaldehyde	NOUN
aji-161	434	5	human	human	ADJ
aji-161	434	6	serum	serum	NOUN
aji-161	434	7	proteins	protein	NOUN
aji-161	434	8	:	:	PUNCT
aji-161	434	9	a	a	DET
aji-161	434	10	comparison	comparison	NOUN
aji-161	434	11	with	with	ADP
aji-161	434	12	other	other	ADJ
aji-161	434	13	igg	igg	PROPN
aji-161	434	14	antibodies	antibody	NOUN
aji-161	434	15	against	against	ADP
aji-161	434	16	inhalant	inhalant	NOUN
aji-161	434	17	proteins	protein	NOUN
aji-161	434	18	and	and	CCONJ
aji-161	434	19	reactive	reactive	ADJ
aji-161	434	20	chemicals	chemical	NOUN
aji-161	434	21	.	.	PUNCT
aji-161	435	1	the	the	DET
aji-161	435	2	journal	journal	PROPN
aji-161	435	3	of	of	ADP
aji-161	435	4	allergy	allergy	NOUN
aji-161	435	5	and	and	CCONJ
aji-161	435	6	clinical	clinical	ADJ
aji-161	435	7	immunology	immunology	NOUN
aji-161	435	8	,	,	PUNCT
aji-161	435	9	84(3	84(3	NUM
aji-161	435	10	)	)	PUNCT
aji-161	435	11	,	,	PUNCT
aji-161	435	12	359–366	359–366	NUM
aji-161	435	13	.	.	PUNCT
aji-161	436	1	patterson	patterson	PROPN
aji-161	436	2	,	,	PUNCT
aji-161	436	3	r.	r.	PROPN
aji-161	436	4	,	,	PUNCT
aji-161	436	5	pateras	pateras	PROPN
aji-161	436	6	,	,	PUNCT
aji-161	436	7	v.	v.	PROPN
aji-161	436	8	,	,	PUNCT
aji-161	436	9	grammer	grammer	PROPN
aji-161	436	10	,	,	PUNCT
aji-161	436	11	l.	l.	PROPN
aji-161	436	12	c.	c.	PROPN
aji-161	436	13	,	,	PUNCT
aji-161	436	14	&	&	CCONJ
aji-161	436	15	harris	harris	PROPN
aji-161	436	16	,	,	PUNCT
aji-161	436	17	k.	k.	PROPN
aji-161	436	18	e.	e.	PROPN
aji-161	436	19	(	(	PUNCT
aji-161	436	20	1986	1986	NUM
aji-161	436	21	)	)	PUNCT
aji-161	436	22	.	.	PUNCT
aji-161	437	1	human	human	ADJ
aji-161	437	2	antibodies	antibody	NOUN
aji-161	437	3	against	against	ADP
aji-161	437	4	formaldehyde	formaldehyde	NOUN
aji-161	437	5	-	-	PUNCT
aji-161	437	6	human	human	NOUN
aji-161	437	7	serum	serum	NOUN
aji-161	437	8	albumin	albumin	ADJ
aji-161	437	9	conjugates	conjugate	NOUN
aji-161	437	10	or	or	CCONJ
aji-161	437	11	human	human	ADJ
aji-161	437	12	serum	serum	NOUN
aji-161	437	13	albumin	albumin	NOUN
aji-161	437	14	in	in	ADP
aji-161	437	15	individuals	individual	NOUN
aji-161	437	16	exposed	expose	VERB
aji-161	437	17	to	to	ADP
aji-161	437	18	formaldehyde	formaldehyde	NOUN
aji-161	437	19	.	.	PUNCT
aji-161	438	1	international	international	ADJ
aji-161	438	2	archives	archive	NOUN
aji-161	438	3	of	of	ADP
aji-161	438	4	allergy	allergy	NOUN
aji-161	438	5	and	and	CCONJ
aji-161	438	6	applied	apply	VERB
aji-161	438	7	immunology	immunology	NOUN
aji-161	438	8	,	,	PUNCT
aji-161	438	9	79(1	79(1	NOUN
aji-161	438	10	)	)	PUNCT
aji-161	438	11	,	,	PUNCT
aji-161	438	12	53–59	53–59	NUM
aji-161	438	13	.	.	PUNCT
aji-161	438	14	pontén	pontén	PROPN
aji-161	438	15	,	,	PUNCT
aji-161	438	16	a.	a.	NOUN
aji-161	438	17	,	,	PUNCT
aji-161	438	18	&	&	CCONJ
aji-161	438	19	bruze	bruze	PROPN
aji-161	438	20	,	,	PUNCT
aji-161	438	21	m.	m.	NOUN
aji-161	438	22	(	(	PUNCT
aji-161	438	23	2015	2015	NUM
aji-161	438	24	)	)	PUNCT
aji-161	438	25	.	.	PUNCT
aji-161	439	1	formaldehyde	formaldehyde	NOUN
aji-161	439	2	.	.	PUNCT
aji-161	440	1	dermatitis	dermatitis	NOUN
aji-161	440	2	,	,	PUNCT
aji-161	440	3	26(1	26(1	NUM
aji-161	440	4	)	)	PUNCT
aji-161	440	5	,	,	PUNCT
aji-161	440	6	3–6	3–6	X
aji-161	440	7	.	.	PUNCT
aji-161	440	8	pougnet	pougnet	PROPN
aji-161	440	9	,	,	PUNCT
aji-161	440	10	r.	r.	PROPN
aji-161	440	11	,	,	PUNCT
aji-161	440	12	lucas	lucas	PROPN
aji-161	440	13	,	,	PUNCT
aji-161	440	14	d.	d.	PROPN
aji-161	440	15	,	,	PUNCT
aji-161	440	16	loddé	loddé	PROPN
aji-161	440	17	,	,	PUNCT
aji-161	440	18	b.	b.	PROPN
aji-161	440	19	,	,	PUNCT
aji-161	440	20	ouedraogo	ouedraogo	PROPN
aji-161	440	21	,	,	PUNCT
aji-161	440	22	s.	s.	PROPN
aji-161	440	23	,	,	PUNCT
aji-161	440	24	eniafe	eniafe	NOUN
aji-161	440	25	-	-	PUNCT
aji-161	440	26	eveillard	eveillard	NOUN
aji-161	440	27	,	,	PUNCT
aji-161	440	28	m.	m.	NOUN
aji-161	440	29	,	,	PUNCT
aji-161	440	30	&	&	CCONJ
aji-161	440	31	pougnet	pougnet	NOUN
aji-161	440	32	,	,	PUNCT
aji-161	440	33	l.	l.	PROPN
aji-161	440	34	(	(	PUNCT
aji-161	440	35	2025	2025	NUM
aji-161	440	36	)	)	PUNCT
aji-161	440	37	.	.	PUNCT
aji-161	441	1	[	[	X
aji-161	441	2	occupational	occupational	ADJ
aji-161	441	3	asthma	asthma	NOUN
aji-161	441	4	in	in	ADP
aji-161	441	5	a	a	DET
aji-161	441	6	laboratory	laboratory	NOUN
aji-161	441	7	technician	technician	NOUN
aji-161	441	8	]	]	X
aji-161	441	9	.	.	PUNCT
aji-161	442	1	annales	annales	PROPN
aji-161	442	2	de	de	PROPN
aji-161	442	3	biologie	biologie	NOUN
aji-161	442	4	clinique	clinique	NOUN
aji-161	442	5	(	(	PUNCT
aji-161	442	6	paris	paris	PROPN
aji-161	442	7	)	)	PUNCT
aji-161	442	8	,	,	PUNCT
aji-161	442	9	82(6	82(6	NUM
aji-161	442	10	)	)	PUNCT
aji-161	442	11	,	,	PUNCT
aji-161	442	12	0	0	X
aji-161	442	13	.	.	PUNCT
aji-161	442	14	rittenberg	rittenberg	PROPN
aji-161	442	15	,	,	PUNCT
aji-161	442	16	m.	m.	PROPN
aji-161	442	17	b.	b.	PROPN
aji-161	442	18	,	,	PUNCT
aji-161	442	19	&	&	CCONJ
aji-161	442	20	amkraut	amkraut	PROPN
aji-161	442	21	,	,	PUNCT
aji-161	442	22	a.	a.	NOUN
aji-161	442	23	a.	a.	NOUN
aji-161	442	24	(	(	PUNCT
aji-161	442	25	1966	1966	NUM
aji-161	442	26	)	)	PUNCT
aji-161	442	27	.	.	PUNCT
aji-161	443	1	immunogenicity	immunogenicity	NOUN
aji-161	443	2	of	of	ADP
aji-161	443	3	trinitrophenylhemocyanin	trinitrophenylhemocyanin	NOUN
aji-161	443	4	:	:	PUNCT
aji-161	443	5	production	production	NOUN
aji-161	443	6	of	of	ADP
aji-161	443	7	primary	primary	ADJ
aji-161	443	8	and	and	CCONJ
aji-161	443	9	secondary	secondary	ADJ
aji-161	443	10	anti	anti	ADJ
aji-161	443	11	-	-	ADJ
aji-161	443	12	hapten	hapten	ADJ
aji-161	443	13	precipitins	precipitin	NOUN
aji-161	443	14	.	.	PUNCT
aji-161	444	1	journal	journal	NOUN
aji-161	444	2	of	of	ADP
aji-161	444	3	immunology	immunology	NOUN
aji-161	444	4	,	,	PUNCT
aji-161	444	5	97(3	97(3	NUM
aji-161	444	6	)	)	PUNCT
aji-161	444	7	,	,	PUNCT
aji-161	444	8	421–430	421–430	NUM
aji-161	444	9	.	.	PUNCT
aji-161	445	1	søgaard	søgaard	PROPN
aji-161	445	2	,	,	PUNCT
aji-161	445	3	r.	r.	PROPN
aji-161	445	4	,	,	PUNCT
aji-161	445	5	poulsen	poulsen	VERB
aji-161	445	6	,	,	PUNCT
aji-161	445	7	p.	p.	PROPN
aji-161	445	8	b.	b.	PROPN
aji-161	445	9	,	,	PUNCT
aji-161	445	10	gelardi	gelardi	PROPN
aji-161	445	11	,	,	PUNCT
aji-161	445	12	r.	r.	PROPN
aji-161	445	13	m.	m.	PROPN
aji-161	445	14	,	,	PUNCT
aji-161	445	15	geschke	geschke	PROPN
aji-161	445	16	,	,	PUNCT
aji-161	445	17	s.	s.	PROPN
aji-161	445	18	,	,	PUNCT
aji-161	445	19	schwensen	schwensen	PROPN
aji-161	445	20	,	,	PUNCT
aji-161	445	21	j.	j.	PROPN
aji-161	445	22	f.	f.	PROPN
aji-161	445	23	b.	b.	PROPN
aji-161	445	24	,	,	PUNCT
aji-161	445	25	&	&	CCONJ
aji-161	445	26	johansen	johansen	PROPN
aji-161	445	27	,	,	PUNCT
aji-161	445	28	j.	j.	PROPN
aji-161	445	29	d.	d.	PROPN
aji-161	445	30	(	(	PUNCT
aji-161	445	31	2024	2024	NUM
aji-161	445	32	)	)	PUNCT
aji-161	445	33	.	.	PUNCT
aji-161	446	1	hidden	hide	VERB
aji-161	446	2	formaldehyde	formaldehyde	NOUN
aji-161	446	3	in	in	ADP
aji-161	446	4	cosmetic	cosmetic	ADJ
aji-161	446	5	products	product	NOUN
aji-161	446	6	.	.	PUNCT
aji-161	447	1	contact	contact	PROPN
aji-161	447	2	dermatitis	dermatitis	PROPN
aji-161	447	3	,	,	PUNCT
aji-161	447	4	91(6	91(6	NOUN
aji-161	447	5	)	)	PUNCT
aji-161	447	6	,	,	PUNCT
aji-161	447	7	497–502	497–502	PROPN
aji-161	447	8	.	.	PUNCT
aji-161	448	1	sompuram	sompuram	PROPN
aji-161	448	2	,	,	PUNCT
aji-161	448	3	s.	s.	PROPN
aji-161	448	4	r.	r.	PROPN
aji-161	448	5	,	,	PUNCT
aji-161	448	6	vani	vani	PROPN
aji-161	448	7	,	,	PUNCT
aji-161	448	8	k.	k.	PROPN
aji-161	448	9	,	,	PUNCT
aji-161	448	10	messana	messana	PROPN
aji-161	448	11	,	,	PUNCT
aji-161	448	12	e.	e.	PROPN
aji-161	448	13	,	,	PUNCT
aji-161	448	14	&	&	CCONJ
aji-161	448	15	bogen	bogen	PROPN
aji-161	448	16	,	,	PUNCT
aji-161	448	17	s.	s.	PROPN
aji-161	448	18	a.	a.	PROPN
aji-161	448	19	(	(	PUNCT
aji-161	448	20	2004	2004	NUM
aji-161	448	21	)	)	PUNCT
aji-161	448	22	.	.	PUNCT
aji-161	449	1	a	a	DET
aji-161	449	2	molecular	molecular	ADJ
aji-161	449	3	mechanism	mechanism	NOUN
aji-161	449	4	of	of	ADP
aji-161	449	5	formalin	formalin	NOUN
aji-161	449	6	fixation	fixation	NOUN
aji-161	449	7	and	and	CCONJ
aji-161	449	8	antigen	antigen	ADJ
aji-161	449	9	retrieval	retrieval	NOUN
aji-161	449	10	.	.	PUNCT
aji-161	450	1	american	american	ADJ
aji-161	450	2	journal	journal	PROPN
aji-161	450	3	of	of	ADP
aji-161	450	4	clinical	clinical	ADJ
aji-161	450	5	pathology	pathology	NOUN
aji-161	450	6	,	,	PUNCT
aji-161	450	7	121(2	121(2	NUM
aji-161	450	8	)	)	PUNCT
aji-161	450	9	,	,	PUNCT
aji-161	450	10	190–199	190–199	NUM
aji-161	450	11	.	.	PUNCT
aji-161	450	12	thrasher	thrasher	NOUN
aji-161	450	13	,	,	PUNCT
aji-161	450	14	j.	j.	PROPN
aji-161	450	15	d.	d.	PROPN
aji-161	450	16	,	,	PUNCT
aji-161	450	17	broughton	broughton	PROPN
aji-161	450	18	,	,	PUNCT
aji-161	450	19	a.	a.	PROPN
aji-161	450	20	,	,	PUNCT
aji-161	450	21	&	&	CCONJ
aji-161	450	22	micevich	micevich	PROPN
aji-161	450	23	,	,	PUNCT
aji-161	450	24	p.	p.	PROPN
aji-161	450	25	(	(	PUNCT
aji-161	450	26	1988	1988	NUM
aji-161	450	27	)	)	PUNCT
aji-161	450	28	.	.	PUNCT
aji-161	451	1	antibodies	antibodie	VERB
aji-161	451	2	and	and	CCONJ
aji-161	451	3	immune	immune	ADJ
aji-161	451	4	profiles	profile	NOUN
aji-161	451	5	of	of	ADP
aji-161	451	6	individuals	individual	NOUN
aji-161	451	7	occupationally	occupationally	ADV
aji-161	451	8	exposed	expose	VERB
aji-161	451	9	to	to	ADP
aji-161	451	10	formaldehyde	formaldehyde	NOUN
aji-161	451	11	:	:	PUNCT
aji-161	451	12	six	six	NUM
aji-161	451	13	case	case	NOUN
aji-161	451	14	reports	report	VERB
aji-161	451	15	.	.	PUNCT
aji-161	452	1	american	american	ADJ
aji-161	452	2	journal	journal	PROPN
aji-161	452	3	of	of	ADP
aji-161	452	4	industrial	industrial	ADJ
aji-161	452	5	medicine	medicine	NOUN
aji-161	452	6	,	,	PUNCT
aji-161	452	7	14(4	14(4	NUM
aji-161	452	8	)	)	PUNCT
aji-161	452	9	,	,	PUNCT
aji-161	452	10	479	479	NUM
aji-161	452	11	–	–	PUNCT
aji-161	452	12	488	488	NUM
aji-161	452	13	.	.	PUNCT
aji-161	453	1	veien	veien	PROPN
aji-161	453	2	,	,	PUNCT
aji-161	453	3	n.	n.	PROPN
aji-161	453	4	k.	k.	PROPN
aji-161	453	5	,	,	PUNCT
aji-161	453	6	&	&	CCONJ
aji-161	453	7	lomholt	lomholt	PROPN
aji-161	453	8	,	,	PUNCT
aji-161	453	9	h.	h.	PROPN
aji-161	453	10	b.	b.	PROPN
aji-161	453	11	(	(	PUNCT
aji-161	453	12	2012	2012	NUM
aji-161	453	13	)	)	PUNCT
aji-161	453	14	.	.	PUNCT
aji-161	454	1	systemic	systemic	ADJ
aji-161	454	2	allergic	allergic	ADJ
aji-161	454	3	dermatitis	dermatitis	NOUN
aji-161	454	4	presumably	presumably	ADV
aji-161	454	5	caused	cause	VERB
aji-161	454	6	by	by	ADP
aji-161	454	7	formaldehyde	formaldehyde	NOUN
aji-161	454	8	derived	derive	VERB
aji-161	454	9	from	from	ADP
aji-161	454	10	aspartame	aspartame	PROPN
aji-161	454	11	.	.	PUNCT
aji-161	455	1	contact	contact	PROPN
aji-161	455	2	dermatitis	dermatitis	PROPN
aji-161	455	3	,	,	PUNCT
aji-161	455	4	67(5	67(5	NUM
aji-161	455	5	)	)	PUNCT
aji-161	455	6	,	,	PUNCT
aji-161	455	7	315–316	315–316	NUM
aji-161	455	8	.	.	PUNCT
aji-161	455	9	walker	walker	PROPN
aji-161	455	10	,	,	PUNCT
aji-161	455	11	j.	j.	PROPN
aji-161	455	12	f.	f.	PROPN
aji-161	455	13	(	(	PUNCT
aji-161	455	14	1964	1964	NUM
aji-161	455	15	)	)	PUNCT
aji-161	455	16	.	.	PUNCT
aji-161	456	1	formaldehyde	formaldehyde	NOUN
aji-161	456	2	production	production	NOUN
aji-161	456	3	chapter	chapter	NOUN
aji-161	456	4	1	1	NUM
aji-161	456	5	,	,	PUNCT
aji-161	456	6	formaldehyde	formaldehyde	NOUN
aji-161	456	7	(	(	PUNCT
aji-161	456	8	3rd	3rd	ADJ
aji-161	456	9	ed	ed	NOUN
aji-161	456	10	.	.	PUNCT
aji-161	456	11	)	)	PUNCT
aji-161	456	12	.	.	PUNCT
aji-161	457	1	new	new	PROPN
aji-161	457	2	york	york	PROPN
aji-161	457	3	:	:	PUNCT
aji-161	457	4	robert	robert	PROPN
aji-161	457	5	e.	e.	PROPN
aji-161	457	6	krieger	krieger	PROPN
aji-161	457	7	publishing	publishing	PROPN
aji-161	457	8	corp	corp	PROPN
aji-161	457	9	.	.	PROPN
aji-161	457	10	olivier	olivier	PROPN
aji-161	457	11	et	et	PROPN
aji-161	457	12	al	al	PROPN
aji-161	457	13	.	.	PROPN
aji-161	457	14	;	;	PUNCT
aji-161	457	15	asian	asian	PROPN
aji-161	457	16	j.	j.	PROPN
aji-161	457	17	immunol	immunol	PROPN
aji-161	457	18	.	.	PROPN
aji-161	457	19	,	,	PUNCT
aji-161	457	20	vol	vol	NOUN
aji-161	457	21	.	.	PROPN
aji-161	457	22	8	8	NUM
aji-161	457	23	,	,	PUNCT
aji-161	457	24	no	no	INTJ
aji-161	457	25	.	.	NOUN
aji-161	457	26	1	1	NUM
aji-161	457	27	,	,	PUNCT
aji-161	457	28	pp	pp	ADJ
aji-161	457	29	.	.	PUNCT
aji-161	458	1	70	70	NUM
aji-161	458	2	-	-	SYM
aji-161	458	3	81	81	NUM
aji-161	458	4	,	,	PUNCT
aji-161	458	5	2025	2025	NUM
aji-161	458	6	;	;	PUNCT
aji-161	458	7	article	article	NOUN
aji-161	458	8	no.aji.134825	no.aji.134825	X
aji-161	458	9	81	81	NUM
aji-161	458	10	disponible	disponible	ADJ
aji-161	458	11	at	at	ADP
aji-161	458	12	internet	internet	NOUN
aji-161	458	13	archive	archive	NOUN
aji-161	458	14	:	:	PUNCT
aji-161	458	15	https://archive.org/details/formaldehyde00	https://archive.org/details/formaldehyde00	PROPN
aji-161	458	16	00walk	00walk	VERB
aji-161	458	17	wantke	wantke	PROPN
aji-161	458	18	,	,	PUNCT
aji-161	458	19	f.	f.	PROPN
aji-161	458	20	,	,	PUNCT
aji-161	458	21	demmer	demmer	NOUN
aji-161	458	22	,	,	PUNCT
aji-161	458	23	c.	c.	NOUN
aji-161	458	24	m.	m.	NOUN
aji-161	458	25	,	,	PUNCT
aji-161	458	26	tappler	tappler	NOUN
aji-161	458	27	,	,	PUNCT
aji-161	458	28	p.	p.	NOUN
aji-161	458	29	,	,	PUNCT
aji-161	458	30	götz	götz	NOUN
aji-161	458	31	,	,	PUNCT
aji-161	458	32	m.	m.	NOUN
aji-161	458	33	,	,	PUNCT
aji-161	458	34	&	&	CCONJ
aji-161	458	35	jarisch	jarisch	PROPN
aji-161	458	36	,	,	PUNCT
aji-161	458	37	r.	r.	PROPN
aji-161	458	38	(	(	PUNCT
aji-161	458	39	1996a	1996a	NUM
aji-161	458	40	)	)	PUNCT
aji-161	458	41	.	.	PUNCT
aji-161	459	1	exposure	exposure	NOUN
aji-161	459	2	to	to	ADP
aji-161	459	3	gaseous	gaseous	ADJ
aji-161	459	4	formaldehyde	formaldehyde	NOUN
aji-161	459	5	induces	induce	NOUN
aji-161	459	6	igemediated	igemediate	VERB
aji-161	459	7	sensitization	sensitization	NOUN
aji-161	459	8	to	to	ADP
aji-161	459	9	formaldehyde	formaldehyde	NOUN
aji-161	459	10	in	in	ADP
aji-161	459	11	school	school	NOUN
aji-161	459	12	-	-	PUNCT
aji-161	459	13	children	child	NOUN
aji-161	459	14	.	.	PUNCT
aji-161	460	1	clinical	clinical	ADJ
aji-161	460	2	and	and	CCONJ
aji-161	460	3	experimental	experimental	ADJ
aji-161	460	4	allergy	allergy	NOUN
aji-161	460	5	,	,	PUNCT
aji-161	460	6	26(3	26(3	NUM
aji-161	460	7	)	)	PUNCT
aji-161	460	8	,	,	PUNCT
aji-161	460	9	276–280	276–280	NUM
aji-161	460	10	.	.	PUNCT
aji-161	460	11	wantke	wantke	PROPN
aji-161	460	12	,	,	PUNCT
aji-161	460	13	f.	f.	PROPN
aji-161	460	14	,	,	PUNCT
aji-161	460	15	focke	focke	PROPN
aji-161	460	16	,	,	PUNCT
aji-161	460	17	m.	m.	NOUN
aji-161	460	18	,	,	PUNCT
aji-161	460	19	hemmer	hemmer	PROPN
aji-161	460	20	,	,	PUNCT
aji-161	460	21	w.	w.	PROPN
aji-161	460	22	,	,	PUNCT
aji-161	460	23	tschabitscher	tschabitscher	NOUN
aji-161	460	24	,	,	PUNCT
aji-161	460	25	m.	m.	NOUN
aji-161	460	26	,	,	PUNCT
aji-161	460	27	gann	gann	PROPN
aji-161	460	28	,	,	PUNCT
aji-161	460	29	m.	m.	NOUN
aji-161	460	30	,	,	PUNCT
aji-161	460	31	tappler	tappler	NOUN
aji-161	460	32	,	,	PUNCT
aji-161	460	33	p.	p.	PROPN
aji-161	460	34	,	,	PUNCT
aji-161	460	35	et	et	PROPN
aji-161	460	36	al	al	PROPN
aji-161	460	37	.	.	PUNCT
aji-161	460	38	(	(	PUNCT
aji-161	460	39	1996b	1996b	NUM
aji-161	460	40	)	)	PUNCT
aji-161	460	41	.	.	PUNCT
aji-161	461	1	formaldehyde	formaldehyde	NOUN
aji-161	461	2	and	and	CCONJ
aji-161	461	3	phenol	phenol	NOUN
aji-161	461	4	exposure	exposure	NOUN
aji-161	461	5	during	during	ADP
aji-161	461	6	an	an	DET
aji-161	461	7	anatomy	anatomy	NOUN
aji-161	461	8	dissection	dissection	NOUN
aji-161	461	9	course	course	NOUN
aji-161	461	10	:	:	PUNCT
aji-161	461	11	a	a	DET
aji-161	461	12	possible	possible	ADJ
aji-161	461	13	source	source	NOUN
aji-161	461	14	of	of	ADP
aji-161	461	15	ige	ige	NOUN
aji-161	461	16	-	-	PUNCT
aji-161	461	17	mediated	mediate	VERB
aji-161	461	18	sensitization	sensitization	NOUN
aji-161	461	19	?	?	PUNCT
aji-161	462	1	allergy	allergy	NOUN
aji-161	462	2	,	,	PUNCT
aji-161	462	3	51(11	51(11	NUM
aji-161	462	4	)	)	PUNCT
aji-161	462	5	,	,	PUNCT
aji-161	462	6	837–841	837–841	NUM
aji-161	462	7	.	.	PUNCT
aji-161	463	1	williams	williams	PROPN
aji-161	463	2	,	,	PUNCT
aji-161	463	3	c.	c.	PROPN
aji-161	463	4	a.	a.	PROPN
aji-161	463	5	,	,	PUNCT
aji-161	463	6	&	&	CCONJ
aji-161	463	7	chase	chase	PROPN
aji-161	463	8	,	,	PUNCT
aji-161	463	9	m.	m.	NOUN
aji-161	463	10	w.	w.	PROPN
aji-161	463	11	(	(	PUNCT
aji-161	463	12	1971	1971	NUM
aji-161	463	13	)	)	PUNCT
aji-161	463	14	.	.	PUNCT
aji-161	464	1	chapter	chapter	NOUN
aji-161	464	2	13	13	NUM
aji-161	464	3	precipitation	precipitation	NOUN
aji-161	464	4	reactions	reaction	NOUN
aji-161	464	5	,	,	PUNCT
aji-161	464	6	reactions	reaction	NOUN
aji-161	464	7	of	of	ADP
aji-161	464	8	antibodies	antibody	NOUN
aji-161	464	9	with	with	ADP
aji-161	464	10	soluble	soluble	ADJ
aji-161	464	11	antigens	antigen	NOUN
aji-161	464	12	.	.	PUNCT
aji-161	465	1	in	in	ADP
aji-161	465	2	vol	vol	NOUN
aji-161	465	3	.	.	PROPN
aji-161	465	4	3	3	NUM
aji-161	465	5	(	(	PUNCT
aji-161	465	6	pp	pp	ADJ
aji-161	465	7	.	.	PUNCT
aji-161	465	8	1–102	1–102	NUM
aji-161	465	9	)	)	PUNCT
aji-161	465	10	.	.	PUNCT
aji-161	466	1	academic	academic	ADJ
aji-161	466	2	press	press	NOUN
aji-161	466	3	.	.	PUNCT
aji-161	467	1	world	world	PROPN
aji-161	467	2	medical	medical	PROPN
aji-161	467	3	association	association	PROPN
aji-161	467	4	(	(	PUNCT
aji-161	467	5	wma	wma	NOUN
aji-161	467	6	)	)	PUNCT
aji-161	467	7	.	.	PUNCT
aji-161	468	1	(	(	PUNCT
aji-161	468	2	2013	2013	NUM
aji-161	468	3	)	)	PUNCT
aji-161	468	4	.	.	PUNCT
aji-161	469	1	world	world	PROPN
aji-161	469	2	medical	medical	PROPN
aji-161	469	3	association	association	PROPN
aji-161	469	4	declaration	declaration	PROPN
aji-161	469	5	of	of	ADP
aji-161	469	6	helsinki	helsinki	PROPN
aji-161	469	7	:	:	PUNCT
aji-161	469	8	ethical	ethical	ADJ
aji-161	469	9	principles	principle	NOUN
aji-161	469	10	for	for	ADP
aji-161	469	11	medical	medical	ADJ
aji-161	469	12	research	research	NOUN
aji-161	469	13	involving	involve	VERB
aji-161	469	14	human	human	ADJ
aji-161	469	15	subjects	subject	NOUN
aji-161	469	16	.	.	PUNCT
aji-161	470	1	jama	jama	PROPN
aji-161	470	2	,	,	PUNCT
aji-161	470	3	310(20	310(20	NUM
aji-161	470	4	)	)	PUNCT
aji-161	470	5	,	,	PUNCT
aji-161	470	6	2191–2194	2191–2194	NUM
aji-161	470	7	.	.	PUNCT
aji-161	471	1	yoon	yoon	PROPN
aji-161	471	2	,	,	PUNCT
aji-161	471	3	y.	y.	PROPN
aji-161	471	4	,	,	PUNCT
aji-161	471	5	&	&	CCONJ
aji-161	471	6	bunyavanich	bunyavanich	PROPN
aji-161	471	7	,	,	PUNCT
aji-161	471	8	s.	s.	PROPN
aji-161	471	9	(	(	PUNCT
aji-161	471	10	2025	2025	NUM
aji-161	471	11	)	)	PUNCT
aji-161	471	12	.	.	PUNCT
aji-161	472	1	multi	multi	ADJ
aji-161	472	2	-	-	ADJ
aji-161	472	3	omic	omic	ADJ
aji-161	472	4	approaches	approach	NOUN
aji-161	472	5	for	for	ADP
aji-161	472	6	endotype	endotype	NOUN
aji-161	472	7	discovery	discovery	NOUN
aji-161	472	8	in	in	ADP
aji-161	472	9	allergy	allergy	NOUN
aji-161	472	10	/	/	SYM
aji-161	472	11	immunology	immunology	NOUN
aji-161	472	12	.	.	PUNCT
aji-161	473	1	journal	journal	PROPN
aji-161	473	2	of	of	ADP
aji-161	473	3	allergy	allergy	NOUN
aji-161	473	4	and	and	CCONJ
aji-161	473	5	clinical	clinical	ADJ
aji-161	473	6	immunology	immunology	NOUN
aji-161	473	7	.	.	PUNCT
aji-161	474	1	https://doi.org/10.1016/j.jaci.2024.12.062	https://doi.org/10.1016/j.jaci.2024.12.062	PROPN
aji-161	474	2	zhang	zhang	PROPN
aji-161	474	3	,	,	PUNCT
aji-161	474	4	c.	c.	PROPN
aji-161	474	5	,	,	PUNCT
aji-161	474	6	li	li	PROPN
aji-161	474	7	,	,	PUNCT
aji-161	474	8	x.	x.	PROPN
aji-161	474	9	,	,	PUNCT
aji-161	474	10	wu	wu	PROPN
aji-161	474	11	,	,	PUNCT
aji-161	474	12	x.	x.	PROPN
aji-161	474	13	,	,	PUNCT
aji-161	474	14	xiao	xiao	PROPN
aji-161	474	15	,	,	PUNCT
aji-161	474	16	j.	j.	PROPN
aji-161	474	17	,	,	PUNCT
aji-161	474	18	lian	lian	PROPN
aji-161	474	19	,	,	PUNCT
aji-161	474	20	h.	h.	PROPN
aji-161	474	21	,	,	PUNCT
aji-161	474	22	&	&	CCONJ
aji-161	474	23	chen	chen	PROPN
aji-161	474	24	,	,	PUNCT
aji-161	474	25	l.	l.	PROPN
aji-161	474	26	(	(	PUNCT
aji-161	474	27	2025	2025	NUM
aji-161	474	28	)	)	PUNCT
aji-161	474	29	.	.	PUNCT
aji-161	475	1	innovative	innovative	ADJ
aji-161	475	2	formaldehyde	formaldehyde	NOUN
aji-161	475	3	adsorption	adsorption	NOUN
aji-161	475	4	with	with	ADP
aji-161	475	5	optimized	optimize	VERB
aji-161	475	6	deep	deep	ADJ
aji-161	475	7	eutectic	eutectic	ADJ
aji-161	475	8	solvents	solvent	NOUN
aji-161	475	9	:	:	PUNCT
aji-161	475	10	an	an	DET
aji-161	475	11	experiment	experiment	NOUN
aji-161	475	12	and	and	CCONJ
aji-161	475	13	multilevel	multilevel	ADJ
aji-161	475	14	computational	computational	ADJ
aji-161	475	15	chemistry	chemistry	NOUN
aji-161	475	16	approach	approach	NOUN
aji-161	475	17	.	.	PUNCT
aji-161	476	1	environmental	environmental	ADJ
aji-161	476	2	research	research	NOUN
aji-161	476	3	,	,	PUNCT
aji-161	476	4	266	266	NUM
aji-161	476	5	,	,	PUNCT
aji-161	476	6	120593	120593	NUM
aji-161	476	7	.	.	PUNCT
aji-161	477	1	disclaimer	disclaimer	ADJ
aji-161	477	2	/	/	SYM
aji-161	477	3	publisher	publisher	NOUN
aji-161	477	4	’s	’s	PART
aji-161	477	5	note	note	NOUN
aji-161	477	6	:	:	PUNCT
aji-161	477	7	the	the	DET
aji-161	477	8	statements	statement	NOUN
aji-161	477	9	,	,	PUNCT
aji-161	477	10	opinions	opinion	NOUN
aji-161	477	11	and	and	CCONJ
aji-161	477	12	data	datum	NOUN
aji-161	477	13	contained	contain	VERB
aji-161	477	14	in	in	ADP
aji-161	477	15	all	all	DET
aji-161	477	16	publications	publication	NOUN
aji-161	477	17	are	be	AUX
aji-161	477	18	solely	solely	ADV
aji-161	477	19	those	those	PRON
aji-161	477	20	of	of	ADP
aji-161	477	21	the	the	DET
aji-161	477	22	individual	individual	ADJ
aji-161	477	23	author(s	author(s	PROPN
aji-161	477	24	)	)	PUNCT
aji-161	477	25	and	and	CCONJ
aji-161	477	26	contributor(s	contributor(s	NOUN
aji-161	477	27	)	)	PUNCT
aji-161	477	28	and	and	CCONJ
aji-161	477	29	not	not	PART
aji-161	477	30	of	of	ADP
aji-161	477	31	the	the	DET
aji-161	477	32	publisher	publisher	NOUN
aji-161	477	33	and/or	and/or	CCONJ
aji-161	477	34	the	the	DET
aji-161	477	35	editor(s	editor(s	NOUN
aji-161	477	36	)	)	PUNCT
aji-161	477	37	.	.	PUNCT
aji-161	478	1	this	this	DET
aji-161	478	2	publisher	publisher	NOUN
aji-161	478	3	and/or	and/or	CCONJ
aji-161	478	4	the	the	DET
aji-161	478	5	editor(s	editor(s	NOUN
aji-161	478	6	)	)	PUNCT
aji-161	478	7	disclaim	disclaim	VERB
aji-161	478	8	responsibility	responsibility	NOUN
aji-161	478	9	for	for	ADP
aji-161	478	10	any	any	DET
aji-161	478	11	injury	injury	NOUN
aji-161	478	12	to	to	ADP
aji-161	478	13	people	people	NOUN
aji-161	478	14	or	or	CCONJ
aji-161	478	15	property	property	NOUN
aji-161	478	16	resulting	result	VERB
aji-161	478	17	from	from	ADP
aji-161	478	18	any	any	DET
aji-161	478	19	ideas	idea	NOUN
aji-161	478	20	,	,	PUNCT
aji-161	478	21	methods	method	NOUN
aji-161	478	22	,	,	PUNCT
aji-161	478	23	instructions	instruction	NOUN
aji-161	478	24	or	or	CCONJ
aji-161	478	25	products	product	NOUN
aji-161	478	26	referred	refer	VERB
aji-161	478	27	to	to	ADP
aji-161	478	28	in	in	ADP
aji-161	478	29	the	the	DET
aji-161	478	30	content	content	NOUN
aji-161	478	31	.	.	PUNCT
aji-161	479	1	_	_	PUNCT
aji-161	480	1	_	_	PUNCT
aji-161	481	1	_	_	PUNCT
aji-161	482	1	_	_	PUNCT
aji-161	483	1	_	_	PUNCT
aji-161	484	1	_	_	PUNCT
aji-161	485	1	_	_	PUNCT
aji-161	486	1	_	_	PUNCT
aji-161	487	1	_	_	PUNCT
aji-161	488	1	_	_	PUNCT
aji-161	489	1	_	_	PUNCT
aji-161	490	1	_	_	PUNCT
aji-161	491	1	_	_	PUNCT
aji-161	492	1	_	_	PUNCT
aji-161	493	1	_	_	PUNCT
aji-161	494	1	_	_	PUNCT
aji-161	495	1	_	_	PUNCT
aji-161	496	1	_	_	PUNCT
aji-161	497	1	_	_	PUNCT
aji-161	498	1	_	_	PUNCT
aji-161	499	1	_	_	PUNCT
aji-161	500	1	_	_	PUNCT
aji-161	501	1	_	_	PUNCT
aji-161	502	1	_	_	PUNCT
aji-161	503	1	_	_	PUNCT
aji-161	504	1	_	_	PUNCT
aji-161	505	1	_	_	PUNCT
aji-161	506	1	_	_	PUNCT
aji-161	507	1	_	_	PUNCT
aji-161	508	1	_	_	PUNCT
aji-161	509	1	_	_	PUNCT
aji-161	510	1	_	_	PUNCT
aji-161	511	1	_	_	PUNCT
aji-161	512	1	_	_	PUNCT
aji-161	513	1	_	_	PUNCT
aji-161	514	1	_	_	PUNCT
aji-161	515	1	_	_	PUNCT
aji-161	516	1	_	_	PUNCT
aji-161	517	1	_	_	PUNCT
aji-161	518	1	_	_	PUNCT
aji-161	519	1	_	_	PUNCT
aji-161	520	1	_	_	PUNCT
aji-161	521	1	_	_	PUNCT
aji-161	522	1	_	_	PUNCT
aji-161	523	1	_	_	PUNCT
aji-161	524	1	_	_	PUNCT
aji-161	525	1	_	_	PUNCT
aji-161	526	1	_	_	PUNCT
aji-161	527	1	_	_	PUNCT
aji-161	528	1	_	_	PUNCT
aji-161	529	1	_	_	PUNCT
aji-161	530	1	_	_	PUNCT
aji-161	531	1	_	_	PUNCT
aji-161	532	1	_	_	PUNCT
aji-161	533	1	_	_	PUNCT
aji-161	534	1	_	_	PUNCT
aji-161	535	1	_	_	PUNCT
aji-161	536	1	_	_	PUNCT
aji-161	537	1	_	_	PUNCT
aji-161	538	1	_	_	PUNCT
aji-161	539	1	_	_	PUNCT
aji-161	540	1	_	_	PUNCT
aji-161	541	1	_	_	PUNCT
aji-161	542	1	_	_	PUNCT
aji-161	543	1	_	_	PUNCT
aji-161	544	1	_	_	PUNCT
aji-161	545	1	_	_	PUNCT
aji-161	546	1	_	_	PUNCT
aji-161	547	1	_	_	PUNCT
aji-161	548	1	_	_	PUNCT
aji-161	549	1	_	_	PUNCT
aji-161	550	1	_	_	PUNCT
aji-161	551	1	_	_	PUNCT
aji-161	552	1	_	_	PUNCT
aji-161	553	1	_	_	PUNCT
aji-161	554	1	_	_	PUNCT
aji-161	555	1	_	_	PUNCT
aji-161	556	1	_	_	PUNCT
aji-161	557	1	_	_	PUNCT
aji-161	558	1	_	_	PUNCT
aji-161	559	1	_	_	PUNCT
aji-161	560	1	©	©	PRON
aji-161	560	2	copyright	copyright	NOUN
aji-161	560	3	(	(	PUNCT
aji-161	560	4	2025	2025	NUM
aji-161	560	5	):	):	PUNCT
aji-161	560	6	author(s	author(s	NOUN
aji-161	560	7	)	)	PUNCT
aji-161	560	8	.	.	PUNCT
aji-161	561	1	the	the	DET
aji-161	561	2	licensee	licensee	NOUN
aji-161	561	3	is	be	AUX
aji-161	561	4	the	the	DET
aji-161	561	5	journal	journal	PROPN
aji-161	561	6	publisher	publisher	NOUN
aji-161	561	7	.	.	PUNCT
aji-161	562	1	this	this	PRON
aji-161	562	2	is	be	AUX
aji-161	562	3	an	an	DET
aji-161	562	4	open	open	ADJ
aji-161	562	5	access	access	NOUN
aji-161	562	6	article	article	NOUN
aji-161	562	7	distributed	distribute	VERB
aji-161	562	8	under	under	ADP
aji-161	562	9	the	the	DET
aji-161	562	10	terms	term	NOUN
aji-161	562	11	of	of	ADP
aji-161	562	12	the	the	DET
aji-161	562	13	creative	creative	ADJ
aji-161	562	14	commons	common	NOUN
aji-161	562	15	attribution	attribution	NOUN
aji-161	562	16	license	license	NOUN
aji-161	562	17	(	(	PUNCT
aji-161	562	18	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN
aji-161	562	19	)	)	PUNCT
aji-161	562	20	,	,	PUNCT
aji-161	562	21	which	which	PRON
aji-161	562	22	permits	permit	VERB
aji-161	562	23	unrestricted	unrestricted	ADJ
aji-161	562	24	use	use	NOUN
aji-161	562	25	,	,	PUNCT
aji-161	562	26	distribution	distribution	NOUN
aji-161	562	27	,	,	PUNCT
aji-161	562	28	and	and	CCONJ
aji-161	562	29	reproduction	reproduction	NOUN
aji-161	562	30	in	in	ADP
aji-161	562	31	any	any	DET
aji-161	562	32	medium	medium	NOUN
aji-161	562	33	,	,	PUNCT
aji-161	562	34	provided	provide	VERB
aji-161	562	35	the	the	DET
aji-161	562	36	original	original	ADJ
aji-161	562	37	work	work	NOUN
aji-161	562	38	is	be	AUX
aji-161	562	39	properly	properly	ADV
aji-161	562	40	cited	cite	VERB
aji-161	562	41	.	.	PUNCT
aji-161	563	1	peer	peer	NOUN
aji-161	563	2	-	-	PUNCT
aji-161	563	3	review	review	NOUN
aji-161	563	4	history	history	NOUN
aji-161	563	5	:	:	PUNCT
aji-161	563	6	the	the	DET
aji-161	563	7	peer	peer	NOUN
aji-161	563	8	review	review	NOUN
aji-161	563	9	history	history	NOUN
aji-161	563	10	for	for	ADP
aji-161	563	11	this	this	DET
aji-161	563	12	paper	paper	NOUN
aji-161	563	13	can	can	AUX
aji-161	563	14	be	be	AUX
aji-161	563	15	accessed	access	VERB
aji-161	563	16	here	here	ADV
aji-161	563	17	:	:	PUNCT
aji-161	563	18	https://pr.sdiarticle5.com/review-history/134825	https://pr.sdiarticle5.com/review-history/134825	PROPN
aji-161	563	19	https://pr.sdiarticle5.com/review-history/134825	https://pr.sdiarticle5.com/review-history/134825	PROPN